data_6r5g_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6r5g _Structure_validation_residue.Date_analyzed 2020-01-31 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo . . . . . 0 CA--C 1.516 -0.38 0 CA-C-O 122.061 0.775 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.59 ' HB ' ' CG ' ' A' ' 113' ' ' PHE . 35.7 p -100.27 5.58 44.59 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.21 -176.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.8 m -75.26 58.73 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.515 0.674 . . . . 0.0 110.579 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.512 ' HG3' ' CZ2' ' A' ' 112' ' ' TRP . 81.5 mm-40 -129.65 -178.5 4.72 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.821 -176.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -84.71 -26.0 27.98 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -174.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.526 ' CZ2' ' HA ' ' A' ' 191' ' ' THR . 0.7 OUTLIER -85.71 -19.63 30.56 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -177.729 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.59 ' CG ' ' HB ' ' A' ' 108' ' ' THR . 72.2 t80 -81.45 123.76 28.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.012 0.434 . . . . 0.0 110.551 175.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -110.52 139.57 45.64 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.62 -88.87 0.03 OUTLIER Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.94 -0.648 . . . . 0.0 113.528 -174.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -100.52 106.63 18.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.03 0.443 . . . . 0.0 111.439 -175.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 64.0 mt -143.45 135.89 27.18 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.789 175.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.6 p -93.69 174.41 7.19 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -50.23 -54.3 20.17 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 121.558 -0.353 . . . . 0.0 113.856 -174.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 60.7 mmtt -77.99 -25.33 48.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 117.27 0.535 . . . . 0.0 111.87 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -65.33 -44.71 86.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.801 0.334 . . . . 0.0 110.627 175.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.463 ' HB1' ' HD3' ' A' ' 138' ' ' ARG . . . -64.11 -34.01 77.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.325 0.583 . . . . 0.0 110.494 176.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.544 ' HG3' ' HB ' ' A' ' 167' ' ' VAL . 16.3 tt0 -69.68 -48.36 59.99 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.962 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -56.47 -35.78 68.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.325 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.64 -51.52 69.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.273 177.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.535 ' CD2' HD13 ' A' ' 216' ' ' LEU . 27.7 mt -74.63 -46.41 38.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.687 -177.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.6 m -67.64 -33.01 74.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.029 -173.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -95.83 -48.27 5.81 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -100.14 -25.65 14.21 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -171.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -89.53 -159.75 35.76 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.573 -177.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -153.1 175.16 13.31 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -55.31 121.0 7.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.876 0.37 . . . . 0.0 111.275 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 99.54 -3.35 57.71 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.765 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.626 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 56.4 m -74.39 140.25 44.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.646 0.26 . . . . 0.0 110.503 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.492 ' CB ' HG13 ' A' ' 151' ' ' VAL . 52.3 p90 -137.45 149.02 46.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.165 177.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.513 ' CD2' ' HB2' ' A' ' 150' ' ' SER . 1.1 pt? -148.91 139.51 22.63 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 175.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 148' ' ' VAL . 10.1 m -104.23 145.04 13.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.463 ' HD3' ' HB1' ' A' ' 122' ' ' ALA . 26.4 ptt85 -146.29 168.21 21.63 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.867 -178.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -76.74 131.41 38.72 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 123.247 0.342 . . . . 0.0 110.63 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.6 t -72.39 137.12 46.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.522 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -98.02 -28.78 13.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.845 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 39.0 m -78.8 -34.1 45.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.027 0.442 . . . . 0.0 109.862 175.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -117.82 78.04 12.11 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.876 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.26 123.1 12.16 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.088 1.859 . . . . 0.0 111.72 -177.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 113.97 -16.68 20.46 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.608 -176.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -109.37 171.68 7.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.06 0.457 . . . . 0.0 110.29 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -123.45 163.6 20.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.604 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 33.3 m -134.11 143.05 39.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.152 0.501 . . . . 0.0 111.401 177.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.543 ' O ' HG13 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -101.86 111.09 23.22 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.225 177.516 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.537 ' HA ' ' HA ' ' A' ' 169' ' ' HIS . 1.2 m -104.17 131.71 51.18 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.592 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.492 HG13 ' CB ' ' A' ' 135' ' ' PHE . 32.7 m -130.57 152.08 36.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.456 -174.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -100.43 103.8 15.18 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.109 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 32.4 p -99.72 147.36 25.52 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.54 -177.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.502 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.15 -176.627 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.681 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.544 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 56.1 t -100.01 133.32 43.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.364 0.602 . . . . 0.0 111.724 -177.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.556 ' CG2' HD11 ' A' ' 210' ' ' LEU . 1.1 m -119.18 141.41 48.89 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.763 171.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 150' ' ' SER . 13.4 m-70 -108.24 138.17 44.97 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.543 HG13 ' O ' ' A' ' 149' ' ' LEU . 1.2 m -114.35 138.62 43.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 41.2 tpp -81.91 126.71 32.23 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.878 0.37 . . . . 0.0 111.213 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 32.6 mt -104.9 107.43 22.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.585 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 4.7 ptp180 -70.44 119.35 14.48 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.023 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . 0.661 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 49.7 t -118.11 93.36 4.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.165 0.507 . . . . 0.0 110.469 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -116.62 125.65 52.11 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.769 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 57.18 39.15 29.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.9 -176.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 82.9 mt 63.16 31.75 15.49 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.324 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.661 ' O ' ' HA ' ' A' ' 174' ' ' CYS . 11.9 tppt? -110.99 132.23 54.39 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.471 ' CD2' ' HG ' ' A' ' 190' ' ' LEU . 81.8 m-85 -111.83 135.09 52.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.585 0.231 . . . . 0.0 111.176 -174.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.585 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 18.4 t0 -157.32 136.39 11.77 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.5 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.53 ' HB ' ' CZ ' ' A' ' 197' ' ' TYR . 56.0 t -90.65 -14.21 8.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.77 0.795 . . . . 0.0 109.031 174.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . 0.527 ' HA2' ' NH1' ' A' ' 173' ' ' ARG . . . 123.57 5.56 7.7 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.248 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -137.21 141.24 12.11 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.662 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 71.78 -158.45 53.47 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.241 -0.504 . . . . 0.0 113.083 174.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -74.08 150.73 40.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.894 0.378 . . . . 0.0 110.738 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 -99.26 132.89 44.27 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.67 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -110.9 150.56 29.02 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.138 -171.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -88.62 0.39 56.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.17 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.51 141.84 50.49 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.656 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.471 ' HG ' ' CD2' ' A' ' 179' ' ' TYR . 1.0 OUTLIER -77.28 -22.86 51.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.045 -175.476 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.526 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 16.4 m -61.97 -44.15 97.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.004 0.431 . . . . 0.0 110.275 177.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -66.41 -34.17 77.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.328 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.487 HD12 HG22 ' A' ' 181' ' ' VAL . 3.2 tm? -62.27 -54.64 37.77 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.199 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 27.2 m -66.39 -39.91 85.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.267 -175.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 191' ' ' THR . 27.8 mt-10 -68.17 -31.7 71.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.274 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -59.15 -47.26 85.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.087 0.47 . . . . 0.0 110.243 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.53 ' CZ ' ' HB ' ' A' ' 181' ' ' VAL . 76.3 m-85 -85.73 -8.85 57.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.762 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.405 ' HA ' ' HB2' ' A' ' 212' ' ' LEU . 39.4 ttpt -70.95 -23.74 62.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.67 175.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -105.74 -22.85 12.86 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.564 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -126.42 89.0 53.22 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.523 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.69 132.29 51.22 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.236 2.624 . . . . 0.0 112.799 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' MET . . . . . 0.499 ' SD ' ' HB2' ' A' ' 210' ' ' LEU . 0.0 OUTLIER -97.48 137.31 36.63 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.066 179.725 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.594 HG22 ' HB ' ' A' ' 209' ' ' VAL . 36.3 t -108.39 137.11 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -169.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.542 ' O ' HG11 ' A' ' 203' ' ' VAL . 27.4 mt-10 -81.71 163.99 22.08 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.817 0.341 . . . . 0.0 110.182 169.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.0 t -76.29 -10.62 59.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.796 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.9 mp -90.95 -1.23 57.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.452 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 103.89 -23.72 31.57 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.471 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 23.2 m -60.77 111.33 1.59 Allowed 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 120.882 0.372 . . . . 0.0 110.307 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.594 ' HB ' HG22 ' A' ' 203' ' ' VAL . 1.1 p -112.58 128.66 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-O 121.826 0.822 . . . . 0.0 110.833 175.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.556 HD11 ' CG2' ' A' ' 168' ' ' THR . 0.3 OUTLIER -81.55 105.31 12.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 113.987 -1.46 . . . . 0.0 110.219 -170.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -93.89 90.47 6.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.637 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 198' ' ' LYS . 6.8 mp -73.85 106.65 5.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.768 178.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -114.6 -55.96 2.43 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.626 ' O ' ' HA ' ' A' ' 134' ' ' SER . 0.7 OUTLIER -134.46 142.22 41.98 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 121.076 0.465 . . . . 0.0 111.179 -179.139 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.414 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 78.7 Cg_endo -76.38 142.24 23.63 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.951 2.434 . . . . 0.0 112.963 -175.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.535 HD13 ' CD2' ' A' ' 126' ' ' LEU . 0.3 OUTLIER -76.6 110.06 10.85 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 175.667 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -57.58 139.67 52.92 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 123.384 0.428 . . . . 0.0 111.103 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 13.4 p -71.99 108.0 5.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.498 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 3.6 t . . . . . 0 C--N 1.318 -0.774 0 CA-C-O 121.68 0.753 . . . . 0.0 109.92 179.344 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . 0.482 ' HA ' ' OE1' ' A' ' 204' ' ' GLU . . . . . . . . 0 N--CA 1.476 0.869 0 CA-C-O 122.503 1.145 . . . . 0.0 113.702 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.52 -44.58 28.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.283 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.493 HG21 ' HB2' ' A' ' 202' ' ' MET . 4.2 mm 55.36 73.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.566 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 2.3 m . . . . . 0 C--N 1.32 -0.694 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.591 179.917 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.439 ' HB2' ' H ' ' A' ' 190' ' ' LEU . 84.2 Cg_endo . . . . . 0 CA--C 1.517 -0.365 0 CA-C-O 121.478 0.533 . . . . 0.0 111.964 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.705 ' HB ' ' CG ' ' A' ' 113' ' ' PHE . 34.7 p -100.19 7.85 44.23 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.562 -171.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 26.7 m -74.68 49.12 0.39 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.169 0.509 . . . . 0.0 110.939 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.4 ' HG3' ' CZ2' ' A' ' 112' ' ' TRP . 70.4 mm-40 -127.04 174.11 9.13 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.662 -176.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -79.55 -20.05 47.99 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -173.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.502 ' HB3' ' CB ' ' A' ' 215' ' ' PRO . 1.8 p-90 -85.95 -19.81 29.89 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.875 -178.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.705 ' CG ' ' HB ' ' A' ' 108' ' ' THR . 75.4 t80 -77.92 124.67 28.29 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.151 0.5 . . . . 0.0 110.707 175.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -122.11 107.04 11.72 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -51.84 -72.09 0.56 Allowed Glycine 0 CA--C 1.519 0.307 0 N-CA-C 114.744 0.657 . . . . 0.0 114.744 -167.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -100.29 86.34 3.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.347 0.594 . . . . 0.0 112.156 -173.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.459 ' O ' ' HD2' ' A' ' 138' ' ' ARG . 33.1 mt -133.38 133.27 42.22 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.165 175.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 35.4 t -93.6 172.76 8.06 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 168.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 123' ' ' GLU . . . -51.77 -44.27 54.88 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.245 -0.502 . . . . 0.0 112.797 -177.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.413 ' HD3' ' N ' ' A' ' 120' ' ' LYS . 3.1 mppt? -69.36 -35.03 75.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.959 0.409 . . . . 0.0 110.607 -175.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -72.61 -47.26 49.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.402 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.476 ' HB2' ' HD3' ' A' ' 138' ' ' ARG . . . -62.56 -34.06 76.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.431 177.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.5 ' HG3' ' HB ' ' A' ' 167' ' ' VAL . 3.7 tt0 -65.36 -50.33 65.97 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.694 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -58.94 -36.22 74.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.418 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.427 HD13 HD12 ' A' ' 216' ' ' LEU . 0.7 OUTLIER -58.48 -53.66 55.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.768 178.368 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.543 ' CD2' HD13 ' A' ' 216' ' ' LEU . 61.3 mt -75.39 -48.44 22.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.759 -176.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.7 m -61.9 -32.78 73.19 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.192 -172.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -97.44 -53.87 3.32 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -91.58 -23.37 19.91 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -169.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -93.32 -160.24 35.2 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.057 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -152.3 175.73 12.35 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 175.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -58.54 125.15 22.18 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 177.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.496 ' HA2' ' O ' ' A' ' 211' ' ' GLN . . . 103.72 -10.98 53.22 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.113 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.694 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 27.8 m -78.65 139.59 38.51 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.658 0.266 . . . . 0.0 110.376 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.516 ' CB ' HG11 ' A' ' 151' ' ' VAL . 44.9 p90 -137.02 150.38 48.06 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.409 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.493 ' CD2' HD12 ' A' ' 126' ' ' LEU . 1.1 pt? -149.04 136.41 20.17 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 148' ' ' VAL . 5.6 m -100.42 139.99 20.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.547 178.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.476 ' HD3' ' HB2' ' A' ' 122' ' ' ALA . 17.6 ptt85 -141.8 167.73 21.45 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.459 -176.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -80.63 133.79 35.79 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.409 ' HB2' HG11 ' A' ' 148' ' ' VAL . 39.2 t -76.14 139.13 41.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.934 0.397 . . . . 0.0 110.048 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -99.87 -18.01 17.35 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.669 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.4 p -84.93 -26.67 27.08 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 171.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -123.34 78.63 53.51 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.178 176.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.97 124.55 15.94 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.869 2.379 . . . . 0.0 112.303 -178.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 106.79 -16.85 39.61 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.012 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -106.98 157.24 17.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.896 0.379 . . . . 0.0 110.351 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -110.58 158.64 18.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.657 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 35.1 m -136.47 139.36 45.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.339 0.59 . . . . 0.0 111.383 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.628 ' HB3' ' CG2' ' A' ' 170' ' ' VAL . 0.5 OUTLIER -95.09 110.54 22.46 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.817 176.23 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.489 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 2.4 m -101.89 130.68 48.44 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.269 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.516 HG11 ' CB ' ' A' ' 135' ' ' PHE . 33.5 m -129.26 150.3 34.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.679 -174.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -93.04 102.4 14.74 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.425 0.631 . . . . 0.0 109.506 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.484 ' O ' ' HB3' ' A' ' 166' ' ' LYS . 0.9 OUTLIER -115.0 97.78 6.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.722 178.758 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.975 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -176.115 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.484 ' HB3' ' O ' ' A' ' 153' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.405 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.5 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 60.1 t -123.39 115.98 47.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 121.086 0.469 . . . . 0.0 111.323 176.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.479 HG21 HD11 ' A' ' 210' ' ' LEU . 4.1 m -92.86 140.73 29.19 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.049 172.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 150' ' ' SER . 37.8 m-70 -114.78 119.72 37.61 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.693 HG12 ' SD ' ' A' ' 202' ' ' MET . 0.8 OUTLIER -98.4 140.14 18.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -177.028 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 40.2 tpp -87.02 117.88 26.03 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.253 -177.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 20.7 mt -97.02 107.04 19.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.558 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 17.9 ptp180 -69.16 122.42 18.76 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.917 0.389 . . . . 0.0 110.0 -177.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 49.5 t -113.88 93.42 4.36 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.805 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -125.92 122.4 35.9 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.158 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 58.63 41.75 21.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.124 -178.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.0 mt 60.49 45.42 10.77 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.165 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 174' ' ' CYS . 10.9 tppt? -131.46 139.11 49.29 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -116.04 129.95 56.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.585 0.231 . . . . 0.0 110.783 -175.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.558 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 13.8 t0 -157.01 129.25 7.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.79 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.544 ' HB ' ' CZ ' ' A' ' 197' ' ' TYR . 31.0 t -83.91 -12.27 11.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.773 0.797 . . . . 0.0 109.312 176.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 122.76 9.02 6.5 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.388 176.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -137.88 140.48 11.26 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.138 -1.029 . . . . 0.0 113.738 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 71.59 -154.8 51.74 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.266 -0.492 . . . . 0.0 112.998 174.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -73.97 142.73 45.84 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.64 0.257 . . . . 0.0 110.364 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -88.0 132.71 34.16 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -106.88 156.44 18.69 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.226 0.536 . . . . 0.0 112.019 -169.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -94.34 -11.52 29.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.24 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.6 m -129.4 142.71 50.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.123 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.439 ' H ' ' HB2' ' A' ' 107' ' ' PRO . 0.9 OUTLIER -72.81 -22.71 60.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.28 -175.4 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 5.8 m -61.82 -46.23 90.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.894 0.378 . . . . 0.0 110.53 177.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -64.72 -34.17 77.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.057 178.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.482 HD11 HG22 ' A' ' 181' ' ' VAL . 3.1 tm? -60.25 -54.28 47.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.298 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 30.8 m -68.62 -43.75 83.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.934 -175.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -59.2 -35.57 73.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.001 0.429 . . . . 0.0 111.232 177.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -62.4 -45.28 93.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.102 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.544 ' CZ ' ' HB ' ' A' ' 181' ' ' VAL . 59.8 m-85 -85.76 -10.36 55.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.948 0.404 . . . . 0.0 111.448 -176.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.425 ' HD2' ' CZ ' ' A' ' 135' ' ' PHE . 47.0 mtpt -70.86 -34.81 72.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.155 0.502 . . . . 0.0 109.865 170.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . 0.431 ' HG3' ' ND2' ' A' ' 200' ' ' ASN . 14.1 tptt -88.85 -36.17 16.16 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.036 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . 0.431 ' ND2' ' HG3' ' A' ' 199' ' ' LYS . 55.4 m-80 -113.49 101.57 53.8 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.432 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.28 126.17 21.62 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.845 2.363 . . . . 0.0 112.77 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' MET . . . . . 0.693 ' SD ' HG12 ' A' ' 170' ' ' VAL . 14.3 ptp -89.31 141.81 28.22 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 175.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' B' ' 3' ' ' ILE . 11.2 t -124.8 139.51 50.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.998 -173.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.444 ' HG2' ' HB2' ' B' ' 1' ' ' ALA . 26.0 mt-10 -82.01 161.24 23.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.898 171.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.3 t -74.32 -9.85 59.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.235 0.54 . . . . 0.0 110.006 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.5 mp -89.68 4.38 49.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.162 176.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.57 -1.27 83.79 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.629 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 23.1 m -73.16 113.51 10.3 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.011 0.434 . . . . 0.0 110.588 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.417 HG21 HG11 ' A' ' 203' ' ' VAL . 69.9 t -98.6 114.34 35.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.637 HD23 ' SD ' ' A' ' 202' ' ' MET . 0.4 OUTLIER -76.52 100.34 5.24 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.496 ' O ' ' HA2' ' A' ' 133' ' ' GLY . 47.1 mt-30 -84.68 92.96 8.31 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.382 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.2 mp -77.57 105.41 8.69 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.956 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -113.86 -57.07 2.33 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.694 ' O ' ' HA ' ' A' ' 134' ' ' SER . 4.6 pm0 -132.0 139.38 34.84 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-O 121.14 0.495 . . . . 0.0 111.209 -177.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.502 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 71.5 Cg_endo -74.37 138.45 24.71 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.982 2.455 . . . . 0.0 112.527 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.543 HD13 ' CD2' ' A' ' 126' ' ' LEU . 0.3 OUTLIER -72.5 106.28 4.52 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.053 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -56.15 133.62 52.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.083 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.6 p -58.02 111.6 1.23 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.436 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 C--N 1.318 -0.772 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.288 -178.897 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . 0.444 ' HB2' ' HG2' ' A' ' 204' ' ' GLU . . . . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.931 0.396 . . . . 0.0 110.627 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 23.5 m -70.87 -38.0 73.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.295 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.61 HD11 ' SD ' ' A' ' 202' ' ' MET . 7.5 mm 70.03 88.0 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 121.613 0.721 . . . . 0.0 111.213 176.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 2.1 m . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.828 179.359 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo . . . . . 0 N--CA 1.462 -0.371 0 N-CA-C 109.597 -0.963 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.508 ' HB ' ' CD1' ' A' ' 113' ' ' PHE . 25.5 p -98.13 7.41 46.32 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 113.628 -1.623 . . . . 0.0 111.153 -176.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.4 p -75.65 30.19 0.11 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.934 0.397 . . . . 0.0 111.755 -178.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.444 ' H ' ' C ' ' A' ' 108' ' ' THR . 10.8 mm-40 -109.88 171.26 7.56 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.42 ' O ' HG22 ' A' ' 218' ' ' THR . 25.3 mmt180 -85.47 -9.62 57.21 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -167.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.46 ' HB3' ' CB ' ' A' ' 215' ' ' PRO . 2.4 p-90 -87.31 -19.14 28.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.954 0.407 . . . . 0.0 110.621 175.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.508 ' CD1' ' HB ' ' A' ' 108' ' ' THR . 80.3 t80 -75.17 119.19 18.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.199 0.524 . . . . 0.0 110.241 173.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.402 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 13.9 m-70 -112.16 147.09 36.89 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 175.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -73.55 -123.99 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.731 -172.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -86.84 83.6 7.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.515 0.674 . . . . 0.0 111.168 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 77.9 mt -98.0 160.6 14.2 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.835 171.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.1 p -102.48 172.46 6.85 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 165.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.64 -50.1 44.08 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 121.312 -0.471 . . . . 0.0 112.619 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -64.64 -41.43 96.15 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 122.466 0.307 . . . . 0.0 111.425 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -61.08 -46.75 89.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.552 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.91 -35.05 79.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.972 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -64.87 -50.83 65.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.071 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -60.65 -34.58 74.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.419 176.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 129' ' ' LYS . 0.4 OUTLIER -57.01 -52.82 63.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.983 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.575 ' CD2' HD13 ' A' ' 216' ' ' LEU . 71.1 mt -75.96 -52.19 10.8 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -178.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 m -64.89 -33.2 75.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.785 -170.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -96.66 -49.81 4.95 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 125' ' ' LEU . 95.9 mttt -92.14 -23.51 19.39 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -169.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -98.54 -149.77 25.2 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.325 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.533 ' HZ2' ' HB2' ' A' ' 131' ' ' LYS . 0.1 OUTLIER -154.29 173.67 15.85 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 176.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 62.9 t60 -51.18 118.87 3.52 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.774 0.321 . . . . 0.0 110.825 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 102.21 -3.21 51.09 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.314 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 33.8 p -72.24 139.67 48.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.276 0.538 . . . . 0.0 110.1 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.466 ' CB ' HG12 ' A' ' 151' ' ' VAL . 53.3 p90 -137.21 151.58 48.92 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.976 0.417 . . . . 0.0 110.636 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.512 ' CD2' HD13 ' A' ' 126' ' ' LEU . 1.2 pt? -153.21 136.05 15.38 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.488 HG13 HD12 ' A' ' 149' ' ' LEU . 5.5 m -96.72 142.44 13.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 175.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.635 HH11 ' HB2' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -147.36 160.08 42.95 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.703 -171.482 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -79.14 110.42 14.37 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.997 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.4 ' HB2' HG13 ' A' ' 148' ' ' VAL . 41.8 t -66.66 124.78 23.81 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -90.99 -15.35 29.8 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 28.0 t -72.83 -39.47 66.55 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 172.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 46.7 m-70 -119.57 81.39 24.07 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.544 172.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.22 134.47 59.45 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.042 2.495 . . . . 0.0 112.968 -172.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 100.0 -21.6 43.98 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.073 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.552 ' HA ' ' SG ' ' A' ' 174' ' ' CYS . 4.5 m-20 -102.56 170.32 8.11 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.243 0.544 . . . . 0.0 111.063 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -117.18 149.95 39.53 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.311 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.4 HG13 ' HB2' ' A' ' 140' ' ' SER . 27.1 m -131.91 138.71 52.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.173 0.511 . . . . 0.0 111.065 176.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.581 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -92.18 109.48 20.85 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.455 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.484 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 2.8 m -101.77 133.49 46.43 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.136 -179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.528 HG23 ' HB3' ' A' ' 210' ' ' LEU . 28.1 m -132.9 153.84 38.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.923 0.392 . . . . 0.0 111.356 -173.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.429 ' HB2' ' HB3' ' A' ' 126' ' ' LEU . 73.6 ttt180 -99.69 103.98 15.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.2 178.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 14.8 p -108.36 147.66 31.21 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.456 -177.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.506 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.112 -178.364 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.419 ' HD2' ' HA ' ' A' ' 166' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.448 -0.53 0 CA-C-O 120.55 0.214 . . . . 0.0 110.751 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 72.6 t -100.41 113.01 34.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.426 0.632 . . . . 0.0 110.626 176.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.437 HG23 HD11 ' A' ' 210' ' ' LEU . 1.4 m -98.21 137.73 36.54 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.726 175.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -105.97 122.48 46.22 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.581 HG22 ' HB3' ' A' ' 149' ' ' LEU . 0.8 OUTLIER -99.5 138.42 23.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.144 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' MET . . . . . 0.432 ' O ' ' HA ' ' A' ' 181' ' ' VAL . 39.8 tpp -82.22 121.28 26.43 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.636 -0.257 . . . . 0.0 111.018 -174.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 28.8 mt -101.64 107.5 21.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 177.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 4.4 ptp180 -73.8 107.66 6.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.064 0.459 . . . . 0.0 110.735 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . 0.552 ' SG ' ' HA ' ' A' ' 146' ' ' ASP . 4.9 p -86.0 101.27 12.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.888 175.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -127.73 111.14 13.35 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.944 -176.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 56.24 43.67 26.17 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.577 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 91.5 mt 66.48 15.96 10.26 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.197 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -105.99 142.86 34.99 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 172.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -117.23 141.35 48.4 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.538 -175.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.565 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 5.9 t0 -158.71 136.25 10.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.59 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 171' ' ' MET . 16.8 m -87.62 -11.01 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 121.051 0.453 . . . . 0.0 110.409 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . 0.51 ' HA2' ' NH1' ' A' ' 173' ' ' ARG . . . 123.31 34.74 0.75 Allowed Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -174.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -102.95 -157.69 25.33 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 121.514 -0.374 . . . . 0.0 112.448 -176.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -86.43 -40.91 7.13 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.031 -177.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -115.89 143.11 45.88 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.905 0.384 . . . . 0.0 111.279 -177.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -93.15 141.53 28.32 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -110.95 137.39 48.64 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.643 0.259 . . . . 0.0 110.677 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -82.86 0.9 41.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.229 0.538 . . . . 0.0 110.372 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.1 p -141.39 142.67 33.73 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.906 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.425 HD13 HG22 ' A' ' 137' ' ' VAL . 1.7 mt -76.52 -23.14 53.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.061 -176.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.441 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 97.6 m -62.02 -49.29 76.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.006 0.431 . . . . 0.0 109.938 174.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.65 -29.89 70.9 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.494 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.439 HD11 ' C ' ' A' ' 193' ' ' LEU . 3.2 tm? -64.34 -54.91 25.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.99 176.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.15 -42.1 79.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.348 -174.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -60.83 -31.76 71.17 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.388 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -67.29 -47.81 69.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.922 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.422 ' CZ ' HG21 ' A' ' 181' ' ' VAL . 80.3 m-85 -82.8 -11.16 58.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.246 0.546 . . . . 0.0 110.639 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -68.96 -29.74 68.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.284 172.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -93.3 -37.76 11.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.375 176.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -119.31 98.06 50.41 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.344 -177.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -56.31 138.28 83.01 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.978 2.452 . . . . 0.0 112.449 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' MET . . . . . 0.473 ' CE ' HD21 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -100.4 135.54 41.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.772 178.803 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.565 HG23 ' HB ' ' A' ' 209' ' ' VAL . 39.3 t -103.55 141.18 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -171.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.513 ' O ' HG12 ' A' ' 203' ' ' VAL . 38.7 mt-10 -86.82 161.98 18.04 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 169.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 13.7 t -74.59 -10.5 59.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.057 0.456 . . . . 0.0 110.346 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.6 mp -92.07 8.77 36.26 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.126 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.77 -29.0 7.74 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.776 177.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 53.4 m -57.98 112.5 1.52 Allowed 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 116.981 0.39 . . . . 0.0 110.164 176.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.565 ' HB ' HG23 ' A' ' 203' ' ' VAL . 1.1 p -111.6 129.35 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-O 121.548 0.689 . . . . 0.0 110.228 174.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.528 ' HB3' HG23 ' A' ' 151' ' ' VAL . 0.4 OUTLIER -78.85 113.23 16.77 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.347 -1.297 . . . . 0.0 111.163 -168.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -90.36 90.16 7.92 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.437 -178.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 8.0 mp -79.17 104.94 10.14 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 175.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 47.5 mttp -112.73 -54.73 2.6 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -177.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.546 ' O ' ' HA ' ' A' ' 134' ' ' SER . 0.1 OUTLIER -142.03 144.7 33.06 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.112 0.482 . . . . 0.0 111.32 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.46 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 74.1 Cg_endo -73.88 144.6 34.89 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.097 2.531 . . . . 0.0 113.202 -176.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.575 HD13 ' CD2' ' A' ' 126' ' ' LEU . 0.4 OUTLIER -82.94 119.92 25.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.513 176.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -58.18 145.43 37.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.265 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.42 HG22 ' O ' ' A' ' 111' ' ' ARG . 4.2 p -74.25 108.22 6.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.532 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 2.8 t . . . . . 0 C--N 1.318 -0.802 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.708 176.694 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . 0.417 ' HB1' HG23 ' A' ' 168' ' ' THR . . . . . . . . 0 N--CA 1.463 0.206 0 CA-C-O 121.459 0.647 . . . . 0.0 112.365 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 7.4 m -61.79 -52.26 64.91 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.189 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 203' ' ' VAL . 33.6 mm 82.74 82.25 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-O 121.853 0.835 . . . . 0.0 109.372 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.438 -1.064 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.629 178.83 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo . . . . . 0 CA--C 1.515 -0.468 0 CA-C-O 121.474 0.531 . . . . 0.0 111.441 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.496 ' HB ' ' CG ' ' A' ' 113' ' ' PHE . 40.4 p -100.44 6.26 44.37 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.154 -175.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.8 p -78.54 45.28 0.57 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.246 0.546 . . . . 0.0 111.09 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -125.9 168.34 14.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.89 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.423 ' O ' HG21 ' A' ' 218' ' ' THR . 14.3 mmt180 -82.82 -14.86 53.58 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -170.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.533 ' HB3' ' CB ' ' A' ' 215' ' ' PRO . 1.7 p-90 -85.17 -18.6 33.64 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.3 175.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.496 ' CG ' ' HB ' ' A' ' 108' ' ' THR . 87.2 t80 -78.98 118.05 20.62 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.215 173.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -115.11 113.36 23.9 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 174.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -64.31 -72.74 0.65 Allowed Glycine 0 N--CA 1.454 -0.163 0 CA-C-N 116.089 -0.505 . . . . 0.0 113.658 -173.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -84.41 89.46 7.4 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.642 -0.328 . . . . 0.0 110.996 -174.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 24.3 mt -143.73 137.15 27.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.661 174.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.1 t -101.05 173.59 6.4 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 169.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 123' ' ' GLU . . . -49.85 -52.87 24.24 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 121.527 -0.368 . . . . 0.0 113.796 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.56 -25.55 57.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.169 0.485 . . . . 0.0 111.229 -176.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.405 ' O ' HD23 ' A' ' 125' ' ' LEU . 28.2 mm-40 -69.99 -47.27 62.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.156 0.503 . . . . 0.0 109.93 178.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.543 ' HB3' ' HD2' ' A' ' 138' ' ' ARG . . . -67.06 -34.11 76.97 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.597 177.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.438 ' HG3' ' HB ' ' A' ' 167' ' ' VAL . 3.3 tt0 -61.66 -49.08 77.98 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.847 177.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -59.67 -34.11 72.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.877 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.405 HD23 ' O ' ' A' ' 121' ' ' GLU . 1.2 mm? -56.72 -53.53 56.7 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.119 0.485 . . . . 0.0 110.405 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.534 HD12 ' CD2' ' A' ' 136' ' ' LEU . 54.0 mt -76.15 -44.36 38.58 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.9 m -61.61 -35.48 78.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 110.757 -175.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -95.6 -52.99 3.89 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -97.86 -22.73 16.2 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -170.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -90.08 177.51 42.96 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.307 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -135.59 175.14 9.87 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -57.98 117.59 4.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.781 0.324 . . . . 0.0 110.574 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 211' ' ' GLN . . . 104.02 -5.29 46.05 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.76 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.524 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 29.6 m -74.61 137.44 42.29 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.649 -0.324 . . . . 0.0 110.434 176.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.451 ' CB ' HG12 ' A' ' 151' ' ' VAL . 51.0 p90 -136.87 149.26 47.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.714 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.558 ' CD2' ' HB2' ' A' ' 150' ' ' SER . 1.2 pt? -150.56 134.15 16.51 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 11.9 m -97.44 141.09 16.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.543 ' HD2' ' HB3' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -140.19 162.94 34.06 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.903 -175.046 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -77.73 128.13 33.54 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.476 ' HB2' HG11 ' A' ' 148' ' ' VAL . 36.4 t -75.82 137.98 40.85 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -101.3 -21.51 14.85 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.033 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 33.5 m -86.12 -29.19 23.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.985 173.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -116.83 81.09 11.58 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 175.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.03 133.11 39.6 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.797 2.331 . . . . 0.0 112.369 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 94.52 -10.08 71.17 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.862 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -113.65 168.37 9.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.071 0.463 . . . . 0.0 110.356 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.475 ' CE1' ' HE1' ' A' ' 179' ' ' TYR . 74.0 m-85 -125.06 163.27 22.74 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.58 -177.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.512 ' CG2' ' HG3' ' A' ' 138' ' ' ARG . 26.7 m -134.62 136.99 51.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.228 0.537 . . . . 0.0 111.193 178.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.577 ' HB3' ' CG2' ' A' ' 170' ' ' VAL . 0.6 OUTLIER -92.29 110.18 21.57 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.14 177.116 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.558 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 3.8 m -101.25 130.43 47.38 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.297 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.486 HG23 ' HB3' ' A' ' 210' ' ' LEU . 33.9 m -131.43 146.9 32.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.848 -174.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 -91.55 104.89 17.32 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.17 0.51 . . . . 0.0 109.964 175.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.478 ' O ' ' HB3' ' A' ' 166' ' ' LYS . 3.7 p -104.11 146.58 28.53 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.977 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.752 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.876 -176.201 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 153' ' ' THR . 51.9 tptt . . . . . 0 N--CA 1.446 -0.662 0 CA-C-O 120.734 0.302 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.438 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 73.9 t -119.17 113.33 41.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.353 0.597 . . . . 0.0 110.319 174.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.519 HG21 HD11 ' A' ' 210' ' ' LEU . 18.9 m -97.95 133.59 42.23 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.905 176.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 150' ' ' SER . 13.4 m-70 -110.9 117.91 34.66 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.577 ' CG2' ' HB3' ' A' ' 149' ' ' LEU . 0.7 OUTLIER -98.15 133.58 39.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -177.064 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 44.0 tpp -78.7 119.27 21.7 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.683 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 24.8 mt -99.58 107.22 20.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.63 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 4.5 ptp180 -69.98 125.51 26.98 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . 0.668 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 49.4 t -118.53 115.5 24.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.72 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -141.44 112.8 7.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.164 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 60.16 49.94 6.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.974 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.0 mt 58.35 47.49 13.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.844 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.668 ' O ' ' HA ' ' A' ' 174' ' ' CYS . 11.3 tppt? -133.97 132.23 39.91 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.475 ' HE1' ' CE1' ' A' ' 147' ' ' PHE . 69.0 m-85 -117.71 134.08 55.27 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.161 0.288 . . . . 0.0 110.715 -175.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.63 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 12.5 t0 -156.12 131.46 9.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.952 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.559 ' HB ' ' CZ ' ' A' ' 197' ' ' TYR . 51.1 t -83.16 -15.69 11.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.701 0.762 . . . . 0.0 109.083 175.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 122.57 8.49 6.91 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.83 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -136.61 141.62 12.67 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.465 -175.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 71.44 -152.03 49.0 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.888 175.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -84.16 144.05 29.24 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.866 0.365 . . . . 0.0 110.835 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -78.98 137.17 37.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.576 177.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -110.74 149.95 29.77 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.193 0.52 . . . . 0.0 111.647 -175.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -84.06 -9.59 58.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.644 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.18 143.43 40.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.273 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.452 ' HG ' ' CD1' ' A' ' 179' ' ' TYR . 0.8 OUTLIER -70.85 -23.39 62.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.441 -174.63 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 20.6 m -61.35 -47.92 83.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.945 0.402 . . . . 0.0 110.15 175.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.21 -30.99 72.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.249 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.519 HD11 HG23 ' A' ' 181' ' ' VAL . 2.9 tm? -65.72 -54.64 24.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.44 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 34.5 m -66.77 -43.17 90.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.239 -173.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -62.25 -31.47 72.04 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.416 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -64.21 -52.1 60.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.817 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.559 ' CZ ' ' HB ' ' A' ' 181' ' ' VAL . 86.6 m-85 -80.92 -8.52 59.77 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.265 0.555 . . . . 0.0 110.393 -177.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -71.74 -23.17 61.56 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 172.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 8.3 tppt? -96.18 -36.5 10.93 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.682 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -121.86 103.72 39.78 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.001 0.429 . . . . 0.0 111.219 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -58.31 126.85 22.69 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 123.038 2.492 . . . . 0.0 112.475 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' MET . . . . . 0.478 ' HE3' HD23 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -89.51 127.66 35.89 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.727 178.785 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.538 HG22 ' HB ' ' A' ' 209' ' ' VAL . 47.2 t -99.42 139.69 20.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.192 0.52 . . . . 0.0 111.63 -173.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.721 ' HB2' ' O ' ' A' ' 208' ' ' THR . 0.4 OUTLIER -85.6 155.95 20.92 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.946 171.592 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 9.2 t -72.41 -11.8 60.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.052 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.5 mp -91.3 6.7 44.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.881 176.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.13 -17.93 53.57 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.788 178.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.721 ' O ' ' HB2' ' A' ' 204' ' ' GLU . 92.7 m -66.34 110.73 3.19 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-O 120.705 0.288 . . . . 0.0 110.239 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.538 ' HB ' HG22 ' A' ' 203' ' ' VAL . 1.4 p -111.8 127.43 68.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.695 0.759 . . . . 0.0 110.517 175.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.519 HD11 HG21 ' A' ' 168' ' ' THR . 0.3 OUTLIER -81.34 110.38 16.72 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.813 -169.377 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.422 ' O ' ' HA2' ' A' ' 133' ' ' GLY . 49.8 mt-30 -91.46 89.53 7.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.371 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 7.4 mp -75.45 111.7 11.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.195 176.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -113.92 -56.12 2.43 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.638 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.524 ' O ' ' HA ' ' A' ' 134' ' ' SER . 0.9 OUTLIER -145.77 149.2 38.92 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 121.096 0.474 . . . . 0.0 111.082 179.594 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.533 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 72.6 Cg_endo -72.94 149.44 47.21 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 123.55 2.833 . . . . 0.0 114.17 -173.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.512 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.2 OUTLIER -84.97 113.74 21.64 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 173.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -62.76 151.06 39.74 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.133 0.492 . . . . 0.0 111.198 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.423 HG21 ' O ' ' A' ' 111' ' ' ARG . 12.6 p -80.02 111.57 16.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.138 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 3.1 t . . . . . 0 C--N 1.321 -0.654 0 CA-C-O 121.385 0.612 . . . . 0.0 109.474 176.069 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . 0.428 ' HB3' ' CG2' ' A' ' 168' ' ' THR . . . . . . . . 0 C--O 1.234 0.244 0 CA-C-O 121.37 0.605 . . . . 0.0 111.357 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 86.0 m -70.7 -47.29 60.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.008 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.453 ' CG2' ' HB2' ' A' ' 202' ' ' MET . 15.7 mm 78.54 89.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 123.318 0.647 . . . . 0.0 110.278 173.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.441 -0.899 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.435 177.639 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 CA--C 1.516 -0.416 0 CA-C-O 121.635 0.598 . . . . 0.0 111.294 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.624 ' HB ' ' CD2' ' A' ' 113' ' ' PHE . 81.5 p -94.77 6.69 48.2 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.59 -176.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 51.3 m -76.64 59.24 1.5 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.299 0.571 . . . . 0.0 110.818 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.477 ' HG3' ' CZ2' ' A' ' 112' ' ' TRP . 76.8 mm-40 -134.39 156.35 48.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.513 -177.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -75.11 -13.76 60.5 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -171.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.486 ' HB3' ' CB ' ' A' ' 215' ' ' PRO . 2.5 p-90 -89.65 -14.16 35.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.947 0.403 . . . . 0.0 110.742 175.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.624 ' CD2' ' HB ' ' A' ' 108' ' ' THR . 76.3 t80 -80.73 120.94 25.27 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.088 0.47 . . . . 0.0 110.149 172.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -111.91 140.4 46.6 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -76.73 -90.3 0.26 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.037 -175.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -92.66 93.54 8.54 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.992 0.425 . . . . 0.0 111.51 -172.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.2 mt -134.38 128.46 33.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.301 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 24.5 m -83.68 173.25 11.51 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 173.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -50.84 -52.62 29.49 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 121.477 -0.392 . . . . 0.0 113.386 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -72.09 -31.75 66.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.491 0.186 . . . . 0.0 111.431 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -64.04 -47.13 81.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.968 0.413 . . . . 0.0 110.481 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.461 ' HB1' ' HD3' ' A' ' 138' ' ' ARG . . . -66.15 -34.03 77.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.723 178.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.421 ' HA ' HG13 ' A' ' 167' ' ' VAL . 0.2 OUTLIER -65.87 -50.77 63.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.51 176.274 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -58.55 -34.78 71.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.615 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.81 -51.59 68.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.218 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.529 ' CD2' HD11 ' A' ' 216' ' ' LEU . 53.2 mt -75.48 -46.66 31.1 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 m -64.97 -28.32 69.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.098 -174.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -95.71 -53.03 3.86 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -103.48 11.65 36.13 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -170.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -127.05 -163.36 11.44 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.254 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -154.34 176.15 12.67 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -46.71 120.74 3.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.937 0.398 . . . . 0.0 111.004 176.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 211' ' ' GLN . . . 99.1 -9.63 61.51 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.797 177.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.648 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 69.0 m -70.41 135.67 48.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.218 0.509 . . . . 0.0 110.526 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.499 ' CB ' HG12 ' A' ' 151' ' ' VAL . 52.5 p90 -137.03 149.54 47.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.923 -178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.537 ' CD2' ' HB2' ' A' ' 150' ' ' SER . 1.2 pt? -149.43 134.8 18.36 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 175.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.437 HG12 HD13 ' A' ' 149' ' ' LEU . 12.3 m -97.52 141.93 15.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.461 ' HD3' ' HB1' ' A' ' 122' ' ' ALA . 30.5 ptt85 -140.98 162.17 36.1 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.357 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -71.38 129.25 38.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.871 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.446 ' OG ' ' HB2' ' A' ' 143' ' ' HIS . 23.3 t -77.94 132.85 38.07 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.328 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -91.08 -40.86 11.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.819 -175.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.6 t -79.81 -12.99 59.74 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.057 0.456 . . . . 0.0 109.789 177.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . 0.446 ' HB2' ' OG ' ' A' ' 140' ' ' SER . 54.3 m80 -126.19 75.04 72.82 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.951 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.5 126.87 21.91 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.847 2.364 . . . . 0.0 112.234 -176.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 106.09 -31.97 7.83 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.943 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -98.16 171.79 8.0 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.155 0.502 . . . . 0.0 110.732 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.413 ' CE2' ' HE1' ' A' ' 179' ' ' TYR . 85.8 m-85 -125.23 165.9 17.46 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.435 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 27.5 m -132.97 136.48 55.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.404 0.621 . . . . 0.0 111.456 176.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.569 ' HB3' ' CG2' ' A' ' 170' ' ' VAL . 0.7 OUTLIER -92.74 110.02 21.45 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.806 174.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.537 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 1.2 m -101.9 128.98 48.05 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.709 -0.796 . . . . 0.0 109.254 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.499 HG12 ' CB ' ' A' ' 135' ' ' PHE . 33.7 m -130.46 147.7 33.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.581 -172.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -93.02 104.25 16.48 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.253 0.549 . . . . 0.0 109.879 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.7 p -104.08 146.93 28.01 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.092 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.666 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.568 179.169 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.459 ' HD2' ' N ' ' A' ' 167' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.638 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.459 ' N ' ' HD2' ' A' ' 166' ' ' LYS . 74.9 t -99.41 116.2 42.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.475 0.655 . . . . 0.0 111.751 -177.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.5 HG21 HD13 ' A' ' 210' ' ' LEU . 4.4 m -97.26 141.19 30.67 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.35 176.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 150' ' ' SER . 17.1 m-70 -117.76 117.47 29.41 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.569 ' CG2' ' HB3' ' A' ' 149' ' ' LEU . 0.7 OUTLIER -98.85 135.37 34.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -173.936 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 35.2 tpp -78.48 115.93 18.52 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.657 -176.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.414 HD12 HD21 ' A' ' 190' ' ' LEU . 29.6 mt -93.61 105.95 17.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 176.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.552 ' HB2' ' OE1' ' A' ' 175' ' ' GLN . 13.6 ptm180 -82.18 118.58 23.18 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.313 -175.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . 0.655 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 38.5 t -104.42 110.0 22.09 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.112 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.552 ' OE1' ' HB2' ' A' ' 173' ' ' ARG . 1.8 mp0 -113.74 107.91 16.39 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 177.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 58.2 52.17 7.78 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 123.562 0.539 . . . . 0.0 111.094 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 93.6 mt 61.05 41.89 13.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.193 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.655 ' O ' ' HA ' ' A' ' 174' ' ' CYS . 5.8 tppt? -134.51 131.03 37.53 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.413 ' HE1' ' CE2' ' A' ' 147' ' ' PHE . 63.5 m-85 -105.52 138.19 42.12 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 122.91 0.131 . . . . 0.0 111.118 -171.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.529 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 24.7 t70 -152.11 139.49 19.48 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.355 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.451 ' HB ' ' CZ ' ' A' ' 197' ' ' TYR . 84.4 t -96.83 55.68 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 122.514 1.15 . . . . 0.0 109.127 173.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 82.52 -39.02 2.64 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 114.7 -1.136 . . . . 0.0 113.674 173.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -138.51 151.88 21.77 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.281 -176.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 110.16 -142.71 16.63 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.653 175.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -106.44 143.75 34.1 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 176.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.44 ' HG2' ' HB2' ' A' ' 180' ' ' ASP . 80.2 mtt180 -92.77 139.49 30.49 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.346 -176.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -113.95 147.86 37.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.184 -175.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -79.16 -16.9 55.95 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.169 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 19.8 m -129.78 143.37 50.78 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.795 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.417 HD22 ' HB3' ' A' ' 193' ' ' LEU . 0.8 OUTLIER -69.89 -22.55 63.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.039 -176.456 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.465 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 6.5 m -58.83 -47.36 85.1 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.992 0.425 . . . . 0.0 110.363 176.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -66.41 -31.52 72.32 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.298 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.417 ' HB3' HD22 ' A' ' 190' ' ' LEU . 3.0 tm? -62.84 -54.48 38.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.779 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 32.7 m -69.22 -41.35 81.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.032 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -62.26 -34.87 77.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.677 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -63.52 -50.01 71.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.739 0.304 . . . . 0.0 110.811 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.451 ' CZ ' ' HB ' ' A' ' 181' ' ' VAL . 76.5 m-85 -82.04 -8.35 59.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.186 0.517 . . . . 0.0 111.014 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.423 ' HA ' ' HB2' ' A' ' 212' ' ' LEU . 35.3 ttpt -73.53 -20.47 60.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.68 0.752 . . . . 0.0 109.358 173.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . 0.402 ' HG3' ' ND2' ' A' ' 200' ' ' ASN . 9.5 tppt? -106.12 -36.21 6.99 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.554 175.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . 0.402 ' ND2' ' HG3' ' A' ' 199' ' ' LYS . 40.7 m-80 -112.68 93.99 26.3 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.834 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -58.22 130.09 36.12 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.99 2.46 . . . . 0.0 112.382 178.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' MET . . . . . 0.491 ' HE1' HD22 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -92.89 130.87 38.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.368 179.328 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.523 HG23 ' HB ' ' A' ' 209' ' ' VAL . 42.7 t -98.5 133.62 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.247 0.546 . . . . 0.0 112.091 -174.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.716 ' HB2' ' O ' ' A' ' 208' ' ' THR . 0.1 OUTLIER -81.56 159.07 24.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.974 170.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 9.0 t -74.06 -10.61 59.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.277 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.4 mp -88.88 -2.29 58.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.373 176.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 95.5 -13.91 65.82 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.07 -177.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.716 ' O ' ' HB2' ' A' ' 204' ' ' GLU . 49.5 m -67.65 110.27 3.65 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 176.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.523 ' HB ' HG23 ' A' ' 203' ' ' VAL . 1.1 p -112.14 120.61 62.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.925 0.869 . . . . 0.0 110.504 175.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.5 HD13 HG21 ' A' ' 168' ' ' THR . 0.4 OUTLIER -76.7 103.55 6.73 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.354 -170.233 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.459 ' O ' ' HA2' ' A' ' 133' ' ' GLY . 44.8 mt-30 -90.09 89.3 7.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.851 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.423 ' HB2' ' HA ' ' A' ' 198' ' ' LYS . 7.6 mp -71.27 113.89 8.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.656 178.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -115.81 -56.6 2.31 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.648 ' O ' ' HA ' ' A' ' 134' ' ' SER . 4.2 pm0 -136.84 140.91 33.16 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.072 0.463 . . . . 0.0 110.898 -177.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.486 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 59.9 Cg_endo -73.68 146.05 37.95 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.645 2.23 . . . . 0.0 112.753 -178.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.529 HD11 ' CD2' ' A' ' 126' ' ' LEU . 0.2 OUTLIER -86.75 105.46 16.98 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 174.712 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -60.78 138.64 58.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.996 0.427 . . . . 0.0 110.953 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 7.0 p -61.83 114.14 3.16 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.671 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.446 -0.669 0 CA-C-O 121.446 0.641 . . . . 0.0 109.523 177.052 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . 0.493 ' HA ' ' OE2' ' A' ' 204' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.416 0 CA-C-O 121.268 0.556 . . . . 0.0 110.507 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 86.0 m -71.5 -42.3 68.19 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.877 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.425 HG13 ' CG1' ' A' ' 181' ' ' VAL . 13.5 mm 73.68 99.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.113 0.565 . . . . 0.0 111.192 175.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 C--N 1.32 -0.678 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.099 -179.892 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo . . . . . 0 N--CA 1.463 -0.321 0 N-CA-C 110.108 -0.766 . . . . 0.0 110.108 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.516 ' HB ' ' CG ' ' A' ' 113' ' ' PHE . 42.1 p -98.39 8.05 45.38 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.609 -178.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 66.5 p -74.86 34.65 0.1 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.933 0.397 . . . . 0.0 111.563 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.463 ' H ' ' C ' ' A' ' 108' ' ' THR . 60.7 mm-40 -115.8 157.22 24.72 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -75.65 -12.2 60.16 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -167.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 4.4 p-90 -85.29 -14.68 45.84 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.827 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.516 ' CG ' ' HB ' ' A' ' 108' ' ' THR . 68.4 t80 -77.59 120.25 22.28 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.125 0.488 . . . . 0.0 110.389 171.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.472 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 10.6 m170 -121.08 106.57 11.68 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 175.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -73.93 -45.96 24.83 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.541 -171.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -99.01 83.72 2.94 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.052 0.453 . . . . 0.0 111.139 -173.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.4 mt -148.44 138.07 22.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.493 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.8 p -90.62 173.25 8.15 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 169.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.71 -48.9 49.1 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.862 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -76.48 -32.35 58.31 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.438 ' O ' HD21 ' A' ' 125' ' ' LEU . 48.6 mt-10 -64.02 -46.79 82.91 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.026 176.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.574 ' HB2' ' HD2' ' A' ' 138' ' ' ARG . . . -66.64 -33.69 76.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.693 177.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.547 ' HG3' ' HB ' ' A' ' 167' ' ' VAL . 4.2 tt0 -62.51 -50.37 71.65 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.215 176.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.66 -34.49 72.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.22 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.438 HD21 ' O ' ' A' ' 121' ' ' GLU . 0.7 OUTLIER -56.22 -52.9 62.74 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.332 0.587 . . . . 0.0 110.494 -178.069 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.562 ' CD2' HD11 ' A' ' 216' ' ' LEU . 54.2 mt -75.7 -46.72 29.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.514 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.6 m -61.28 -32.54 72.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.337 -172.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -97.36 -53.7 3.38 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 178.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -93.03 -21.35 19.79 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -170.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -89.1 -161.24 37.32 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.937 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -153.88 175.63 13.12 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 174.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -51.08 117.63 2.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.918 0.39 . . . . 0.0 110.891 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 99.93 -3.75 57.32 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.996 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.62 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 68.7 m -75.96 139.63 41.66 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.52 -0.4 . . . . 0.0 110.647 178.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.482 ' CB ' HG13 ' A' ' 151' ' ' VAL . 52.8 p90 -137.5 151.4 48.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.771 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.568 ' CD2' ' HB2' ' A' ' 150' ' ' SER . 1.2 pt? -151.71 138.02 18.47 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.435 HG21 HD12 ' A' ' 190' ' ' LEU . 14.2 m -97.62 137.94 23.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.308 176.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.574 ' HD2' ' HB2' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -137.64 162.14 34.61 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.053 -174.765 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -76.66 134.38 39.29 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.483 ' HB2' HG13 ' A' ' 148' ' ' VAL . 33.2 t -80.93 143.65 32.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.174 -175.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -101.15 -22.76 14.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.914 174.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 72.7 m -69.86 -40.35 75.82 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.439 0.637 . . . . 0.0 109.356 170.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -121.93 83.14 43.49 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.036 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -55.47 123.58 14.15 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.506 2.137 . . . . 0.0 111.553 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 106.7 -32.14 7.57 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.906 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -88.28 170.29 11.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.877 0.37 . . . . 0.0 110.431 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -121.65 153.96 37.45 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.151 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.515 ' CG2' ' HG3' ' A' ' 138' ' ' ARG . 30.2 m -129.38 138.86 53.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.159 0.504 . . . . 0.0 110.52 176.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.488 ' HB3' ' CG2' ' A' ' 170' ' ' VAL . 0.6 OUTLIER -92.18 110.13 21.51 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.149 177.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.568 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 3.3 m -101.42 132.01 47.23 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.408 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.542 HG22 ' HB3' ' A' ' 210' ' ' LEU . 32.0 m -132.47 149.44 32.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.96 -174.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.453 ' HB2' ' HB3' ' A' ' 126' ' ' LEU . 72.9 ttt180 -96.0 104.16 16.09 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.031 0.443 . . . . 0.0 109.898 176.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -107.69 147.15 31.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.224 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.648 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.405 -178.77 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.889 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.547 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 71.4 t -99.96 112.52 32.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.396 0.617 . . . . 0.0 110.492 177.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.586 ' CG2' ' HB1' ' B' ' 1' ' ' ALA . 6.3 m -92.01 140.5 29.59 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.641 175.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 150' ' ' SER . 7.5 m-70 -118.5 120.15 36.66 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.669 HG11 ' SD ' ' A' ' 202' ' ' MET . 1.1 m -98.16 138.8 21.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -177.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 5.7 ttm -90.45 118.69 30.12 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.941 -174.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 25.6 mt -93.47 127.97 45.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.661 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.584 ' NH1' ' HA2' ' A' ' 182' ' ' GLY . 5.0 ptp180 -87.77 112.26 22.24 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.043 0.449 . . . . 0.0 109.942 177.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 47.0 t -96.89 92.6 6.2 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -113.77 113.78 25.42 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.48 -175.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 58.63 40.89 23.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.857 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 93.9 mt 67.1 18.78 10.49 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.82 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -109.95 139.05 45.48 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 172.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.449 ' CD1' ' HG ' ' A' ' 190' ' ' LEU . 51.5 m-85 -109.54 138.53 45.77 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.841 -175.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.567 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 9.6 t0 -155.73 140.99 17.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.028 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.545 ' HB ' ' CE1' ' A' ' 197' ' ' TYR . 14.4 t -94.62 -12.43 8.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.657 0.742 . . . . 0.0 109.342 176.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . 0.584 ' HA2' ' NH1' ' A' ' 173' ' ' ARG . . . 123.21 9.02 6.24 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.166 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -138.07 140.59 11.3 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.242 -0.98 . . . . 0.0 113.755 -176.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.67 -119.87 5.59 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.376 173.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -115.76 158.69 22.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.631 0.253 . . . . 0.0 110.564 -173.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -95.43 128.65 42.46 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -110.31 144.28 39.26 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.076 -173.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -79.8 -8.66 59.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.413 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 85.1 p -130.46 143.9 51.06 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.479 177.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.449 ' HG ' ' CD1' ' A' ' 179' ' ' TYR . 1.1 mt -70.65 -22.08 62.54 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.37 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.489 ' O ' ' HG3' ' A' ' 195' ' ' GLU . 4.0 m -60.42 -49.18 78.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.637 177.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -67.14 -30.52 70.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.705 0.288 . . . . 0.0 110.565 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.501 HD12 HG21 ' A' ' 181' ' ' VAL . 3.4 tm? -62.15 -54.83 35.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.836 177.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 35.7 m -68.97 -39.69 80.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.999 -175.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 191' ' ' THR . 22.7 mt-10 -66.67 -35.27 79.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.414 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -60.26 -42.78 96.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.818 0.342 . . . . 0.0 110.414 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.545 ' CE1' ' HB ' ' A' ' 181' ' ' VAL . 40.5 m-85 -85.44 -11.62 53.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.376 0.608 . . . . 0.0 110.649 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.401 ' HE2' ' HA ' ' A' ' 195' ' ' GLU . 38.4 ttpt -73.67 -27.67 61.35 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 173.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -90.29 -35.99 14.95 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.442 175.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -116.38 102.78 53.42 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.511 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -57.93 126.43 21.64 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.603 2.202 . . . . 0.0 111.974 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' MET . . . . . 0.691 ' SD ' HD21 ' A' ' 210' ' ' LEU . 9.5 ptp -89.11 120.48 30.54 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.633 -177.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.552 HG22 ' HB ' ' A' ' 209' ' ' VAL . 28.7 t -97.91 136.55 28.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.662 0.268 . . . . 0.0 111.72 -175.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.546 ' O ' HG11 ' A' ' 203' ' ' VAL . 22.6 mt-10 -85.79 167.09 15.53 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.877 0.37 . . . . 0.0 110.063 169.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 12.1 t -75.16 -14.83 60.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.276 0.56 . . . . 0.0 109.978 177.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.434 ' N ' HD12 ' A' ' 206' ' ' LEU . 5.1 mp -81.73 -7.44 59.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.153 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 99.82 -21.23 45.87 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.869 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 89.8 m -62.94 112.13 2.44 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.552 ' HB ' HG22 ' A' ' 203' ' ' VAL . 0.8 OUTLIER -112.82 121.82 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 CA-C-O 121.616 0.722 . . . . 0.0 110.574 173.836 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.691 HD21 ' SD ' ' A' ' 202' ' ' MET . 0.4 OUTLIER -77.12 107.94 9.84 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.767 -174.708 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -93.54 90.23 6.59 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.008 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 7.8 mp -74.02 103.4 4.49 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.242 -177.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -115.47 -55.79 2.41 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.62 ' O ' ' HA ' ' A' ' 134' ' ' SER . 0.1 OUTLIER -115.09 132.89 22.8 Favored Pre-proline 0 C--O 1.223 -0.305 0 CA-C-O 120.483 0.182 . . . . 0.0 111.323 -173.706 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.09 132.78 11.81 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.315 2.01 . . . . 0.0 111.817 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.562 HD11 ' CD2' ' A' ' 126' ' ' LEU . 0.3 OUTLIER -78.88 102.02 8.0 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.173 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -58.13 140.24 53.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.705 178.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.3 p -62.58 125.54 24.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.335 0.588 . . . . 0.0 111.554 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.318 -0.763 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.076 -179.85 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . 0.586 ' HB1' ' CG2' ' A' ' 168' ' ' THR . . . . . . . . 0 N--CA 1.465 0.287 0 CA-C-O 121.797 0.808 . . . . 0.0 113.1 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 63.4 m -73.48 -47.03 44.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.443 -1.253 . . . . 0.0 111.521 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.68 HD13 ' SD ' ' A' ' 202' ' ' MET . 6.4 mm 66.32 105.25 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 123.224 0.61 . . . . 0.0 111.63 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.323 -0.555 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.333 175.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo . . . . . 0 CA--C 1.508 -0.816 0 CA-C-O 121.807 0.67 . . . . 0.0 110.741 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.439 ' HB ' ' HB2' ' A' ' 190' ' ' LEU . 8.9 t -101.07 5.94 43.14 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.348 175.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.7 t -71.74 65.54 0.51 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 121.792 0.805 . . . . 0.0 110.035 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -130.27 169.89 14.83 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.033 -175.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -64.83 -17.1 63.95 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -167.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.427 ' CZ2' ' HA ' ' A' ' 191' ' ' THR . 1.3 p-90 -92.93 -13.33 29.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.858 0.361 . . . . 0.0 111.467 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 137' ' ' VAL . 24.6 t80 -89.37 118.57 29.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.175 0.512 . . . . 0.0 110.806 177.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -109.65 119.26 38.84 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -49.8 -86.02 0.01 OUTLIER Glycine 0 C--N 1.331 0.256 0 O-C-N 123.98 0.8 . . . . 0.0 114.213 -170.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -100.4 107.2 18.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.521 0.677 . . . . 0.0 111.227 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 33.9 mt -129.57 140.92 51.08 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.951 174.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 18.1 t -90.0 171.31 9.65 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 173.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.34 -53.18 42.58 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.835 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 20.9 mmtm -76.73 -25.45 53.54 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.445 ' O ' HD22 ' A' ' 125' ' ' LEU . 15.2 mm-40 -65.29 -47.03 78.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.948 0.404 . . . . 0.0 110.225 175.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.504 ' HB2' ' HD2' ' A' ' 138' ' ' ARG . . . -65.59 -34.26 77.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.282 0.563 . . . . 0.0 110.492 178.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -67.94 -50.14 57.73 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.851 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -56.97 -34.65 68.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.788 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' A' ' 129' ' ' LYS . 0.7 OUTLIER -57.14 -52.69 64.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.275 178.484 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.539 ' CD2' HD11 ' A' ' 216' ' ' LEU . 55.1 mt -76.04 -51.88 11.38 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.5 m -61.07 -35.84 78.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.75 -171.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -97.68 -46.63 5.92 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 125' ' ' LEU . 89.0 mttt -91.23 -28.88 17.52 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.668 -0.413 . . . . 0.0 112.015 -171.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -93.17 -158.98 34.56 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.831 -176.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.426 ' C ' ' HD3' ' A' ' 152' ' ' ARG . 14.9 ptmm? -148.08 176.0 10.56 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -51.92 123.85 11.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.707 0.289 . . . . 0.0 110.513 176.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 94.87 -3.64 67.66 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.239 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.612 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 69.0 m -73.61 139.15 45.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.059 0.429 . . . . 0.0 110.313 178.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.488 ' CB ' HG13 ' A' ' 151' ' ' VAL . 50.4 p90 -136.93 149.38 47.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.71 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.529 ' CD2' ' HB2' ' A' ' 150' ' ' SER . 1.2 pt? -150.64 140.4 21.77 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 11.4 m -99.73 144.1 12.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.186 175.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.504 ' HD2' ' HB2' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -146.0 156.69 43.67 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.845 -173.682 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -70.31 132.73 46.13 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 175.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.459 ' HB2' HG11 ' A' ' 148' ' ' VAL . 37.9 t -86.22 143.43 27.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.916 0.389 . . . . 0.0 110.38 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -100.63 -20.25 15.74 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.691 178.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 65.9 m -78.75 -30.56 45.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.141 0.496 . . . . 0.0 109.789 172.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -120.55 86.16 39.26 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.858 173.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -61.49 123.19 12.28 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.241 1.96 . . . . 0.0 111.892 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 101.35 -14.82 57.99 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.166 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -105.61 164.08 12.17 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.168 0.509 . . . . 0.0 110.865 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -119.24 153.89 34.28 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.721 -177.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.459 HG11 ' HB2' ' A' ' 140' ' ' SER . 34.5 m -130.31 139.94 50.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.393 0.616 . . . . 0.0 111.371 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.53 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -92.64 110.37 21.79 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.256 178.17 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.529 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 1.5 m -102.97 131.27 50.05 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.115 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.5 HG22 ' HB3' ' A' ' 210' ' ' LEU . 35.3 m -132.12 146.81 32.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.166 -173.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.426 ' HD3' ' C ' ' A' ' 131' ' ' LYS . 75.0 ttt180 -90.56 104.67 17.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.339 0.59 . . . . 0.0 109.968 176.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 8.8 p -102.23 147.43 26.66 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.392 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.603 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.76 -177.671 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 166' ' ' LYS . 25.6 mmmt . . . . . 0 N--CA 1.448 -0.541 0 CA-C-O 121.09 0.471 . . . . 0.0 111.846 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 71.3 t -125.73 113.32 34.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.71 170.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.51 ' CG2' ' HB3' ' B' ' 1' ' ' ALA . 1.8 m -97.83 138.18 35.57 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.898 175.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 150' ' ' SER . 14.2 m-70 -112.73 117.99 33.74 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.53 HG22 ' HB3' ' A' ' 149' ' ' LEU . 1.3 m -98.35 135.72 32.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -175.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 40.1 tpp -81.3 116.78 21.32 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.893 -174.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.481 HG21 HD22 ' A' ' 190' ' ' LEU . 16.6 mt -97.03 107.67 20.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.563 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 3.9 ptp180 -70.11 117.73 12.05 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.617 -178.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 36.6 t -93.02 94.59 8.97 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -113.78 109.59 18.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.47 -174.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 53.01 40.52 31.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.802 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 96.1 mt 72.66 15.13 4.97 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.169 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.88 142.94 34.74 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 170.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -110.8 140.99 44.74 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.53 -176.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.563 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 10.6 t0 -156.02 137.95 14.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.753 0.311 . . . . 0.0 111.048 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.486 HG22 HD12 ' A' ' 193' ' ' LEU . 48.6 t -90.11 -13.16 9.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.724 0.773 . . . . 0.0 109.322 175.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . 0.554 ' HA2' ' NH1' ' A' ' 173' ' ' ARG . . . 124.09 5.23 7.5 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.763 178.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -137.14 140.41 11.37 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 119.807 -1.187 . . . . 0.0 113.918 -174.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 79.45 -116.46 4.31 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.088 -0.577 . . . . 0.0 113.18 174.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -115.92 150.18 37.53 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 122.291 0.236 . . . . 0.0 110.436 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -80.96 126.96 32.03 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 171.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -105.62 138.69 41.4 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.099 0.476 . . . . 0.0 111.326 -172.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -70.13 -22.77 62.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.788 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 82.2 p -130.71 144.62 51.56 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.517 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.481 HD22 HG21 ' A' ' 172' ' ' ILE . 8.8 mt -65.66 -20.92 66.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.11 176.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.427 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 3.7 m -55.89 -48.91 74.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.694 0.283 . . . . 0.0 110.538 176.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -69.24 -34.73 75.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.764 0.316 . . . . 0.0 110.334 176.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.486 HD12 HG22 ' A' ' 181' ' ' VAL . 2.9 tm? -59.75 -54.0 51.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.987 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 30.5 m -69.58 -41.86 80.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.389 -174.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -66.68 -36.37 82.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.447 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -61.03 -44.9 96.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.751 0.31 . . . . 0.0 110.752 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.415 ' CZ ' ' HB ' ' A' ' 181' ' ' VAL . 55.6 m-85 -85.23 -10.48 56.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.008 0.432 . . . . 0.0 110.799 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.473 ' HA ' ' HB2' ' A' ' 212' ' ' LEU . 38.9 ttpt -70.13 -34.03 72.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.608 0.718 . . . . 0.0 109.228 174.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -88.01 -25.75 22.96 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.043 176.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -128.31 90.78 45.97 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.801 -174.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -55.17 127.98 28.57 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.177 2.584 . . . . 0.0 112.587 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' MET . . . . . 0.489 ' HE1' HD22 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -91.63 123.78 35.28 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.956 0.408 . . . . 0.0 110.415 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.55 HG22 ' HB ' ' A' ' 209' ' ' VAL . 36.3 t -93.87 134.89 29.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 120.85 0.357 . . . . 0.0 111.871 -176.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.533 ' O ' HG12 ' A' ' 203' ' ' VAL . 0.7 OUTLIER -79.2 163.64 24.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.49 169.245 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 7.7 t -76.33 -10.0 59.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.452 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.4 mp -92.2 5.03 51.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.432 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 90.99 -14.5 63.27 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.703 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.493 ' O ' ' HB2' ' A' ' 204' ' ' GLU . 88.2 m -71.6 111.42 6.88 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.55 ' HB ' HG22 ' A' ' 203' ' ' VAL . 1.4 p -111.81 128.27 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-O 121.82 0.819 . . . . 0.0 110.854 176.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.5 ' HB3' HG22 ' A' ' 151' ' ' VAL . 0.3 OUTLIER -84.8 103.49 13.93 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.83 -172.884 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -90.88 89.41 7.45 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.216 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.473 ' HB2' ' HA ' ' A' ' 198' ' ' LYS . 7.6 mp -71.79 108.55 5.15 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.314 177.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -115.11 -56.01 2.41 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -177.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.612 ' O ' ' HA ' ' A' ' 134' ' ' SER . 5.0 pm0 -131.95 136.46 28.32 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 121.068 0.461 . . . . 0.0 110.746 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.01 137.54 26.75 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.918 2.412 . . . . 0.0 112.798 -178.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.539 HD11 ' CD2' ' A' ' 126' ' ' LEU . 0.2 OUTLIER -76.7 98.88 4.89 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 175.792 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -63.77 139.18 58.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.905 0.384 . . . . 0.0 110.574 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 7.5 p -61.66 110.49 1.51 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.394 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 C--N 1.319 -0.74 0 CA-C-O 121.463 0.649 . . . . 0.0 109.517 177.474 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . 0.51 ' HB3' ' CG2' ' A' ' 168' ' ' THR . . . . . . . . 0 C--O 1.232 0.157 0 CA-C-O 121.305 0.574 . . . . 0.0 111.746 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 71.8 m -76.05 -41.81 49.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.742 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.417 HG13 ' CG1' ' A' ' 181' ' ' VAL . 8.5 mm 68.48 120.54 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.291 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.466 0.355 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.224 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo . . . . . 0 CA--C 1.515 -0.471 0 N-CA-C 109.29 -1.081 . . . . 0.0 109.29 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.694 ' HB ' ' CG ' ' A' ' 113' ' ' PHE . 22.9 p -88.12 7.37 31.92 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 113.619 -1.628 . . . . 0.0 110.738 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.4 p -71.26 47.07 0.11 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.483 0.659 . . . . 0.0 111.258 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.425 ' HG3' ' CZ2' ' A' ' 112' ' ' TRP . 70.8 mm-40 -122.03 -176.9 3.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.84 -176.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -85.92 -23.43 27.0 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -176.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.445 ' CZ2' ' HA ' ' A' ' 191' ' ' THR . 2.8 p-90 -85.16 -20.34 30.4 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.812 -177.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.694 ' CG ' ' HB ' ' A' ' 108' ' ' THR . 60.2 t80 -80.27 127.15 32.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.98 0.419 . . . . 0.0 110.405 173.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -118.56 113.09 20.74 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.427 ' HA2' ' CZ ' ' A' ' 113' ' ' PHE . . . -50.44 -82.4 0.04 OUTLIER Glycine 0 C--O 1.237 0.315 0 O-C-N 123.971 0.794 . . . . 0.0 114.599 -169.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -99.83 90.59 4.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.185 0.517 . . . . 0.0 111.393 -173.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 44.5 mt -126.21 130.56 51.19 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.164 173.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.4 m -81.85 170.82 15.22 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 171.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -54.66 -47.45 70.69 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.45 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -64.71 -44.39 90.4 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 122.704 0.402 . . . . 0.0 110.974 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -62.7 -46.75 86.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.238 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.538 ' HB1' ' HD2' ' A' ' 138' ' ' ARG . . . -60.32 -34.32 73.64 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.945 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.501 ' HG3' ' HB ' ' A' ' 167' ' ' VAL . 3.7 tt0 -69.93 -46.64 64.91 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.529 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -56.92 -36.21 69.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.647 175.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.64 -52.59 64.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.601 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.526 ' CD2' HD12 ' A' ' 216' ' ' LEU . 58.2 mt -75.12 -49.43 19.62 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.568 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.7 m -61.95 -29.58 70.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.326 -172.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -95.56 -51.97 4.32 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 177.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -105.77 -0.81 25.06 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -163.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -106.09 -161.52 22.72 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.169 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -149.86 173.8 13.36 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 174.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 55.0 t60 -53.61 117.39 3.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.964 0.411 . . . . 0.0 111.025 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 100.95 -3.76 55.83 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.985 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.68 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 68.5 m -72.57 139.87 47.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.99 0.395 . . . . 0.0 110.608 178.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.464 ' CB ' HG11 ' A' ' 151' ' ' VAL . 52.1 p90 -136.92 150.82 48.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.612 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.562 ' CD2' ' HB2' ' A' ' 150' ' ' SER . 1.3 pt? -151.22 138.04 18.94 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 148' ' ' VAL . 11.2 m -100.55 140.23 20.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 120.231 -0.588 . . . . 0.0 109.441 177.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.538 ' HD2' ' HB1' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -141.04 161.56 37.55 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.311 -174.683 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -72.84 132.83 44.05 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.579 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.47 ' HB2' HG11 ' A' ' 148' ' ' VAL . 29.5 t -77.37 143.46 38.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.531 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -100.6 -30.1 11.96 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.145 178.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 72.6 m -74.32 -30.73 62.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.02 0.438 . . . . 0.0 110.256 173.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -121.49 85.53 43.27 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.193 175.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.66 123.73 14.21 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.525 2.15 . . . . 0.0 111.808 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 105.94 -27.69 16.6 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.701 -176.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -89.99 171.65 9.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.247 0.546 . . . . 0.0 110.614 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -124.36 157.52 34.84 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.314 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.487 ' CG2' ' HG3' ' A' ' 138' ' ' ARG . 32.1 m -128.13 136.58 59.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.298 0.571 . . . . 0.0 110.717 174.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.522 ' HB3' ' CG2' ' A' ' 170' ' ' VAL . 0.5 OUTLIER -91.77 109.61 20.94 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.318 -0.856 . . . . 0.0 108.848 176.81 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.562 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 2.1 m -102.46 132.38 48.53 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.212 -178.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.498 HG21 ' HB3' ' A' ' 210' ' ' LEU . 34.7 m -130.43 147.8 33.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.128 -172.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -92.84 105.08 17.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.744 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 166' ' ' LYS . 1.2 p -108.52 148.43 30.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.777 -175.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.738 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.883 177.221 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 153' ' ' THR . 46.1 tptt . . . . . 0 N--CA 1.446 -0.637 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.501 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 69.2 t -126.62 112.61 29.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.51 0.671 . . . . 0.0 110.503 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.55 ' CG2' ' HB2' ' B' ' 1' ' ' ALA . 3.9 m -96.38 140.3 31.24 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.623 174.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 150' ' ' SER . 18.9 m-70 -115.57 119.16 35.24 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.529 HG11 ' SD ' ' A' ' 202' ' ' MET . 1.0 OUTLIER -98.37 134.91 35.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -178.835 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 9.8 ttm -88.6 119.04 28.69 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.395 -176.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 12.5 mt -94.05 113.73 29.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.072 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.601 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 19.9 ptp180 -74.21 118.28 16.98 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.146 0.498 . . . . 0.0 110.189 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 46.1 t -102.56 93.07 4.94 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -114.73 108.5 16.86 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.364 -176.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 57.64 48.39 14.22 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.704 0.628 . . . . 0.0 110.573 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 88.9 mt 64.82 24.88 12.85 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.768 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 10.4 tppt? -115.08 133.46 56.02 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -113.38 130.87 56.18 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 123.012 0.195 . . . . 0.0 111.026 -173.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.601 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 34.6 t0 -156.42 136.15 12.51 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.945 0.402 . . . . 0.0 110.796 175.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.534 ' HB ' ' CZ ' ' A' ' 197' ' ' TYR . 25.9 t -85.41 -15.64 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 123.69 4.23 8.16 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.251 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -136.19 141.14 12.18 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.812 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 80.42 -158.09 41.21 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.685 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -85.76 155.16 21.15 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -84.94 130.58 34.61 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -105.89 153.54 21.8 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.031 0.443 . . . . 0.0 111.58 -172.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -91.61 -7.39 50.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.379 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 49.3 m -130.12 142.56 50.58 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.59 176.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 2.0 mt -72.87 -22.69 60.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.622 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.445 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 3.7 m -59.71 -46.28 89.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.671 176.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -66.3 -35.5 80.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.123 177.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.493 HD11 HG22 ' A' ' 181' ' ' VAL . 3.2 tm? -61.76 -54.96 35.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.306 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 34.6 m -66.69 -42.9 90.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.224 -173.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -70.38 -30.75 67.74 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.557 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -59.89 -42.93 94.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.775 0.321 . . . . 0.0 110.441 176.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.534 ' CZ ' ' HB ' ' A' ' 181' ' ' VAL . 56.3 m-85 -85.1 -13.29 50.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.207 0.527 . . . . 0.0 110.619 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.405 ' HA ' ' HB2' ' A' ' 212' ' ' LEU . 39.8 ttpt -72.68 -25.33 61.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.546 0.689 . . . . 0.0 109.487 174.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . 0.41 ' HE2' ' HA ' ' A' ' 199' ' ' LYS . 11.8 mmpt? -91.65 -36.0 13.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.903 175.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -120.78 102.15 44.78 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.623 -176.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.11 133.47 58.29 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.853 2.369 . . . . 0.0 112.58 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' MET . . . . . 0.831 ' SD ' HD13 ' B' ' 3' ' ' ILE . 7.3 ptp -96.65 128.15 43.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.493 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.567 HG22 ' HB ' ' A' ' 209' ' ' VAL . 40.6 t -101.52 137.87 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -175.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.556 ' O ' HG13 ' A' ' 203' ' ' VAL . 35.8 mt-10 -84.39 166.07 17.67 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.209 0.528 . . . . 0.0 110.382 170.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 12.1 t -77.21 -10.37 59.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.761 174.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.6 mp -91.43 8.91 34.05 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.402 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 86.77 -21.36 19.37 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.87 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 65.6 m -65.58 113.2 4.03 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.567 ' HB ' HG22 ' A' ' 203' ' ' VAL . 0.8 OUTLIER -111.64 124.66 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-O 121.785 0.802 . . . . 0.0 110.505 174.477 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.536 HD21 ' SD ' ' A' ' 202' ' ' MET . 0.4 OUTLIER -78.84 107.39 11.53 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.215 -172.523 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -92.3 89.43 6.84 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.836 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 198' ' ' LYS . 7.4 mp -74.57 110.8 9.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.767 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -114.27 -56.21 2.41 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.68 ' O ' ' HA ' ' A' ' 134' ' ' SER . 4.3 pm0 -135.69 142.56 41.3 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 121.024 0.44 . . . . 0.0 111.103 -176.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.441 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 74.4 Cg_endo -74.27 138.1 24.45 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.992 2.461 . . . . 0.0 112.728 -178.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.526 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.3 OUTLIER -74.12 108.39 6.9 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.787 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -55.75 131.42 46.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.9 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 2.6 p -61.68 126.85 28.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.342 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 3.1 t . . . . . 0 C--N 1.323 -0.579 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.362 179.603 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . 0.55 ' HB2' ' CG2' ' A' ' 168' ' ' THR . . . . . . . . 0 CA--C 1.52 -0.178 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 22.8 m -63.78 -44.47 93.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.045 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.831 HD13 ' SD ' ' A' ' 202' ' ' MET . 4.4 mm 60.06 96.84 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 123.267 0.627 . . . . 0.0 111.017 -177.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.459 -178.552 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo . . . . . 0 N--CA 1.457 -0.641 0 N-CA-C 109.543 -0.983 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.74 ' HB ' ' CG ' ' A' ' 113' ' ' PHE . 48.2 p -100.26 4.3 44.1 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 114.018 -1.447 . . . . 0.0 111.098 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 44.4 m -75.57 45.31 0.31 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.609 0.718 . . . . 0.0 110.667 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -117.11 -170.46 1.85 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.625 -175.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.518 ' O ' HG23 ' A' ' 218' ' ' THR . 33.9 mtm180 -83.05 -28.05 29.85 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -176.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.472 ' CZ2' ' HA ' ' A' ' 191' ' ' THR . 2.2 p-90 -85.66 -21.53 28.34 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -174.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.74 ' CG ' ' HB ' ' A' ' 108' ' ' THR . 80.9 t80 -79.62 121.0 24.74 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.282 0.563 . . . . 0.0 111.067 177.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.478 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 11.8 m170 -116.88 124.56 49.77 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 173.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -68.5 -95.29 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.479 -173.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -76.46 93.09 3.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.139 0.495 . . . . 0.0 111.257 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.3 mt -131.37 139.16 49.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.424 174.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.409 ' HB3' ' HG2' ' A' ' 121' ' ' GLU . 21.1 t -94.57 172.58 8.09 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 172.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.44 -52.95 46.82 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.011 -176.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -75.71 -25.51 56.7 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.568 0.21 . . . . 0.0 111.568 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.409 ' HG2' ' HB3' ' A' ' 118' ' ' SER . 52.5 mm-40 -66.45 -47.5 72.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.108 0.48 . . . . 0.0 109.72 177.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.544 ' HB3' ' HD2' ' A' ' 138' ' ' ARG . . . -67.62 -34.16 76.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.68 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.529 ' HG3' ' HB ' ' A' ' 167' ' ' VAL . 5.9 tt0 -63.53 -47.28 82.26 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.198 177.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.82 -34.86 75.18 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.774 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.445 HD11 HD12 ' A' ' 216' ' ' LEU . 0.8 OUTLIER -56.71 -53.25 59.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.516 -179.667 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.53 ' CD2' HD13 ' A' ' 216' ' ' LEU . 58.7 mt -75.75 -44.04 43.66 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.627 -177.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 9.5 m -61.0 -35.01 75.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.29 -173.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -95.68 -52.85 3.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.073 0.463 . . . . 0.0 111.862 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -96.85 -11.33 24.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.325 -166.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -96.32 -164.15 33.35 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.82 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -153.76 173.88 15.28 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -55.13 116.02 2.56 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.928 0.394 . . . . 0.0 110.5 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 100.8 -3.27 55.89 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.525 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 42.6 p -71.12 137.48 48.88 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 117.494 0.647 . . . . 0.0 110.317 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.448 ' CB ' HG12 ' A' ' 151' ' ' VAL . 45.8 p90 -136.85 150.64 48.4 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.438 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.526 ' CD2' HD11 ' A' ' 126' ' ' LEU . 1.2 pt? -153.2 134.19 14.0 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.367 176.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.408 HG11 HD12 ' A' ' 149' ' ' LEU . 10.6 m -96.89 138.75 21.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 176.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.544 ' HD2' ' HB3' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -139.55 162.81 34.16 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.869 -173.403 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -71.0 132.76 45.64 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 121.089 -0.244 . . . . 0.0 110.343 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.456 ' HB2' HG11 ' A' ' 148' ' ' VAL . 41.3 t -77.11 136.68 38.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.357 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -100.39 -26.18 13.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.826 0.346 . . . . 0.0 110.163 176.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.1 t -72.49 -36.0 68.3 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 172.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 47.6 m-70 -121.41 81.51 38.64 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.018 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.94 123.49 13.92 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.524 2.149 . . . . 0.0 112.267 -178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 107.32 -26.66 17.89 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.915 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -89.99 170.64 10.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.95 0.405 . . . . 0.0 110.518 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -122.13 153.56 38.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.825 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.497 ' CG2' ' HG3' ' A' ' 138' ' ' ARG . 21.9 m -127.86 137.47 57.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.105 0.479 . . . . 0.0 110.668 176.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.551 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -92.63 110.11 21.53 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.407 178.353 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.518 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 2.3 m -101.65 132.63 47.23 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.517 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.495 HG23 ' HB3' ' A' ' 210' ' ' LEU . 35.1 m -131.25 149.79 33.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.988 -174.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.414 ' HB2' ' HB3' ' A' ' 126' ' ' LEU . 41.6 ttt180 -96.38 104.7 16.69 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.289 0.566 . . . . 0.0 109.925 176.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.511 ' O ' ' HB3' ' A' ' 166' ' ' LYS . 5.0 p -101.51 147.32 26.52 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.877 -178.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.912 0 C-N-CA 119.942 -1.123 . . . . 0.0 112.05 -176.814 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 153' ' ' THR . 47.6 tptt . . . . . 0 N--CA 1.45 -0.466 0 CA-C-O 121.013 0.435 . . . . 0.0 111.073 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.529 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 70.6 t -124.68 114.42 40.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.267 173.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.49 HG23 HD13 ' A' ' 210' ' ' LEU . 18.6 m -98.96 137.51 37.39 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.965 175.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 150' ' ' SER . 21.1 m-70 -112.29 118.83 36.35 Favored 'General case' 0 C--O 1.211 -0.922 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.551 HG22 ' HB3' ' A' ' 149' ' ' LEU . 1.0 OUTLIER -99.02 138.05 24.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.362 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' MET . . . . . 0.405 ' SD ' HG12 ' A' ' 148' ' ' VAL . 44.6 tpp -85.56 120.11 26.65 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.723 0.297 . . . . 0.0 110.756 -175.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 32.4 mt -94.04 107.08 18.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.606 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 3.6 ptp180 -67.55 107.1 2.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.211 0.529 . . . . 0.0 110.034 -178.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 36.8 m -98.46 93.13 6.0 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.647 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -114.31 108.91 17.55 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.005 -176.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 58.93 46.29 13.91 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 123.446 0.466 . . . . 0.0 110.698 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 91.5 mt 64.58 21.98 12.55 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.589 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 174' ' ' CYS . 1.7 tppp? -106.89 137.92 44.04 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 175.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -119.14 132.78 56.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.768 0.318 . . . . 0.0 111.454 -172.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.606 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 10.5 t70 -156.0 139.35 15.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.201 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.587 ' HB ' ' CZ ' ' A' ' 197' ' ' TYR . 37.9 t -89.23 -16.19 8.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.853 0.835 . . . . 0.0 109.075 175.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . 0.545 ' HA2' ' NH1' ' A' ' 173' ' ' ARG . . . 123.36 10.23 5.64 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.163 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -136.61 140.27 11.34 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 119.943 -1.123 . . . . 0.0 113.676 -176.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 67.13 -148.99 50.82 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 121.286 -0.483 . . . . 0.0 113.184 175.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -79.31 145.08 33.68 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.546 -0.327 . . . . 0.0 110.517 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.416 ' HG2' ' HB2' ' A' ' 180' ' ' ASP . 79.0 mtt180 -85.55 133.21 34.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.972 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -108.18 149.88 27.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.329 0.585 . . . . 0.0 111.723 -173.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.439 ' OD1' ' HE2' ' A' ' 178' ' ' LYS . 3.2 m-20 -87.55 -15.28 37.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.984 -178.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.4 p -130.64 142.4 50.44 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.231 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.404 HD11 HG22 ' A' ' 137' ' ' VAL . 9.1 mt -71.47 -22.99 61.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.232 -175.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.472 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 18.0 m -61.74 -43.52 98.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.018 0.437 . . . . 0.0 110.321 177.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -72.98 -32.92 65.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.932 177.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.484 HD13 HG22 ' A' ' 181' ' ' VAL . 3.2 tm? -61.02 -54.44 44.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.294 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 26.9 m -66.78 -43.08 90.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.629 -173.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.459 ' HA ' ' HE2' ' A' ' 198' ' ' LYS . 9.5 mt-10 -70.08 -30.46 67.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.511 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -59.02 -41.89 88.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.716 0.294 . . . . 0.0 110.498 176.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.587 ' CZ ' ' HB ' ' A' ' 181' ' ' VAL . 69.1 m-85 -86.15 -7.16 58.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.834 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.459 ' HE2' ' HA ' ' A' ' 195' ' ' GLU . 40.8 mtmt -69.27 -32.53 71.76 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 170.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -92.28 -36.2 13.34 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.856 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -111.57 96.28 31.42 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.229 -178.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.34 126.96 19.68 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.648 2.232 . . . . 0.0 112.001 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' MET . . . . . 0.484 ' HE1' HD22 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -89.1 118.11 28.58 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.07 0.462 . . . . 0.0 110.356 179.125 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.548 HG22 ' HB ' ' A' ' 209' ' ' VAL . 51.7 t -96.6 129.89 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.72 -175.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.621 ' HB2' ' O ' ' A' ' 208' ' ' THR . 2.4 mm-40 -78.63 159.98 27.79 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.668 0.747 . . . . 0.0 112.83 168.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.452 ' HB ' HG23 ' B' ' 4' ' ' VAL . 4.1 t -72.94 -10.96 60.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.024 177.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.3 mp -88.88 -2.28 58.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.968 177.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 96.98 -26.65 21.7 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.212 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.621 ' O ' ' HB2' ' A' ' 204' ' ' GLU . 99.0 m -60.44 111.23 1.49 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.999 0.428 . . . . 0.0 110.207 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.548 ' HB ' HG22 ' A' ' 203' ' ' VAL . 0.8 OUTLIER -112.08 127.66 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-O 121.57 0.7 . . . . 0.0 110.287 175.146 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.495 ' HB3' HG23 ' A' ' 151' ' ' VAL . 0.4 OUTLIER -82.55 111.03 18.17 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.783 -170.553 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -96.15 91.23 5.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.412 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 7.1 mp -74.81 109.83 8.6 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.983 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -114.58 -57.12 2.31 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.63 -0.428 . . . . 0.0 112.154 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.522 ' O ' ' HA ' ' A' ' 134' ' ' SER . 4.6 pm0 -133.16 142.83 45.88 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 121.099 0.476 . . . . 0.0 111.196 -176.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.467 ' HB3' ' HB3' ' A' ' 112' ' ' TRP . 74.5 Cg_endo -74.12 135.67 21.22 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.923 2.415 . . . . 0.0 112.479 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.53 HD13 ' CD2' ' A' ' 126' ' ' LEU . 0.4 OUTLIER -71.09 114.37 9.08 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.056 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -52.18 131.57 32.5 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 123.621 0.576 . . . . 0.0 110.863 -178.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 111' ' ' ARG . 18.1 p -73.49 107.9 6.04 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.064 0.459 . . . . 0.0 110.918 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 6.1 t . . . . . 0 C--N 1.317 -0.826 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.849 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . 0.489 ' HA ' ' OE1' ' A' ' 204' ' ' GLU . . . . . . . . 0 C--O 1.233 0.228 0 CA-C-O 121.48 0.657 . . . . 0.0 111.292 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 13.3 m -69.35 -44.02 72.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.171 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.467 HG22 ' HB2' ' A' ' 202' ' ' MET . 15.5 mm 75.27 103.55 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 123.206 0.602 . . . . 0.0 111.398 175.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.452 HG23 ' HB ' ' A' ' 205' ' ' THR . 2.8 m . . . . . 0 C--N 1.323 -0.565 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.508 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo . . . . . 0 CA--C 1.515 -0.437 0 CA-C-O 122.124 0.802 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.607 ' HB ' ' CD1' ' A' ' 113' ' ' PHE . 40.6 p -92.49 6.79 45.82 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.079 -1.419 . . . . 0.0 111.121 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.7 t -75.31 52.7 0.62 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.521 0.676 . . . . 0.0 110.588 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.476 ' HG3' ' CZ2' ' A' ' 112' ' ' TRP . 65.3 mm-40 -130.92 169.6 15.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.292 -177.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.412 ' O ' HG21 ' A' ' 218' ' ' THR . 18.7 mmt180 -83.67 -11.61 57.0 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -170.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.483 ' CZ2' ' HA ' ' A' ' 191' ' ' THR . 1.5 p-90 -92.96 -12.04 31.77 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.054 177.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.607 ' CD1' ' HB ' ' A' ' 108' ' ' THR . 57.5 t80 -84.69 119.5 25.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.385 0.612 . . . . 0.0 110.843 174.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -111.94 117.03 31.61 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -65.11 -66.57 2.39 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.739 -0.664 . . . . 0.0 113.261 -174.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -100.23 104.99 16.52 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.288 0.566 . . . . 0.0 111.34 -175.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 17.4 mt -154.56 130.74 10.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.598 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 68.3 p -84.03 173.06 11.45 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 172.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.73 -49.84 63.82 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.65 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.0 mmtm -61.24 -45.64 93.69 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 123.942 0.436 . . . . 0.0 111.526 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -66.79 -47.22 72.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.677 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.488 ' HB2' ' NH1' ' A' ' 138' ' ' ARG . . . -63.85 -33.87 76.65 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.088 0.47 . . . . 0.0 110.771 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.525 ' HG3' ' HB ' ' A' ' 167' ' ' VAL . 9.1 tt0 -67.26 -46.43 73.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.426 176.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -60.76 -33.25 72.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.757 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.467 HD11 HD11 ' A' ' 216' ' ' LEU . 0.5 OUTLIER -55.69 -52.32 64.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.178 0.514 . . . . 0.0 110.154 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.562 ' CD2' HD12 ' A' ' 216' ' ' LEU . 42.5 mt -75.62 -47.29 27.15 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.5 m -64.18 -33.29 75.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.294 -172.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -96.99 -53.28 3.56 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -91.35 -31.97 15.86 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -171.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -86.95 -163.27 38.61 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.191 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.514 ' C ' ' HD3' ' A' ' 152' ' ' ARG . 0.5 OUTLIER -146.4 174.41 11.4 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 177.813 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -50.86 120.25 4.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.85 0.357 . . . . 0.0 110.937 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.435 ' HA3' ' HD3' ' A' ' 213' ' ' LYS . . . 98.39 -4.51 60.21 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.199 178.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.62 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 66.9 m -72.84 138.51 46.38 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 176.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.438 ' CB ' HG12 ' A' ' 151' ' ' VAL . 49.4 p90 -136.63 149.12 47.82 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.986 0.422 . . . . 0.0 110.62 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.548 ' CD2' ' HB3' ' A' ' 150' ' ' SER . 1.2 pt? -149.99 136.66 19.21 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 148' ' ' VAL . 16.2 m -99.5 133.96 40.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.488 ' NH1' ' HB2' ' A' ' 122' ' ' ALA . 10.7 ptt-85 -129.81 172.09 12.02 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -178.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -76.98 127.27 32.4 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.411 ' HB2' HG23 ' A' ' 148' ' ' VAL . 46.2 t -69.55 133.3 47.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.39 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -96.19 -26.03 15.6 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.552 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 41.6 m -81.0 -25.67 37.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.924 0.393 . . . . 0.0 109.94 174.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -126.04 87.23 56.45 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.983 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.0 124.18 15.11 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.342 2.028 . . . . 0.0 111.255 176.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.523 ' O ' ' HB3' ' A' ' 174' ' ' CYS . . . 101.77 -10.44 57.38 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.079 -177.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -114.36 171.9 7.34 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.404 ' CE1' ' HE2' ' A' ' 179' ' ' TYR . 96.6 m-85 -125.8 163.99 21.66 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.832 0.349 . . . . 0.0 110.347 -177.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 4.7 t -125.37 127.27 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.923 -177.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.488 ' HB3' ' CG2' ' A' ' 170' ' ' VAL . 1.2 tp -91.46 109.36 20.65 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.548 ' HB3' ' CD2' ' A' ' 136' ' ' LEU . 40.3 t -101.89 124.88 48.27 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.535 HG21 ' HB3' ' A' ' 210' ' ' LEU . 34.8 m -128.28 142.95 42.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.829 -173.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.514 ' HD3' ' C ' ' A' ' 131' ' ' LYS . 73.2 ttt180 -90.04 103.14 15.84 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.369 0.604 . . . . 0.0 109.688 176.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.5 p -107.42 148.62 28.89 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.799 -1.092 . . . . 0.0 110.162 -177.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.088 0 C-N-CA 119.67 -1.252 . . . . 0.0 111.21 -175.697 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm . . . . . 0 N--CA 1.442 -0.834 0 CA-C-O 121.262 0.554 . . . . 0.0 111.893 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.525 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 69.8 t -120.84 113.76 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.768 169.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.579 ' CG2' ' HB1' ' B' ' 1' ' ' ALA . 21.6 m -90.2 140.65 29.47 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.462 172.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -118.47 116.4 26.6 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.603 HG11 ' SD ' ' A' ' 202' ' ' MET . 0.8 OUTLIER -98.53 138.95 21.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -177.143 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 38.8 tpp -84.91 116.51 23.38 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.995 0.426 . . . . 0.0 110.792 -175.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.416 HD11 ' HB2' ' A' ' 149' ' ' LEU . 24.5 mt -97.4 108.12 21.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.184 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.666 ' O ' ' HA ' ' A' ' 179' ' ' TYR . 77.3 mtm180 -65.56 123.24 19.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.487 176.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . 0.523 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 48.3 t -116.82 91.6 3.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.459 0.647 . . . . 0.0 109.562 174.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -114.51 114.53 25.91 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.235 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 57.16 45.12 21.19 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.661 0.601 . . . . 0.0 111.116 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 95.7 mt 63.79 22.57 13.11 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.943 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -113.43 132.24 55.71 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 172.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.666 ' HA ' ' O ' ' A' ' 173' ' ' ARG . 71.1 m-85 -110.16 137.57 47.73 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.206 -173.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -152.91 127.35 9.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.121 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.452 HG21 HD12 ' A' ' 193' ' ' LEU . 3.1 t -77.58 -0.64 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-O 121.707 0.765 . . . . 0.0 111.567 -176.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 124.99 -19.44 6.89 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.067 177.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -137.56 159.6 24.92 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 121.024 -0.607 . . . . 0.0 112.032 177.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 89.32 -135.31 12.9 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.055 175.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -116.06 145.03 43.33 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.56 0.219 . . . . 0.0 110.831 -176.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -75.69 128.79 35.96 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 175.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -105.92 144.04 33.22 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.808 0.337 . . . . 0.0 110.725 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -76.01 -9.81 58.91 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.752 -174.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 35.4 p -140.74 143.9 35.24 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.476 ' HG ' ' CD2' ' A' ' 179' ' ' TYR . 0.5 OUTLIER -67.35 -23.08 65.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.914 179.674 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.483 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 13.9 m -61.1 -49.01 79.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.355 175.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -65.63 -30.88 71.65 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.833 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.452 HD12 HG21 ' A' ' 181' ' ' VAL . 3.3 tm? -64.32 -54.78 27.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.404 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 27.8 m -70.19 -42.21 79.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.558 -174.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -61.42 -39.11 89.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.91 0.386 . . . . 0.0 111.051 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -59.99 -42.27 93.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.823 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -85.24 -13.59 49.37 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.124 0.488 . . . . 0.0 110.951 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -74.2 -27.3 60.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.446 0.641 . . . . 0.0 109.351 176.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -88.79 -36.5 16.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.477 175.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -119.92 105.33 42.98 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.425 -176.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.28 128.96 32.68 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.884 2.389 . . . . 0.0 112.474 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' MET . . . . . 0.759 ' SD ' HD23 ' A' ' 210' ' ' LEU . 7.4 ptp -89.6 122.81 33.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.261 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.544 HG22 ' HB ' ' A' ' 209' ' ' VAL . 44.7 t -101.53 139.8 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 120.703 0.287 . . . . 0.0 111.59 -176.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.492 ' O ' HG13 ' A' ' 203' ' ' VAL . 25.6 mt-10 -89.22 162.35 15.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.37 . . . . 0.0 110.245 170.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 14.9 t -74.08 -11.91 60.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.324 0.583 . . . . 0.0 110.024 177.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.0 mp -83.98 -8.31 59.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.018 178.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 101.04 -18.89 53.93 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.007 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 58.9 m -65.65 111.76 3.33 Favored 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 175.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.544 ' HB ' HG22 ' A' ' 203' ' ' VAL . 0.9 OUTLIER -112.22 126.99 69.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.6 0.714 . . . . 0.0 110.348 173.68 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.759 HD23 ' SD ' ' A' ' 202' ' ' MET . 0.4 OUTLIER -82.03 110.06 16.93 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.336 -172.188 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -85.17 89.51 7.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.584 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 8.2 mp -77.87 99.19 5.88 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 175.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.435 ' HD3' ' HA3' ' A' ' 133' ' ' GLY . 28.6 mtpp -109.61 -48.84 3.17 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.141 -173.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.62 ' O ' ' HA ' ' A' ' 134' ' ' SER . 0.4 OUTLIER -147.45 147.19 27.33 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 121.081 0.467 . . . . 0.0 111.007 178.006 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.453 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 93.0 Cg_endo -78.39 147.27 22.69 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.958 2.439 . . . . 0.0 113.222 -175.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.562 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.3 OUTLIER -83.86 109.88 17.92 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -56.55 145.98 26.42 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.43 0.456 . . . . 0.0 111.29 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.412 HG21 ' O ' ' A' ' 111' ' ' ARG . 4.8 p -82.13 136.02 35.22 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.58 -177.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.319 -0.743 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.288 173.603 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . 0.579 ' HB1' ' CG2' ' A' ' 168' ' ' THR . . . . . . . . 0 C--O 1.231 0.096 0 CA-C-O 121.505 0.669 . . . . 0.0 112.384 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 46.2 m -76.02 -49.44 17.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.176 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.674 HD11 ' SD ' ' A' ' 202' ' ' MET . 8.0 mm 73.32 94.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 123.244 0.617 . . . . 0.0 110.732 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 13.8 m . . . . . 0 C--N 1.32 -0.678 0 CA-C-O 121.624 0.726 . . . . 0.0 109.991 176.179 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.838 0 N-CA-C 112.058 -0.417 . . . . 0.0 112.058 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.45 -33.12 23.83 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.872 2.381 . . . . 0.0 112.815 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 58.5 ttp -76.21 -31.72 58.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.198 0.523 . . . . 0.0 109.9 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.91 82.66 8.05 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.346 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 5.4 m-20 -62.77 129.94 93.4 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.728 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 6.0 Cg_exo -75.43 -7.26 18.63 Favored 'Trans proline' 0 CA--C 1.516 -0.38 0 C-N-CA 122.636 2.224 . . . . 0.0 110.275 177.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.59 ' HB ' ' CG ' ' A' ' 113' ' ' PHE . 35.7 p -100.27 5.58 44.59 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.21 -176.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.8 m -75.26 58.73 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.515 0.674 . . . . 0.0 110.579 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.512 ' HG3' ' CZ2' ' A' ' 112' ' ' TRP . 81.5 mm-40 -129.65 -178.5 4.72 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.821 -176.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -84.71 -26.0 27.98 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -174.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.526 ' CZ2' ' HA ' ' A' ' 191' ' ' THR . 0.7 OUTLIER -85.71 -19.63 30.56 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -177.729 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.59 ' CG ' ' HB ' ' A' ' 108' ' ' THR . 72.2 t80 -81.45 123.76 28.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.012 0.434 . . . . 0.0 110.551 175.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -110.52 139.57 45.64 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.62 -88.87 0.03 OUTLIER Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.94 -0.648 . . . . 0.0 113.528 -174.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -100.52 106.63 18.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.03 0.443 . . . . 0.0 111.439 -175.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 64.0 mt -143.45 135.89 27.18 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.789 175.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.6 p -93.69 174.41 7.19 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -50.23 -54.3 20.17 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 121.558 -0.353 . . . . 0.0 113.856 -174.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 60.7 mmtt -77.99 -25.33 48.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 117.27 0.535 . . . . 0.0 111.87 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -65.33 -44.71 86.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.801 0.334 . . . . 0.0 110.627 175.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.463 ' HB1' ' HD3' ' A' ' 138' ' ' ARG . . . -64.11 -34.01 77.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.325 0.583 . . . . 0.0 110.494 176.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.544 ' HG3' ' HB ' ' A' ' 167' ' ' VAL . 16.3 tt0 -69.68 -48.36 59.99 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.962 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -56.47 -35.78 68.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.325 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.64 -51.52 69.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.273 177.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.535 ' CD2' HD13 ' A' ' 216' ' ' LEU . 27.7 mt -74.63 -46.41 38.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.687 -177.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.6 m -67.64 -33.01 74.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.029 -173.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -95.83 -48.27 5.81 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -100.14 -25.65 14.21 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -171.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -89.53 -159.75 35.76 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.573 -177.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -153.1 175.16 13.31 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -55.31 121.0 7.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.876 0.37 . . . . 0.0 111.275 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 99.54 -3.35 57.71 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.765 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.626 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 56.4 m -74.39 140.25 44.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.646 0.26 . . . . 0.0 110.503 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.492 ' CB ' HG13 ' A' ' 151' ' ' VAL . 52.3 p90 -137.45 149.02 46.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.165 177.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.513 ' CD2' ' HB2' ' A' ' 150' ' ' SER . 1.1 pt? -148.91 139.51 22.63 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 175.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 148' ' ' VAL . 10.1 m -104.23 145.04 13.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.463 ' HD3' ' HB1' ' A' ' 122' ' ' ALA . 26.4 ptt85 -146.29 168.21 21.63 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.867 -178.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -76.74 131.41 38.72 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 123.247 0.342 . . . . 0.0 110.63 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.6 t -72.39 137.12 46.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.522 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -98.02 -28.78 13.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.845 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 39.0 m -78.8 -34.1 45.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.027 0.442 . . . . 0.0 109.862 175.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -117.82 78.04 12.11 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.876 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.26 123.1 12.16 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.088 1.859 . . . . 0.0 111.72 -177.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 113.97 -16.68 20.46 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.608 -176.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -109.37 171.68 7.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.06 0.457 . . . . 0.0 110.29 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -123.45 163.6 20.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.604 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 33.3 m -134.11 143.05 39.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.152 0.501 . . . . 0.0 111.401 177.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.543 ' O ' HG13 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -101.86 111.09 23.22 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.225 177.516 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.537 ' HA ' ' HA ' ' A' ' 169' ' ' HIS . 1.2 m -104.17 131.71 51.18 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.592 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.492 HG13 ' CB ' ' A' ' 135' ' ' PHE . 32.7 m -130.57 152.08 36.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.456 -174.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -100.43 103.8 15.18 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.109 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 32.4 p -99.72 147.36 25.52 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.54 -177.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 75.57 161.82 10.52 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.15 -176.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.526 ' OD2' ' HE2' ' A' ' 157' ' ' LYS . 20.7 t70 -105.02 152.88 22.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.774 0.321 . . . . 0.0 110.908 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -90.03 -6.55 55.44 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -172.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.526 ' HE2' ' OD2' ' A' ' 155' ' ' ASP . 3.5 mppt? -91.15 -1.96 57.63 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.881 0.372 . . . . 0.0 110.925 178.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 161' ' ' ASN . . . 89.28 36.36 7.6 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.473 174.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -109.39 18.34 20.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.664 0.745 . . . . 0.0 110.37 174.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 21.5 m -154.11 -48.84 0.09 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.909 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.463 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 3.8 p-10 -149.46 165.44 32.13 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.753 176.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -110.55 163.53 13.62 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 82.12 58.39 2.48 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -175.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm 55.31 -167.15 0.1 Allowed 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 122.949 0.5 . . . . 0.0 111.176 -173.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 48.1 m -79.68 166.8 21.45 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.229 176.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.68 121.73 41.66 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.98 -175.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.544 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 56.1 t -100.01 133.32 43.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.364 0.602 . . . . 0.0 111.724 -177.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.556 ' CG2' HD11 ' A' ' 210' ' ' LEU . 1.1 m -119.18 141.41 48.89 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.763 171.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.678 ' CD2' ' HA ' ' B' ' -2' ' ' THR . 13.4 m-70 -108.24 138.17 44.97 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.543 HG13 ' O ' ' A' ' 149' ' ' LEU . 1.2 m -114.35 138.62 43.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.479 ' HB2' ' HB2' ' B' ' 0' ' ' PTR . 41.2 tpp -81.91 126.71 32.23 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.878 0.37 . . . . 0.0 111.213 -178.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 32.6 mt -104.9 107.43 22.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.585 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 4.7 ptp180 -70.44 119.35 14.48 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.023 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . 0.661 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 49.7 t -118.11 93.36 4.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.165 0.507 . . . . 0.0 110.469 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -116.62 125.65 52.11 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.769 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 57.18 39.15 29.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.9 -176.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 82.9 mt 63.16 31.75 15.49 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.324 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.661 ' O ' ' HA ' ' A' ' 174' ' ' CYS . 11.9 tppt? -110.99 132.23 54.39 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.471 ' CD2' ' HG ' ' A' ' 190' ' ' LEU . 81.8 m-85 -111.83 135.09 52.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.585 0.231 . . . . 0.0 111.176 -174.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.585 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 18.4 t0 -157.32 136.39 11.77 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.5 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.53 ' HB ' ' CZ ' ' A' ' 197' ' ' TYR . 56.0 t -90.65 -14.21 8.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.77 0.795 . . . . 0.0 109.031 174.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . 0.527 ' HA2' ' NH1' ' A' ' 173' ' ' ARG . . . 123.57 5.56 7.7 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.248 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -137.21 141.24 12.11 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.662 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 71.78 -158.45 53.47 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.241 -0.504 . . . . 0.0 113.083 174.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -74.08 150.73 40.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.894 0.378 . . . . 0.0 110.738 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 -99.26 132.89 44.27 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.67 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -110.9 150.56 29.02 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.138 -171.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -88.62 0.39 56.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.17 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.51 141.84 50.49 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.656 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.471 ' HG ' ' CD2' ' A' ' 179' ' ' TYR . 1.0 OUTLIER -77.28 -22.86 51.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.045 -175.476 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.526 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 16.4 m -61.97 -44.15 97.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.004 0.431 . . . . 0.0 110.275 177.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -66.41 -34.17 77.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.328 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.487 HD12 HG22 ' A' ' 181' ' ' VAL . 3.2 tm? -62.27 -54.64 37.77 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.199 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 27.2 m -66.39 -39.91 85.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.267 -175.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 191' ' ' THR . 27.8 mt-10 -68.17 -31.7 71.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.274 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -59.15 -47.26 85.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.087 0.47 . . . . 0.0 110.243 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.53 ' CZ ' ' HB ' ' A' ' 181' ' ' VAL . 76.3 m-85 -85.73 -8.85 57.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.762 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.405 ' HA ' ' HB2' ' A' ' 212' ' ' LEU . 39.4 ttpt -70.95 -23.74 62.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.67 175.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -105.74 -22.85 12.86 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.564 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -126.42 89.0 53.22 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.523 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.69 132.29 51.22 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.236 2.624 . . . . 0.0 112.799 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' MET . . . . . 0.499 ' SD ' ' HB2' ' A' ' 210' ' ' LEU . 0.0 OUTLIER -97.48 137.31 36.63 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.066 179.725 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.594 HG22 ' HB ' ' A' ' 209' ' ' VAL . 36.3 t -108.39 137.11 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -169.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.542 ' O ' HG11 ' A' ' 203' ' ' VAL . 27.4 mt-10 -81.71 163.99 22.08 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.817 0.341 . . . . 0.0 110.182 169.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.0 t -76.29 -10.62 59.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.796 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.9 mp -90.95 -1.23 57.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.452 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 103.89 -23.72 31.57 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.471 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 23.2 m -60.77 111.33 1.59 Allowed 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 120.882 0.372 . . . . 0.0 110.307 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.594 ' HB ' HG22 ' A' ' 203' ' ' VAL . 1.1 p -112.58 128.66 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-O 121.826 0.822 . . . . 0.0 110.833 175.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.556 HD11 ' CG2' ' A' ' 168' ' ' THR . 0.3 OUTLIER -81.55 105.31 12.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 113.987 -1.46 . . . . 0.0 110.219 -170.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -93.89 90.47 6.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.637 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 198' ' ' LYS . 6.8 mp -73.85 106.65 5.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.768 178.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -114.6 -55.96 2.43 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.626 ' O ' ' HA ' ' A' ' 134' ' ' SER . 0.7 OUTLIER -134.46 142.22 41.98 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 121.076 0.465 . . . . 0.0 111.179 -179.139 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.414 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 78.7 Cg_endo -76.38 142.24 23.63 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.951 2.434 . . . . 0.0 112.963 -175.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.535 HD13 ' CD2' ' A' ' 126' ' ' LEU . 0.3 OUTLIER -76.6 110.06 10.85 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 175.667 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -57.58 139.67 52.92 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 123.384 0.428 . . . . 0.0 111.103 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 13.4 p -71.99 108.0 5.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.498 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 3.6 t -81.96 105.49 13.12 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.68 0.753 . . . . 0.0 109.92 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 . . . . . 0 C--O 1.247 0.923 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.024 -176.935 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' -4' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 111.558 0.207 . . . . 0.0 111.558 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -57.16 112.34 1.34 Allowed 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.273 0.358 . . . . 0.0 110.631 -175.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' -2' ' ' THR . . . . . 0.678 ' HA ' ' CD2' ' A' ' 169' ' ' HIS . 7.2 m 47.76 -113.89 0.55 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -165.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' -1' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 70.69 -35.37 0.32 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 167.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 0' ' ' PTR . . . . . 0.479 ' HB2' ' HB2' ' A' ' 171' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.482 ' HA ' ' OE1' ' A' ' 204' ' ' GLU . . . 57.46 146.48 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 O-C-N 125.005 1.44 . . . . 0.0 113.702 168.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.52 -44.58 28.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.283 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.493 HG21 ' HB2' ' A' ' 202' ' ' MET . 4.2 mm 55.36 73.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.566 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.433 ' O ' ' HD3' ' B' ' 6' ' ' PRO . 2.3 m -101.03 97.76 6.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.591 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' PHE . . . . . 0.493 ' CE2' HG22 ' B' ' 3' ' ' ILE . 93.3 m-85 -76.55 108.71 6.87 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.848 173.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' B' ' 4' ' ' VAL . 1.7 Cg_endo . . . . . 0 C--O 1.251 1.134 0 C-N-CA 122.354 2.036 . . . . 0.0 111.466 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.793 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.33 -23.62 65.44 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.777 2.318 . . . . 0.0 112.758 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.7 tpt -104.21 74.29 1.18 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.505 0.669 . . . . 0.0 109.929 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.23 83.81 5.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.414 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -65.1 110.72 4.58 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.188 0.518 . . . . 0.0 110.494 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.439 ' HB2' ' H ' ' A' ' 190' ' ' LEU . 84.2 Cg_endo -78.21 -9.28 16.48 Favored 'Trans proline' 0 CA--C 1.517 -0.365 0 C-N-CA 123.399 2.732 . . . . 0.0 111.964 -174.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.705 ' HB ' ' CG ' ' A' ' 113' ' ' PHE . 34.7 p -100.19 7.85 44.23 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.562 -171.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 26.7 m -74.68 49.12 0.39 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.169 0.509 . . . . 0.0 110.939 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.4 ' HG3' ' CZ2' ' A' ' 112' ' ' TRP . 70.4 mm-40 -127.04 174.11 9.13 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.662 -176.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -79.55 -20.05 47.99 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -173.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.502 ' HB3' ' CB ' ' A' ' 215' ' ' PRO . 1.8 p-90 -85.95 -19.81 29.89 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.875 -178.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.705 ' CG ' ' HB ' ' A' ' 108' ' ' THR . 75.4 t80 -77.92 124.67 28.29 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.151 0.5 . . . . 0.0 110.707 175.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -122.11 107.04 11.72 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -51.84 -72.09 0.56 Allowed Glycine 0 CA--C 1.519 0.307 0 N-CA-C 114.744 0.657 . . . . 0.0 114.744 -167.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -100.29 86.34 3.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.347 0.594 . . . . 0.0 112.156 -173.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.459 ' O ' ' HD2' ' A' ' 138' ' ' ARG . 33.1 mt -133.38 133.27 42.22 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.165 175.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 35.4 t -93.6 172.76 8.06 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 168.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 123' ' ' GLU . . . -51.77 -44.27 54.88 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.245 -0.502 . . . . 0.0 112.797 -177.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.413 ' HD3' ' N ' ' A' ' 120' ' ' LYS . 3.1 mppt? -69.36 -35.03 75.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.959 0.409 . . . . 0.0 110.607 -175.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -72.61 -47.26 49.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.402 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.476 ' HB2' ' HD3' ' A' ' 138' ' ' ARG . . . -62.56 -34.06 76.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.431 177.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.5 ' HG3' ' HB ' ' A' ' 167' ' ' VAL . 3.7 tt0 -65.36 -50.33 65.97 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.694 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -58.94 -36.22 74.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.418 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.427 HD13 HD12 ' A' ' 216' ' ' LEU . 0.7 OUTLIER -58.48 -53.66 55.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.768 178.368 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.543 ' CD2' HD13 ' A' ' 216' ' ' LEU . 61.3 mt -75.39 -48.44 22.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.759 -176.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.7 m -61.9 -32.78 73.19 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.192 -172.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -97.44 -53.87 3.32 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -91.58 -23.37 19.91 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -169.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -93.32 -160.24 35.2 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.057 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -152.3 175.73 12.35 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 175.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -58.54 125.15 22.18 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 177.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.496 ' HA2' ' O ' ' A' ' 211' ' ' GLN . . . 103.72 -10.98 53.22 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.113 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.694 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 27.8 m -78.65 139.59 38.51 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.658 0.266 . . . . 0.0 110.376 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.516 ' CB ' HG11 ' A' ' 151' ' ' VAL . 44.9 p90 -137.02 150.38 48.06 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.409 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.493 ' CD2' HD12 ' A' ' 126' ' ' LEU . 1.1 pt? -149.04 136.41 20.17 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 148' ' ' VAL . 5.6 m -100.42 139.99 20.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.547 178.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.476 ' HD3' ' HB2' ' A' ' 122' ' ' ALA . 17.6 ptt85 -141.8 167.73 21.45 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.459 -176.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -80.63 133.79 35.79 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.409 ' HB2' HG11 ' A' ' 148' ' ' VAL . 39.2 t -76.14 139.13 41.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.934 0.397 . . . . 0.0 110.048 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -99.87 -18.01 17.35 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.669 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.508 ' OG ' ' HE2' ' B' ' 0' ' ' PTR . 51.4 p -84.93 -26.67 27.08 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 171.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -123.34 78.63 53.51 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.178 176.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.97 124.55 15.94 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.869 2.379 . . . . 0.0 112.303 -178.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 106.79 -16.85 39.61 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.012 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -106.98 157.24 17.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.896 0.379 . . . . 0.0 110.351 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -110.58 158.64 18.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.657 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.482 HG13 ' CE1' ' B' ' 0' ' ' PTR . 35.1 m -136.47 139.36 45.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.339 0.59 . . . . 0.0 111.383 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.628 ' HB3' ' CG2' ' A' ' 170' ' ' VAL . 0.5 OUTLIER -95.09 110.54 22.46 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.817 176.23 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.489 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 2.4 m -101.89 130.68 48.44 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.269 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.516 HG11 ' CB ' ' A' ' 135' ' ' PHE . 33.5 m -129.26 150.3 34.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.679 -174.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -93.04 102.4 14.74 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.425 0.631 . . . . 0.0 109.506 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.484 ' O ' ' HB3' ' A' ' 166' ' ' LYS . 0.9 OUTLIER -115.0 97.78 6.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.722 178.758 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.432 ' HA2' ' HB2' ' A' ' 160' ' ' SER . . . 139.7 142.1 4.17 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -176.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.509 ' HB2' ' HB2' ' A' ' 159' ' ' GLU . 0.7 OUTLIER -104.82 146.17 29.35 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.38 0.609 . . . . 0.0 112.052 -172.621 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -72.49 4.21 4.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.576 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -99.57 12.83 35.42 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.781 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 88.12 38.23 7.41 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.908 176.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.509 ' HB2' ' HB2' ' A' ' 155' ' ' ASP . 37.5 mt-10 -120.92 131.12 54.17 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.432 ' HB2' ' HA2' ' A' ' 154' ' ' GLY . 49.1 m 70.62 8.09 6.45 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 123.937 0.773 . . . . 0.0 111.178 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -171.37 163.64 6.96 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -81.02 79.09 7.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.941 0.4 . . . . 0.0 111.394 -176.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 92.63 -52.48 2.67 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 121.116 -0.564 . . . . 0.0 113.286 172.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -92.45 174.12 7.45 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.751 0.31 . . . . 0.0 110.791 -175.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 19.4 m -76.03 169.11 18.79 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.447 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.484 ' HB3' ' O ' ' A' ' 153' ' ' THR . 0.0 OUTLIER -131.23 142.26 50.14 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.267 -176.667 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.5 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 60.1 t -123.39 115.98 47.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 121.086 0.469 . . . . 0.0 111.323 176.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.479 HG21 HD11 ' A' ' 210' ' ' LEU . 4.1 m -92.86 140.73 29.19 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.049 172.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.684 ' O ' ' HA ' ' B' ' 0' ' ' PTR . 37.8 m-70 -114.78 119.72 37.61 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.693 HG12 ' SD ' ' A' ' 202' ' ' MET . 0.8 OUTLIER -98.4 140.14 18.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -177.028 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 40.2 tpp -87.02 117.88 26.03 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.253 -177.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 20.7 mt -97.02 107.04 19.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.558 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 17.9 ptp180 -69.16 122.42 18.76 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.917 0.389 . . . . 0.0 110.0 -177.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 49.5 t -113.88 93.42 4.36 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.805 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -125.92 122.4 35.9 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.158 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 58.63 41.75 21.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.124 -178.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.0 mt 60.49 45.42 10.77 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.165 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 174' ' ' CYS . 10.9 tppt? -131.46 139.11 49.29 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -116.04 129.95 56.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.585 0.231 . . . . 0.0 110.783 -175.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.558 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 13.8 t0 -157.01 129.25 7.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.79 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.544 ' HB ' ' CZ ' ' A' ' 197' ' ' TYR . 31.0 t -83.91 -12.27 11.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.773 0.797 . . . . 0.0 109.312 176.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 122.76 9.02 6.5 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.388 176.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.601 ' HA3' ' CE2' ' B' ' 5' ' ' PHE . . . -137.88 140.48 11.26 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.138 -1.029 . . . . 0.0 113.738 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 71.59 -154.8 51.74 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.266 -0.492 . . . . 0.0 112.998 174.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -73.97 142.73 45.84 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.64 0.257 . . . . 0.0 110.364 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -88.0 132.71 34.16 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -106.88 156.44 18.69 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.226 0.536 . . . . 0.0 112.019 -169.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -94.34 -11.52 29.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.24 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.6 m -129.4 142.71 50.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.123 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.439 ' H ' ' HB2' ' A' ' 107' ' ' PRO . 0.9 OUTLIER -72.81 -22.71 60.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.28 -175.4 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 5.8 m -61.82 -46.23 90.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.894 0.378 . . . . 0.0 110.53 177.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -64.72 -34.17 77.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.057 178.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.482 HD11 HG22 ' A' ' 181' ' ' VAL . 3.1 tm? -60.25 -54.28 47.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.298 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 30.8 m -68.62 -43.75 83.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.934 -175.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -59.2 -35.57 73.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.001 0.429 . . . . 0.0 111.232 177.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -62.4 -45.28 93.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.102 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.544 ' CZ ' ' HB ' ' A' ' 181' ' ' VAL . 59.8 m-85 -85.76 -10.36 55.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.948 0.404 . . . . 0.0 111.448 -176.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.425 ' HD2' ' CZ ' ' A' ' 135' ' ' PHE . 47.0 mtpt -70.86 -34.81 72.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.155 0.502 . . . . 0.0 109.865 170.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . 0.431 ' HG3' ' ND2' ' A' ' 200' ' ' ASN . 14.1 tptt -88.85 -36.17 16.16 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.036 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . 0.431 ' ND2' ' HG3' ' A' ' 199' ' ' LYS . 55.4 m-80 -113.49 101.57 53.8 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.432 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.28 126.17 21.62 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.845 2.363 . . . . 0.0 112.77 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' MET . . . . . 0.693 ' SD ' HG12 ' A' ' 170' ' ' VAL . 14.3 ptp -89.31 141.81 28.22 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 175.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' B' ' 3' ' ' ILE . 11.2 t -124.8 139.51 50.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.998 -173.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.444 ' HG2' ' HB2' ' B' ' 1' ' ' ALA . 26.0 mt-10 -82.01 161.24 23.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.898 171.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.3 t -74.32 -9.85 59.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.235 0.54 . . . . 0.0 110.006 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.5 mp -89.68 4.38 49.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.162 176.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.57 -1.27 83.79 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.629 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 23.1 m -73.16 113.51 10.3 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.011 0.434 . . . . 0.0 110.588 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.417 HG21 HG11 ' A' ' 203' ' ' VAL . 69.9 t -98.6 114.34 35.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.637 HD23 ' SD ' ' A' ' 202' ' ' MET . 0.4 OUTLIER -76.52 100.34 5.24 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.496 ' O ' ' HA2' ' A' ' 133' ' ' GLY . 47.1 mt-30 -84.68 92.96 8.31 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.382 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.2 mp -77.57 105.41 8.69 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.956 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -113.86 -57.07 2.33 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.694 ' O ' ' HA ' ' A' ' 134' ' ' SER . 4.6 pm0 -132.0 139.38 34.84 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-O 121.14 0.495 . . . . 0.0 111.209 -177.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.502 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 71.5 Cg_endo -74.37 138.45 24.71 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.982 2.455 . . . . 0.0 112.527 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.543 HD13 ' CD2' ' A' ' 126' ' ' LEU . 0.3 OUTLIER -72.5 106.28 4.52 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.053 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -56.15 133.62 52.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.083 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.6 p -58.02 111.6 1.23 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.436 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 2.0 t -104.02 110.7 22.95 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.288 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.467 -0.778 . . . . 0.0 109.57 -179.848 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' -4' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 63.38 -157.21 0.32 Allowed 'General case' 0 CA--C 1.532 0.277 0 O-C-N 123.583 0.552 . . . . 0.0 110.898 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' -2' ' ' THR . . . . . 0.545 ' HA ' ' CD2' ' A' ' 169' ' ' HIS . 25.2 m -71.08 -95.14 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 119.233 -0.413 . . . . 0.0 110.361 175.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' -1' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 71.0 -39.01 0.44 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.215 0.606 . . . . 0.0 111.745 175.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 0' ' ' PTR . . . . . 0.684 ' HA ' ' O ' ' A' ' 169' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.444 ' HB2' ' HG2' ' A' ' 204' ' ' GLU . . . -56.17 130.68 45.26 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.627 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 23.5 m -70.87 -38.0 73.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.295 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.61 HD11 ' SD ' ' A' ' 202' ' ' MET . 7.5 mm 70.03 88.0 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 121.613 0.721 . . . . 0.0 111.213 176.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 2.1 m -108.79 98.33 6.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.828 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' PHE . . . . . 0.601 ' CE2' ' HA3' ' A' ' 183' ' ' GLY . 92.2 m-85 -74.75 118.88 73.71 Favored Pre-proline 0 C--N 1.313 -0.983 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.452 173.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo . . . . . 0 C--O 1.252 1.179 0 C-N-CA 122.451 2.101 . . . . 0.0 112.168 -178.882 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.705 0 CA-C-O 119.657 -0.524 . . . . 0.0 111.881 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -56.34 -49.17 15.91 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.089 2.526 . . . . 0.0 112.902 -178.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 86.3 mtp -108.98 26.87 10.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.98 0.419 . . . . 0.0 110.57 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.88 69.32 10.74 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.312 0.577 . . . . 0.0 109.64 176.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -74.73 128.82 84.77 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.046 -176.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -76.09 -6.86 17.74 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.718 2.278 . . . . 0.0 109.597 172.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.508 ' HB ' ' CD1' ' A' ' 113' ' ' PHE . 25.5 p -98.13 7.41 46.32 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 113.628 -1.623 . . . . 0.0 111.153 -176.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.4 p -75.65 30.19 0.11 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.934 0.397 . . . . 0.0 111.755 -178.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.444 ' H ' ' C ' ' A' ' 108' ' ' THR . 10.8 mm-40 -109.88 171.26 7.56 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.42 ' O ' HG22 ' A' ' 218' ' ' THR . 25.3 mmt180 -85.47 -9.62 57.21 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -167.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.46 ' HB3' ' CB ' ' A' ' 215' ' ' PRO . 2.4 p-90 -87.31 -19.14 28.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.954 0.407 . . . . 0.0 110.621 175.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.508 ' CD1' ' HB ' ' A' ' 108' ' ' THR . 80.3 t80 -75.17 119.19 18.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.199 0.524 . . . . 0.0 110.241 173.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.402 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 13.9 m-70 -112.16 147.09 36.89 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 175.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -73.55 -123.99 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.731 -172.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -86.84 83.6 7.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.515 0.674 . . . . 0.0 111.168 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 77.9 mt -98.0 160.6 14.2 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.835 171.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.1 p -102.48 172.46 6.85 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 165.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.64 -50.1 44.08 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 121.312 -0.471 . . . . 0.0 112.619 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -64.64 -41.43 96.15 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 122.466 0.307 . . . . 0.0 111.425 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -61.08 -46.75 89.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.552 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.91 -35.05 79.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.972 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -64.87 -50.83 65.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.071 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -60.65 -34.58 74.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.419 176.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 129' ' ' LYS . 0.4 OUTLIER -57.01 -52.82 63.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.983 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.575 ' CD2' HD13 ' A' ' 216' ' ' LEU . 71.1 mt -75.96 -52.19 10.8 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -178.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 m -64.89 -33.2 75.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.785 -170.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -96.66 -49.81 4.95 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 125' ' ' LEU . 95.9 mttt -92.14 -23.51 19.39 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -169.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -98.54 -149.77 25.2 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.325 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.533 ' HZ2' ' HB2' ' A' ' 131' ' ' LYS . 0.1 OUTLIER -154.29 173.67 15.85 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 176.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 62.9 t60 -51.18 118.87 3.52 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.774 0.321 . . . . 0.0 110.825 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 102.21 -3.21 51.09 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.314 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 33.8 p -72.24 139.67 48.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.276 0.538 . . . . 0.0 110.1 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.466 ' CB ' HG12 ' A' ' 151' ' ' VAL . 53.3 p90 -137.21 151.58 48.92 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.976 0.417 . . . . 0.0 110.636 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.512 ' CD2' HD13 ' A' ' 126' ' ' LEU . 1.2 pt? -153.21 136.05 15.38 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.488 HG13 HD12 ' A' ' 149' ' ' LEU . 5.5 m -96.72 142.44 13.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 175.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.635 HH11 ' HB2' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -147.36 160.08 42.95 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.703 -171.482 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -79.14 110.42 14.37 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.997 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.4 ' HB2' HG13 ' A' ' 148' ' ' VAL . 41.8 t -66.66 124.78 23.81 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -90.99 -15.35 29.8 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 28.0 t -72.83 -39.47 66.55 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 172.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 46.7 m-70 -119.57 81.39 24.07 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.544 172.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.22 134.47 59.45 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.042 2.495 . . . . 0.0 112.968 -172.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 100.0 -21.6 43.98 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.073 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.552 ' HA ' ' SG ' ' A' ' 174' ' ' CYS . 4.5 m-20 -102.56 170.32 8.11 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.243 0.544 . . . . 0.0 111.063 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -117.18 149.95 39.53 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.311 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.4 HG13 ' HB2' ' A' ' 140' ' ' SER . 27.1 m -131.91 138.71 52.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.173 0.511 . . . . 0.0 111.065 176.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.581 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -92.18 109.48 20.85 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.455 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.484 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 2.8 m -101.77 133.49 46.43 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.136 -179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.528 HG23 ' HB3' ' A' ' 210' ' ' LEU . 28.1 m -132.9 153.84 38.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.923 0.392 . . . . 0.0 111.356 -173.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.464 HH21 ' HB2' ' A' ' 156' ' ' ASP . 73.6 ttt180 -99.69 103.98 15.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.2 178.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 14.8 p -108.36 147.66 31.21 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.456 -177.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 88.89 172.25 46.23 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.112 -178.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -102.32 151.42 22.27 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.789 0.328 . . . . 0.0 110.6 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.464 ' HB2' HH21 ' A' ' 152' ' ' ARG . 3.3 t70 -96.03 23.59 6.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.532 0.682 . . . . 0.0 110.293 -175.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -81.42 -5.73 58.2 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.987 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 163' ' ' GLY . . . 84.63 -64.01 4.32 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.048 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -64.82 -17.08 63.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.01 0.434 . . . . 0.0 111.586 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 5.4 m -87.09 -10.64 52.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.156 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -146.38 -161.52 1.34 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -173.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -63.97 -28.26 69.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.864 0.84 . . . . 0.0 109.902 175.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.407 ' O ' ' HA2' ' A' ' 158' ' ' GLY . . . 162.21 -34.23 0.34 Allowed Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.81 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -132.09 168.92 17.13 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 18.0 m -58.48 147.59 31.27 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 123.464 0.478 . . . . 0.0 110.637 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.419 ' HD2' ' HA ' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -96.39 124.91 40.55 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.751 -179.024 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 72.6 t -100.41 113.01 34.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.426 0.632 . . . . 0.0 110.626 176.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.437 HG23 HD11 ' A' ' 210' ' ' LEU . 1.4 m -98.21 137.73 36.54 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.726 175.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.733 ' O ' ' HA ' ' B' ' 0' ' ' PTR . 23.7 m-70 -105.97 122.48 46.22 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.581 HG22 ' HB3' ' A' ' 149' ' ' LEU . 0.8 OUTLIER -99.5 138.42 23.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.144 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.432 ' O ' ' HA ' ' A' ' 181' ' ' VAL . 39.8 tpp -82.22 121.28 26.43 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.636 -0.257 . . . . 0.0 111.018 -174.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 28.8 mt -101.64 107.5 21.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 177.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 4.4 ptp180 -73.8 107.66 6.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.064 0.459 . . . . 0.0 110.735 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . 0.552 ' SG ' ' HA ' ' A' ' 146' ' ' ASP . 4.9 p -86.0 101.27 12.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.888 175.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -127.73 111.14 13.35 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.944 -176.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 56.24 43.67 26.17 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.577 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 91.5 mt 66.48 15.96 10.26 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.197 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -105.99 142.86 34.99 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 172.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -117.23 141.35 48.4 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.538 -175.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.565 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 5.9 t0 -158.71 136.25 10.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.59 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 171' ' ' MET . 16.8 m -87.62 -11.01 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 121.051 0.453 . . . . 0.0 110.409 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . 0.51 ' HA2' ' NH1' ' A' ' 173' ' ' ARG . . . 123.31 34.74 0.75 Allowed Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -174.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.451 ' HA2' ' CE1' ' B' ' 5' ' ' PHE . . . -102.95 -157.69 25.33 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 121.514 -0.374 . . . . 0.0 112.448 -176.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -86.43 -40.91 7.13 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.031 -177.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -115.89 143.11 45.88 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.905 0.384 . . . . 0.0 111.279 -177.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -93.15 141.53 28.32 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -110.95 137.39 48.64 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.643 0.259 . . . . 0.0 110.677 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -82.86 0.9 41.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.229 0.538 . . . . 0.0 110.372 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.1 p -141.39 142.67 33.73 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.906 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.425 HD13 HG22 ' A' ' 137' ' ' VAL . 1.7 mt -76.52 -23.14 53.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.061 -176.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.441 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 97.6 m -62.02 -49.29 76.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.006 0.431 . . . . 0.0 109.938 174.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.65 -29.89 70.9 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.494 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.439 HD11 ' C ' ' A' ' 193' ' ' LEU . 3.2 tm? -64.34 -54.91 25.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.99 176.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.15 -42.1 79.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.348 -174.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -60.83 -31.76 71.17 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.388 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -67.29 -47.81 69.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.922 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.422 ' CZ ' HG21 ' A' ' 181' ' ' VAL . 80.3 m-85 -82.8 -11.16 58.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.246 0.546 . . . . 0.0 110.639 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -68.96 -29.74 68.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.284 172.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -93.3 -37.76 11.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.375 176.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -119.31 98.06 50.41 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.344 -177.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -56.31 138.28 83.01 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.978 2.452 . . . . 0.0 112.449 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' MET . . . . . 0.473 ' CE ' HD21 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -100.4 135.54 41.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.772 178.803 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.565 HG23 ' HB ' ' A' ' 209' ' ' VAL . 39.3 t -103.55 141.18 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -171.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.513 ' O ' HG12 ' A' ' 203' ' ' VAL . 38.7 mt-10 -86.82 161.98 18.04 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 169.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 13.7 t -74.59 -10.5 59.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.057 0.456 . . . . 0.0 110.346 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.6 mp -92.07 8.77 36.26 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.126 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.77 -29.0 7.74 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.776 177.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 53.4 m -57.98 112.5 1.52 Allowed 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 116.981 0.39 . . . . 0.0 110.164 176.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.565 ' HB ' HG23 ' A' ' 203' ' ' VAL . 1.1 p -111.6 129.35 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-O 121.548 0.689 . . . . 0.0 110.228 174.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.528 ' HB3' HG23 ' A' ' 151' ' ' VAL . 0.4 OUTLIER -78.85 113.23 16.77 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.347 -1.297 . . . . 0.0 111.163 -168.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -90.36 90.16 7.92 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.437 -178.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 8.0 mp -79.17 104.94 10.14 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 175.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 47.5 mttp -112.73 -54.73 2.6 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -177.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.546 ' O ' ' HA ' ' A' ' 134' ' ' SER . 0.1 OUTLIER -142.03 144.7 33.06 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.112 0.482 . . . . 0.0 111.32 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.46 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 74.1 Cg_endo -73.88 144.6 34.89 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.097 2.531 . . . . 0.0 113.202 -176.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.575 HD13 ' CD2' ' A' ' 126' ' ' LEU . 0.4 OUTLIER -82.94 119.92 25.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.513 176.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -58.18 145.43 37.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.265 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.42 HG22 ' O ' ' A' ' 111' ' ' ARG . 4.2 p -74.25 108.22 6.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.532 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 2.8 t -109.81 115.6 30.12 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.708 176.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 69.8 mtp180 . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.523 -0.751 . . . . 0.0 110.239 -178.668 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' -4' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 58.26 24.54 11.61 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.483 0.658 . . . . 0.0 110.961 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' -2' ' ' THR . . . . . 0.552 HG23 ' O1P' ' B' ' 0' ' ' PTR . 6.6 m -137.94 -94.6 0.2 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' -1' ' ' GLU . . . . . 0.431 ' H ' ' HB ' ' B' ' -2' ' ' THR . 1.5 mp0 72.35 -47.05 0.66 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.371 0.669 . . . . 0.0 111.01 171.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 0' ' ' PTR . . . . . 0.733 ' HA ' ' O ' ' A' ' 169' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.417 ' HB1' HG23 ' A' ' 168' ' ' THR . . . -40.92 125.12 2.28 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 113.59 -1.641 . . . . 0.0 112.365 -173.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 7.4 m -61.79 -52.26 64.91 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.189 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 203' ' ' VAL . 33.6 mm 82.74 82.25 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-O 121.853 0.835 . . . . 0.0 109.372 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.641 ' O ' ' HD3' ' B' ' 6' ' ' PRO . 28.7 m -106.84 130.16 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.629 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' PHE . . . . . 0.451 ' CE1' ' HA2' ' A' ' 183' ' ' GLY . 74.7 m-85 -98.97 92.55 1.68 Allowed Pre-proline 0 C--N 1.305 -1.327 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.074 175.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.641 ' HD3' ' O ' ' B' ' 4' ' ' VAL . 16.2 Cg_exo . . . . . 0 C--O 1.249 1.068 0 C-N-CA 122.912 2.408 . . . . 0.0 111.918 -176.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.8 0 CA-C-O 119.627 -0.54 . . . . 0.0 111.808 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -77.71 52.09 3.83 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.138 2.559 . . . . 0.0 112.405 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 24.5 ttt -135.97 -50.83 0.71 Allowed 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 173.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.67 20.06 9.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.857 175.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.426 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 8.7 p-10 -72.03 147.19 90.91 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.018 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 5.4 Cg_exo -76.02 -7.01 17.95 Favored 'Trans proline' 0 CA--C 1.515 -0.468 0 C-N-CA 123.058 2.505 . . . . 0.0 111.441 -175.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.496 ' HB ' ' CG ' ' A' ' 113' ' ' PHE . 40.4 p -100.44 6.26 44.37 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.154 -175.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.8 p -78.54 45.28 0.57 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.246 0.546 . . . . 0.0 111.09 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -125.9 168.34 14.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.89 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.423 ' O ' HG21 ' A' ' 218' ' ' THR . 14.3 mmt180 -82.82 -14.86 53.58 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -170.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.533 ' HB3' ' CB ' ' A' ' 215' ' ' PRO . 1.7 p-90 -85.17 -18.6 33.64 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.3 175.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.496 ' CG ' ' HB ' ' A' ' 108' ' ' THR . 87.2 t80 -78.98 118.05 20.62 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.215 173.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -115.11 113.36 23.9 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 174.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -64.31 -72.74 0.65 Allowed Glycine 0 N--CA 1.454 -0.163 0 CA-C-N 116.089 -0.505 . . . . 0.0 113.658 -173.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -84.41 89.46 7.4 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.642 -0.328 . . . . 0.0 110.996 -174.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 24.3 mt -143.73 137.15 27.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.661 174.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.1 t -101.05 173.59 6.4 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 169.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 123' ' ' GLU . . . -49.85 -52.87 24.24 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 121.527 -0.368 . . . . 0.0 113.796 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.56 -25.55 57.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.169 0.485 . . . . 0.0 111.229 -176.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.405 ' O ' HD23 ' A' ' 125' ' ' LEU . 28.2 mm-40 -69.99 -47.27 62.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.156 0.503 . . . . 0.0 109.93 178.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.543 ' HB3' ' HD2' ' A' ' 138' ' ' ARG . . . -67.06 -34.11 76.97 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.597 177.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.438 ' HG3' ' HB ' ' A' ' 167' ' ' VAL . 3.3 tt0 -61.66 -49.08 77.98 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.847 177.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -59.67 -34.11 72.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.877 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.405 HD23 ' O ' ' A' ' 121' ' ' GLU . 1.2 mm? -56.72 -53.53 56.7 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.119 0.485 . . . . 0.0 110.405 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.534 HD12 ' CD2' ' A' ' 136' ' ' LEU . 54.0 mt -76.15 -44.36 38.58 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.419 HG23 ' HB2' ' A' ' 165' ' ' SER . 6.9 m -61.61 -35.48 78.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 110.757 -175.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -95.6 -52.99 3.89 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -97.86 -22.73 16.2 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -170.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -90.08 177.51 42.96 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.307 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -135.59 175.14 9.87 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -57.98 117.59 4.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.781 0.324 . . . . 0.0 110.574 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 211' ' ' GLN . . . 104.02 -5.29 46.05 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.76 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.524 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 29.6 m -74.61 137.44 42.29 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.649 -0.324 . . . . 0.0 110.434 176.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.451 ' CB ' HG12 ' A' ' 151' ' ' VAL . 51.0 p90 -136.87 149.26 47.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.714 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.558 ' CD2' ' HB2' ' A' ' 150' ' ' SER . 1.2 pt? -150.56 134.15 16.51 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 11.9 m -97.44 141.09 16.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.543 ' HD2' ' HB3' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -140.19 162.94 34.06 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.903 -175.046 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -77.73 128.13 33.54 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.476 ' HB2' HG11 ' A' ' 148' ' ' VAL . 36.4 t -75.82 137.98 40.85 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -101.3 -21.51 14.85 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.033 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 33.5 m -86.12 -29.19 23.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.985 173.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -116.83 81.09 11.58 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 175.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.03 133.11 39.6 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.797 2.331 . . . . 0.0 112.369 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 94.52 -10.08 71.17 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.862 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -113.65 168.37 9.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.071 0.463 . . . . 0.0 110.356 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.475 ' CE1' ' HE1' ' A' ' 179' ' ' TYR . 74.0 m-85 -125.06 163.27 22.74 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.58 -177.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.512 ' CG2' ' HG3' ' A' ' 138' ' ' ARG . 26.7 m -134.62 136.99 51.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.228 0.537 . . . . 0.0 111.193 178.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.577 ' HB3' ' CG2' ' A' ' 170' ' ' VAL . 0.6 OUTLIER -92.29 110.18 21.57 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.14 177.116 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.558 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 3.8 m -101.25 130.43 47.38 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.297 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.486 HG23 ' HB3' ' A' ' 210' ' ' LEU . 33.9 m -131.43 146.9 32.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.848 -174.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 -91.55 104.89 17.32 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.17 0.51 . . . . 0.0 109.964 175.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.478 ' O ' ' HB3' ' A' ' 166' ' ' LYS . 3.7 p -104.11 146.58 28.53 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.977 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 76.14 172.9 34.72 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.876 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.5 ' OD1' ' HE2' ' A' ' 157' ' ' LYS . 25.0 t70 -106.98 172.79 6.63 Favored 'General case' 0 C--N 1.316 -0.857 0 O-C-N 122.869 -0.195 . . . . 0.0 110.587 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.468 ' HB3' ' OG ' ' A' ' 165' ' ' SER . 11.3 p-10 -95.4 -9.94 31.38 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.863 0.363 . . . . 0.0 111.232 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.5 ' HE2' ' OD1' ' A' ' 155' ' ' ASP . 3.9 mppt? -97.63 -19.79 18.06 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.392 0.615 . . . . 0.0 109.711 171.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 96.08 69.08 1.01 Allowed Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.304 -0.862 . . . . 0.0 113.129 175.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -76.2 -58.49 3.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.153 0.501 . . . . 0.0 110.025 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 36.5 t -123.28 30.49 6.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.465 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -163.04 -169.83 2.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.083 -177.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -77.11 -179.39 5.55 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -83.92 44.48 3.33 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.843 -175.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 10.8 mmmm -143.59 139.26 29.58 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.468 ' OG ' ' HB3' ' A' ' 156' ' ' ASP . 7.4 m -70.01 124.07 23.13 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 178.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 153' ' ' THR . 51.9 tptt -95.77 137.45 34.81 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.247 -177.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.438 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 73.9 t -119.17 113.33 41.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.353 0.597 . . . . 0.0 110.319 174.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.519 HG21 HD11 ' A' ' 210' ' ' LEU . 18.9 m -97.95 133.59 42.23 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.905 176.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.672 ' O ' ' HA ' ' B' ' 0' ' ' PTR . 13.4 m-70 -110.9 117.91 34.66 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.577 ' CG2' ' HB3' ' A' ' 149' ' ' LEU . 0.7 OUTLIER -98.15 133.58 39.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -177.064 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 44.0 tpp -78.7 119.27 21.7 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.683 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 24.8 mt -99.58 107.22 20.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.63 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 4.5 ptp180 -69.98 125.51 26.98 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . 0.668 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 49.4 t -118.53 115.5 24.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.72 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -141.44 112.8 7.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.164 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 60.16 49.94 6.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.974 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.0 mt 58.35 47.49 13.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.844 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.668 ' O ' ' HA ' ' A' ' 174' ' ' CYS . 11.3 tppt? -133.97 132.23 39.91 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.475 ' HE1' ' CE1' ' A' ' 147' ' ' PHE . 69.0 m-85 -117.71 134.08 55.27 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.161 0.288 . . . . 0.0 110.715 -175.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.63 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 12.5 t0 -156.12 131.46 9.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.952 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.559 ' HB ' ' CZ ' ' A' ' 197' ' ' TYR . 51.1 t -83.16 -15.69 11.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.701 0.762 . . . . 0.0 109.083 175.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 122.57 8.49 6.91 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.83 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.405 ' HA3' ' CZ ' ' B' ' 5' ' ' PHE . . . -136.61 141.62 12.67 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.465 -175.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 71.44 -152.03 49.0 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.888 175.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -84.16 144.05 29.24 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.866 0.365 . . . . 0.0 110.835 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -78.98 137.17 37.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.576 177.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -110.74 149.95 29.77 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.193 0.52 . . . . 0.0 111.647 -175.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -84.06 -9.59 58.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.644 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.18 143.43 40.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.273 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.452 ' HG ' ' CD1' ' A' ' 179' ' ' TYR . 0.8 OUTLIER -70.85 -23.39 62.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.441 -174.63 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 20.6 m -61.35 -47.92 83.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.945 0.402 . . . . 0.0 110.15 175.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.21 -30.99 72.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.249 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.519 HD11 HG23 ' A' ' 181' ' ' VAL . 2.9 tm? -65.72 -54.64 24.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.44 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 34.5 m -66.77 -43.17 90.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.239 -173.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -62.25 -31.47 72.04 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.416 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -64.21 -52.1 60.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.817 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.559 ' CZ ' ' HB ' ' A' ' 181' ' ' VAL . 86.6 m-85 -80.92 -8.52 59.77 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.265 0.555 . . . . 0.0 110.393 -177.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -71.74 -23.17 61.56 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 172.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 8.3 tppt? -96.18 -36.5 10.93 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.682 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -121.86 103.72 39.78 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.001 0.429 . . . . 0.0 111.219 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -58.31 126.85 22.69 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 123.038 2.492 . . . . 0.0 112.475 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' MET . . . . . 0.478 ' HE3' HD23 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -89.51 127.66 35.89 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.727 178.785 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.538 HG22 ' HB ' ' A' ' 209' ' ' VAL . 47.2 t -99.42 139.69 20.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.192 0.52 . . . . 0.0 111.63 -173.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.721 ' HB2' ' O ' ' A' ' 208' ' ' THR . 0.4 OUTLIER -85.6 155.95 20.92 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.946 171.592 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 9.2 t -72.41 -11.8 60.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.052 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.5 mp -91.3 6.7 44.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.881 176.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.13 -17.93 53.57 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.788 178.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.721 ' O ' ' HB2' ' A' ' 204' ' ' GLU . 92.7 m -66.34 110.73 3.19 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-O 120.705 0.288 . . . . 0.0 110.239 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.538 ' HB ' HG22 ' A' ' 203' ' ' VAL . 1.4 p -111.8 127.43 68.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.695 0.759 . . . . 0.0 110.517 175.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.519 HD11 HG21 ' A' ' 168' ' ' THR . 0.3 OUTLIER -81.34 110.38 16.72 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.813 -169.377 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.422 ' O ' ' HA2' ' A' ' 133' ' ' GLY . 49.8 mt-30 -91.46 89.53 7.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.371 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 7.4 mp -75.45 111.7 11.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.195 176.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -113.92 -56.12 2.43 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.638 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.524 ' O ' ' HA ' ' A' ' 134' ' ' SER . 0.9 OUTLIER -145.77 149.2 38.92 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 121.096 0.474 . . . . 0.0 111.082 179.594 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.533 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 72.6 Cg_endo -72.94 149.44 47.21 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 123.55 2.833 . . . . 0.0 114.17 -173.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.512 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.2 OUTLIER -84.97 113.74 21.64 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 173.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -62.76 151.06 39.74 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.133 0.492 . . . . 0.0 111.198 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.423 HG21 ' O ' ' A' ' 111' ' ' ARG . 12.6 p -80.02 111.57 16.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.138 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 3.1 t -88.8 105.68 17.88 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.385 0.612 . . . . 0.0 109.474 176.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.527 -175.413 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' -4' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 121.02 0.438 . . . . 0.0 110.485 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -100.75 160.13 14.61 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 176.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' -2' ' ' THR . . . . . 0.595 ' HA ' ' CD2' ' A' ' 169' ' ' HIS . 12.3 m 53.33 -109.52 0.48 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-O 118.675 -0.679 . . . . 0.0 109.427 -172.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' -1' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' B' ' 0' ' ' PTR . 11.3 tp10 70.88 -42.69 0.54 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.195 0.598 . . . . 0.0 111.535 174.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 0' ' ' PTR . . . . . 0.672 ' HA ' ' O ' ' A' ' 169' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.428 ' HB3' ' CG2' ' A' ' 168' ' ' THR . . . -55.23 132.08 46.89 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.09 -1.413 . . . . 0.0 111.357 -175.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 86.0 m -70.7 -47.29 60.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.008 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.468 HG23 ' CE1' ' B' ' 5' ' ' PHE . 15.7 mm 78.54 89.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 123.318 0.647 . . . . 0.0 110.278 173.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.672 ' O ' ' HD3' ' B' ' 6' ' ' PRO . 5.9 m -98.66 124.31 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.435 177.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' PHE . . . . . 0.468 ' CE1' HG23 ' B' ' 3' ' ' ILE . 96.5 m-85 -102.23 82.37 0.42 Allowed Pre-proline 0 C--N 1.308 -1.215 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.925 170.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.672 ' HD3' ' O ' ' B' ' 4' ' ' VAL . 7.1 Cg_endo . . . . . 0 N--CA 1.448 -1.178 0 C-N-CA 122.875 2.384 . . . . 0.0 111.092 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.717 0 N-CA-C 112.132 -0.387 . . . . 0.0 112.132 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -86.77 -5.85 7.86 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.801 2.334 . . . . 0.0 112.959 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 86.8 mmm -93.34 4.51 53.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.4 0.619 . . . . 0.0 110.088 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.36 -164.58 2.05 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.703 176.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -78.63 138.43 58.55 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 173.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.12 -5.49 17.27 Favored 'Trans proline' 0 CA--C 1.516 -0.416 0 C-N-CA 122.774 2.316 . . . . 0.0 111.294 -173.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.624 ' HB ' ' CD2' ' A' ' 113' ' ' PHE . 81.5 p -94.77 6.69 48.2 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.59 -176.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 51.3 m -76.64 59.24 1.5 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.299 0.571 . . . . 0.0 110.818 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.477 ' HG3' ' CZ2' ' A' ' 112' ' ' TRP . 76.8 mm-40 -134.39 156.35 48.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.513 -177.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -75.11 -13.76 60.5 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -171.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.486 ' HB3' ' CB ' ' A' ' 215' ' ' PRO . 2.5 p-90 -89.65 -14.16 35.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.947 0.403 . . . . 0.0 110.742 175.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.624 ' CD2' ' HB ' ' A' ' 108' ' ' THR . 76.3 t80 -80.73 120.94 25.27 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.088 0.47 . . . . 0.0 110.149 172.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -111.91 140.4 46.6 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -76.73 -90.3 0.26 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.037 -175.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -92.66 93.54 8.54 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.992 0.425 . . . . 0.0 111.51 -172.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.2 mt -134.38 128.46 33.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.301 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 24.5 m -83.68 173.25 11.51 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 173.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -50.84 -52.62 29.49 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 121.477 -0.392 . . . . 0.0 113.386 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -72.09 -31.75 66.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.491 0.186 . . . . 0.0 111.431 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -64.04 -47.13 81.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.968 0.413 . . . . 0.0 110.481 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.461 ' HB1' ' HD3' ' A' ' 138' ' ' ARG . . . -66.15 -34.03 77.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.723 178.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.421 ' HA ' HG13 ' A' ' 167' ' ' VAL . 0.2 OUTLIER -65.87 -50.77 63.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.51 176.274 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -58.55 -34.78 71.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.615 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.81 -51.59 68.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.218 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.529 ' CD2' HD11 ' A' ' 216' ' ' LEU . 53.2 mt -75.48 -46.66 31.1 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 m -64.97 -28.32 69.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.098 -174.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -95.71 -53.03 3.86 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -103.48 11.65 36.13 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -170.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -127.05 -163.36 11.44 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.254 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -154.34 176.15 12.67 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -46.71 120.74 3.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.937 0.398 . . . . 0.0 111.004 176.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 211' ' ' GLN . . . 99.1 -9.63 61.51 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.797 177.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.648 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 69.0 m -70.41 135.67 48.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.218 0.509 . . . . 0.0 110.526 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.499 ' CB ' HG12 ' A' ' 151' ' ' VAL . 52.5 p90 -137.03 149.54 47.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.923 -178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.537 ' CD2' ' HB2' ' A' ' 150' ' ' SER . 1.2 pt? -149.43 134.8 18.36 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 175.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.437 HG12 HD13 ' A' ' 149' ' ' LEU . 12.3 m -97.52 141.93 15.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.461 ' HD3' ' HB1' ' A' ' 122' ' ' ALA . 30.5 ptt85 -140.98 162.17 36.1 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.357 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -71.38 129.25 38.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.871 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.446 ' OG ' ' HB2' ' A' ' 143' ' ' HIS . 23.3 t -77.94 132.85 38.07 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.328 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -91.08 -40.86 11.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.819 -175.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.6 t -79.81 -12.99 59.74 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.057 0.456 . . . . 0.0 109.789 177.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.446 ' HB2' ' OG ' ' A' ' 140' ' ' SER . 54.3 m80 -126.19 75.04 72.82 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.951 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.5 126.87 21.91 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.847 2.364 . . . . 0.0 112.234 -176.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 106.09 -31.97 7.83 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.943 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -98.16 171.79 8.0 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.155 0.502 . . . . 0.0 110.732 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.413 ' CE2' ' HE1' ' A' ' 179' ' ' TYR . 85.8 m-85 -125.23 165.9 17.46 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.435 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 27.5 m -132.97 136.48 55.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.404 0.621 . . . . 0.0 111.456 176.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.569 ' HB3' ' CG2' ' A' ' 170' ' ' VAL . 0.7 OUTLIER -92.74 110.02 21.45 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.806 174.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.537 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 1.2 m -101.9 128.98 48.05 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.709 -0.796 . . . . 0.0 109.254 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.499 HG12 ' CB ' ' A' ' 135' ' ' PHE . 33.7 m -130.46 147.7 33.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.581 -172.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -93.02 104.25 16.48 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.253 0.549 . . . . 0.0 109.879 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.7 p -104.08 146.93 28.01 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.092 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 86.51 -176.01 47.85 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.568 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -104.12 155.21 18.89 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 177.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -99.83 -1.08 38.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.042 0.449 . . . . 0.0 110.37 177.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -116.69 141.79 47.74 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.75 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 98.03 -18.47 57.09 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.647 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 59.58 47.08 11.2 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.273 0.559 . . . . 0.0 110.607 -178.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.6 p -77.15 -9.73 58.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.221 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -111.74 -133.44 0.34 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 174.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -78.39 -14.51 59.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.447 0.641 . . . . 0.0 109.973 176.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 163.2 -58.07 0.28 Allowed Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.877 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -100.26 -161.16 0.85 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 174.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 26.0 m -67.6 164.43 19.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.102 173.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.459 ' HD2' ' N ' ' A' ' 167' ' ' VAL . 0.0 OUTLIER -120.18 130.65 54.67 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.199 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.459 ' N ' ' HD2' ' A' ' 166' ' ' LYS . 74.9 t -99.41 116.2 42.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.475 0.655 . . . . 0.0 111.751 -177.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.5 HG21 HD13 ' A' ' 210' ' ' LEU . 4.4 m -97.26 141.19 30.67 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.35 176.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.567 ' O ' ' HA ' ' B' ' 0' ' ' PTR . 17.1 m-70 -117.76 117.47 29.41 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.569 ' CG2' ' HB3' ' A' ' 149' ' ' LEU . 0.7 OUTLIER -98.85 135.37 34.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -173.936 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 35.2 tpp -78.48 115.93 18.52 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.657 -176.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.414 HD12 HD21 ' A' ' 190' ' ' LEU . 29.6 mt -93.61 105.95 17.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 176.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.552 ' HB2' ' OE1' ' A' ' 175' ' ' GLN . 13.6 ptm180 -82.18 118.58 23.18 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.313 -175.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . 0.655 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 38.5 t -104.42 110.0 22.09 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.112 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.552 ' OE1' ' HB2' ' A' ' 173' ' ' ARG . 1.8 mp0 -113.74 107.91 16.39 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 177.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 58.2 52.17 7.78 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 123.562 0.539 . . . . 0.0 111.094 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 93.6 mt 61.05 41.89 13.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.193 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.655 ' O ' ' HA ' ' A' ' 174' ' ' CYS . 5.8 tppt? -134.51 131.03 37.53 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.413 ' HE1' ' CE2' ' A' ' 147' ' ' PHE . 63.5 m-85 -105.52 138.19 42.12 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 122.91 0.131 . . . . 0.0 111.118 -171.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.529 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 24.7 t70 -152.11 139.49 19.48 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.355 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.451 ' HB ' ' CZ ' ' A' ' 197' ' ' TYR . 84.4 t -96.83 55.68 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 122.514 1.15 . . . . 0.0 109.127 173.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 82.52 -39.02 2.64 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 114.7 -1.136 . . . . 0.0 113.674 173.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.412 ' HA3' ' CD1' ' B' ' 5' ' ' PHE . . . -138.51 151.88 21.77 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.281 -176.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 110.16 -142.71 16.63 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.653 175.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -106.44 143.75 34.1 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 176.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.44 ' HG2' ' HB2' ' A' ' 180' ' ' ASP . 80.2 mtt180 -92.77 139.49 30.49 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.346 -176.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -113.95 147.86 37.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.184 -175.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -79.16 -16.9 55.95 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.169 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 19.8 m -129.78 143.37 50.78 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.795 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.417 HD22 ' HB3' ' A' ' 193' ' ' LEU . 0.8 OUTLIER -69.89 -22.55 63.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.039 -176.456 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.465 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 6.5 m -58.83 -47.36 85.1 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.992 0.425 . . . . 0.0 110.363 176.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -66.41 -31.52 72.32 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.298 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.417 ' HB3' HD22 ' A' ' 190' ' ' LEU . 3.0 tm? -62.84 -54.48 38.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.779 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 32.7 m -69.22 -41.35 81.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.032 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -62.26 -34.87 77.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.677 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -63.52 -50.01 71.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.739 0.304 . . . . 0.0 110.811 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.451 ' CZ ' ' HB ' ' A' ' 181' ' ' VAL . 76.5 m-85 -82.04 -8.35 59.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.186 0.517 . . . . 0.0 111.014 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.423 ' HA ' ' HB2' ' A' ' 212' ' ' LEU . 35.3 ttpt -73.53 -20.47 60.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.68 0.752 . . . . 0.0 109.358 173.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . 0.402 ' HG3' ' ND2' ' A' ' 200' ' ' ASN . 9.5 tppt? -106.12 -36.21 6.99 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.554 175.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . 0.402 ' ND2' ' HG3' ' A' ' 199' ' ' LYS . 40.7 m-80 -112.68 93.99 26.3 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.834 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -58.22 130.09 36.12 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.99 2.46 . . . . 0.0 112.382 178.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' MET . . . . . 0.491 ' HE1' HD22 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -92.89 130.87 38.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.368 179.328 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.523 HG23 ' HB ' ' A' ' 209' ' ' VAL . 42.7 t -98.5 133.62 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.247 0.546 . . . . 0.0 112.091 -174.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.716 ' HB2' ' O ' ' A' ' 208' ' ' THR . 0.1 OUTLIER -81.56 159.07 24.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.974 170.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 9.0 t -74.06 -10.61 59.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.277 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.4 mp -88.88 -2.29 58.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.373 176.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 95.5 -13.91 65.82 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.07 -177.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.716 ' O ' ' HB2' ' A' ' 204' ' ' GLU . 49.5 m -67.65 110.27 3.65 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 176.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.523 ' HB ' HG23 ' A' ' 203' ' ' VAL . 1.1 p -112.14 120.61 62.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.925 0.869 . . . . 0.0 110.504 175.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.5 HD13 HG21 ' A' ' 168' ' ' THR . 0.4 OUTLIER -76.7 103.55 6.73 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.354 -170.233 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.459 ' O ' ' HA2' ' A' ' 133' ' ' GLY . 44.8 mt-30 -90.09 89.3 7.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.851 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.423 ' HB2' ' HA ' ' A' ' 198' ' ' LYS . 7.6 mp -71.27 113.89 8.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.656 178.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -115.81 -56.6 2.31 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.648 ' O ' ' HA ' ' A' ' 134' ' ' SER . 4.2 pm0 -136.84 140.91 33.16 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.072 0.463 . . . . 0.0 110.898 -177.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.486 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 59.9 Cg_endo -73.68 146.05 37.95 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.645 2.23 . . . . 0.0 112.753 -178.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.529 HD11 ' CD2' ' A' ' 126' ' ' LEU . 0.2 OUTLIER -86.75 105.46 16.98 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 174.712 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -60.78 138.64 58.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.996 0.427 . . . . 0.0 110.953 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 7.0 p -61.83 114.14 3.16 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.671 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 2.6 t -89.84 106.41 18.45 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.446 0.641 . . . . 0.0 109.523 177.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 . . . . . 0 C--O 1.246 0.91 0 CA-C-O 118.366 -0.826 . . . . 0.0 110.241 -174.75 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' -4' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 120.812 0.339 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -94.89 141.58 28.47 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -176.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' -2' ' ' THR . . . . . 0.519 ' C ' ' H ' ' B' ' 0' ' ' PTR . 1.3 m 69.04 -146.99 0.11 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.094 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' -1' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' B' ' -2' ' ' THR . 42.7 mt-10 75.21 -13.2 0.87 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.635 0.774 . . . . 0.0 110.198 -170.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 0' ' ' PTR . . . . . 0.567 ' HA ' ' O ' ' A' ' 169' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.493 ' HA ' ' OE2' ' A' ' 204' ' ' GLU . . . -71.49 125.06 26.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.507 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 86.0 m -71.5 -42.3 68.19 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.877 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.425 HG13 ' CG1' ' A' ' 181' ' ' VAL . 13.5 mm 73.68 99.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.113 0.565 . . . . 0.0 111.192 175.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 3.0 m -111.02 94.49 3.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.099 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' PHE . . . . . 0.412 ' CD1' ' HA3' ' A' ' 183' ' ' GLY . 93.8 m-85 -75.6 115.84 49.57 Favored Pre-proline 0 C--N 1.318 -0.777 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 172.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo . . . . . 0 C--O 1.249 1.063 0 C-N-CA 122.731 2.288 . . . . 0.0 111.936 178.861 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.411 ' HA2' ' HD3' ' A' ' 103' ' ' PRO . . . . . . . . 0 N--CA 1.481 1.676 0 N-CA-C 112.22 -0.352 . . . . 0.0 112.22 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.411 ' HD3' ' HA2' ' A' ' 102' ' ' GLY . 17.4 Cg_exo -66.56 -31.77 40.56 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.822 2.348 . . . . 0.0 112.44 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 90.2 mtp -87.67 -29.64 21.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.715 -178.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 52.63 67.93 0.91 Allowed 'General case' 0 C--O 1.238 0.454 0 O-C-N 123.699 0.625 . . . . 0.0 110.973 177.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -59.0 126.0 79.89 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.478 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -77.03 -7.13 17.18 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.77 2.314 . . . . 0.0 110.108 172.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.516 ' HB ' ' CG ' ' A' ' 113' ' ' PHE . 42.1 p -98.39 8.05 45.38 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.609 -178.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 66.5 p -74.86 34.65 0.1 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.933 0.397 . . . . 0.0 111.563 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.463 ' H ' ' C ' ' A' ' 108' ' ' THR . 60.7 mm-40 -115.8 157.22 24.72 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -75.65 -12.2 60.16 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -167.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 4.4 p-90 -85.29 -14.68 45.84 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.827 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.516 ' CG ' ' HB ' ' A' ' 108' ' ' THR . 68.4 t80 -77.59 120.25 22.28 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.125 0.488 . . . . 0.0 110.389 171.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.472 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 10.6 m170 -121.08 106.57 11.68 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 175.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -73.93 -45.96 24.83 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.541 -171.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -99.01 83.72 2.94 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.052 0.453 . . . . 0.0 111.139 -173.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.4 mt -148.44 138.07 22.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.493 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.8 p -90.62 173.25 8.15 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 169.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.71 -48.9 49.1 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.862 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -76.48 -32.35 58.31 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.438 ' O ' HD21 ' A' ' 125' ' ' LEU . 48.6 mt-10 -64.02 -46.79 82.91 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.026 176.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.574 ' HB2' ' HD2' ' A' ' 138' ' ' ARG . . . -66.64 -33.69 76.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.693 177.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.547 ' HG3' ' HB ' ' A' ' 167' ' ' VAL . 4.2 tt0 -62.51 -50.37 71.65 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.215 176.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.66 -34.49 72.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.22 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.438 HD21 ' O ' ' A' ' 121' ' ' GLU . 0.7 OUTLIER -56.22 -52.9 62.74 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.332 0.587 . . . . 0.0 110.494 -178.069 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.562 ' CD2' HD11 ' A' ' 216' ' ' LEU . 54.2 mt -75.7 -46.72 29.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.514 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.6 m -61.28 -32.54 72.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.337 -172.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -97.36 -53.7 3.38 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 178.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -93.03 -21.35 19.79 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -170.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -89.1 -161.24 37.32 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.937 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -153.88 175.63 13.12 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 174.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -51.08 117.63 2.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.918 0.39 . . . . 0.0 110.891 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 99.93 -3.75 57.32 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.996 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.62 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 68.7 m -75.96 139.63 41.66 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.52 -0.4 . . . . 0.0 110.647 178.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.482 ' CB ' HG13 ' A' ' 151' ' ' VAL . 52.8 p90 -137.5 151.4 48.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.771 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.568 ' CD2' ' HB2' ' A' ' 150' ' ' SER . 1.2 pt? -151.71 138.02 18.47 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.435 HG21 HD12 ' A' ' 190' ' ' LEU . 14.2 m -97.62 137.94 23.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.308 176.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.574 ' HD2' ' HB2' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -137.64 162.14 34.61 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.053 -174.765 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -76.66 134.38 39.29 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.483 ' HB2' HG13 ' A' ' 148' ' ' VAL . 33.2 t -80.93 143.65 32.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.174 -175.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -101.15 -22.76 14.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.914 174.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 72.7 m -69.86 -40.35 75.82 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.439 0.637 . . . . 0.0 109.356 170.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -121.93 83.14 43.49 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.036 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -55.47 123.58 14.15 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.506 2.137 . . . . 0.0 111.553 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 106.7 -32.14 7.57 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.906 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -88.28 170.29 11.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.877 0.37 . . . . 0.0 110.431 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -121.65 153.96 37.45 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.151 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.515 ' CG2' ' HG3' ' A' ' 138' ' ' ARG . 30.2 m -129.38 138.86 53.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.159 0.504 . . . . 0.0 110.52 176.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.488 ' HB3' ' CG2' ' A' ' 170' ' ' VAL . 0.6 OUTLIER -92.18 110.13 21.51 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.149 177.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.568 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 3.3 m -101.42 132.01 47.23 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.408 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.542 HG22 ' HB3' ' A' ' 210' ' ' LEU . 32.0 m -132.47 149.44 32.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.96 -174.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.503 HH21 ' HB2' ' A' ' 156' ' ' ASP . 72.9 ttt180 -96.0 104.16 16.09 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.031 0.443 . . . . 0.0 109.898 176.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -107.69 147.15 31.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.224 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 85.17 -178.52 50.79 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.405 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -96.12 176.42 6.09 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.762 0.315 . . . . 0.0 110.493 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.503 ' HB2' HH21 ' A' ' 152' ' ' ARG . 21.9 t70 -126.16 -3.94 6.86 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.238 0.542 . . . . 0.0 111.003 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -98.9 60.4 1.24 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.163 0.506 . . . . 0.0 111.575 -172.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 78.5 -72.26 2.39 Favored Glycine 0 C--N 1.318 -0.431 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.882 176.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -78.16 110.61 13.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.126 0.488 . . . . 0.0 110.439 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 45.5 t -168.36 -55.84 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.359 -176.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.441 HD22 ' HB2' ' A' ' 166' ' ' LYS . 4.9 p30 -168.07 -65.52 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.159 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -124.81 -10.9 7.24 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.105 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 152.1 -78.1 0.21 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.781 177.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -88.07 -176.1 5.31 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.472 ' OG ' ' HB2' ' A' ' 156' ' ' ASP . 58.9 m -67.71 154.5 41.36 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.25 0.548 . . . . 0.0 111.363 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.441 ' HB2' HD22 ' A' ' 161' ' ' ASN . 0.0 OUTLIER -110.72 126.27 54.38 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 176.379 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.547 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 71.4 t -99.96 112.52 32.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.396 0.617 . . . . 0.0 110.492 177.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.586 ' CG2' ' HB1' ' B' ' 1' ' ' ALA . 6.3 m -92.01 140.5 29.59 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.641 175.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.775 ' O ' ' HA ' ' B' ' 0' ' ' PTR . 7.5 m-70 -118.5 120.15 36.66 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.669 HG11 ' SD ' ' A' ' 202' ' ' MET . 1.1 m -98.16 138.8 21.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -177.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 5.7 ttm -90.45 118.69 30.12 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.941 -174.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 25.6 mt -93.47 127.97 45.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.661 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.584 ' NH1' ' HA2' ' A' ' 182' ' ' GLY . 5.0 ptp180 -87.77 112.26 22.24 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.043 0.449 . . . . 0.0 109.942 177.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 47.0 t -96.89 92.6 6.2 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -113.77 113.78 25.42 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.48 -175.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 58.63 40.89 23.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.857 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 93.9 mt 67.1 18.78 10.49 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.82 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -109.95 139.05 45.48 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 172.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.449 ' CD1' ' HG ' ' A' ' 190' ' ' LEU . 51.5 m-85 -109.54 138.53 45.77 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.841 -175.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.567 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 9.6 t0 -155.73 140.99 17.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.028 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.545 ' HB ' ' CE1' ' A' ' 197' ' ' TYR . 14.4 t -94.62 -12.43 8.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.657 0.742 . . . . 0.0 109.342 176.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . 0.584 ' HA2' ' NH1' ' A' ' 173' ' ' ARG . . . 123.21 9.02 6.24 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.166 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.641 ' HA3' ' CE1' ' B' ' 5' ' ' PHE . . . -138.07 140.59 11.3 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.242 -0.98 . . . . 0.0 113.755 -176.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.67 -119.87 5.59 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.376 173.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -115.76 158.69 22.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.631 0.253 . . . . 0.0 110.564 -173.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -95.43 128.65 42.46 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -110.31 144.28 39.26 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.076 -173.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -79.8 -8.66 59.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.413 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 85.1 p -130.46 143.9 51.06 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.479 177.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.449 ' HG ' ' CD1' ' A' ' 179' ' ' TYR . 1.1 mt -70.65 -22.08 62.54 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.37 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.489 ' O ' ' HG3' ' A' ' 195' ' ' GLU . 4.0 m -60.42 -49.18 78.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.637 177.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -67.14 -30.52 70.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.705 0.288 . . . . 0.0 110.565 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.501 HD12 HG21 ' A' ' 181' ' ' VAL . 3.4 tm? -62.15 -54.83 35.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.836 177.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 35.7 m -68.97 -39.69 80.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.999 -175.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 191' ' ' THR . 22.7 mt-10 -66.67 -35.27 79.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.414 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -60.26 -42.78 96.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.818 0.342 . . . . 0.0 110.414 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.545 ' CE1' ' HB ' ' A' ' 181' ' ' VAL . 40.5 m-85 -85.44 -11.62 53.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.376 0.608 . . . . 0.0 110.649 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.401 ' HE2' ' HA ' ' A' ' 195' ' ' GLU . 38.4 ttpt -73.67 -27.67 61.35 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 173.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -90.29 -35.99 14.95 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.442 175.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -116.38 102.78 53.42 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.511 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -57.93 126.43 21.64 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.603 2.202 . . . . 0.0 111.974 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' MET . . . . . 0.691 ' SD ' HD21 ' A' ' 210' ' ' LEU . 9.5 ptp -89.11 120.48 30.54 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.633 -177.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.552 HG22 ' HB ' ' A' ' 209' ' ' VAL . 28.7 t -97.91 136.55 28.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.662 0.268 . . . . 0.0 111.72 -175.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.546 ' O ' HG11 ' A' ' 203' ' ' VAL . 22.6 mt-10 -85.79 167.09 15.53 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.877 0.37 . . . . 0.0 110.063 169.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 12.1 t -75.16 -14.83 60.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.276 0.56 . . . . 0.0 109.978 177.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.434 ' N ' HD12 ' A' ' 206' ' ' LEU . 5.1 mp -81.73 -7.44 59.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.153 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 99.82 -21.23 45.87 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.869 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 89.8 m -62.94 112.13 2.44 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.552 ' HB ' HG22 ' A' ' 203' ' ' VAL . 0.8 OUTLIER -112.82 121.82 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 CA-C-O 121.616 0.722 . . . . 0.0 110.574 173.836 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.691 HD21 ' SD ' ' A' ' 202' ' ' MET . 0.4 OUTLIER -77.12 107.94 9.84 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.767 -174.708 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -93.54 90.23 6.59 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.008 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 7.8 mp -74.02 103.4 4.49 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.242 -177.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -115.47 -55.79 2.41 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.62 ' O ' ' HA ' ' A' ' 134' ' ' SER . 0.1 OUTLIER -115.09 132.89 22.8 Favored Pre-proline 0 C--O 1.223 -0.305 0 CA-C-O 120.483 0.182 . . . . 0.0 111.323 -173.706 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.09 132.78 11.81 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.315 2.01 . . . . 0.0 111.817 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.562 HD11 ' CD2' ' A' ' 126' ' ' LEU . 0.3 OUTLIER -78.88 102.02 8.0 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.173 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -58.13 140.24 53.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.705 178.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.3 p -62.58 125.54 24.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.335 0.588 . . . . 0.0 111.554 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.2 t -118.08 116.38 26.74 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.076 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.696 -0.669 . . . . 0.0 110.639 179.536 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' -4' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 121.088 0.47 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' -3' ' ' GLN . . . . . 0.446 ' HB3' ' OE1' ' A' ' 123' ' ' GLU . 92.4 mt-30 -116.59 158.78 23.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.703 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' -2' ' ' THR . . . . . 0.64 ' HA ' ' CD2' ' A' ' 169' ' ' HIS . 6.9 m 54.13 -110.57 0.56 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.471 -0.776 . . . . 0.0 109.279 -172.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' -1' ' ' GLU . . . . . 0.42 ' O ' ' HB3' ' B' ' 0' ' ' PTR . 43.2 tt0 74.37 -42.51 0.5 Allowed 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.369 0.531 . . . . 0.0 111.195 171.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 0' ' ' PTR . . . . . 0.775 ' HA ' ' O ' ' A' ' 169' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.586 ' HB1' ' CG2' ' A' ' 168' ' ' THR . . . -51.03 141.67 13.47 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 113.584 -1.644 . . . . 0.0 113.1 -169.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 63.4 m -73.48 -47.03 44.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.443 -1.253 . . . . 0.0 111.521 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.68 HD13 ' SD ' ' A' ' 202' ' ' MET . 6.4 mm 66.32 105.25 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 123.224 0.61 . . . . 0.0 111.63 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -129.97 86.0 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.333 175.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' PHE . . . . . 0.641 ' CE1' ' HA3' ' A' ' 183' ' ' GLY . 77.0 m-85 -58.07 114.15 7.98 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.143 174.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo . . . . . 0 C--O 1.249 1.073 0 C-N-CA 122.764 2.309 . . . . 0.0 112.094 178.892 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.678 0 N-CA-C 111.729 -0.549 . . . . 0.0 111.729 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -66.49 -41.33 11.94 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.742 2.295 . . . . 0.0 112.426 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 64.9 mtt -86.83 -47.26 9.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.896 0.379 . . . . 0.0 110.923 -177.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -105.67 125.89 51.51 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.735 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -63.77 150.29 91.26 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.421 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -75.32 -12.61 20.9 Favored 'Trans proline' 0 CA--C 1.508 -0.816 0 C-N-CA 122.693 2.262 . . . . 0.0 110.741 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.439 ' HB ' ' HB2' ' A' ' 190' ' ' LEU . 8.9 t -101.07 5.94 43.14 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.348 175.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.7 t -71.74 65.54 0.51 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 121.792 0.805 . . . . 0.0 110.035 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -130.27 169.89 14.83 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.033 -175.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -64.83 -17.1 63.95 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -167.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.427 ' CZ2' ' HA ' ' A' ' 191' ' ' THR . 1.3 p-90 -92.93 -13.33 29.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.858 0.361 . . . . 0.0 111.467 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 137' ' ' VAL . 24.6 t80 -89.37 118.57 29.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.175 0.512 . . . . 0.0 110.806 177.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -109.65 119.26 38.84 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -49.8 -86.02 0.01 OUTLIER Glycine 0 C--N 1.331 0.256 0 O-C-N 123.98 0.8 . . . . 0.0 114.213 -170.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -100.4 107.2 18.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.521 0.677 . . . . 0.0 111.227 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 33.9 mt -129.57 140.92 51.08 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.951 174.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 18.1 t -90.0 171.31 9.65 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 173.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.34 -53.18 42.58 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.835 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 20.9 mmtm -76.73 -25.45 53.54 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.445 ' O ' HD22 ' A' ' 125' ' ' LEU . 15.2 mm-40 -65.29 -47.03 78.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.948 0.404 . . . . 0.0 110.225 175.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.504 ' HB2' ' HD2' ' A' ' 138' ' ' ARG . . . -65.59 -34.26 77.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.282 0.563 . . . . 0.0 110.492 178.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -67.94 -50.14 57.73 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.851 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -56.97 -34.65 68.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.788 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' A' ' 129' ' ' LYS . 0.7 OUTLIER -57.14 -52.69 64.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.275 178.484 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.539 ' CD2' HD11 ' A' ' 216' ' ' LEU . 55.1 mt -76.04 -51.88 11.38 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.5 m -61.07 -35.84 78.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.75 -171.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -97.68 -46.63 5.92 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 125' ' ' LEU . 89.0 mttt -91.23 -28.88 17.52 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.668 -0.413 . . . . 0.0 112.015 -171.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -93.17 -158.98 34.56 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.831 -176.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.426 ' C ' ' HD3' ' A' ' 152' ' ' ARG . 14.9 ptmm? -148.08 176.0 10.56 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -51.92 123.85 11.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.707 0.289 . . . . 0.0 110.513 176.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 94.87 -3.64 67.66 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.239 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.612 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 69.0 m -73.61 139.15 45.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.059 0.429 . . . . 0.0 110.313 178.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.488 ' CB ' HG13 ' A' ' 151' ' ' VAL . 50.4 p90 -136.93 149.38 47.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.71 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.529 ' CD2' ' HB2' ' A' ' 150' ' ' SER . 1.2 pt? -150.64 140.4 21.77 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 11.4 m -99.73 144.1 12.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.186 175.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.504 ' HD2' ' HB2' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -146.0 156.69 43.67 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.845 -173.682 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -70.31 132.73 46.13 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 175.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.459 ' HB2' HG11 ' A' ' 148' ' ' VAL . 37.9 t -86.22 143.43 27.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.916 0.389 . . . . 0.0 110.38 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -100.63 -20.25 15.74 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.691 178.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 65.9 m -78.75 -30.56 45.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.141 0.496 . . . . 0.0 109.789 172.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -120.55 86.16 39.26 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.858 173.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -61.49 123.19 12.28 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.241 1.96 . . . . 0.0 111.892 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 101.35 -14.82 57.99 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.166 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -105.61 164.08 12.17 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.168 0.509 . . . . 0.0 110.865 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -119.24 153.89 34.28 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.721 -177.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.459 HG11 ' HB2' ' A' ' 140' ' ' SER . 34.5 m -130.31 139.94 50.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.393 0.616 . . . . 0.0 111.371 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.53 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -92.64 110.37 21.79 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.256 178.17 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.529 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 1.5 m -102.97 131.27 50.05 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.115 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.5 HG22 ' HB3' ' A' ' 210' ' ' LEU . 35.3 m -132.12 146.81 32.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.166 -173.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.426 ' HD3' ' C ' ' A' ' 131' ' ' LYS . 75.0 ttt180 -90.56 104.67 17.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.339 0.59 . . . . 0.0 109.968 176.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 8.8 p -102.23 147.43 26.66 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.392 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 83.0 173.47 49.68 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.76 -177.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -102.89 177.51 4.82 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.082 0.468 . . . . 0.0 110.744 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.666 ' HA ' ' ND2' ' A' ' 161' ' ' ASN . 34.6 t70 -123.86 14.12 9.25 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.725 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -98.13 -44.2 6.71 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.027 -176.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 144.12 19.37 0.2 Allowed Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.304 -0.95 . . . . 0.0 114.235 177.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.67 -57.3 3.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.526 0.663 . . . . 0.0 109.514 175.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 10.1 t -129.04 46.61 2.6 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 176.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.666 ' ND2' ' HA ' ' A' ' 156' ' ' ASP . 26.4 t-20 -118.58 109.89 16.7 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.612 -175.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -92.29 66.36 4.74 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.21 0.529 . . . . 0.0 110.528 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 84.76 -50.54 4.42 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -129.36 161.94 29.14 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 28.1 m -76.78 164.54 25.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.932 -177.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 166' ' ' LYS . 25.6 mmmt -95.89 139.14 32.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.846 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 71.3 t -125.73 113.32 34.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.71 170.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.51 ' CG2' ' HB3' ' B' ' 1' ' ' ALA . 1.8 m -97.83 138.18 35.57 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.898 175.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.717 ' O ' ' HA ' ' B' ' 0' ' ' PTR . 14.2 m-70 -112.73 117.99 33.74 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.53 HG22 ' HB3' ' A' ' 149' ' ' LEU . 1.3 m -98.35 135.72 32.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -175.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 40.1 tpp -81.3 116.78 21.32 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.893 -174.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.481 HG21 HD22 ' A' ' 190' ' ' LEU . 16.6 mt -97.03 107.67 20.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.563 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 3.9 ptp180 -70.11 117.73 12.05 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.617 -178.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 36.6 t -93.02 94.59 8.97 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -113.78 109.59 18.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.47 -174.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 53.01 40.52 31.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.802 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 96.1 mt 72.66 15.13 4.97 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.169 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.88 142.94 34.74 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 170.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -110.8 140.99 44.74 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.53 -176.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.563 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 10.6 t0 -156.02 137.95 14.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.753 0.311 . . . . 0.0 111.048 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.486 HG22 HD12 ' A' ' 193' ' ' LEU . 48.6 t -90.11 -13.16 9.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.724 0.773 . . . . 0.0 109.322 175.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . 0.554 ' HA2' ' NH1' ' A' ' 173' ' ' ARG . . . 124.09 5.23 7.5 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.763 178.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -137.14 140.41 11.37 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 119.807 -1.187 . . . . 0.0 113.918 -174.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 79.45 -116.46 4.31 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.088 -0.577 . . . . 0.0 113.18 174.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -115.92 150.18 37.53 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 122.291 0.236 . . . . 0.0 110.436 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -80.96 126.96 32.03 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 171.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -105.62 138.69 41.4 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.099 0.476 . . . . 0.0 111.326 -172.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -70.13 -22.77 62.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.788 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 82.2 p -130.71 144.62 51.56 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.517 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.481 HD22 HG21 ' A' ' 172' ' ' ILE . 8.8 mt -65.66 -20.92 66.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.11 176.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.427 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 3.7 m -55.89 -48.91 74.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.694 0.283 . . . . 0.0 110.538 176.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -69.24 -34.73 75.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.764 0.316 . . . . 0.0 110.334 176.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.486 HD12 HG22 ' A' ' 181' ' ' VAL . 2.9 tm? -59.75 -54.0 51.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.987 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 30.5 m -69.58 -41.86 80.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.389 -174.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -66.68 -36.37 82.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.447 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -61.03 -44.9 96.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.751 0.31 . . . . 0.0 110.752 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.415 ' CZ ' ' HB ' ' A' ' 181' ' ' VAL . 55.6 m-85 -85.23 -10.48 56.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.008 0.432 . . . . 0.0 110.799 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.473 ' HA ' ' HB2' ' A' ' 212' ' ' LEU . 38.9 ttpt -70.13 -34.03 72.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.608 0.718 . . . . 0.0 109.228 174.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -88.01 -25.75 22.96 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.043 176.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -128.31 90.78 45.97 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.801 -174.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -55.17 127.98 28.57 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.177 2.584 . . . . 0.0 112.587 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' MET . . . . . 0.489 ' HE1' HD22 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -91.63 123.78 35.28 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.956 0.408 . . . . 0.0 110.415 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.56 ' HB ' ' CD ' ' B' ' 6' ' ' PRO . 36.3 t -93.87 134.89 29.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 120.85 0.357 . . . . 0.0 111.871 -176.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.533 ' O ' HG12 ' A' ' 203' ' ' VAL . 0.7 OUTLIER -79.2 163.64 24.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.49 169.245 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 7.7 t -76.33 -10.0 59.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.452 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.4 mp -92.2 5.03 51.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.432 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 90.99 -14.5 63.27 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.703 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.493 ' O ' ' HB2' ' A' ' 204' ' ' GLU . 88.2 m -71.6 111.42 6.88 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.55 ' HB ' HG22 ' A' ' 203' ' ' VAL . 1.4 p -111.81 128.27 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-O 121.82 0.819 . . . . 0.0 110.854 176.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.5 ' HB3' HG22 ' A' ' 151' ' ' VAL . 0.3 OUTLIER -84.8 103.49 13.93 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.83 -172.884 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -90.88 89.41 7.45 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.216 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.473 ' HB2' ' HA ' ' A' ' 198' ' ' LYS . 7.6 mp -71.79 108.55 5.15 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.314 177.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -115.11 -56.01 2.41 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -177.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.612 ' O ' ' HA ' ' A' ' 134' ' ' SER . 5.0 pm0 -131.95 136.46 28.32 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 121.068 0.461 . . . . 0.0 110.746 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.01 137.54 26.75 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.918 2.412 . . . . 0.0 112.798 -178.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.539 HD11 ' CD2' ' A' ' 126' ' ' LEU . 0.2 OUTLIER -76.7 98.88 4.89 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 175.792 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -63.77 139.18 58.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.905 0.384 . . . . 0.0 110.574 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 7.5 p -61.66 110.49 1.51 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.394 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 2.0 t -87.28 105.22 17.08 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.463 0.649 . . . . 0.0 109.517 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.658 -0.686 . . . . 0.0 110.138 -175.245 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' -4' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 120.944 0.402 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -145.57 -160.7 1.18 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' -2' ' ' THR . . . . . 0.698 ' HA ' ' CD2' ' A' ' 169' ' ' HIS . 0.5 OUTLIER -51.66 -69.64 0.11 Allowed 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 120.883 0.373 . . . . 0.0 110.578 170.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' -1' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 60.49 50.86 5.56 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 173.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 0' ' ' PTR . . . . . 0.717 ' HA ' ' O ' ' A' ' 169' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.51 ' HB3' ' CG2' ' A' ' 168' ' ' THR . . . -55.97 133.33 51.56 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.746 -172.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 71.8 m -76.05 -41.81 49.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.742 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.417 HG13 ' CG1' ' A' ' 181' ' ' VAL . 8.5 mm 68.48 120.54 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.291 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 1.3 m -120.32 -17.88 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 48.02 71.29 1.64 Allowed Pre-proline 0 C--N 1.317 -0.832 0 O-C-N 123.373 0.421 . . . . 0.0 111.544 -175.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.56 ' CD ' ' HB ' ' A' ' 203' ' ' VAL . 5.5 Cg_exo . . . . . 0 C--O 1.248 0.99 0 C-N-CA 122.856 2.37 . . . . 0.0 111.445 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.785 0 N-CA-C 112.014 -0.434 . . . . 0.0 112.014 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -62.21 -24.33 76.11 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.083 2.522 . . . . 0.0 113.194 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 64.5 mtt -97.99 21.2 11.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.082 0.468 . . . . 0.0 110.891 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -118.98 98.51 6.22 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 175.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -65.68 117.22 39.25 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.925 -173.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -76.9 -9.51 18.13 Favored 'Trans proline' 0 CA--C 1.515 -0.471 0 C-N-CA 122.811 2.341 . . . . 0.0 109.29 169.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.694 ' HB ' ' CG ' ' A' ' 113' ' ' PHE . 22.9 p -88.12 7.37 31.92 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 113.619 -1.628 . . . . 0.0 110.738 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.4 p -71.26 47.07 0.11 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.483 0.659 . . . . 0.0 111.258 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.425 ' HG3' ' CZ2' ' A' ' 112' ' ' TRP . 70.8 mm-40 -122.03 -176.9 3.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.84 -176.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -85.92 -23.43 27.0 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -176.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.445 ' CZ2' ' HA ' ' A' ' 191' ' ' THR . 2.8 p-90 -85.16 -20.34 30.4 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.812 -177.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.694 ' CG ' ' HB ' ' A' ' 108' ' ' THR . 60.2 t80 -80.27 127.15 32.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.98 0.419 . . . . 0.0 110.405 173.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -118.56 113.09 20.74 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.427 ' HA2' ' CZ ' ' A' ' 113' ' ' PHE . . . -50.44 -82.4 0.04 OUTLIER Glycine 0 C--O 1.237 0.315 0 O-C-N 123.971 0.794 . . . . 0.0 114.599 -169.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -99.83 90.59 4.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.185 0.517 . . . . 0.0 111.393 -173.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 44.5 mt -126.21 130.56 51.19 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.164 173.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.4 m -81.85 170.82 15.22 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 171.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -54.66 -47.45 70.69 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.45 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -64.71 -44.39 90.4 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 122.704 0.402 . . . . 0.0 110.974 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -62.7 -46.75 86.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.238 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.538 ' HB1' ' HD2' ' A' ' 138' ' ' ARG . . . -60.32 -34.32 73.64 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.945 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.651 ' OE1' ' HA ' ' B' ' -3' ' ' GLN . 3.7 tt0 -69.93 -46.64 64.91 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.529 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -56.92 -36.21 69.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.647 175.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.64 -52.59 64.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.601 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.526 ' CD2' HD12 ' A' ' 216' ' ' LEU . 58.2 mt -75.12 -49.43 19.62 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.568 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.7 m -61.95 -29.58 70.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.326 -172.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -95.56 -51.97 4.32 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 177.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -105.77 -0.81 25.06 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -163.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -106.09 -161.52 22.72 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.169 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -149.86 173.8 13.36 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 174.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 55.0 t60 -53.61 117.39 3.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.964 0.411 . . . . 0.0 111.025 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 100.95 -3.76 55.83 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.985 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.68 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 68.5 m -72.57 139.87 47.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.99 0.395 . . . . 0.0 110.608 178.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.464 ' CB ' HG11 ' A' ' 151' ' ' VAL . 52.1 p90 -136.92 150.82 48.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.612 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.562 ' CD2' ' HB2' ' A' ' 150' ' ' SER . 1.3 pt? -151.22 138.04 18.94 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 148' ' ' VAL . 11.2 m -100.55 140.23 20.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 120.231 -0.588 . . . . 0.0 109.441 177.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.538 ' HD2' ' HB1' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -141.04 161.56 37.55 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.311 -174.683 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -72.84 132.83 44.05 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.579 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.47 ' HB2' HG11 ' A' ' 148' ' ' VAL . 29.5 t -77.37 143.46 38.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.531 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -100.6 -30.1 11.96 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.145 178.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 72.6 m -74.32 -30.73 62.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.02 0.438 . . . . 0.0 110.256 173.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -121.49 85.53 43.27 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.193 175.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.66 123.73 14.21 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.525 2.15 . . . . 0.0 111.808 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 105.94 -27.69 16.6 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.701 -176.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -89.99 171.65 9.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.247 0.546 . . . . 0.0 110.614 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -124.36 157.52 34.84 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.314 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.487 ' CG2' ' HG3' ' A' ' 138' ' ' ARG . 32.1 m -128.13 136.58 59.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.298 0.571 . . . . 0.0 110.717 174.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.522 ' HB3' ' CG2' ' A' ' 170' ' ' VAL . 0.5 OUTLIER -91.77 109.61 20.94 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.318 -0.856 . . . . 0.0 108.848 176.81 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.562 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 2.1 m -102.46 132.38 48.53 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.212 -178.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.498 HG21 ' HB3' ' A' ' 210' ' ' LEU . 34.7 m -130.43 147.8 33.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.128 -172.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -92.84 105.08 17.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.744 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 166' ' ' LYS . 1.2 p -108.52 148.43 30.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.777 -175.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 93.66 169.14 38.51 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.883 177.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -101.45 140.83 35.2 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.844 0.354 . . . . 0.0 111.107 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -123.59 -3.87 8.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.399 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -96.18 -24.49 16.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.599 -176.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -100.1 23.88 34.27 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.962 178.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 55.75 37.34 28.75 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 122.682 0.393 . . . . 0.0 111.398 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 46.9 m -73.36 -20.53 60.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.155 0.502 . . . . 0.0 110.437 177.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -152.19 62.27 0.83 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 52.55 -100.01 0.09 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.751 -175.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -135.46 17.14 4.03 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.596 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -114.41 143.35 45.06 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.764 0.316 . . . . 0.0 110.395 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 14.8 m -95.96 165.41 12.28 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 174.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 153' ' ' THR . 46.1 tptt -94.65 143.09 26.72 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.501 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 69.2 t -126.62 112.61 29.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.51 0.671 . . . . 0.0 110.503 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.55 ' CG2' ' HB2' ' B' ' 1' ' ' ALA . 3.9 m -96.38 140.3 31.24 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.623 174.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.771 ' O ' ' HA ' ' B' ' 0' ' ' PTR . 18.9 m-70 -115.57 119.16 35.24 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.529 HG11 ' SD ' ' A' ' 202' ' ' MET . 1.0 OUTLIER -98.37 134.91 35.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -178.835 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 9.8 ttm -88.6 119.04 28.69 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.395 -176.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 12.5 mt -94.05 113.73 29.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.072 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.601 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 19.9 ptp180 -74.21 118.28 16.98 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.146 0.498 . . . . 0.0 110.189 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 46.1 t -102.56 93.07 4.94 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -114.73 108.5 16.86 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.364 -176.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 57.64 48.39 14.22 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.704 0.628 . . . . 0.0 110.573 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 88.9 mt 64.82 24.88 12.85 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.768 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 10.4 tppt? -115.08 133.46 56.02 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -113.38 130.87 56.18 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 123.012 0.195 . . . . 0.0 111.026 -173.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.601 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 34.6 t0 -156.42 136.15 12.51 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.945 0.402 . . . . 0.0 110.796 175.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.534 ' HB ' ' CZ ' ' A' ' 197' ' ' TYR . 25.9 t -85.41 -15.64 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 123.69 4.23 8.16 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.251 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.475 ' HA3' ' CE1' ' B' ' 5' ' ' PHE . . . -136.19 141.14 12.18 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.812 -177.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 80.42 -158.09 41.21 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.685 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -85.76 155.16 21.15 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -84.94 130.58 34.61 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -105.89 153.54 21.8 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.031 0.443 . . . . 0.0 111.58 -172.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -91.61 -7.39 50.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.379 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 49.3 m -130.12 142.56 50.58 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.59 176.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 2.0 mt -72.87 -22.69 60.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.622 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.445 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 3.7 m -59.71 -46.28 89.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.671 176.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -66.3 -35.5 80.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.123 177.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.493 HD11 HG22 ' A' ' 181' ' ' VAL . 3.2 tm? -61.76 -54.96 35.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.306 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 34.6 m -66.69 -42.9 90.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.224 -173.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -70.38 -30.75 67.74 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.557 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -59.89 -42.93 94.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.775 0.321 . . . . 0.0 110.441 176.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.534 ' CZ ' ' HB ' ' A' ' 181' ' ' VAL . 56.3 m-85 -85.1 -13.29 50.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.207 0.527 . . . . 0.0 110.619 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.405 ' HA ' ' HB2' ' A' ' 212' ' ' LEU . 39.8 ttpt -72.68 -25.33 61.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.546 0.689 . . . . 0.0 109.487 174.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . 0.41 ' HE2' ' HA ' ' A' ' 199' ' ' LYS . 11.8 mmpt? -91.65 -36.0 13.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.903 175.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -120.78 102.15 44.78 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.623 -176.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.11 133.47 58.29 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.853 2.369 . . . . 0.0 112.58 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' MET . . . . . 0.831 ' SD ' HD13 ' B' ' 3' ' ' ILE . 7.3 ptp -96.65 128.15 43.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.493 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.567 HG22 ' HB ' ' A' ' 209' ' ' VAL . 40.6 t -101.52 137.87 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -175.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.556 ' O ' HG13 ' A' ' 203' ' ' VAL . 35.8 mt-10 -84.39 166.07 17.67 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.209 0.528 . . . . 0.0 110.382 170.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 12.1 t -77.21 -10.37 59.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.761 174.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.6 mp -91.43 8.91 34.05 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.402 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 86.77 -21.36 19.37 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.87 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 65.6 m -65.58 113.2 4.03 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.567 ' HB ' HG22 ' A' ' 203' ' ' VAL . 0.8 OUTLIER -111.64 124.66 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-O 121.785 0.802 . . . . 0.0 110.505 174.477 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.536 HD21 ' SD ' ' A' ' 202' ' ' MET . 0.4 OUTLIER -78.84 107.39 11.53 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.215 -172.523 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -92.3 89.43 6.84 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.836 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 198' ' ' LYS . 7.4 mp -74.57 110.8 9.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.767 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -114.27 -56.21 2.41 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.68 ' O ' ' HA ' ' A' ' 134' ' ' SER . 4.3 pm0 -135.69 142.56 41.3 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 121.024 0.44 . . . . 0.0 111.103 -176.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.441 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 74.4 Cg_endo -74.27 138.1 24.45 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.992 2.461 . . . . 0.0 112.728 -178.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.526 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.3 OUTLIER -74.12 108.39 6.9 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.787 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -55.75 131.42 46.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.9 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 2.6 p -61.68 126.85 28.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.342 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 3.1 t -123.77 110.93 15.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.362 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.634 -0.698 . . . . 0.0 109.903 178.165 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' -4' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 120.56 0.219 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' -3' ' ' GLN . . . . . 0.651 ' HA ' ' OE1' ' A' ' 123' ' ' GLU . 4.6 pm0 -164.7 149.06 9.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.788 174.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' -2' ' ' THR . . . . . 0.579 ' HA ' ' CD2' ' A' ' 169' ' ' HIS . 3.2 p 57.32 179.69 0.05 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.743 0.782 . . . . 0.0 112.782 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' -1' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 170.57 -39.25 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -172.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 0' ' ' PTR . . . . . 0.771 ' HA ' ' O ' ' A' ' 169' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.55 ' HB2' ' CG2' ' A' ' 168' ' ' THR . . . -52.99 135.34 37.05 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 113.3 -1.773 . . . . 0.0 112.774 -170.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 22.8 m -63.78 -44.47 93.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.045 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.831 HD13 ' SD ' ' A' ' 202' ' ' MET . 4.4 mm 60.06 96.84 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 123.267 0.627 . . . . 0.0 111.017 -177.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 3.7 m -114.78 86.02 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.459 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' PHE . . . . . 0.475 ' CE1' ' HA3' ' A' ' 183' ' ' GLY . 96.0 m-85 -67.83 114.8 22.23 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.504 173.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo . . . . . 0 C--O 1.249 1.049 0 C-N-CA 122.67 2.246 . . . . 0.0 111.804 -178.747 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.675 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -60.03 -63.26 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.691 2.26 . . . . 0.0 112.415 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 90.1 mtp -130.14 21.9 5.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.16 0.505 . . . . 0.0 110.33 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.44 97.55 11.25 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.535 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -92.3 158.8 38.39 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.297 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -75.06 -7.27 18.96 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.622 2.215 . . . . 0.0 109.543 174.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.74 ' HB ' ' CG ' ' A' ' 113' ' ' PHE . 48.2 p -100.26 4.3 44.1 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 114.018 -1.447 . . . . 0.0 111.098 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 44.4 m -75.57 45.31 0.31 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.609 0.718 . . . . 0.0 110.667 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -117.11 -170.46 1.85 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.625 -175.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.518 ' O ' HG23 ' A' ' 218' ' ' THR . 33.9 mtm180 -83.05 -28.05 29.85 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -176.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.472 ' CZ2' ' HA ' ' A' ' 191' ' ' THR . 2.2 p-90 -85.66 -21.53 28.34 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -174.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.74 ' CG ' ' HB ' ' A' ' 108' ' ' THR . 80.9 t80 -79.62 121.0 24.74 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.282 0.563 . . . . 0.0 111.067 177.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.478 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 11.8 m170 -116.88 124.56 49.77 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 173.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -68.5 -95.29 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.479 -173.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -76.46 93.09 3.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.139 0.495 . . . . 0.0 111.257 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.3 mt -131.37 139.16 49.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.424 174.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.409 ' HB3' ' HG2' ' A' ' 121' ' ' GLU . 21.1 t -94.57 172.58 8.09 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 172.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.44 -52.95 46.82 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.011 -176.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -75.71 -25.51 56.7 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.568 0.21 . . . . 0.0 111.568 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.409 ' HG2' ' HB3' ' A' ' 118' ' ' SER . 52.5 mm-40 -66.45 -47.5 72.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.108 0.48 . . . . 0.0 109.72 177.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.544 ' HB3' ' HD2' ' A' ' 138' ' ' ARG . . . -67.62 -34.16 76.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.68 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.529 ' HG3' ' HB ' ' A' ' 167' ' ' VAL . 5.9 tt0 -63.53 -47.28 82.26 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.198 177.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.82 -34.86 75.18 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.774 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.445 HD11 HD12 ' A' ' 216' ' ' LEU . 0.8 OUTLIER -56.71 -53.25 59.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.516 -179.667 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.53 ' CD2' HD13 ' A' ' 216' ' ' LEU . 58.7 mt -75.75 -44.04 43.66 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.627 -177.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 9.5 m -61.0 -35.01 75.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.29 -173.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -95.68 -52.85 3.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.073 0.463 . . . . 0.0 111.862 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -96.85 -11.33 24.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.325 -166.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -96.32 -164.15 33.35 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.82 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -153.76 173.88 15.28 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -55.13 116.02 2.56 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.928 0.394 . . . . 0.0 110.5 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 100.8 -3.27 55.89 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.525 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 42.6 p -71.12 137.48 48.88 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 117.494 0.647 . . . . 0.0 110.317 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.448 ' CB ' HG12 ' A' ' 151' ' ' VAL . 45.8 p90 -136.85 150.64 48.4 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.438 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.526 ' CD2' HD11 ' A' ' 126' ' ' LEU . 1.2 pt? -153.2 134.19 14.0 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.367 176.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.408 HG11 HD12 ' A' ' 149' ' ' LEU . 10.6 m -96.89 138.75 21.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 176.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.544 ' HD2' ' HB3' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -139.55 162.81 34.16 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.869 -173.403 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -71.0 132.76 45.64 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 121.089 -0.244 . . . . 0.0 110.343 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.456 ' HB2' HG11 ' A' ' 148' ' ' VAL . 41.3 t -77.11 136.68 38.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.357 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -100.39 -26.18 13.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.826 0.346 . . . . 0.0 110.163 176.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.438 ' HB2' ' O3P' ' B' ' 0' ' ' PTR . 23.1 t -72.49 -36.0 68.3 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 172.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 47.6 m-70 -121.41 81.51 38.64 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.018 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.94 123.49 13.92 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.524 2.149 . . . . 0.0 112.267 -178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 107.32 -26.66 17.89 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.915 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -89.99 170.64 10.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.95 0.405 . . . . 0.0 110.518 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -122.13 153.56 38.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.825 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.497 ' CG2' ' HG3' ' A' ' 138' ' ' ARG . 21.9 m -127.86 137.47 57.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.105 0.479 . . . . 0.0 110.668 176.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.551 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -92.63 110.11 21.53 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.407 178.353 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.518 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 2.3 m -101.65 132.63 47.23 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.517 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.495 HG23 ' HB3' ' A' ' 210' ' ' LEU . 35.1 m -131.25 149.79 33.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.988 -174.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.468 ' NH2' ' HB3' ' A' ' 156' ' ' ASP . 41.6 ttt180 -96.38 104.7 16.69 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.289 0.566 . . . . 0.0 109.925 176.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.511 ' O ' ' HB3' ' A' ' 166' ' ' LYS . 5.0 p -101.51 147.32 26.52 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.877 -178.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 85.64 173.65 49.61 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 119.942 -1.123 . . . . 0.0 112.05 -176.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -104.81 164.92 11.43 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 176.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.468 ' HB3' ' NH2' ' A' ' 152' ' ' ARG . 6.3 p-10 -96.09 -5.17 41.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.628 0.251 . . . . 0.0 111.475 -176.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -122.37 127.39 49.69 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.842 0.353 . . . . 0.0 111.03 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 96.04 14.2 46.58 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.953 176.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 55.5 92.35 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.185 0.594 . . . . 0.0 112.016 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 29.4 t -61.24 -69.77 0.22 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.515 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -122.2 -38.49 2.69 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -125.89 -169.22 1.97 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.062 173.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -65.09 -37.2 93.89 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.145 -177.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.412 ' HD2' ' N ' ' A' ' 164' ' ' LYS . 12.5 mptt -100.88 -171.49 2.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.181 0.515 . . . . 0.0 111.345 -174.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 9.6 m -76.47 147.02 38.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.481 174.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 153' ' ' THR . 47.6 tptt -96.42 137.83 34.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.013 0.435 . . . . 0.0 111.073 -177.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.529 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 70.6 t -124.68 114.42 40.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.267 173.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.49 HG23 HD13 ' A' ' 210' ' ' LEU . 18.6 m -98.96 137.51 37.39 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.965 175.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.775 ' O ' ' HA ' ' B' ' 0' ' ' PTR . 21.1 m-70 -112.29 118.83 36.35 Favored 'General case' 0 C--O 1.211 -0.922 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.551 HG22 ' HB3' ' A' ' 149' ' ' LEU . 1.0 OUTLIER -99.02 138.05 24.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.362 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.405 ' SD ' HG12 ' A' ' 148' ' ' VAL . 44.6 tpp -85.56 120.11 26.65 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.723 0.297 . . . . 0.0 110.756 -175.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 32.4 mt -94.04 107.08 18.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.606 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 3.6 ptp180 -67.55 107.1 2.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.211 0.529 . . . . 0.0 110.034 -178.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 36.8 m -98.46 93.13 6.0 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.647 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -114.31 108.91 17.55 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.005 -176.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 58.93 46.29 13.91 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 123.446 0.466 . . . . 0.0 110.698 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 91.5 mt 64.58 21.98 12.55 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.589 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 174' ' ' CYS . 1.7 tppp? -106.89 137.92 44.04 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 175.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -119.14 132.78 56.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.768 0.318 . . . . 0.0 111.454 -172.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.606 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 10.5 t70 -156.0 139.35 15.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.201 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.587 ' HB ' ' CZ ' ' A' ' 197' ' ' TYR . 37.9 t -89.23 -16.19 8.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.853 0.835 . . . . 0.0 109.075 175.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . 0.545 ' HA2' ' NH1' ' A' ' 173' ' ' ARG . . . 123.36 10.23 5.64 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.163 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.472 ' HA3' ' CE2' ' B' ' 5' ' ' PHE . . . -136.61 140.27 11.34 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 119.943 -1.123 . . . . 0.0 113.676 -176.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 67.13 -148.99 50.82 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 121.286 -0.483 . . . . 0.0 113.184 175.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -79.31 145.08 33.68 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.546 -0.327 . . . . 0.0 110.517 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.416 ' HG2' ' HB2' ' A' ' 180' ' ' ASP . 79.0 mtt180 -85.55 133.21 34.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.972 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -108.18 149.88 27.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.329 0.585 . . . . 0.0 111.723 -173.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.439 ' OD1' ' HE2' ' A' ' 178' ' ' LYS . 3.2 m-20 -87.55 -15.28 37.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.984 -178.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.4 p -130.64 142.4 50.44 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.231 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.404 HD11 HG22 ' A' ' 137' ' ' VAL . 9.1 mt -71.47 -22.99 61.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.232 -175.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.472 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 18.0 m -61.74 -43.52 98.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.018 0.437 . . . . 0.0 110.321 177.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -72.98 -32.92 65.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.932 177.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.484 HD13 HG22 ' A' ' 181' ' ' VAL . 3.2 tm? -61.02 -54.44 44.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.294 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 26.9 m -66.78 -43.08 90.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.629 -173.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.459 ' HA ' ' HE2' ' A' ' 198' ' ' LYS . 9.5 mt-10 -70.08 -30.46 67.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.511 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -59.02 -41.89 88.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.716 0.294 . . . . 0.0 110.498 176.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.587 ' CZ ' ' HB ' ' A' ' 181' ' ' VAL . 69.1 m-85 -86.15 -7.16 58.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.834 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.459 ' HE2' ' HA ' ' A' ' 195' ' ' GLU . 40.8 mtmt -69.27 -32.53 71.76 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 170.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -92.28 -36.2 13.34 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.856 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -111.57 96.28 31.42 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.229 -178.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.34 126.96 19.68 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.648 2.232 . . . . 0.0 112.001 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' MET . . . . . 0.484 ' HE1' HD22 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -89.1 118.11 28.58 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.07 0.462 . . . . 0.0 110.356 179.125 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.548 HG22 ' HB ' ' A' ' 209' ' ' VAL . 51.7 t -96.6 129.89 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.72 -175.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.621 ' HB2' ' O ' ' A' ' 208' ' ' THR . 2.4 mm-40 -78.63 159.98 27.79 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.668 0.747 . . . . 0.0 112.83 168.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.452 ' HB ' HG23 ' B' ' 4' ' ' VAL . 4.1 t -72.94 -10.96 60.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.024 177.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.3 mp -88.88 -2.28 58.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.968 177.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 96.98 -26.65 21.7 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.212 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.621 ' O ' ' HB2' ' A' ' 204' ' ' GLU . 99.0 m -60.44 111.23 1.49 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.999 0.428 . . . . 0.0 110.207 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.548 ' HB ' HG22 ' A' ' 203' ' ' VAL . 0.8 OUTLIER -112.08 127.66 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-O 121.57 0.7 . . . . 0.0 110.287 175.146 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.495 ' HB3' HG23 ' A' ' 151' ' ' VAL . 0.4 OUTLIER -82.55 111.03 18.17 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.783 -170.553 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -96.15 91.23 5.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.412 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 7.1 mp -74.81 109.83 8.6 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.983 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -114.58 -57.12 2.31 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.63 -0.428 . . . . 0.0 112.154 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.522 ' O ' ' HA ' ' A' ' 134' ' ' SER . 4.6 pm0 -133.16 142.83 45.88 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 121.099 0.476 . . . . 0.0 111.196 -176.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.467 ' HB3' ' HB3' ' A' ' 112' ' ' TRP . 74.5 Cg_endo -74.12 135.67 21.22 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.923 2.415 . . . . 0.0 112.479 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.53 HD13 ' CD2' ' A' ' 126' ' ' LEU . 0.4 OUTLIER -71.09 114.37 9.08 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.056 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -52.18 131.57 32.5 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 123.621 0.576 . . . . 0.0 110.863 -178.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 111' ' ' ARG . 18.1 p -73.49 107.9 6.04 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.064 0.459 . . . . 0.0 110.918 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 6.1 t -93.17 105.35 17.45 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 30.2 mtt180 . . . . . 0 C--O 1.247 0.949 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.17 -171.885 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' -4' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 . . . . . 0 N--CA 1.478 0.96 0 CA-C-O 120.957 0.408 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -133.56 138.0 45.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.775 -175.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' -2' ' ' THR . . . . . 0.538 ' HA ' ' CD2' ' A' ' 169' ' ' HIS . 0.8 OUTLIER 43.56 -90.82 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 O-C-N 124.293 0.995 . . . . 0.0 113.611 176.339 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' -1' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 75.05 -41.73 0.47 Allowed 'General case' 0 N--CA 1.47 0.567 0 O-C-N 123.987 0.805 . . . . 0.0 109.957 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 0' ' ' PTR . . . . . 0.775 ' HA ' ' O ' ' A' ' 169' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.489 ' HA ' ' OE1' ' A' ' 204' ' ' GLU . . . -50.18 128.23 18.76 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 113.981 -1.463 . . . . 0.0 111.292 -175.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 13.3 m -69.35 -44.02 72.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.171 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.467 HG22 ' HB2' ' A' ' 202' ' ' MET . 15.5 mm 75.27 103.55 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 123.206 0.602 . . . . 0.0 111.398 175.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.452 HG23 ' HB ' ' A' ' 205' ' ' THR . 2.8 m -131.51 86.78 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.508 177.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' PHE . . . . . 0.472 ' CE2' ' HA3' ' A' ' 183' ' ' GLY . 67.5 m-85 -57.2 106.77 0.73 Allowed Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.502 177.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo . . . . . 0 C--O 1.246 0.906 0 C-N-CA 122.76 2.307 . . . . 0.0 112.067 -175.489 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.699 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.83 -166.76 0.36 Allowed 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.864 2.376 . . . . 0.0 112.166 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 97.1 mmm -81.39 78.14 8.19 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.19 0.519 . . . . 0.0 110.479 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -114.62 57.15 0.71 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.285 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.462 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 3.0 m-20 -64.99 127.23 92.59 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.859 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 4.1 Cg_exo -75.63 -5.44 16.5 Favored 'Trans proline' 0 CA--C 1.515 -0.437 0 C-N-CA 123.114 2.542 . . . . 0.0 110.46 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.607 ' HB ' ' CD1' ' A' ' 113' ' ' PHE . 40.6 p -92.49 6.79 45.82 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.079 -1.419 . . . . 0.0 111.121 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.7 t -75.31 52.7 0.62 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.521 0.676 . . . . 0.0 110.588 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.476 ' HG3' ' CZ2' ' A' ' 112' ' ' TRP . 65.3 mm-40 -130.92 169.6 15.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.292 -177.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.412 ' O ' HG21 ' A' ' 218' ' ' THR . 18.7 mmt180 -83.67 -11.61 57.0 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -170.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.483 ' CZ2' ' HA ' ' A' ' 191' ' ' THR . 1.5 p-90 -92.96 -12.04 31.77 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.054 177.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.607 ' CD1' ' HB ' ' A' ' 108' ' ' THR . 57.5 t80 -84.69 119.5 25.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.385 0.612 . . . . 0.0 110.843 174.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -111.94 117.03 31.61 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -65.11 -66.57 2.39 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.739 -0.664 . . . . 0.0 113.261 -174.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -100.23 104.99 16.52 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.288 0.566 . . . . 0.0 111.34 -175.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 17.4 mt -154.56 130.74 10.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.598 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 68.3 p -84.03 173.06 11.45 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 172.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.73 -49.84 63.82 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.65 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.0 mmtm -61.24 -45.64 93.69 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 123.942 0.436 . . . . 0.0 111.526 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -66.79 -47.22 72.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.677 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.488 ' HB2' ' NH1' ' A' ' 138' ' ' ARG . . . -63.85 -33.87 76.65 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.088 0.47 . . . . 0.0 110.771 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.525 ' HG3' ' HB ' ' A' ' 167' ' ' VAL . 9.1 tt0 -67.26 -46.43 73.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.426 176.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -60.76 -33.25 72.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.757 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.467 HD11 HD11 ' A' ' 216' ' ' LEU . 0.5 OUTLIER -55.69 -52.32 64.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.178 0.514 . . . . 0.0 110.154 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.562 ' CD2' HD12 ' A' ' 216' ' ' LEU . 42.5 mt -75.62 -47.29 27.15 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.5 m -64.18 -33.29 75.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.294 -172.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -96.99 -53.28 3.56 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -91.35 -31.97 15.86 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -171.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -86.95 -163.27 38.61 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.191 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.514 ' C ' ' HD3' ' A' ' 152' ' ' ARG . 0.5 OUTLIER -146.4 174.41 11.4 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 177.813 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -50.86 120.25 4.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.85 0.357 . . . . 0.0 110.937 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.435 ' HA3' ' HD3' ' A' ' 213' ' ' LYS . . . 98.39 -4.51 60.21 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.199 178.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.62 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 66.9 m -72.84 138.51 46.38 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 176.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.438 ' CB ' HG12 ' A' ' 151' ' ' VAL . 49.4 p90 -136.63 149.12 47.82 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.986 0.422 . . . . 0.0 110.62 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.548 ' CD2' ' HB3' ' A' ' 150' ' ' SER . 1.2 pt? -149.99 136.66 19.21 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 148' ' ' VAL . 16.2 m -99.5 133.96 40.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.488 ' NH1' ' HB2' ' A' ' 122' ' ' ALA . 10.7 ptt-85 -129.81 172.09 12.02 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -178.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -76.98 127.27 32.4 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.411 ' HB2' HG23 ' A' ' 148' ' ' VAL . 46.2 t -69.55 133.3 47.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.39 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -96.19 -26.03 15.6 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.552 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 41.6 m -81.0 -25.67 37.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.924 0.393 . . . . 0.0 109.94 174.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -126.04 87.23 56.45 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.983 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.0 124.18 15.11 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.342 2.028 . . . . 0.0 111.255 176.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.523 ' O ' ' HB3' ' A' ' 174' ' ' CYS . . . 101.77 -10.44 57.38 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.079 -177.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -114.36 171.9 7.34 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.404 ' CE1' ' HE2' ' A' ' 179' ' ' TYR . 96.6 m-85 -125.8 163.99 21.66 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.832 0.349 . . . . 0.0 110.347 -177.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 4.7 t -125.37 127.27 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.923 -177.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.488 ' HB3' ' CG2' ' A' ' 170' ' ' VAL . 1.2 tp -91.46 109.36 20.65 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.548 ' HB3' ' CD2' ' A' ' 136' ' ' LEU . 40.3 t -101.89 124.88 48.27 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.535 HG21 ' HB3' ' A' ' 210' ' ' LEU . 34.8 m -128.28 142.95 42.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.829 -173.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.514 ' HD3' ' C ' ' A' ' 131' ' ' LYS . 73.2 ttt180 -90.04 103.14 15.84 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.369 0.604 . . . . 0.0 109.688 176.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.5 p -107.42 148.62 28.89 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.799 -1.092 . . . . 0.0 110.162 -177.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 93.57 143.16 12.8 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 119.67 -1.252 . . . . 0.0 111.21 -175.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -104.78 111.13 23.75 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.586 0.708 . . . . 0.0 110.828 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -68.79 -39.2 80.29 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 122.324 1.059 . . . . 0.0 108.878 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -84.36 93.1 8.18 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.069 176.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 143.1 -5.81 1.96 Allowed Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.496 -171.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.472 ' HA ' ' HB3' ' A' ' 162' ' ' ASP . 46.4 mt-10 72.43 26.61 2.56 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.196 0.599 . . . . 0.0 111.927 173.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 12.5 m -90.59 76.16 6.57 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 8.0 t30 61.8 68.4 0.7 Allowed 'General case' 0 C--O 1.231 0.105 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -170.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.472 ' HB3' ' HA ' ' A' ' 159' ' ' GLU . 4.8 p-10 -86.33 169.7 12.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.278 -174.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 94.32 -50.73 2.13 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -131.04 121.81 25.67 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 172.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 41.6 m -81.66 149.93 28.3 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.858 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -82.41 138.15 34.51 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.262 0.554 . . . . 0.0 111.893 -177.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.525 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 69.8 t -120.84 113.76 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.768 169.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.579 ' CG2' ' HB1' ' B' ' 1' ' ' ALA . 21.6 m -90.2 140.65 29.47 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.462 172.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.793 ' O ' ' HA ' ' B' ' 0' ' ' PTR . 19.4 m-70 -118.47 116.4 26.6 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.603 HG11 ' SD ' ' A' ' 202' ' ' MET . 0.8 OUTLIER -98.53 138.95 21.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -177.143 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 38.8 tpp -84.91 116.51 23.38 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.995 0.426 . . . . 0.0 110.792 -175.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.416 HD11 ' HB2' ' A' ' 149' ' ' LEU . 24.5 mt -97.4 108.12 21.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.184 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.666 ' O ' ' HA ' ' A' ' 179' ' ' TYR . 77.3 mtm180 -65.56 123.24 19.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.487 176.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . 0.523 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 48.3 t -116.82 91.6 3.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.459 0.647 . . . . 0.0 109.562 174.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -114.51 114.53 25.91 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.235 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 57.16 45.12 21.19 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.661 0.601 . . . . 0.0 111.116 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 95.7 mt 63.79 22.57 13.11 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.943 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -113.43 132.24 55.71 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 172.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.666 ' HA ' ' O ' ' A' ' 173' ' ' ARG . 71.1 m-85 -110.16 137.57 47.73 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.206 -173.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -152.91 127.35 9.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.121 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.452 HG21 HD12 ' A' ' 193' ' ' LEU . 3.1 t -77.58 -0.64 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-O 121.707 0.765 . . . . 0.0 111.567 -176.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 124.99 -19.44 6.89 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.067 177.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.561 ' HA3' ' CE2' ' B' ' 5' ' ' PHE . . . -137.56 159.6 24.92 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 121.024 -0.607 . . . . 0.0 112.032 177.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 89.32 -135.31 12.9 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.055 175.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -116.06 145.03 43.33 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.56 0.219 . . . . 0.0 110.831 -176.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -75.69 128.79 35.96 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 175.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -105.92 144.04 33.22 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.808 0.337 . . . . 0.0 110.725 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -76.01 -9.81 58.91 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.752 -174.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 35.4 p -140.74 143.9 35.24 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.476 ' HG ' ' CD2' ' A' ' 179' ' ' TYR . 0.5 OUTLIER -67.35 -23.08 65.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.914 179.674 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.483 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 13.9 m -61.1 -49.01 79.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.355 175.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -65.63 -30.88 71.65 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.833 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.452 HD12 HG21 ' A' ' 181' ' ' VAL . 3.3 tm? -64.32 -54.78 27.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.404 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 27.8 m -70.19 -42.21 79.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.558 -174.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -61.42 -39.11 89.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.91 0.386 . . . . 0.0 111.051 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -59.99 -42.27 93.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.823 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -85.24 -13.59 49.37 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.124 0.488 . . . . 0.0 110.951 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -74.2 -27.3 60.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.446 0.641 . . . . 0.0 109.351 176.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -88.79 -36.5 16.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.477 175.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -119.92 105.33 42.98 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.425 -176.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.28 128.96 32.68 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.884 2.389 . . . . 0.0 112.474 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' MET . . . . . 0.759 ' SD ' HD23 ' A' ' 210' ' ' LEU . 7.4 ptp -89.6 122.81 33.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.261 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.544 HG22 ' HB ' ' A' ' 209' ' ' VAL . 44.7 t -101.53 139.8 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 120.703 0.287 . . . . 0.0 111.59 -176.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.492 ' O ' HG13 ' A' ' 203' ' ' VAL . 25.6 mt-10 -89.22 162.35 15.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.37 . . . . 0.0 110.245 170.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 14.9 t -74.08 -11.91 60.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.324 0.583 . . . . 0.0 110.024 177.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.0 mp -83.98 -8.31 59.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.018 178.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 101.04 -18.89 53.93 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.007 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 58.9 m -65.65 111.76 3.33 Favored 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 175.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.544 ' HB ' HG22 ' A' ' 203' ' ' VAL . 0.9 OUTLIER -112.22 126.99 69.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.6 0.714 . . . . 0.0 110.348 173.68 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.759 HD23 ' SD ' ' A' ' 202' ' ' MET . 0.4 OUTLIER -82.03 110.06 16.93 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.336 -172.188 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -85.17 89.51 7.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.584 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 8.2 mp -77.87 99.19 5.88 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 175.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.435 ' HD3' ' HA3' ' A' ' 133' ' ' GLY . 28.6 mtpp -109.61 -48.84 3.17 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.141 -173.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.62 ' O ' ' HA ' ' A' ' 134' ' ' SER . 0.4 OUTLIER -147.45 147.19 27.33 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 121.081 0.467 . . . . 0.0 111.007 178.006 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.453 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 93.0 Cg_endo -78.39 147.27 22.69 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.958 2.439 . . . . 0.0 113.222 -175.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.562 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.3 OUTLIER -83.86 109.88 17.92 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -56.55 145.98 26.42 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.43 0.456 . . . . 0.0 111.29 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.412 HG21 ' O ' ' A' ' 111' ' ' ARG . 4.8 p -82.13 136.02 35.22 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.58 -177.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.8 t -114.15 118.08 33.01 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.288 173.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 . . . . . 0 C--O 1.246 0.91 0 CA-C-O 118.411 -0.804 . . . . 0.0 110.484 -176.377 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' -4' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 120.949 0.404 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -92.3 158.79 15.92 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' -2' ' ' THR . . . . . 0.691 ' HA ' ' CD2' ' A' ' 169' ' ' HIS . 4.4 m 55.66 -110.68 0.57 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 118.932 -0.556 . . . . 0.0 109.715 -175.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' -1' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 76.84 -38.19 0.3 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.006 0.522 . . . . 0.0 111.225 169.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 0' ' ' PTR . . . . . 0.793 ' HA ' ' O ' ' A' ' 169' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.579 ' HB1' ' CG2' ' A' ' 168' ' ' THR . . . -56.63 141.33 43.86 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 113.929 -1.487 . . . . 0.0 112.384 -171.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 46.2 m -76.02 -49.44 17.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.176 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.674 HD11 ' SD ' ' A' ' 202' ' ' MET . 8.0 mm 73.32 94.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 123.244 0.617 . . . . 0.0 110.732 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.61 ' O ' ' HD3' ' B' ' 6' ' ' PRO . 13.8 m -103.64 113.46 40.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.624 0.726 . . . . 0.0 109.991 176.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' PHE . . . . . 0.561 ' CE2' ' HA3' ' A' ' 183' ' ' GLY . 89.4 m-85 -85.87 100.36 1.3 Allowed Pre-proline 0 C--N 1.308 -1.227 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.8 171.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.61 ' HD3' ' O ' ' B' ' 4' ' ' VAL . 6.9 Cg_endo . . . . . 0 C--O 1.251 1.131 0 C-N-CA 122.929 2.419 . . . . 0.0 111.516 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo . . . . . 0 CA--C 1.516 -0.38 0 CA-C-O 122.061 0.775 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.6 ' HB ' ' CG ' ' A' ' 113' ' ' PHE . 35.7 p -100.27 5.58 44.59 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.21 -176.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.8 m -75.26 58.73 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.515 0.674 . . . . 0.0 110.579 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.511 ' HG3' ' CZ2' ' A' ' 112' ' ' TRP . 81.5 mm-40 -129.65 -178.5 4.72 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.821 -176.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -84.71 -26.0 27.98 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -174.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.541 ' CZ2' ' HA ' ' A' ' 191' ' ' THR . 0.7 OUTLIER -85.71 -19.63 30.56 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -177.729 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.6 ' CG ' ' HB ' ' A' ' 108' ' ' THR . 72.2 t80 -81.45 123.76 28.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.012 0.434 . . . . 0.0 110.551 175.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -110.52 139.57 45.64 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.62 -88.87 0.03 OUTLIER Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.94 -0.648 . . . . 0.0 113.528 -174.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -100.52 106.63 18.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.03 0.443 . . . . 0.0 111.439 -175.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 64.0 mt -143.45 135.89 27.18 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.789 175.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.6 p -93.69 174.41 7.19 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -50.23 -54.3 20.17 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 121.558 -0.353 . . . . 0.0 113.856 -174.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 60.7 mmtt -77.99 -25.33 48.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 117.27 0.535 . . . . 0.0 111.87 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -65.33 -44.71 86.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.801 0.334 . . . . 0.0 110.627 175.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.553 ' HB2' ' HD3' ' A' ' 138' ' ' ARG . . . -64.11 -34.01 77.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.325 0.583 . . . . 0.0 110.494 176.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.546 ' HG3' ' HB ' ' A' ' 167' ' ' VAL . 16.3 tt0 -69.68 -48.36 59.99 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.962 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -56.47 -35.78 68.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.325 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.64 -51.52 69.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.273 177.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.549 ' CD2' HD12 ' A' ' 216' ' ' LEU . 27.7 mt -74.63 -46.41 38.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.687 -177.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.6 m -67.64 -33.01 74.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.029 -173.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -95.83 -48.27 5.81 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -100.14 -25.65 14.21 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -171.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -89.53 -159.75 35.76 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.573 -177.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -153.1 175.16 13.31 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -55.31 121.0 7.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.876 0.37 . . . . 0.0 111.275 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 99.54 -3.35 57.71 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.765 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 56.4 m -74.39 140.25 44.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.646 0.26 . . . . 0.0 110.503 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.508 ' CB ' HG12 ' A' ' 151' ' ' VAL . 52.3 p90 -137.45 149.02 46.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.165 177.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.534 HD21 ' HB2' ' A' ' 150' ' ' SER . 1.1 pt? -148.91 139.51 22.63 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 175.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.747 HG21 HD13 ' A' ' 190' ' ' LEU . 10.1 m -104.23 145.04 13.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.553 ' HD3' ' HB2' ' A' ' 122' ' ' ALA . 26.4 ptt85 -146.29 168.21 21.63 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.867 -178.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -76.74 131.41 38.72 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 123.247 0.342 . . . . 0.0 110.63 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.6 t -72.39 137.12 46.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.522 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -98.02 -28.78 13.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.845 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 39.0 m -78.8 -34.1 45.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.027 0.442 . . . . 0.0 109.862 175.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -117.82 78.04 12.11 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.876 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.26 123.1 12.16 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.088 1.859 . . . . 0.0 111.72 -177.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 113.97 -16.68 20.46 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.608 -176.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -109.37 171.68 7.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.06 0.457 . . . . 0.0 110.29 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -123.45 163.6 20.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.604 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 33.3 m -134.11 143.05 39.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.152 0.501 . . . . 0.0 111.401 177.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.907 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -101.86 111.09 23.22 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.225 177.516 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.573 ' HA ' ' HA ' ' A' ' 169' ' ' HIS . 1.2 m -104.17 131.71 51.18 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.592 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' A' ' 210' ' ' LEU . 32.7 m -130.57 152.08 36.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.456 -174.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.403 ' HB2' ' HB3' ' A' ' 126' ' ' LEU . 56.7 ttt180 -100.43 103.8 15.18 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.109 177.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 32.4 p -99.72 147.36 25.52 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.54 -177.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.502 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.15 -176.627 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.681 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.546 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 56.1 t -100.01 133.32 43.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.364 0.602 . . . . 0.0 111.724 -177.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.65 HG21 HD11 ' A' ' 210' ' ' LEU . 1.1 m -119.18 141.41 48.89 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.763 171.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 150' ' ' SER . 13.4 m-70 -108.24 138.17 44.97 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.907 HG22 ' HB3' ' A' ' 149' ' ' LEU . 1.2 m -114.35 138.62 43.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 41.2 tpp -81.91 126.71 32.23 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.878 0.37 . . . . 0.0 111.213 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.514 HD13 HD21 ' A' ' 190' ' ' LEU . 32.6 mt -104.9 107.43 22.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 175.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.604 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 4.7 ptp180 -70.44 119.35 14.48 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.023 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' CYS . . . . . 0.672 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 49.7 t -118.11 93.36 4.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.165 0.507 . . . . 0.0 110.469 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -116.62 125.65 52.11 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.769 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 57.18 39.15 29.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.9 -176.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 82.9 mt 63.16 31.75 15.49 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.324 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.672 ' O ' ' HA ' ' A' ' 174' ' ' CYS . 11.9 tppt? -110.99 132.23 54.39 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.471 ' CD2' ' HG ' ' A' ' 190' ' ' LEU . 81.8 m-85 -111.83 135.09 52.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.585 0.231 . . . . 0.0 111.176 -174.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.604 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 18.4 t0 -157.32 136.39 11.77 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.5 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.535 ' HB ' ' CZ ' ' A' ' 197' ' ' TYR . 56.0 t -90.65 -14.21 8.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.77 0.795 . . . . 0.0 109.031 174.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' GLY . . . . . 0.541 ' HA2' ' NH1' ' A' ' 173' ' ' ARG . . . 123.57 5.56 7.7 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.248 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -137.21 141.24 12.11 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.662 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 71.78 -158.45 53.47 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.241 -0.504 . . . . 0.0 113.083 174.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -74.08 150.73 40.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.894 0.378 . . . . 0.0 110.738 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 186' ' ' ARG . 54.2 mtt180 -99.26 132.89 44.27 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.67 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -110.9 150.56 29.02 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.138 -171.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -88.62 0.39 56.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.17 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.51 141.84 50.49 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.656 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.747 HD13 HG21 ' A' ' 137' ' ' VAL . 1.0 OUTLIER -77.28 -22.86 51.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.045 -175.476 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.541 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 16.4 m -61.97 -44.15 97.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.004 0.431 . . . . 0.0 110.275 177.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -66.41 -34.17 77.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.328 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.503 HD11 HG23 ' A' ' 181' ' ' VAL . 3.2 tm? -62.27 -54.64 37.77 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.199 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 27.2 m -66.39 -39.91 85.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.267 -175.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 191' ' ' THR . 27.8 mt-10 -68.17 -31.7 71.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.274 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -59.15 -47.26 85.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.087 0.47 . . . . 0.0 110.243 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.641 ' HB2' HD22 ' A' ' 212' ' ' LEU . 76.3 m-85 -85.73 -8.85 57.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.762 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.416 ' HA ' ' HB2' ' A' ' 212' ' ' LEU . 39.4 ttpt -70.95 -23.74 62.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.67 175.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -105.74 -22.85 12.86 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.564 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -126.42 89.0 53.22 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.523 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.69 132.29 51.22 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.236 2.624 . . . . 0.0 112.799 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' MET . . . . . 0.516 ' HB2' HG23 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -97.48 137.31 36.63 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.066 179.725 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.621 HG22 ' HB ' ' A' ' 209' ' ' VAL . 36.3 t -108.39 137.11 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -169.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.547 ' O ' HG12 ' A' ' 203' ' ' VAL . 27.4 mt-10 -81.71 163.99 22.08 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.817 0.341 . . . . 0.0 110.182 169.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.0 t -76.29 -10.62 59.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.796 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.9 mp -90.95 -1.23 57.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.452 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 103.89 -23.72 31.57 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.471 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 23.2 m -60.77 111.33 1.59 Allowed 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 120.882 0.372 . . . . 0.0 110.307 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.621 ' HB ' HG22 ' A' ' 203' ' ' VAL . 1.1 p -112.58 128.66 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-O 121.826 0.822 . . . . 0.0 110.833 175.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.65 HD11 HG21 ' A' ' 168' ' ' THR . 0.3 OUTLIER -81.55 105.31 12.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 113.987 -1.46 . . . . 0.0 110.219 -170.849 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -93.89 90.47 6.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.637 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.641 HD22 ' HB2' ' A' ' 197' ' ' TYR . 6.8 mp -73.85 106.65 5.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.768 178.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -114.6 -55.96 2.43 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.633 ' O ' ' HA ' ' A' ' 134' ' ' SER . 0.7 OUTLIER -134.46 142.22 41.98 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 121.076 0.465 . . . . 0.0 111.179 -179.139 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.413 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 78.7 Cg_endo -76.38 142.24 23.63 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.951 2.434 . . . . 0.0 112.963 -175.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.549 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.3 OUTLIER -76.6 110.06 10.85 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 175.667 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -57.58 139.67 52.92 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 123.384 0.428 . . . . 0.0 111.103 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 13.4 p -71.99 108.0 5.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.498 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 3.6 t . . . . . 0 C--N 1.318 -0.774 0 CA-C-O 121.68 0.753 . . . . 0.0 109.92 179.344 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.481 ' HA ' ' OE1' ' A' ' 204' ' ' GLU . . . . . . . . 0 N--CA 1.476 0.869 0 CA-C-O 122.503 1.145 . . . . 0.0 113.702 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.52 -44.58 28.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.283 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.516 HG23 ' HB2' ' A' ' 202' ' ' MET . 4.2 mm 55.36 73.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.566 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 2.3 m . . . . . 0 C--N 1.32 -0.694 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.591 179.917 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.49 ' HB2' ' H ' ' A' ' 190' ' ' LEU . 84.2 Cg_endo . . . . . 0 CA--C 1.517 -0.365 0 CA-C-O 121.478 0.533 . . . . 0.0 111.964 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.714 ' HB ' ' CG ' ' A' ' 113' ' ' PHE . 34.7 p -100.19 7.85 44.23 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.562 -171.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 26.7 m -74.68 49.12 0.39 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.169 0.509 . . . . 0.0 110.939 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.407 ' HG3' ' CZ2' ' A' ' 112' ' ' TRP . 70.4 mm-40 -127.04 174.11 9.13 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.662 -176.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -79.55 -20.05 47.99 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -173.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.503 ' HB3' ' CB ' ' A' ' 215' ' ' PRO . 1.8 p-90 -85.95 -19.81 29.89 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.875 -178.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.714 ' CG ' ' HB ' ' A' ' 108' ' ' THR . 75.4 t80 -77.92 124.67 28.29 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.151 0.5 . . . . 0.0 110.707 175.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -122.11 107.04 11.72 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -51.84 -72.09 0.56 Allowed Glycine 0 CA--C 1.519 0.307 0 N-CA-C 114.744 0.657 . . . . 0.0 114.744 -167.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -100.29 86.34 3.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.347 0.594 . . . . 0.0 112.156 -173.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.475 ' O ' ' HD2' ' A' ' 138' ' ' ARG . 33.1 mt -133.38 133.27 42.22 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.165 175.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 35.4 t -93.6 172.76 8.06 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 168.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 123' ' ' GLU . . . -51.77 -44.27 54.88 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.245 -0.502 . . . . 0.0 112.797 -177.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.408 ' HD3' ' N ' ' A' ' 120' ' ' LYS . 3.1 mppt? -69.36 -35.03 75.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.959 0.409 . . . . 0.0 110.607 -175.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -72.61 -47.26 49.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.402 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.492 ' HB2' ' HD3' ' A' ' 138' ' ' ARG . . . -62.56 -34.06 76.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.431 177.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.505 ' HG3' ' HB ' ' A' ' 167' ' ' VAL . 3.7 tt0 -65.36 -50.33 65.97 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.694 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -58.94 -36.22 74.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.418 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.475 HD12 HD13 ' A' ' 216' ' ' LEU . 0.7 OUTLIER -58.48 -53.66 55.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.768 178.368 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.542 ' CD2' HD12 ' A' ' 216' ' ' LEU . 61.3 mt -75.39 -48.44 22.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.759 -176.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.7 m -61.9 -32.78 73.19 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.192 -172.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -97.44 -53.87 3.32 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.406 ' CD ' HG21 ' A' ' 219' ' ' THR . 96.9 mttt -91.58 -23.37 19.91 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -169.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -93.32 -160.24 35.2 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.057 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -152.3 175.73 12.35 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 175.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -58.54 125.15 22.18 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 177.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.505 ' HA2' ' O ' ' A' ' 211' ' ' GLN . . . 103.72 -10.98 53.22 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.113 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.708 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 27.8 m -78.65 139.59 38.51 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.658 0.266 . . . . 0.0 110.376 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.527 ' CB ' HG12 ' A' ' 151' ' ' VAL . 44.9 p90 -137.02 150.38 48.06 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.409 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.5 ' CD2' ' HB2' ' A' ' 150' ' ' SER . 1.1 pt? -149.04 136.41 20.17 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.697 HG21 HD13 ' A' ' 190' ' ' LEU . 5.6 m -100.42 139.99 20.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.547 178.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.492 ' HD3' ' HB2' ' A' ' 122' ' ' ALA . 17.6 ptt85 -141.8 167.73 21.45 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.459 -176.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -80.63 133.79 35.79 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.496 ' HB2' HG13 ' A' ' 148' ' ' VAL . 39.2 t -76.14 139.13 41.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.934 0.397 . . . . 0.0 110.048 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -99.87 -18.01 17.35 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.669 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.4 p -84.93 -26.67 27.08 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 171.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -123.34 78.63 53.51 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.178 176.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.97 124.55 15.94 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.869 2.379 . . . . 0.0 112.303 -178.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 106.79 -16.85 39.61 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.012 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -106.98 157.24 17.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.896 0.379 . . . . 0.0 110.351 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -110.58 158.64 18.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.657 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.496 HG13 ' HB2' ' A' ' 140' ' ' SER . 35.1 m -136.47 139.36 45.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.339 0.59 . . . . 0.0 111.383 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.968 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -95.09 110.54 22.46 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.817 176.23 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.5 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 2.4 m -101.89 130.68 48.44 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.269 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.527 HG12 ' CB ' ' A' ' 135' ' ' PHE . 33.5 m -129.26 150.3 34.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.679 -174.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.402 ' HB2' ' HB3' ' A' ' 126' ' ' LEU . 70.0 ttt180 -93.04 102.4 14.74 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.425 0.631 . . . . 0.0 109.506 175.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.504 HG21 ' HA ' ' A' ' 210' ' ' LEU . 0.9 OUTLIER -115.0 97.78 6.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.722 178.758 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.975 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -176.115 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.502 ' HB3' ' O ' ' A' ' 153' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.405 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.505 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 60.1 t -123.39 115.98 47.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 121.086 0.469 . . . . 0.0 111.323 176.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.715 HG21 HD11 ' A' ' 210' ' ' LEU . 4.1 m -92.86 140.73 29.19 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.049 172.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 150' ' ' SER . 37.8 m-70 -114.78 119.72 37.61 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.968 HG22 ' HB3' ' A' ' 149' ' ' LEU . 0.8 OUTLIER -98.4 140.14 18.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -177.028 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 40.2 tpp -87.02 117.88 26.03 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.253 -177.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.542 HD13 HD21 ' A' ' 190' ' ' LEU . 20.7 mt -97.02 107.04 19.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 175.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.567 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 17.9 ptp180 -69.16 122.42 18.76 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.917 0.389 . . . . 0.0 110.0 -177.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 49.5 t -113.88 93.42 4.36 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.805 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -125.92 122.4 35.9 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.158 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 58.63 41.75 21.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.124 -178.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.0 mt 60.49 45.42 10.77 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.165 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 174' ' ' CYS . 10.9 tppt? -131.46 139.11 49.29 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -116.04 129.95 56.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.585 0.231 . . . . 0.0 110.783 -175.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.567 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 13.8 t0 -157.01 129.25 7.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.79 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.557 ' HB ' ' CZ ' ' A' ' 197' ' ' TYR . 31.0 t -83.91 -12.27 11.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.773 0.797 . . . . 0.0 109.312 176.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 122.76 9.02 6.5 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.388 176.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -137.88 140.48 11.26 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.138 -1.029 . . . . 0.0 113.738 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 71.59 -154.8 51.74 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.266 -0.492 . . . . 0.0 112.998 174.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -73.97 142.73 45.84 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.64 0.257 . . . . 0.0 110.364 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -88.0 132.71 34.16 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -106.88 156.44 18.69 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.226 0.536 . . . . 0.0 112.019 -169.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -94.34 -11.52 29.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.24 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.6 m -129.4 142.71 50.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.123 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.697 HD13 HG21 ' A' ' 137' ' ' VAL . 0.9 OUTLIER -72.81 -22.71 60.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.28 -175.4 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 5.8 m -61.82 -46.23 90.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.894 0.378 . . . . 0.0 110.53 177.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -64.72 -34.17 77.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.057 178.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.502 HD11 HG23 ' A' ' 181' ' ' VAL . 3.1 tm? -60.25 -54.28 47.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.298 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 30.8 m -68.62 -43.75 83.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.934 -175.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -59.2 -35.57 73.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.001 0.429 . . . . 0.0 111.232 177.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -62.4 -45.28 93.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.102 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.557 ' CZ ' ' HB ' ' A' ' 181' ' ' VAL . 59.8 m-85 -85.76 -10.36 55.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.948 0.404 . . . . 0.0 111.448 -176.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.443 ' HD2' ' CZ ' ' A' ' 135' ' ' PHE . 47.0 mtpt -70.86 -34.81 72.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.155 0.502 . . . . 0.0 109.865 170.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 14.1 tptt -88.85 -36.17 16.16 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.036 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -113.49 101.57 53.8 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.432 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.28 126.17 21.62 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.845 2.363 . . . . 0.0 112.77 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' MET . . . . . 0.755 ' SD ' HG11 ' A' ' 170' ' ' VAL . 14.3 ptp -89.31 141.81 28.22 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 175.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.558 HG22 HG22 ' A' ' 209' ' ' VAL . 11.2 t -124.8 139.51 50.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.998 -173.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.671 ' HG2' ' HB1' ' B' ' 1' ' ' ALA . 26.0 mt-10 -82.01 161.24 23.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.898 171.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.3 t -74.32 -9.85 59.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.235 0.54 . . . . 0.0 110.006 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.5 mp -89.68 4.38 49.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.162 176.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.57 -1.27 83.79 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.629 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.414 HG22 HD13 ' A' ' 210' ' ' LEU . 23.1 m -73.16 113.51 10.3 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.011 0.434 . . . . 0.0 110.588 177.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.558 HG22 HG22 ' A' ' 203' ' ' VAL . 69.9 t -98.6 114.34 35.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.715 HD11 HG21 ' A' ' 168' ' ' THR . 0.4 OUTLIER -76.52 100.34 5.24 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.505 ' O ' ' HA2' ' A' ' 133' ' ' GLY . 51.1 mt-30 -84.68 92.96 8.31 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.382 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.505 HD22 ' HB2' ' A' ' 197' ' ' TYR . 9.2 mp -77.57 105.41 8.69 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.956 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -113.86 -57.07 2.33 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.708 ' O ' ' HA ' ' A' ' 134' ' ' SER . 4.6 pm0 -132.0 139.38 34.84 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-O 121.14 0.495 . . . . 0.0 111.209 -177.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.503 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 71.5 Cg_endo -74.37 138.45 24.71 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.982 2.455 . . . . 0.0 112.527 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.542 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.3 OUTLIER -72.5 106.28 4.52 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.053 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -56.15 133.62 52.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.083 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.6 p -58.02 111.6 1.23 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.436 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.406 HG21 ' CD ' ' A' ' 129' ' ' LYS . 2.0 t . . . . . 0 C--N 1.318 -0.772 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.288 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.671 ' HB1' ' HG2' ' A' ' 204' ' ' GLU . . . . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.931 0.396 . . . . 0.0 110.627 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 23.5 m -70.87 -38.0 73.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.295 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.512 HD12 ' SD ' ' A' ' 202' ' ' MET . 7.5 mm 70.03 88.0 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 121.613 0.721 . . . . 0.0 111.213 176.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 2.1 m . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.828 179.359 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo . . . . . 0 N--CA 1.462 -0.371 0 N-CA-C 109.597 -0.963 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.536 HG22 HD12 ' A' ' 190' ' ' LEU . 25.5 p -98.13 7.41 46.32 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 113.628 -1.623 . . . . 0.0 111.153 -176.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.4 p -75.65 30.19 0.11 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.934 0.397 . . . . 0.0 111.755 -178.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.429 ' H ' ' C ' ' A' ' 108' ' ' THR . 10.8 mm-40 -109.88 171.26 7.56 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.434 ' O ' HG23 ' A' ' 218' ' ' THR . 25.3 mmt180 -85.47 -9.62 57.21 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -167.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.467 ' HB3' ' CB ' ' A' ' 215' ' ' PRO . 2.4 p-90 -87.31 -19.14 28.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.954 0.407 . . . . 0.0 110.621 175.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.516 ' CD1' ' HB ' ' A' ' 108' ' ' THR . 80.3 t80 -75.17 119.19 18.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.199 0.524 . . . . 0.0 110.241 173.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.411 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 13.9 m-70 -112.16 147.09 36.89 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 175.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -73.55 -123.99 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.731 -172.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -86.84 83.6 7.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.515 0.674 . . . . 0.0 111.168 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.401 ' HB2' ' NH1' ' A' ' 138' ' ' ARG . 77.9 mt -98.0 160.6 14.2 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.835 171.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.1 p -102.48 172.46 6.85 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 165.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.64 -50.1 44.08 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 121.312 -0.471 . . . . 0.0 112.619 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -64.64 -41.43 96.15 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 122.466 0.307 . . . . 0.0 111.425 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -61.08 -46.75 89.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.552 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.91 -35.05 79.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.972 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -64.87 -50.83 65.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.071 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -60.65 -34.58 74.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.419 176.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 129' ' ' LYS . 0.4 OUTLIER -57.01 -52.82 63.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.983 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.586 HD23 HD12 ' A' ' 216' ' ' LEU . 71.1 mt -75.96 -52.19 10.8 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -178.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 m -64.89 -33.2 75.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.785 -170.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -96.66 -49.81 4.95 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 125' ' ' LEU . 95.9 mttt -92.14 -23.51 19.39 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -169.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -98.54 -149.77 25.2 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.325 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.29 173.67 15.85 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 176.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 62.9 t60 -51.18 118.87 3.52 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.774 0.321 . . . . 0.0 110.825 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 211' ' ' GLN . . . 102.21 -3.21 51.09 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.314 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 33.8 p -72.24 139.67 48.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.276 0.538 . . . . 0.0 110.1 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.479 ' CB ' HG12 ' A' ' 151' ' ' VAL . 53.3 p90 -137.21 151.58 48.92 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.976 0.417 . . . . 0.0 110.636 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.558 HD21 ' HB2' ' A' ' 150' ' ' SER . 1.2 pt? -153.21 136.05 15.38 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.645 HG21 HD13 ' A' ' 190' ' ' LEU . 5.5 m -96.72 142.44 13.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 175.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.668 ' HB2' HH11 ' A' ' 138' ' ' ARG . 0.0 OUTLIER -147.36 160.08 42.95 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.703 -171.482 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -79.14 110.42 14.37 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.997 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.574 ' HB2' HG13 ' A' ' 148' ' ' VAL . 41.8 t -66.66 124.78 23.81 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -90.99 -15.35 29.8 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 28.0 t -72.83 -39.47 66.55 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 172.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 46.7 m-70 -119.57 81.39 24.07 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.544 172.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.22 134.47 59.45 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.042 2.495 . . . . 0.0 112.968 -172.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 100.0 -21.6 43.98 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.073 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.56 ' HA ' ' SG ' ' A' ' 174' ' ' CYS . 4.5 m-20 -102.56 170.32 8.11 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.243 0.544 . . . . 0.0 111.063 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -117.18 149.95 39.53 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.311 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.574 HG13 ' HB2' ' A' ' 140' ' ' SER . 27.1 m -131.91 138.71 52.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.173 0.511 . . . . 0.0 111.065 176.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.927 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -92.18 109.48 20.85 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.455 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.558 ' HB2' HD21 ' A' ' 136' ' ' LEU . 2.8 m -101.77 133.49 46.43 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.136 -179.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.56 HG21 ' HB3' ' A' ' 210' ' ' LEU . 28.1 m -132.9 153.84 38.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.923 0.392 . . . . 0.0 111.356 -173.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.458 ' HB2' ' HB3' ' A' ' 126' ' ' LEU . 73.6 ttt180 -99.69 103.98 15.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.2 178.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 14.8 p -108.36 147.66 31.21 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.456 -177.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.506 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.112 -178.364 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.413 ' HD2' ' HA ' ' A' ' 166' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.448 -0.53 0 CA-C-O 120.55 0.214 . . . . 0.0 110.751 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 72.6 t -100.41 113.01 34.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.426 0.632 . . . . 0.0 110.626 176.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.639 HG21 HD11 ' A' ' 210' ' ' LEU . 1.4 m -98.21 137.73 36.54 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.726 175.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 150' ' ' SER . 23.7 m-70 -105.97 122.48 46.22 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.927 HG22 ' HB3' ' A' ' 149' ' ' LEU . 0.8 OUTLIER -99.5 138.42 23.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.144 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 171' ' ' MET . . . . . 0.414 ' O ' ' HA ' ' A' ' 181' ' ' VAL . 39.8 tpp -82.22 121.28 26.43 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.636 -0.257 . . . . 0.0 111.018 -174.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.537 HD13 HD21 ' A' ' 190' ' ' LEU . 28.8 mt -101.64 107.5 21.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 177.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.581 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 4.4 ptp180 -73.8 107.66 6.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.064 0.459 . . . . 0.0 110.735 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' CYS . . . . . 0.56 ' SG ' ' HA ' ' A' ' 146' ' ' ASP . 4.9 p -86.0 101.27 12.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.888 175.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -127.73 111.14 13.35 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.944 -176.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 56.24 43.67 26.17 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.577 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 91.5 mt 66.48 15.96 10.26 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.197 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -105.99 142.86 34.99 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 172.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -117.23 141.35 48.4 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.538 -175.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.581 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 5.9 t0 -158.71 136.25 10.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.59 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.472 HG22 ' CZ ' ' A' ' 197' ' ' TYR . 16.8 m -87.62 -11.01 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 121.051 0.453 . . . . 0.0 110.409 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' GLY . . . . . 0.519 ' HA2' ' NH1' ' A' ' 173' ' ' ARG . . . 123.31 34.74 0.75 Allowed Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -174.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -102.95 -157.69 25.33 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 121.514 -0.374 . . . . 0.0 112.448 -176.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -86.43 -40.91 7.13 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.031 -177.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -115.89 143.11 45.88 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.905 0.384 . . . . 0.0 111.279 -177.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -93.15 141.53 28.32 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -110.95 137.39 48.64 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.643 0.259 . . . . 0.0 110.677 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -82.86 0.9 41.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.229 0.538 . . . . 0.0 110.372 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.1 p -141.39 142.67 33.73 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.906 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.645 HD13 HG21 ' A' ' 137' ' ' VAL . 1.7 mt -76.52 -23.14 53.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.061 -176.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.462 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 97.6 m -62.02 -49.29 76.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.006 0.431 . . . . 0.0 109.938 174.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.65 -29.89 70.9 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.494 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.411 HD13 ' C ' ' A' ' 193' ' ' LEU . 3.2 tm? -64.34 -54.91 25.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.99 176.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.15 -42.1 79.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.348 -174.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -60.83 -31.76 71.17 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.388 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -67.29 -47.81 69.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.922 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.528 ' HB2' HD22 ' A' ' 212' ' ' LEU . 80.3 m-85 -82.8 -11.16 58.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.246 0.546 . . . . 0.0 110.639 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -68.96 -29.74 68.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.284 172.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -93.3 -37.76 11.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.375 176.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -119.31 98.06 50.41 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.344 -177.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -56.31 138.28 83.01 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.978 2.452 . . . . 0.0 112.449 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' MET . . . . . 0.704 ' HB2' HG23 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -100.4 135.54 41.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.772 178.803 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.575 HG22 ' HB ' ' A' ' 209' ' ' VAL . 39.3 t -103.55 141.18 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -171.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.573 ' HG2' ' HB1' ' B' ' 1' ' ' ALA . 38.7 mt-10 -86.82 161.98 18.04 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 169.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 13.7 t -74.59 -10.5 59.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.057 0.456 . . . . 0.0 110.346 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.6 mp -92.07 8.77 36.26 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.126 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.77 -29.0 7.74 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.776 177.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 53.4 m -57.98 112.5 1.52 Allowed 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 116.981 0.39 . . . . 0.0 110.164 176.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.575 ' HB ' HG22 ' A' ' 203' ' ' VAL . 1.1 p -111.6 129.35 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-O 121.548 0.689 . . . . 0.0 110.228 174.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.639 HD11 HG21 ' A' ' 168' ' ' THR . 0.4 OUTLIER -78.85 113.23 16.77 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.347 -1.297 . . . . 0.0 111.163 -168.854 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.404 ' O ' ' HA2' ' A' ' 133' ' ' GLY . 65.9 mt-30 -90.36 90.16 7.92 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.437 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.528 HD22 ' HB2' ' A' ' 197' ' ' TYR . 8.0 mp -79.17 104.94 10.14 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 175.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 47.5 mttp -112.73 -54.73 2.6 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -177.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.552 ' O ' ' HA ' ' A' ' 134' ' ' SER . 0.1 OUTLIER -142.03 144.7 33.06 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.112 0.482 . . . . 0.0 111.32 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.467 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 74.1 Cg_endo -73.88 144.6 34.89 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.097 2.531 . . . . 0.0 113.202 -176.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.586 HD12 HD23 ' A' ' 126' ' ' LEU . 0.4 OUTLIER -82.94 119.92 25.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.513 176.991 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -58.18 145.43 37.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.265 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 111' ' ' ARG . 4.2 p -74.25 108.22 6.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.532 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 2.8 t . . . . . 0 C--N 1.318 -0.802 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.708 176.694 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.573 ' HB1' ' HG2' ' A' ' 204' ' ' GLU . . . . . . . . 0 N--CA 1.463 0.206 0 CA-C-O 121.459 0.647 . . . . 0.0 112.365 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 7.4 m -61.79 -52.26 64.91 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.189 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.704 HG23 ' HB2' ' A' ' 202' ' ' MET . 33.6 mm 82.74 82.25 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-O 121.853 0.835 . . . . 0.0 109.372 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.438 -1.064 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.629 178.83 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.416 ' HB2' ' H ' ' A' ' 190' ' ' LEU . 5.4 Cg_exo . . . . . 0 CA--C 1.515 -0.468 0 CA-C-O 121.474 0.531 . . . . 0.0 111.441 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.506 ' HB ' ' CG ' ' A' ' 113' ' ' PHE . 40.4 p -100.44 6.26 44.37 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.154 -175.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.8 p -78.54 45.28 0.57 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.246 0.546 . . . . 0.0 111.09 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -125.9 168.34 14.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.89 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.434 ' O ' HG23 ' A' ' 218' ' ' THR . 14.3 mmt180 -82.82 -14.86 53.58 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -170.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.538 ' HB3' ' CB ' ' A' ' 215' ' ' PRO . 1.7 p-90 -85.17 -18.6 33.64 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.3 175.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.506 ' CG ' ' HB ' ' A' ' 108' ' ' THR . 87.2 t80 -78.98 118.05 20.62 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.215 173.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -115.11 113.36 23.9 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 174.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -64.31 -72.74 0.65 Allowed Glycine 0 N--CA 1.454 -0.163 0 CA-C-N 116.089 -0.505 . . . . 0.0 113.658 -173.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -84.41 89.46 7.4 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.642 -0.328 . . . . 0.0 110.996 -174.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 24.3 mt -143.73 137.15 27.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.661 174.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.1 t -101.05 173.59 6.4 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 169.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 123' ' ' GLU . . . -49.85 -52.87 24.24 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 121.527 -0.368 . . . . 0.0 113.796 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.56 -25.55 57.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.169 0.485 . . . . 0.0 111.229 -176.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -69.99 -47.27 62.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.156 0.503 . . . . 0.0 109.93 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.667 ' HB2' ' HD2' ' A' ' 138' ' ' ARG . . . -67.06 -34.11 76.97 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.597 177.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.474 ' HG3' ' HB ' ' A' ' 167' ' ' VAL . 3.3 tt0 -61.66 -49.08 77.98 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.847 177.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -59.67 -34.11 72.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.877 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.401 HD12 HD13 ' A' ' 216' ' ' LEU . 1.2 mm? -56.72 -53.53 56.7 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.119 0.485 . . . . 0.0 110.405 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.526 ' CD2' HD12 ' A' ' 216' ' ' LEU . 54.0 mt -76.15 -44.36 38.58 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.9 m -61.61 -35.48 78.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 110.757 -175.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -95.6 -52.99 3.89 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -97.86 -22.73 16.2 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -170.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -90.08 177.51 42.96 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.307 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -135.59 175.14 9.87 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -57.98 117.59 4.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.781 0.324 . . . . 0.0 110.574 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 211' ' ' GLN . . . 104.02 -5.29 46.05 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.76 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 29.6 m -74.61 137.44 42.29 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.649 -0.324 . . . . 0.0 110.434 176.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.463 ' CB ' HG12 ' A' ' 151' ' ' VAL . 51.0 p90 -136.87 149.26 47.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.714 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.582 HD21 ' HB2' ' A' ' 150' ' ' SER . 1.2 pt? -150.56 134.15 16.51 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.71 HG21 HD13 ' A' ' 190' ' ' LEU . 11.9 m -97.44 141.09 16.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.667 ' HD2' ' HB2' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -140.19 162.94 34.06 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.903 -175.046 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -77.73 128.13 33.54 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.53 ' HB2' HG13 ' A' ' 148' ' ' VAL . 36.4 t -75.82 137.98 40.85 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -101.3 -21.51 14.85 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.033 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 33.5 m -86.12 -29.19 23.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.985 173.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -116.83 81.09 11.58 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 175.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.03 133.11 39.6 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.797 2.331 . . . . 0.0 112.369 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 94.52 -10.08 71.17 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.862 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -113.65 168.37 9.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.071 0.463 . . . . 0.0 110.356 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.475 ' CE1' ' HE1' ' A' ' 179' ' ' TYR . 74.0 m-85 -125.06 163.27 22.74 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.58 -177.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.532 ' CG2' ' HG3' ' A' ' 138' ' ' ARG . 26.7 m -134.62 136.99 51.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.228 0.537 . . . . 0.0 111.193 178.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.986 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -92.29 110.18 21.57 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.14 177.116 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.582 ' HB2' HD21 ' A' ' 136' ' ' LEU . 3.8 m -101.25 130.43 47.38 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.297 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.499 HG21 ' HB3' ' A' ' 210' ' ' LEU . 33.9 m -131.43 146.9 32.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.848 -174.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.409 ' HB2' ' HB3' ' A' ' 126' ' ' LEU . 39.5 ttt180 -91.55 104.89 17.32 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.17 0.51 . . . . 0.0 109.964 175.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.489 ' O ' ' HB3' ' A' ' 166' ' ' LYS . 3.7 p -104.11 146.58 28.53 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.977 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.752 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.876 -176.201 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 153' ' ' THR . 51.9 tptt . . . . . 0 N--CA 1.446 -0.662 0 CA-C-O 120.734 0.302 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.474 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 73.9 t -119.17 113.33 41.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.353 0.597 . . . . 0.0 110.319 174.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.822 HG21 HD11 ' A' ' 210' ' ' LEU . 18.9 m -97.95 133.59 42.23 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.905 176.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 150' ' ' SER . 13.4 m-70 -110.9 117.91 34.66 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.986 HG22 ' HB3' ' A' ' 149' ' ' LEU . 0.7 OUTLIER -98.15 133.58 39.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -177.064 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 44.0 tpp -78.7 119.27 21.7 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.683 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.559 HD13 HD21 ' A' ' 190' ' ' LEU . 24.8 mt -99.58 107.22 20.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.644 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 4.5 ptp180 -69.98 125.51 26.98 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' CYS . . . . . 0.673 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 49.4 t -118.53 115.5 24.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.72 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -141.44 112.8 7.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.164 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 60.16 49.94 6.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.974 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.0 mt 58.35 47.49 13.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.844 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.673 ' O ' ' HA ' ' A' ' 174' ' ' CYS . 11.3 tppt? -133.97 132.23 39.91 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.475 ' HE1' ' CE1' ' A' ' 147' ' ' PHE . 69.0 m-85 -117.71 134.08 55.27 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.161 0.288 . . . . 0.0 110.715 -175.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.644 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 12.5 t0 -156.12 131.46 9.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.952 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.561 ' HB ' ' CZ ' ' A' ' 197' ' ' TYR . 51.1 t -83.16 -15.69 11.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.701 0.762 . . . . 0.0 109.083 175.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' GLY . . . . . 0.411 ' HA2' ' NH1' ' A' ' 173' ' ' ARG . . . 122.57 8.49 6.91 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.83 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -136.61 141.62 12.67 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.465 -175.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 71.44 -152.03 49.0 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.888 175.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -84.16 144.05 29.24 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.866 0.365 . . . . 0.0 110.835 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -78.98 137.17 37.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.576 177.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -110.74 149.95 29.77 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.193 0.52 . . . . 0.0 111.647 -175.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -84.06 -9.59 58.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.644 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.18 143.43 40.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.273 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.71 HD13 HG21 ' A' ' 137' ' ' VAL . 0.8 OUTLIER -70.85 -23.39 62.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.441 -174.63 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 20.6 m -61.35 -47.92 83.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.945 0.402 . . . . 0.0 110.15 175.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.21 -30.99 72.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.249 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.547 HD11 HG23 ' A' ' 181' ' ' VAL . 2.9 tm? -65.72 -54.64 24.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.44 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 34.5 m -66.77 -43.17 90.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.239 -173.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -62.25 -31.47 72.04 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.416 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -64.21 -52.1 60.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.817 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.561 ' CZ ' ' HB ' ' A' ' 181' ' ' VAL . 86.6 m-85 -80.92 -8.52 59.77 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.265 0.555 . . . . 0.0 110.393 -177.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -71.74 -23.17 61.56 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 172.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 8.3 tppt? -96.18 -36.5 10.93 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.682 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -121.86 103.72 39.78 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.001 0.429 . . . . 0.0 111.219 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -58.31 126.85 22.69 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 123.038 2.492 . . . . 0.0 112.475 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' MET . . . . . 0.464 ' HB2' ' CG2' ' B' ' 3' ' ' ILE . 0.0 OUTLIER -89.51 127.66 35.89 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.727 178.785 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.573 HG22 ' HB ' ' A' ' 209' ' ' VAL . 47.2 t -99.42 139.69 20.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.192 0.52 . . . . 0.0 111.63 -173.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.724 ' HB2' ' O ' ' A' ' 208' ' ' THR . 0.4 OUTLIER -85.6 155.95 20.92 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.946 171.592 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 9.2 t -72.41 -11.8 60.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.052 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.403 HD12 ' N ' ' A' ' 206' ' ' LEU . 5.5 mp -91.3 6.7 44.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.881 176.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.13 -17.93 53.57 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.788 178.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.724 ' O ' ' HB2' ' A' ' 204' ' ' GLU . 92.7 m -66.34 110.73 3.19 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-O 120.705 0.288 . . . . 0.0 110.239 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.573 ' HB ' HG22 ' A' ' 203' ' ' VAL . 1.4 p -111.8 127.43 68.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.695 0.759 . . . . 0.0 110.517 175.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.822 HD11 HG21 ' A' ' 168' ' ' THR . 0.3 OUTLIER -81.34 110.38 16.72 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.813 -169.377 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.434 ' O ' ' HA2' ' A' ' 133' ' ' GLY . 49.8 mt-30 -91.46 89.53 7.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.371 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.412 HD11 HD21 ' A' ' 149' ' ' LEU . 7.4 mp -75.45 111.7 11.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.195 176.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -113.92 -56.12 2.43 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.638 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.537 ' O ' ' HA ' ' A' ' 134' ' ' SER . 0.0 OUTLIER -145.77 149.2 38.92 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 121.096 0.474 . . . . 0.0 111.082 179.594 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.538 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 72.6 Cg_endo -72.94 149.44 47.21 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 123.55 2.833 . . . . 0.0 114.17 -173.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.526 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.2 OUTLIER -84.97 113.74 21.64 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 173.868 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -62.76 151.06 39.74 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.133 0.492 . . . . 0.0 111.198 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 111' ' ' ARG . 12.6 p -80.02 111.57 16.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.138 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 3.1 t . . . . . 0 C--N 1.321 -0.654 0 CA-C-O 121.385 0.612 . . . . 0.0 109.474 176.069 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.438 ' HB2' ' CG2' ' A' ' 168' ' ' THR . . . . . . . . 0 C--O 1.234 0.244 0 CA-C-O 121.37 0.605 . . . . 0.0 111.357 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 86.0 m -70.7 -47.29 60.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.008 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.464 ' CG2' ' HB2' ' A' ' 202' ' ' MET . 15.7 mm 78.54 89.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 123.318 0.647 . . . . 0.0 110.278 173.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.441 -0.899 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.435 177.639 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 CA--C 1.516 -0.416 0 CA-C-O 121.635 0.598 . . . . 0.0 111.294 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.63 ' HB ' ' CD2' ' A' ' 113' ' ' PHE . 81.5 p -94.77 6.69 48.2 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.59 -176.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 51.3 m -76.64 59.24 1.5 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.299 0.571 . . . . 0.0 110.818 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.474 ' HG3' ' CZ2' ' A' ' 112' ' ' TRP . 76.8 mm-40 -134.39 156.35 48.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.513 -177.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -75.11 -13.76 60.5 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -171.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.492 ' HB3' ' CB ' ' A' ' 215' ' ' PRO . 2.5 p-90 -89.65 -14.16 35.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.947 0.403 . . . . 0.0 110.742 175.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.63 ' CD2' ' HB ' ' A' ' 108' ' ' THR . 76.3 t80 -80.73 120.94 25.27 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.088 0.47 . . . . 0.0 110.149 172.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -111.91 140.4 46.6 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -76.73 -90.3 0.26 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.037 -175.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -92.66 93.54 8.54 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.992 0.425 . . . . 0.0 111.51 -172.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.2 mt -134.38 128.46 33.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.301 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 24.5 m -83.68 173.25 11.51 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 173.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -50.84 -52.62 29.49 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 121.477 -0.392 . . . . 0.0 113.386 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -72.09 -31.75 66.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.491 0.186 . . . . 0.0 111.431 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -64.04 -47.13 81.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.968 0.413 . . . . 0.0 110.481 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.465 ' HB2' ' HD3' ' A' ' 138' ' ' ARG . . . -66.15 -34.03 77.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.723 178.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.444 ' HA ' HG11 ' A' ' 167' ' ' VAL . 0.2 OUTLIER -65.87 -50.77 63.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.51 176.274 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -58.55 -34.78 71.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.615 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.411 HD12 HD13 ' A' ' 216' ' ' LEU . 0.7 OUTLIER -56.81 -51.59 68.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.218 178.065 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.541 ' CD2' HD12 ' A' ' 216' ' ' LEU . 53.2 mt -75.48 -46.66 31.1 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 m -64.97 -28.32 69.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.098 -174.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -95.71 -53.03 3.86 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -103.48 11.65 36.13 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -170.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -127.05 -163.36 11.44 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.254 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -154.34 176.15 12.67 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -46.71 120.74 3.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.937 0.398 . . . . 0.0 111.004 176.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 211' ' ' GLN . . . 99.1 -9.63 61.51 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.797 177.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.658 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 69.0 m -70.41 135.67 48.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.218 0.509 . . . . 0.0 110.526 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.517 ' CB ' HG12 ' A' ' 151' ' ' VAL . 52.5 p90 -137.03 149.54 47.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.923 -178.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.551 ' CD2' ' HB2' ' A' ' 150' ' ' SER . 1.2 pt? -149.43 134.8 18.36 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 175.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.652 HG21 HD13 ' A' ' 190' ' ' LEU . 12.3 m -97.52 141.93 15.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.465 ' HD3' ' HB2' ' A' ' 122' ' ' ALA . 30.5 ptt85 -140.98 162.17 36.1 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.357 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -71.38 129.25 38.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.871 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.436 ' OG ' ' HB2' ' A' ' 143' ' ' HIS . 23.3 t -77.94 132.85 38.07 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.328 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -91.08 -40.86 11.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.819 -175.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.6 t -79.81 -12.99 59.74 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.057 0.456 . . . . 0.0 109.789 177.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' HIS . . . . . 0.436 ' HB2' ' OG ' ' A' ' 140' ' ' SER . 54.3 m80 -126.19 75.04 72.82 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.951 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.5 126.87 21.91 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.847 2.364 . . . . 0.0 112.234 -176.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 106.09 -31.97 7.83 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.943 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -98.16 171.79 8.0 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.155 0.502 . . . . 0.0 110.732 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.412 ' CE2' ' HE1' ' A' ' 179' ' ' TYR . 85.8 m-85 -125.23 165.9 17.46 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.435 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 27.5 m -132.97 136.48 55.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.404 0.621 . . . . 0.0 111.456 176.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.973 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -92.74 110.02 21.45 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.806 174.907 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.551 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 1.2 m -101.9 128.98 48.05 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.709 -0.796 . . . . 0.0 109.254 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.517 HG12 ' CB ' ' A' ' 135' ' ' PHE . 33.7 m -130.46 147.7 33.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.581 -172.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.423 ' HB2' ' HB3' ' A' ' 126' ' ' LEU . 62.7 ttt180 -93.02 104.25 16.48 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.253 0.549 . . . . 0.0 109.879 176.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.7 p -104.08 146.93 28.01 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.092 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.666 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.568 179.169 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 167' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.638 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.449 ' N ' ' HD2' ' A' ' 166' ' ' LYS . 74.9 t -99.41 116.2 42.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.475 0.655 . . . . 0.0 111.751 -177.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.745 HG21 HD11 ' A' ' 210' ' ' LEU . 4.4 m -97.26 141.19 30.67 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.35 176.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 150' ' ' SER . 17.1 m-70 -117.76 117.47 29.41 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.973 HG22 ' HB3' ' A' ' 149' ' ' LEU . 0.7 OUTLIER -98.85 135.37 34.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -173.936 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 35.2 tpp -78.48 115.93 18.52 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.657 -176.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.582 HD13 HD21 ' A' ' 190' ' ' LEU . 29.6 mt -93.61 105.95 17.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 176.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.552 ' HB2' ' OE1' ' A' ' 175' ' ' GLN . 13.6 ptm180 -82.18 118.58 23.18 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.313 -175.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' CYS . . . . . 0.666 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 38.5 t -104.42 110.0 22.09 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.112 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.552 ' OE1' ' HB2' ' A' ' 173' ' ' ARG . 1.8 mp0 -113.74 107.91 16.39 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 177.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 58.2 52.17 7.78 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 123.562 0.539 . . . . 0.0 111.094 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 93.6 mt 61.05 41.89 13.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.193 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.666 ' O ' ' HA ' ' A' ' 174' ' ' CYS . 5.8 tppt? -134.51 131.03 37.53 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.412 ' HE1' ' CE2' ' A' ' 147' ' ' PHE . 63.5 m-85 -105.52 138.19 42.12 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 122.91 0.131 . . . . 0.0 111.118 -171.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.549 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 24.7 t70 -152.11 139.49 19.48 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.355 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.551 HG12 ' O ' ' A' ' 181' ' ' VAL . 84.4 t -96.83 55.68 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 122.514 1.15 . . . . 0.0 109.127 173.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 82.52 -39.02 2.64 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 114.7 -1.136 . . . . 0.0 113.674 173.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -138.51 151.88 21.77 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.281 -176.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 110.16 -142.71 16.63 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.653 175.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -106.44 143.75 34.1 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 176.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.438 ' HG2' ' HB2' ' A' ' 180' ' ' ASP . 80.2 mtt180 -92.77 139.49 30.49 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.346 -176.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -113.95 147.86 37.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.184 -175.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -79.16 -16.9 55.95 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.169 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 19.8 m -129.78 143.37 50.78 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.795 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.652 HD13 HG21 ' A' ' 137' ' ' VAL . 0.8 OUTLIER -69.89 -22.55 63.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.039 -176.456 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.478 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 6.5 m -58.83 -47.36 85.1 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.992 0.425 . . . . 0.0 110.363 176.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -66.41 -31.52 72.32 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.298 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.52 ' HB3' HD23 ' A' ' 190' ' ' LEU . 3.0 tm? -62.84 -54.48 38.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.779 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 32.7 m -69.22 -41.35 81.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.032 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -62.26 -34.87 77.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.677 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -63.52 -50.01 71.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.739 0.304 . . . . 0.0 110.811 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.598 ' HB2' HD22 ' A' ' 212' ' ' LEU . 76.5 m-85 -82.04 -8.35 59.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.186 0.517 . . . . 0.0 111.014 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 212' ' ' LEU . 35.3 ttpt -73.53 -20.47 60.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.68 0.752 . . . . 0.0 109.358 173.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 9.5 tppt? -106.12 -36.21 6.99 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.554 175.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' A' ' 197' ' ' TYR . 18.7 m120 -112.68 93.99 26.3 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.834 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -58.22 130.09 36.12 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.99 2.46 . . . . 0.0 112.382 178.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' MET . . . . . 0.505 ' HG3' HD12 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -92.89 130.87 38.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.368 179.328 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.552 HG22 ' HB ' ' A' ' 209' ' ' VAL . 42.7 t -98.5 133.62 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.247 0.546 . . . . 0.0 112.091 -174.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.722 ' HB2' ' O ' ' A' ' 208' ' ' THR . 0.1 OUTLIER -81.56 159.07 24.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.974 170.848 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 9.0 t -74.06 -10.61 59.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.277 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 206' ' ' LEU . 5.4 mp -88.88 -2.29 58.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.373 176.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 95.5 -13.91 65.82 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.07 -177.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.722 ' O ' ' HB2' ' A' ' 204' ' ' GLU . 49.5 m -67.65 110.27 3.65 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 176.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.552 ' HB ' HG22 ' A' ' 203' ' ' VAL . 1.1 p -112.14 120.61 62.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.925 0.869 . . . . 0.0 110.504 175.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.745 HD11 HG21 ' A' ' 168' ' ' THR . 0.4 OUTLIER -76.7 103.55 6.73 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.354 -170.233 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.478 ' O ' ' HA2' ' A' ' 133' ' ' GLY . 44.8 mt-30 -90.09 89.3 7.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.851 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.598 HD22 ' HB2' ' A' ' 197' ' ' TYR . 7.6 mp -71.27 113.89 8.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.656 178.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -115.81 -56.6 2.31 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.658 ' O ' ' HA ' ' A' ' 134' ' ' SER . 4.2 pm0 -136.84 140.91 33.16 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.072 0.463 . . . . 0.0 110.898 -177.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.492 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 59.9 Cg_endo -73.68 146.05 37.95 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.645 2.23 . . . . 0.0 112.753 -178.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.541 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.2 OUTLIER -86.75 105.46 16.98 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 174.712 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -60.78 138.64 58.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.996 0.427 . . . . 0.0 110.953 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 7.0 p -61.83 114.14 3.16 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.671 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.446 -0.669 0 CA-C-O 121.446 0.641 . . . . 0.0 109.523 177.052 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.533 ' HB2' ' CG2' ' A' ' 168' ' ' THR . . . . . . . . 0 N--CA 1.451 -0.416 0 CA-C-O 121.268 0.556 . . . . 0.0 110.507 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 86.0 m -71.5 -42.3 68.19 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.877 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.505 HD12 ' HG3' ' A' ' 202' ' ' MET . 13.5 mm 73.68 99.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.113 0.565 . . . . 0.0 111.192 175.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 C--N 1.32 -0.678 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.099 -179.892 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo . . . . . 0 N--CA 1.463 -0.321 0 N-CA-C 110.108 -0.766 . . . . 0.0 110.108 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.526 ' HB ' ' CG ' ' A' ' 113' ' ' PHE . 42.1 p -98.39 8.05 45.38 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.609 -178.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 66.5 p -74.86 34.65 0.1 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.933 0.397 . . . . 0.0 111.563 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 108' ' ' THR . 60.7 mm-40 -115.8 157.22 24.72 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -75.65 -12.2 60.16 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -167.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.4 ' CZ2' ' HA ' ' A' ' 191' ' ' THR . 4.4 p-90 -85.29 -14.68 45.84 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.827 176.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.526 ' CG ' ' HB ' ' A' ' 108' ' ' THR . 68.4 t80 -77.59 120.25 22.28 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.125 0.488 . . . . 0.0 110.389 171.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.482 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 10.6 m170 -121.08 106.57 11.68 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 175.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -73.93 -45.96 24.83 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.541 -171.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -99.01 83.72 2.94 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.052 0.453 . . . . 0.0 111.139 -173.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.4 mt -148.44 138.07 22.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.493 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.8 p -90.62 173.25 8.15 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 169.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 123' ' ' GLU . . . -51.71 -48.9 49.1 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.862 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -76.48 -32.35 58.31 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -64.02 -46.79 82.91 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.026 176.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.612 ' HB2' ' HD2' ' A' ' 138' ' ' ARG . . . -66.64 -33.69 76.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.693 177.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.562 ' HG3' ' HB ' ' A' ' 167' ' ' VAL . 4.2 tt0 -62.51 -50.37 71.65 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.215 176.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.66 -34.49 72.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.22 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.453 HD12 HD13 ' A' ' 216' ' ' LEU . 0.7 OUTLIER -56.22 -52.9 62.74 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.332 0.587 . . . . 0.0 110.494 -178.069 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.569 ' CD2' HD12 ' A' ' 216' ' ' LEU . 54.2 mt -75.7 -46.72 29.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.514 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.6 m -61.28 -32.54 72.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.337 -172.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -97.36 -53.7 3.38 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 178.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -93.03 -21.35 19.79 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -170.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -89.1 -161.24 37.32 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.937 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -153.88 175.63 13.12 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 174.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -51.08 117.63 2.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.918 0.39 . . . . 0.0 110.891 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 99.93 -3.75 57.32 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.996 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 68.7 m -75.96 139.63 41.66 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.52 -0.4 . . . . 0.0 110.647 178.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.497 ' CB ' HG12 ' A' ' 151' ' ' VAL . 52.8 p90 -137.5 151.4 48.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.771 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.582 ' CD2' ' HB2' ' A' ' 150' ' ' SER . 1.2 pt? -151.71 138.02 18.47 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.693 HG21 HD13 ' A' ' 190' ' ' LEU . 14.2 m -97.62 137.94 23.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.308 176.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.612 ' HD2' ' HB2' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -137.64 162.14 34.61 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.053 -174.765 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -76.66 134.38 39.29 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.507 ' HB2' HG13 ' A' ' 148' ' ' VAL . 33.2 t -80.93 143.65 32.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.174 -175.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -101.15 -22.76 14.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.914 174.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 72.7 m -69.86 -40.35 75.82 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.439 0.637 . . . . 0.0 109.356 170.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -121.93 83.14 43.49 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.036 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -55.47 123.58 14.15 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.506 2.137 . . . . 0.0 111.553 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 106.7 -32.14 7.57 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.906 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -88.28 170.29 11.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.877 0.37 . . . . 0.0 110.431 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -121.65 153.96 37.45 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.151 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.536 ' CG2' ' HG3' ' A' ' 138' ' ' ARG . 30.2 m -129.38 138.86 53.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.159 0.504 . . . . 0.0 110.52 176.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.853 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -92.18 110.13 21.51 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.149 177.928 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.582 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 3.3 m -101.42 132.01 47.23 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.408 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.555 HG21 ' HB3' ' A' ' 210' ' ' LEU . 32.0 m -132.47 149.44 32.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.96 -174.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.486 ' HB2' ' HB3' ' A' ' 126' ' ' LEU . 72.9 ttt180 -96.0 104.16 16.09 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.031 0.443 . . . . 0.0 109.898 176.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -107.69 147.15 31.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.224 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.648 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.405 -178.77 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.889 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.562 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 71.4 t -99.96 112.52 32.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.396 0.617 . . . . 0.0 110.492 177.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.702 HG21 HD11 ' A' ' 210' ' ' LEU . 6.3 m -92.01 140.5 29.59 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.641 175.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 150' ' ' SER . 7.5 m-70 -118.5 120.15 36.66 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.853 HG22 ' HB3' ' A' ' 149' ' ' LEU . 1.1 m -98.16 138.8 21.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -177.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 5.7 ttm -90.45 118.69 30.12 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.941 -174.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.485 HD13 HD21 ' A' ' 190' ' ' LEU . 25.6 mt -93.47 127.97 45.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.661 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.597 ' NH1' ' HA2' ' A' ' 182' ' ' GLY . 5.0 ptp180 -87.77 112.26 22.24 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.043 0.449 . . . . 0.0 109.942 177.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 47.0 t -96.89 92.6 6.2 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -113.77 113.78 25.42 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.48 -175.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 58.63 40.89 23.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.857 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 93.9 mt 67.1 18.78 10.49 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.82 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -109.95 139.05 45.48 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 172.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.452 ' CD1' ' HG ' ' A' ' 190' ' ' LEU . 51.5 m-85 -109.54 138.53 45.77 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.841 -175.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.586 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 9.6 t0 -155.73 140.99 17.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.028 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.53 ' HB ' ' CE1' ' A' ' 197' ' ' TYR . 14.4 t -94.62 -12.43 8.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.657 0.742 . . . . 0.0 109.342 176.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' GLY . . . . . 0.597 ' HA2' ' NH1' ' A' ' 173' ' ' ARG . . . 123.21 9.02 6.24 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.166 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -138.07 140.59 11.3 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.242 -0.98 . . . . 0.0 113.755 -176.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.67 -119.87 5.59 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.376 173.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -115.76 158.69 22.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.631 0.253 . . . . 0.0 110.564 -173.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -95.43 128.65 42.46 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -110.31 144.28 39.26 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.076 -173.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -79.8 -8.66 59.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.413 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 85.1 p -130.46 143.9 51.06 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.479 177.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.693 HD13 HG21 ' A' ' 137' ' ' VAL . 1.1 mt -70.65 -22.08 62.54 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.37 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.492 ' O ' ' HG3' ' A' ' 195' ' ' GLU . 4.0 m -60.42 -49.18 78.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.637 177.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -67.14 -30.52 70.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.705 0.288 . . . . 0.0 110.565 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.528 HD11 HG23 ' A' ' 181' ' ' VAL . 3.4 tm? -62.15 -54.83 35.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.836 177.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 35.7 m -68.97 -39.69 80.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.999 -175.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 191' ' ' THR . 22.7 mt-10 -66.67 -35.27 79.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.414 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -60.26 -42.78 96.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.818 0.342 . . . . 0.0 110.414 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.53 ' CE1' ' HB ' ' A' ' 181' ' ' VAL . 40.5 m-85 -85.44 -11.62 53.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.376 0.608 . . . . 0.0 110.649 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.408 ' HE2' ' HA ' ' A' ' 195' ' ' GLU . 38.4 ttpt -73.67 -27.67 61.35 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 173.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -90.29 -35.99 14.95 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.442 175.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -116.38 102.78 53.42 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.511 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -57.93 126.43 21.64 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.603 2.202 . . . . 0.0 111.974 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' MET . . . . . 0.729 ' SD ' HD23 ' A' ' 210' ' ' LEU . 9.5 ptp -89.11 120.48 30.54 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.633 -177.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.591 HG22 ' HB ' ' A' ' 209' ' ' VAL . 28.7 t -97.91 136.55 28.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.662 0.268 . . . . 0.0 111.72 -175.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.558 ' O ' HG12 ' A' ' 203' ' ' VAL . 22.6 mt-10 -85.79 167.09 15.53 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.877 0.37 . . . . 0.0 110.063 169.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 12.1 t -75.16 -14.83 60.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.276 0.56 . . . . 0.0 109.978 177.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.469 HD12 ' N ' ' A' ' 206' ' ' LEU . 5.1 mp -81.73 -7.44 59.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.153 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 99.82 -21.23 45.87 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.869 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 89.8 m -62.94 112.13 2.44 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.591 ' HB ' HG22 ' A' ' 203' ' ' VAL . 0.8 OUTLIER -112.82 121.82 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 CA-C-O 121.616 0.722 . . . . 0.0 110.574 173.836 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.729 HD23 ' SD ' ' A' ' 202' ' ' MET . 0.4 OUTLIER -77.12 107.94 9.84 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.767 -174.708 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -93.54 90.23 6.59 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.008 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.488 HD22 ' HB2' ' A' ' 197' ' ' TYR . 7.8 mp -74.02 103.4 4.49 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.242 -177.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -115.47 -55.79 2.41 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.633 ' O ' ' HA ' ' A' ' 134' ' ' SER . 0.1 OUTLIER -115.09 132.89 22.8 Favored Pre-proline 0 C--O 1.223 -0.305 0 CA-C-O 120.483 0.182 . . . . 0.0 111.323 -173.706 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.09 132.78 11.81 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.315 2.01 . . . . 0.0 111.817 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.569 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.3 OUTLIER -78.88 102.02 8.0 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.173 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -58.13 140.24 53.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.705 178.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.3 p -62.58 125.54 24.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.335 0.588 . . . . 0.0 111.554 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.318 -0.763 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.076 -179.85 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.599 ' HB2' ' CG2' ' A' ' 168' ' ' THR . . . . . . . . 0 N--CA 1.465 0.287 0 CA-C-O 121.797 0.808 . . . . 0.0 113.1 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 63.4 m -73.48 -47.03 44.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.443 -1.253 . . . . 0.0 111.521 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.56 HD12 ' SD ' ' A' ' 202' ' ' MET . 6.4 mm 66.32 105.25 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 123.224 0.61 . . . . 0.0 111.63 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.323 -0.555 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.333 175.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo . . . . . 0 CA--C 1.508 -0.816 0 CA-C-O 121.807 0.67 . . . . 0.0 110.741 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 190' ' ' LEU . 8.9 t -101.07 5.94 43.14 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.348 175.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.7 t -71.74 65.54 0.51 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 121.792 0.805 . . . . 0.0 110.035 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -130.27 169.89 14.83 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.033 -175.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -64.83 -17.1 63.95 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -167.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.436 ' CZ2' ' HA ' ' A' ' 191' ' ' THR . 1.3 p-90 -92.93 -13.33 29.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.858 0.361 . . . . 0.0 111.467 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.494 ' HA ' ' O ' ' A' ' 137' ' ' VAL . 24.6 t80 -89.37 118.57 29.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.175 0.512 . . . . 0.0 110.806 177.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -109.65 119.26 38.84 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -49.8 -86.02 0.01 OUTLIER Glycine 0 C--N 1.331 0.256 0 O-C-N 123.98 0.8 . . . . 0.0 114.213 -170.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -100.4 107.2 18.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.521 0.677 . . . . 0.0 111.227 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 33.9 mt -129.57 140.92 51.08 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.951 174.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.422 ' H ' ' HB2' ' A' ' 121' ' ' GLU . 18.1 t -90.0 171.31 9.65 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 173.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.34 -53.18 42.58 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.835 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 20.9 mmtm -76.73 -25.45 53.54 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.422 ' HB2' ' H ' ' A' ' 118' ' ' SER . 15.2 mm-40 -65.29 -47.03 78.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.948 0.404 . . . . 0.0 110.225 175.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.596 ' HB2' ' HD2' ' A' ' 138' ' ' ARG . . . -65.59 -34.26 77.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.282 0.563 . . . . 0.0 110.492 178.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -67.94 -50.14 57.73 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.851 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -56.97 -34.65 68.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.788 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.453 HD12 HD13 ' A' ' 216' ' ' LEU . 0.7 OUTLIER -57.14 -52.69 64.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.275 178.484 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.558 ' CD2' HD12 ' A' ' 216' ' ' LEU . 55.1 mt -76.04 -51.88 11.38 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.5 m -61.07 -35.84 78.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.75 -171.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -97.68 -46.63 5.92 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 125' ' ' LEU . 89.0 mttt -91.23 -28.88 17.52 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.668 -0.413 . . . . 0.0 112.015 -171.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -93.17 -158.98 34.56 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.831 -176.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.432 ' C ' ' HD3' ' A' ' 152' ' ' ARG . 14.9 ptmm? -148.08 176.0 10.56 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -51.92 123.85 11.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.707 0.289 . . . . 0.0 110.513 176.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 94.87 -3.64 67.66 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.239 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.624 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 69.0 m -73.61 139.15 45.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.059 0.429 . . . . 0.0 110.313 178.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.501 ' CB ' HG12 ' A' ' 151' ' ' VAL . 50.4 p90 -136.93 149.38 47.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.71 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.593 HD21 ' HB2' ' A' ' 150' ' ' SER . 1.2 pt? -150.64 140.4 21.77 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.657 HG21 HD13 ' A' ' 190' ' ' LEU . 11.4 m -99.73 144.1 12.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.186 175.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.596 ' HD2' ' HB2' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -146.0 156.69 43.67 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.845 -173.682 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -70.31 132.73 46.13 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 175.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.645 ' HB2' HG13 ' A' ' 148' ' ' VAL . 37.9 t -86.22 143.43 27.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.916 0.389 . . . . 0.0 110.38 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -100.63 -20.25 15.74 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.691 178.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 65.9 m -78.75 -30.56 45.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.141 0.496 . . . . 0.0 109.789 172.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' HIS . . . . . 0.403 ' HB3' ' HB2' ' A' ' 146' ' ' ASP . 27.1 m-70 -120.55 86.16 39.26 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.858 173.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -61.49 123.19 12.28 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.241 1.96 . . . . 0.0 111.892 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 101.35 -14.82 57.99 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.166 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.403 ' HB2' ' HB3' ' A' ' 143' ' ' HIS . 4.2 m-20 -105.61 164.08 12.17 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.168 0.509 . . . . 0.0 110.865 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -119.24 153.89 34.28 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.721 -177.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.645 HG13 ' HB2' ' A' ' 140' ' ' SER . 34.5 m -130.31 139.94 50.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.393 0.616 . . . . 0.0 111.371 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.779 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -92.64 110.37 21.79 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.256 178.17 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.593 ' HB2' HD21 ' A' ' 136' ' ' LEU . 1.5 m -102.97 131.27 50.05 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.115 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.538 HG21 ' HB3' ' A' ' 210' ' ' LEU . 35.3 m -132.12 146.81 32.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.166 -173.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.432 ' HD3' ' C ' ' A' ' 131' ' ' LYS . 75.0 ttt180 -90.56 104.67 17.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.339 0.59 . . . . 0.0 109.968 176.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.429 HG21 HD12 ' A' ' 210' ' ' LEU . 8.8 p -102.23 147.43 26.66 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.392 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.603 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.76 -177.671 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.442 ' HD2' ' HA ' ' A' ' 166' ' ' LYS . 25.6 mmmt . . . . . 0 N--CA 1.448 -0.541 0 CA-C-O 121.09 0.471 . . . . 0.0 111.846 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 71.3 t -125.73 113.32 34.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.71 170.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.69 HG21 HD11 ' A' ' 210' ' ' LEU . 1.8 m -97.83 138.18 35.57 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.898 175.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 150' ' ' SER . 14.2 m-70 -112.73 117.99 33.74 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.779 HG22 ' HB3' ' A' ' 149' ' ' LEU . 1.3 m -98.35 135.72 32.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -175.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 40.1 tpp -81.3 116.78 21.32 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.893 -174.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.562 HG21 HD21 ' A' ' 190' ' ' LEU . 16.6 mt -97.03 107.67 20.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 3.9 ptp180 -70.11 117.73 12.05 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.617 -178.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 36.6 t -93.02 94.59 8.97 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -113.78 109.59 18.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.47 -174.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 53.01 40.52 31.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.802 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 96.1 mt 72.66 15.13 4.97 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.169 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.88 142.94 34.74 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 170.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -110.8 140.99 44.74 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.53 -176.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.582 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 10.6 t0 -156.02 137.95 14.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.753 0.311 . . . . 0.0 111.048 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.483 HG23 HD11 ' A' ' 193' ' ' LEU . 48.6 t -90.11 -13.16 9.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.724 0.773 . . . . 0.0 109.322 175.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' GLY . . . . . 0.57 ' HA2' ' NH1' ' A' ' 173' ' ' ARG . . . 124.09 5.23 7.5 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.763 178.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -137.14 140.41 11.37 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 119.807 -1.187 . . . . 0.0 113.918 -174.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 79.45 -116.46 4.31 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.088 -0.577 . . . . 0.0 113.18 174.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -115.92 150.18 37.53 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 122.291 0.236 . . . . 0.0 110.436 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -80.96 126.96 32.03 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 171.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -105.62 138.69 41.4 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.099 0.476 . . . . 0.0 111.326 -172.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -70.13 -22.77 62.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.788 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 82.2 p -130.71 144.62 51.56 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.517 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.657 HD13 HG21 ' A' ' 137' ' ' VAL . 8.8 mt -65.66 -20.92 66.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.11 176.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.436 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 3.7 m -55.89 -48.91 74.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.694 0.283 . . . . 0.0 110.538 176.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -69.24 -34.73 75.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.764 0.316 . . . . 0.0 110.334 176.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.483 HD11 HG23 ' A' ' 181' ' ' VAL . 2.9 tm? -59.75 -54.0 51.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.987 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 30.5 m -69.58 -41.86 80.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.389 -174.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -66.68 -36.37 82.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.447 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -61.03 -44.9 96.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.751 0.31 . . . . 0.0 110.752 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.498 ' HB2' HD22 ' A' ' 212' ' ' LEU . 55.6 m-85 -85.23 -10.48 56.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.008 0.432 . . . . 0.0 110.799 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.492 ' HA ' ' HB2' ' A' ' 212' ' ' LEU . 38.9 ttpt -70.13 -34.03 72.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.608 0.718 . . . . 0.0 109.228 174.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -88.01 -25.75 22.96 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.043 176.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -128.31 90.78 45.97 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.801 -174.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -55.17 127.98 28.57 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.177 2.584 . . . . 0.0 112.587 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' MET . . . . . 0.519 ' HG3' HD12 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -91.63 123.78 35.28 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.956 0.408 . . . . 0.0 110.415 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.579 HG22 ' HB ' ' A' ' 209' ' ' VAL . 36.3 t -93.87 134.89 29.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 120.85 0.357 . . . . 0.0 111.871 -176.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.54 ' O ' HG12 ' A' ' 203' ' ' VAL . 0.7 OUTLIER -79.2 163.64 24.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.49 169.245 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 7.7 t -76.33 -10.0 59.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.452 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.415 HD12 ' N ' ' A' ' 206' ' ' LEU . 5.4 mp -92.2 5.03 51.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.432 178.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 90.99 -14.5 63.27 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.703 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.486 ' O ' ' HB2' ' A' ' 204' ' ' GLU . 88.2 m -71.6 111.42 6.88 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.579 ' HB ' HG22 ' A' ' 203' ' ' VAL . 1.4 p -111.81 128.27 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-O 121.82 0.819 . . . . 0.0 110.854 176.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.69 HD11 HG21 ' A' ' 168' ' ' THR . 0.3 OUTLIER -84.8 103.49 13.93 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.83 -172.884 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -90.88 89.41 7.45 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.216 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.498 HD22 ' HB2' ' A' ' 197' ' ' TYR . 7.6 mp -71.79 108.55 5.15 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.314 177.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -115.11 -56.01 2.41 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -177.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.624 ' O ' ' HA ' ' A' ' 134' ' ' SER . 5.0 pm0 -131.95 136.46 28.32 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 121.068 0.461 . . . . 0.0 110.746 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.01 137.54 26.75 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.918 2.412 . . . . 0.0 112.798 -178.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.558 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.2 OUTLIER -76.7 98.88 4.89 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 175.792 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -63.77 139.18 58.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.905 0.384 . . . . 0.0 110.574 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 7.5 p -61.66 110.49 1.51 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.394 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 C--N 1.319 -0.74 0 CA-C-O 121.463 0.649 . . . . 0.0 109.517 177.474 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.538 ' HB2' ' CG2' ' A' ' 168' ' ' THR . . . . . . . . 0 C--O 1.232 0.157 0 CA-C-O 121.305 0.574 . . . . 0.0 111.746 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 71.8 m -76.05 -41.81 49.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.742 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.519 HD12 ' HG3' ' A' ' 202' ' ' MET . 8.5 mm 68.48 120.54 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.291 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.466 0.355 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.224 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo . . . . . 0 CA--C 1.515 -0.471 0 N-CA-C 109.29 -1.081 . . . . 0.0 109.29 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.703 ' HB ' ' CG ' ' A' ' 113' ' ' PHE . 22.9 p -88.12 7.37 31.92 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 113.619 -1.628 . . . . 0.0 110.738 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.4 p -71.26 47.07 0.11 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.483 0.659 . . . . 0.0 111.258 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.43 ' HG3' ' CZ2' ' A' ' 112' ' ' TRP . 70.8 mm-40 -122.03 -176.9 3.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.84 -176.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -85.92 -23.43 27.0 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -176.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.452 ' HE3' HG22 ' A' ' 137' ' ' VAL . 2.8 p-90 -85.16 -20.34 30.4 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.812 -177.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.703 ' CG ' ' HB ' ' A' ' 108' ' ' THR . 60.2 t80 -80.27 127.15 32.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.98 0.419 . . . . 0.0 110.405 173.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -118.56 113.09 20.74 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.436 ' HA2' ' CZ ' ' A' ' 113' ' ' PHE . . . -50.44 -82.4 0.04 OUTLIER Glycine 0 C--O 1.237 0.315 0 O-C-N 123.971 0.794 . . . . 0.0 114.599 -169.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -99.83 90.59 4.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.185 0.517 . . . . 0.0 111.393 -173.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.414 HD13 ' HA ' ' A' ' 122' ' ' ALA . 44.5 mt -126.21 130.56 51.19 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.164 173.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.4 m -81.85 170.82 15.22 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 171.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -54.66 -47.45 70.69 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.45 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -64.71 -44.39 90.4 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 122.704 0.402 . . . . 0.0 110.974 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -62.7 -46.75 86.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.238 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.685 ' HB2' ' HD2' ' A' ' 138' ' ' ARG . . . -60.32 -34.32 73.64 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.945 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.5 ' HG3' ' HB ' ' A' ' 167' ' ' VAL . 3.7 tt0 -69.93 -46.64 64.91 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.529 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -56.92 -36.21 69.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.647 175.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.64 -52.59 64.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.601 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.559 ' CD2' HD12 ' A' ' 216' ' ' LEU . 58.2 mt -75.12 -49.43 19.62 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.568 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.7 m -61.95 -29.58 70.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.326 -172.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -95.56 -51.97 4.32 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 177.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.415 ' HD3' HG21 ' A' ' 219' ' ' THR . 55.5 mttp -105.77 -0.81 25.06 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -163.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -106.09 -161.52 22.72 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.169 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -149.86 173.8 13.36 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 174.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 55.0 t60 -53.61 117.39 3.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.964 0.411 . . . . 0.0 111.025 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 100.95 -3.76 55.83 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.985 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.692 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 68.5 m -72.57 139.87 47.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.99 0.395 . . . . 0.0 110.608 178.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.488 ' HB3' HG12 ' A' ' 151' ' ' VAL . 52.1 p90 -136.92 150.82 48.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.612 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.586 HD21 ' HB2' ' A' ' 150' ' ' SER . 1.3 pt? -151.22 138.04 18.94 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.627 HG21 HD13 ' A' ' 190' ' ' LEU . 11.2 m -100.55 140.23 20.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 120.231 -0.588 . . . . 0.0 109.441 177.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.685 ' HD2' ' HB2' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -141.04 161.56 37.55 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.311 -174.683 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -72.84 132.83 44.05 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.579 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.48 ' HB2' HG13 ' A' ' 148' ' ' VAL . 29.5 t -77.37 143.46 38.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.531 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -100.6 -30.1 11.96 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.145 178.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 72.6 m -74.32 -30.73 62.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.02 0.438 . . . . 0.0 110.256 173.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -121.49 85.53 43.27 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.193 175.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.66 123.73 14.21 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.525 2.15 . . . . 0.0 111.808 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 105.94 -27.69 16.6 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.701 -176.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -89.99 171.65 9.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.247 0.546 . . . . 0.0 110.614 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -124.36 157.52 34.84 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.314 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.504 ' CG2' ' HG3' ' A' ' 138' ' ' ARG . 32.1 m -128.13 136.58 59.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.298 0.571 . . . . 0.0 110.717 174.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.906 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -91.77 109.61 20.94 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.318 -0.856 . . . . 0.0 108.848 176.81 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.586 ' HB2' HD21 ' A' ' 136' ' ' LEU . 2.1 m -102.46 132.38 48.53 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.212 -178.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.505 HG21 ' HB3' ' A' ' 210' ' ' LEU . 34.7 m -130.43 147.8 33.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.128 -172.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -92.84 105.08 17.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.744 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.422 ' O ' ' HB3' ' A' ' 166' ' ' LYS . 1.2 p -108.52 148.43 30.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.777 -175.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.738 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.883 177.221 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.422 ' HB3' ' O ' ' A' ' 153' ' ' THR . 46.1 tptt . . . . . 0 N--CA 1.446 -0.637 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.5 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 69.2 t -126.62 112.61 29.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.51 0.671 . . . . 0.0 110.503 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.717 HG21 HD11 ' A' ' 210' ' ' LEU . 3.9 m -96.38 140.3 31.24 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.623 174.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 150' ' ' SER . 18.9 m-70 -115.57 119.16 35.24 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.906 HG22 ' HB3' ' A' ' 149' ' ' LEU . 1.0 OUTLIER -98.37 134.91 35.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -178.835 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 9.8 ttm -88.6 119.04 28.69 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.395 -176.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.492 HD13 HD21 ' A' ' 190' ' ' LEU . 12.5 mt -94.05 113.73 29.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.072 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.608 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 19.9 ptp180 -74.21 118.28 16.98 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.146 0.498 . . . . 0.0 110.189 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 46.1 t -102.56 93.07 4.94 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -114.73 108.5 16.86 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.364 -176.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 57.64 48.39 14.22 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.704 0.628 . . . . 0.0 110.573 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 88.9 mt 64.82 24.88 12.85 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.768 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 10.4 tppt? -115.08 133.46 56.02 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -113.38 130.87 56.18 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 123.012 0.195 . . . . 0.0 111.026 -173.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.608 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 34.6 t0 -156.42 136.15 12.51 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.945 0.402 . . . . 0.0 110.796 175.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.544 ' HB ' ' CZ ' ' A' ' 197' ' ' TYR . 25.9 t -85.41 -15.64 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 123.69 4.23 8.16 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.251 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -136.19 141.14 12.18 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.812 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 80.42 -158.09 41.21 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.685 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -85.76 155.16 21.15 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -84.94 130.58 34.61 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -105.89 153.54 21.8 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.031 0.443 . . . . 0.0 111.58 -172.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -91.61 -7.39 50.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.379 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 49.3 m -130.12 142.56 50.58 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.59 176.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.627 HD13 HG21 ' A' ' 137' ' ' VAL . 2.0 mt -72.87 -22.69 60.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.622 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.445 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 3.7 m -59.71 -46.28 89.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.671 176.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -66.3 -35.5 80.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.123 177.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.517 HD11 HG23 ' A' ' 181' ' ' VAL . 3.2 tm? -61.76 -54.96 35.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.306 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 34.6 m -66.69 -42.9 90.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.224 -173.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' A' ' 199' ' ' LYS . 27.7 mt-10 -70.38 -30.75 67.74 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.557 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -59.89 -42.93 94.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.775 0.321 . . . . 0.0 110.441 176.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.544 ' CZ ' ' HB ' ' A' ' 181' ' ' VAL . 56.3 m-85 -85.1 -13.29 50.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.207 0.527 . . . . 0.0 110.619 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 212' ' ' LEU . 39.8 ttpt -72.68 -25.33 61.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.546 0.689 . . . . 0.0 109.487 174.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.422 ' HA ' ' HE2' ' A' ' 199' ' ' LYS . 11.8 mmpt? -91.65 -36.0 13.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.903 175.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -120.78 102.15 44.78 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.623 -176.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.11 133.47 58.29 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.853 2.369 . . . . 0.0 112.58 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' MET . . . . . 0.709 ' SD ' HD12 ' B' ' 3' ' ' ILE . 7.3 ptp -96.65 128.15 43.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.493 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.612 HG22 ' HB ' ' A' ' 209' ' ' VAL . 40.6 t -101.52 137.87 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -175.079 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.563 ' O ' HG12 ' A' ' 203' ' ' VAL . 35.8 mt-10 -84.39 166.07 17.67 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.209 0.528 . . . . 0.0 110.382 170.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 12.1 t -77.21 -10.37 59.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.761 174.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.6 mp -91.43 8.91 34.05 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.402 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 86.77 -21.36 19.37 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.87 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 65.6 m -65.58 113.2 4.03 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.612 ' HB ' HG22 ' A' ' 203' ' ' VAL . 0.8 OUTLIER -111.64 124.66 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-O 121.785 0.802 . . . . 0.0 110.505 174.477 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.717 HD11 HG21 ' A' ' 168' ' ' THR . 0.4 OUTLIER -78.84 107.39 11.53 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.215 -172.523 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -92.3 89.43 6.84 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.836 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.528 HD22 ' HB2' ' A' ' 197' ' ' TYR . 7.4 mp -74.57 110.8 9.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.767 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -114.27 -56.21 2.41 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.692 ' O ' ' HA ' ' A' ' 134' ' ' SER . 4.3 pm0 -135.69 142.56 41.3 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 121.024 0.44 . . . . 0.0 111.103 -176.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.444 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 74.4 Cg_endo -74.27 138.1 24.45 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.992 2.461 . . . . 0.0 112.728 -178.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.559 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.3 OUTLIER -74.12 108.39 6.9 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.787 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -55.75 131.42 46.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.9 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 2.6 p -61.68 126.85 28.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.342 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.415 HG21 ' HD3' ' A' ' 129' ' ' LYS . 3.1 t . . . . . 0 C--N 1.323 -0.579 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.362 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.639 ' HB2' ' CG2' ' A' ' 168' ' ' THR . . . . . . . . 0 CA--C 1.52 -0.178 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 22.8 m -63.78 -44.47 93.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.045 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.709 HD12 ' SD ' ' A' ' 202' ' ' MET . 4.4 mm 60.06 96.84 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 123.267 0.627 . . . . 0.0 111.017 -177.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.459 -178.552 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo . . . . . 0 N--CA 1.457 -0.641 0 N-CA-C 109.543 -0.983 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.749 ' HB ' ' CG ' ' A' ' 113' ' ' PHE . 48.2 p -100.26 4.3 44.1 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 114.018 -1.447 . . . . 0.0 111.098 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 44.4 m -75.57 45.31 0.31 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.609 0.718 . . . . 0.0 110.667 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -117.11 -170.46 1.85 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.625 -175.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.527 ' O ' HG23 ' A' ' 218' ' ' THR . 33.9 mtm180 -83.05 -28.05 29.85 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -176.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.484 ' CZ2' ' HA ' ' A' ' 191' ' ' THR . 2.2 p-90 -85.66 -21.53 28.34 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -174.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.749 ' CG ' ' HB ' ' A' ' 108' ' ' THR . 80.9 t80 -79.62 121.0 24.74 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.282 0.563 . . . . 0.0 111.067 177.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.492 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 11.8 m170 -116.88 124.56 49.77 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 173.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -68.5 -95.29 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.479 -173.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -76.46 93.09 3.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.139 0.495 . . . . 0.0 111.257 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.3 mt -131.37 139.16 49.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.424 174.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.451 ' HB3' ' HG2' ' A' ' 121' ' ' GLU . 21.1 t -94.57 172.58 8.09 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 172.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.44 -52.95 46.82 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.011 -176.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -75.71 -25.51 56.7 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.568 0.21 . . . . 0.0 111.568 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.451 ' HG2' ' HB3' ' A' ' 118' ' ' SER . 52.5 mm-40 -66.45 -47.5 72.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.108 0.48 . . . . 0.0 109.72 177.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.64 ' HB2' ' HD2' ' A' ' 138' ' ' ARG . . . -67.62 -34.16 76.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.68 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.546 ' HG3' ' HB ' ' A' ' 167' ' ' VAL . 5.9 tt0 -63.53 -47.28 82.26 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.198 177.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.82 -34.86 75.18 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.774 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.487 HD12 HD13 ' A' ' 216' ' ' LEU . 0.8 OUTLIER -56.71 -53.25 59.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.516 -179.667 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.533 ' CD2' HD12 ' A' ' 216' ' ' LEU . 58.7 mt -75.75 -44.04 43.66 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.627 -177.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 9.5 m -61.0 -35.01 75.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.29 -173.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -95.68 -52.85 3.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.073 0.463 . . . . 0.0 111.862 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -96.85 -11.33 24.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.325 -166.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -96.32 -164.15 33.35 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.82 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -153.76 173.88 15.28 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -55.13 116.02 2.56 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.928 0.394 . . . . 0.0 110.5 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 100.8 -3.27 55.89 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.525 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 42.6 p -71.12 137.48 48.88 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 117.494 0.647 . . . . 0.0 110.317 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.462 ' CB ' HG12 ' A' ' 151' ' ' VAL . 45.8 p90 -136.85 150.64 48.4 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.438 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.568 HD21 ' HB2' ' A' ' 150' ' ' SER . 1.2 pt? -153.2 134.19 14.0 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.367 176.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.642 HG21 HD13 ' A' ' 190' ' ' LEU . 10.6 m -96.89 138.75 21.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 176.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.64 ' HD2' ' HB2' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -139.55 162.81 34.16 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.869 -173.403 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -71.0 132.76 45.64 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 121.089 -0.244 . . . . 0.0 110.343 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.472 ' HB2' HG13 ' A' ' 148' ' ' VAL . 41.3 t -77.11 136.68 38.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.357 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -100.39 -26.18 13.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.826 0.346 . . . . 0.0 110.163 176.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.1 t -72.49 -36.0 68.3 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 172.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 47.6 m-70 -121.41 81.51 38.64 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.018 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.94 123.49 13.92 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.524 2.149 . . . . 0.0 112.267 -178.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 107.32 -26.66 17.89 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.915 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -89.99 170.64 10.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.95 0.405 . . . . 0.0 110.518 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -122.13 153.56 38.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.825 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.517 ' CG2' ' HG3' ' A' ' 138' ' ' ARG . 21.9 m -127.86 137.47 57.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.105 0.479 . . . . 0.0 110.668 176.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.912 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -92.63 110.11 21.53 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.407 178.353 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.568 ' HB2' HD21 ' A' ' 136' ' ' LEU . 2.3 m -101.65 132.63 47.23 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.517 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.497 HG21 ' HB3' ' A' ' 210' ' ' LEU . 35.1 m -131.25 149.79 33.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.988 -174.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.437 ' HB2' ' HB3' ' A' ' 126' ' ' LEU . 41.6 ttt180 -96.38 104.7 16.69 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.289 0.566 . . . . 0.0 109.925 176.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.521 ' O ' ' HB3' ' A' ' 166' ' ' LYS . 5.0 p -101.51 147.32 26.52 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.877 -178.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.912 0 C-N-CA 119.942 -1.123 . . . . 0.0 112.05 -176.814 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 153' ' ' THR . 47.6 tptt . . . . . 0 N--CA 1.45 -0.466 0 CA-C-O 121.013 0.435 . . . . 0.0 111.073 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.546 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 70.6 t -124.68 114.42 40.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.267 173.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.72 HG21 HD11 ' A' ' 210' ' ' LEU . 18.6 m -98.96 137.51 37.39 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.965 175.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 150' ' ' SER . 21.1 m-70 -112.29 118.83 36.35 Favored 'General case' 0 C--O 1.211 -0.922 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.912 HG22 ' HB3' ' A' ' 149' ' ' LEU . 1.0 OUTLIER -99.02 138.05 24.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.362 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 171' ' ' MET . . . . . 0.407 ' SD ' HG12 ' A' ' 148' ' ' VAL . 44.6 tpp -85.56 120.11 26.65 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.723 0.297 . . . . 0.0 110.756 -175.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 32.4 mt -94.04 107.08 18.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.623 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 3.6 ptp180 -67.55 107.1 2.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.211 0.529 . . . . 0.0 110.034 -178.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' CYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 36.8 m -98.46 93.13 6.0 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.647 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -114.31 108.91 17.55 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.005 -176.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 58.93 46.29 13.91 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 123.446 0.466 . . . . 0.0 110.698 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 91.5 mt 64.58 21.98 12.55 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.589 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 174' ' ' CYS . 1.7 tppp? -106.89 137.92 44.04 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 175.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -119.14 132.78 56.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.768 0.318 . . . . 0.0 111.454 -172.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.623 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 10.5 t70 -156.0 139.35 15.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.201 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.596 ' HB ' ' CZ ' ' A' ' 197' ' ' TYR . 37.9 t -89.23 -16.19 8.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.853 0.835 . . . . 0.0 109.075 175.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' GLY . . . . . 0.562 ' HA2' ' NH1' ' A' ' 173' ' ' ARG . . . 123.36 10.23 5.64 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.163 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -136.61 140.27 11.34 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 119.943 -1.123 . . . . 0.0 113.676 -176.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 67.13 -148.99 50.82 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 121.286 -0.483 . . . . 0.0 113.184 175.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -79.31 145.08 33.68 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.546 -0.327 . . . . 0.0 110.517 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.415 ' HG2' ' HB2' ' A' ' 180' ' ' ASP . 79.0 mtt180 -85.55 133.21 34.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.972 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -108.18 149.88 27.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.329 0.585 . . . . 0.0 111.723 -173.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.448 ' OD1' ' HE2' ' A' ' 178' ' ' LYS . 3.2 m-20 -87.55 -15.28 37.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.984 -178.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.4 p -130.64 142.4 50.44 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.231 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.642 HD13 HG21 ' A' ' 137' ' ' VAL . 9.1 mt -71.47 -22.99 61.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.232 -175.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.484 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 18.0 m -61.74 -43.52 98.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.018 0.437 . . . . 0.0 110.321 177.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -72.98 -32.92 65.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.932 177.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.487 HD11 HG23 ' A' ' 181' ' ' VAL . 3.2 tm? -61.02 -54.44 44.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.294 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 26.9 m -66.78 -43.08 90.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.629 -173.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.489 ' HA ' ' HE2' ' A' ' 198' ' ' LYS . 9.5 mt-10 -70.08 -30.46 67.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.511 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -59.02 -41.89 88.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.716 0.294 . . . . 0.0 110.498 176.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.596 ' CZ ' ' HB ' ' A' ' 181' ' ' VAL . 69.1 m-85 -86.15 -7.16 58.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.834 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.489 ' HE2' ' HA ' ' A' ' 195' ' ' GLU . 40.8 mtmt -69.27 -32.53 71.76 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 170.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.409 ' O ' ' HD3' ' A' ' 201' ' ' PRO . 1.9 tppp? -92.28 -36.2 13.34 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.856 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -111.57 96.28 31.42 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.229 -178.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 199' ' ' LYS . 25.3 Cg_exo -62.34 126.96 19.68 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.648 2.232 . . . . 0.0 112.001 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' MET . . . . . 0.662 ' HB2' HG23 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -89.1 118.11 28.58 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.07 0.462 . . . . 0.0 110.356 179.125 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.577 HG22 ' HB ' ' A' ' 209' ' ' VAL . 51.7 t -96.6 129.89 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.72 -175.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.613 ' HB2' ' O ' ' A' ' 208' ' ' THR . 2.4 mm-40 -78.63 159.98 27.79 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.668 0.747 . . . . 0.0 112.83 168.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.568 ' HB ' HG21 ' B' ' 4' ' ' VAL . 4.1 t -72.94 -10.96 60.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.024 177.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 206' ' ' LEU . 5.3 mp -88.88 -2.28 58.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.968 177.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 96.98 -26.65 21.7 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.212 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.613 ' O ' ' HB2' ' A' ' 204' ' ' GLU . 99.0 m -60.44 111.23 1.49 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.999 0.428 . . . . 0.0 110.207 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.577 ' HB ' HG22 ' A' ' 203' ' ' VAL . 0.8 OUTLIER -112.08 127.66 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-O 121.57 0.7 . . . . 0.0 110.287 175.146 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.72 HD11 HG21 ' A' ' 168' ' ' THR . 0.4 OUTLIER -82.55 111.03 18.17 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.783 -170.553 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -96.15 91.23 5.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.412 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.492 HD22 ' HB2' ' A' ' 197' ' ' TYR . 7.1 mp -74.81 109.83 8.6 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.983 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -114.58 -57.12 2.31 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.63 -0.428 . . . . 0.0 112.154 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.528 ' O ' ' HA ' ' A' ' 134' ' ' SER . 4.6 pm0 -133.16 142.83 45.88 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 121.099 0.476 . . . . 0.0 111.196 -176.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.477 ' HB3' ' HB3' ' A' ' 112' ' ' TRP . 74.5 Cg_endo -74.12 135.67 21.22 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.923 2.415 . . . . 0.0 112.479 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.533 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.4 OUTLIER -71.09 114.37 9.08 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.056 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -52.18 131.57 32.5 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 123.621 0.576 . . . . 0.0 110.863 -178.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 111' ' ' ARG . 18.1 p -73.49 107.9 6.04 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.064 0.459 . . . . 0.0 110.918 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 6.1 t . . . . . 0 C--N 1.317 -0.826 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.849 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.502 ' HA ' ' OE1' ' A' ' 204' ' ' GLU . . . . . . . . 0 C--O 1.233 0.228 0 CA-C-O 121.48 0.657 . . . . 0.0 111.292 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 13.3 m -69.35 -44.02 72.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.171 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.662 HG23 ' HB2' ' A' ' 202' ' ' MET . 15.5 mm 75.27 103.55 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 123.206 0.602 . . . . 0.0 111.398 175.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.568 HG21 ' HB ' ' A' ' 205' ' ' THR . 2.8 m . . . . . 0 C--N 1.323 -0.565 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.508 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo . . . . . 0 CA--C 1.515 -0.437 0 CA-C-O 122.124 0.802 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.614 ' HB ' ' CD1' ' A' ' 113' ' ' PHE . 40.6 p -92.49 6.79 45.82 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.079 -1.419 . . . . 0.0 111.121 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.7 t -75.31 52.7 0.62 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.521 0.676 . . . . 0.0 110.588 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.477 ' HG3' ' CZ2' ' A' ' 112' ' ' TRP . 65.3 mm-40 -130.92 169.6 15.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.292 -177.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.423 ' O ' HG23 ' A' ' 218' ' ' THR . 18.7 mmt180 -83.67 -11.61 57.0 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -170.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.518 ' HE3' HG22 ' A' ' 137' ' ' VAL . 1.5 p-90 -92.96 -12.04 31.77 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.054 177.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.614 ' CD1' ' HB ' ' A' ' 108' ' ' THR . 57.5 t80 -84.69 119.5 25.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.385 0.612 . . . . 0.0 110.843 174.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -111.94 117.03 31.61 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -65.11 -66.57 2.39 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.739 -0.664 . . . . 0.0 113.261 -174.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -100.23 104.99 16.52 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.288 0.566 . . . . 0.0 111.34 -175.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 17.4 mt -154.56 130.74 10.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.598 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 68.3 p -84.03 173.06 11.45 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 172.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.73 -49.84 63.82 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.65 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.0 mmtm -61.24 -45.64 93.69 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 123.942 0.436 . . . . 0.0 111.526 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -66.79 -47.22 72.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.677 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.488 ' HB3' ' NH1' ' A' ' 138' ' ' ARG . . . -63.85 -33.87 76.65 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.088 0.47 . . . . 0.0 110.771 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.537 ' HG3' ' HB ' ' A' ' 167' ' ' VAL . 9.1 tt0 -67.26 -46.43 73.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.426 176.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -60.76 -33.25 72.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.757 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.581 HD12 HD13 ' A' ' 216' ' ' LEU . 0.5 OUTLIER -55.69 -52.32 64.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.178 0.514 . . . . 0.0 110.154 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.571 ' CD2' HD12 ' A' ' 216' ' ' LEU . 42.5 mt -75.62 -47.29 27.15 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.5 m -64.18 -33.29 75.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.294 -172.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -96.99 -53.28 3.56 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -91.35 -31.97 15.86 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -171.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -86.95 -163.27 38.61 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.191 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.518 ' C ' ' HD3' ' A' ' 152' ' ' ARG . 0.5 OUTLIER -146.4 174.41 11.4 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 177.813 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -50.86 120.25 4.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.85 0.357 . . . . 0.0 110.937 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.462 ' HA3' ' HD3' ' A' ' 213' ' ' LYS . . . 98.39 -4.51 60.21 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.199 178.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.628 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 66.9 m -72.84 138.51 46.38 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 176.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.448 ' CB ' HG12 ' A' ' 151' ' ' VAL . 49.4 p90 -136.63 149.12 47.82 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.986 0.422 . . . . 0.0 110.62 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.558 ' CD2' ' HB3' ' A' ' 150' ' ' SER . 1.2 pt? -149.99 136.66 19.21 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.655 HG21 HD13 ' A' ' 190' ' ' LEU . 16.2 m -99.5 133.96 40.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.488 ' NH1' ' HB3' ' A' ' 122' ' ' ALA . 10.7 ptt-85 -129.81 172.09 12.02 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -178.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -76.98 127.27 32.4 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.416 ' HB2' HG23 ' A' ' 148' ' ' VAL . 46.2 t -69.55 133.3 47.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.39 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -96.19 -26.03 15.6 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.552 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 41.6 m -81.0 -25.67 37.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.924 0.393 . . . . 0.0 109.94 174.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -126.04 87.23 56.45 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.983 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.0 124.18 15.11 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.342 2.028 . . . . 0.0 111.255 176.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.529 ' O ' ' HB3' ' A' ' 174' ' ' CYS . . . 101.77 -10.44 57.38 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.079 -177.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -114.36 171.9 7.34 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.405 ' CE1' ' HE2' ' A' ' 179' ' ' TYR . 96.6 m-85 -125.8 163.99 21.66 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.832 0.349 . . . . 0.0 110.347 -177.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 4.7 t -125.37 127.27 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.923 -177.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.893 ' HB3' HG22 ' A' ' 170' ' ' VAL . 1.2 tp -91.46 109.36 20.65 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.558 ' HB3' ' CD2' ' A' ' 136' ' ' LEU . 40.3 t -101.89 124.88 48.27 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.541 HG21 ' HB3' ' A' ' 210' ' ' LEU . 34.8 m -128.28 142.95 42.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.829 -173.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.518 ' HD3' ' C ' ' A' ' 131' ' ' LYS . 73.2 ttt180 -90.04 103.14 15.84 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.369 0.604 . . . . 0.0 109.688 176.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.504 HG21 HD12 ' A' ' 210' ' ' LEU . 1.5 p -107.42 148.62 28.89 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.799 -1.092 . . . . 0.0 110.162 -177.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.088 0 C-N-CA 119.67 -1.252 . . . . 0.0 111.21 -175.697 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm . . . . . 0 N--CA 1.442 -0.834 0 CA-C-O 121.262 0.554 . . . . 0.0 111.893 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.537 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 69.8 t -120.84 113.76 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.768 169.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.771 HG21 HD11 ' A' ' 210' ' ' LEU . 21.6 m -90.2 140.65 29.47 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.462 172.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -118.47 116.4 26.6 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.893 HG22 ' HB3' ' A' ' 149' ' ' LEU . 0.8 OUTLIER -98.53 138.95 21.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -177.143 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 38.8 tpp -84.91 116.51 23.38 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.995 0.426 . . . . 0.0 110.792 -175.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.567 HD13 HD21 ' A' ' 190' ' ' LEU . 24.5 mt -97.4 108.12 21.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.184 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.682 ' O ' ' HA ' ' A' ' 179' ' ' TYR . 77.3 mtm180 -65.56 123.24 19.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.487 176.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' CYS . . . . . 0.529 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 48.3 t -116.82 91.6 3.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.459 0.647 . . . . 0.0 109.562 174.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -114.51 114.53 25.91 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.235 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 57.16 45.12 21.19 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.661 0.601 . . . . 0.0 111.116 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 95.7 mt 63.79 22.57 13.11 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.943 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -113.43 132.24 55.71 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 172.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.682 ' HA ' ' O ' ' A' ' 173' ' ' ARG . 71.1 m-85 -110.16 137.57 47.73 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.206 -173.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -152.91 127.35 9.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.121 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.44 HG23 HD11 ' A' ' 193' ' ' LEU . 3.1 t -77.58 -0.64 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-O 121.707 0.765 . . . . 0.0 111.567 -176.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 124.99 -19.44 6.89 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.067 177.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -137.56 159.6 24.92 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 121.024 -0.607 . . . . 0.0 112.032 177.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 89.32 -135.31 12.9 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.055 175.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -116.06 145.03 43.33 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.56 0.219 . . . . 0.0 110.831 -176.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -75.69 128.79 35.96 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 175.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -105.92 144.04 33.22 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.808 0.337 . . . . 0.0 110.725 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -76.01 -9.81 58.91 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.752 -174.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 35.4 p -140.74 143.9 35.24 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.655 HD13 HG21 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -67.35 -23.08 65.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.914 179.674 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.49 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 13.9 m -61.1 -49.01 79.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.355 175.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -65.63 -30.88 71.65 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.833 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.456 ' HB3' HD23 ' A' ' 190' ' ' LEU . 3.3 tm? -64.32 -54.78 27.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.404 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 27.8 m -70.19 -42.21 79.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.558 -174.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -61.42 -39.11 89.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.91 0.386 . . . . 0.0 111.051 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -59.99 -42.27 93.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.823 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.501 ' HB2' HD22 ' A' ' 212' ' ' LEU . 36.6 m-85 -85.24 -13.59 49.37 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.124 0.488 . . . . 0.0 110.951 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -74.2 -27.3 60.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.446 0.641 . . . . 0.0 109.351 176.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -88.79 -36.5 16.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.477 175.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -119.92 105.33 42.98 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.425 -176.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.28 128.96 32.68 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.884 2.389 . . . . 0.0 112.474 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' MET . . . . . 0.784 ' SD ' HD23 ' A' ' 210' ' ' LEU . 7.4 ptp -89.6 122.81 33.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.261 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.595 HG22 ' HB ' ' A' ' 209' ' ' VAL . 44.7 t -101.53 139.8 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 120.703 0.287 . . . . 0.0 111.59 -176.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.497 ' O ' HG12 ' A' ' 203' ' ' VAL . 25.6 mt-10 -89.22 162.35 15.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.37 . . . . 0.0 110.245 170.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.429 ' HB ' HG11 ' B' ' 4' ' ' VAL . 14.9 t -74.08 -11.91 60.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.324 0.583 . . . . 0.0 110.024 177.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.434 HD12 ' N ' ' A' ' 206' ' ' LEU . 5.0 mp -83.98 -8.31 59.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.018 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 101.04 -18.89 53.93 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.007 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 58.9 m -65.65 111.76 3.33 Favored 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 175.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.595 ' HB ' HG22 ' A' ' 203' ' ' VAL . 0.9 OUTLIER -112.22 126.99 69.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.6 0.714 . . . . 0.0 110.348 173.68 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.784 HD23 ' SD ' ' A' ' 202' ' ' MET . 0.4 OUTLIER -82.03 110.06 16.93 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.336 -172.188 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -85.17 89.51 7.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.584 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.501 HD22 ' HB2' ' A' ' 197' ' ' TYR . 8.2 mp -77.87 99.19 5.88 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 175.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.462 ' HD3' ' HA3' ' A' ' 133' ' ' GLY . 28.6 mtpp -109.61 -48.84 3.17 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.141 -173.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.628 ' O ' ' HA ' ' A' ' 134' ' ' SER . 0.4 OUTLIER -147.45 147.19 27.33 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 121.081 0.467 . . . . 0.0 111.007 178.006 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.458 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 93.0 Cg_endo -78.39 147.27 22.69 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.958 2.439 . . . . 0.0 113.222 -175.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.581 HD13 HD12 ' A' ' 125' ' ' LEU . 0.3 OUTLIER -83.86 109.88 17.92 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.726 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -56.55 145.98 26.42 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.43 0.456 . . . . 0.0 111.29 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 111' ' ' ARG . 4.8 p -82.13 136.02 35.22 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.58 -177.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.319 -0.743 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.288 173.603 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.588 ' HB2' ' CG2' ' A' ' 168' ' ' THR . . . . . . . . 0 C--O 1.231 0.096 0 CA-C-O 121.505 0.669 . . . . 0.0 112.384 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 46.2 m -76.02 -49.44 17.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.176 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.576 HD12 ' SD ' ' A' ' 202' ' ' MET . 8.0 mm 73.32 94.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 123.244 0.617 . . . . 0.0 110.732 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.429 HG11 ' HB ' ' A' ' 205' ' ' THR . 13.8 m . . . . . 0 C--N 1.32 -0.678 0 CA-C-O 121.624 0.726 . . . . 0.0 109.991 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.838 0 N-CA-C 112.058 -0.417 . . . . 0.0 112.058 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.45 -33.12 23.83 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.872 2.381 . . . . 0.0 112.815 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 58.5 ttp -76.21 -31.72 58.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.198 0.523 . . . . 0.0 109.9 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.91 82.66 8.05 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.346 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.409 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 5.4 m-20 -62.77 129.94 93.4 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.728 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 6.0 Cg_exo -75.43 -7.26 18.63 Favored 'Trans proline' 0 CA--C 1.516 -0.38 0 C-N-CA 122.636 2.224 . . . . 0.0 110.275 177.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.6 ' HB ' ' CG ' ' A' ' 113' ' ' PHE . 35.7 p -100.27 5.58 44.59 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.21 -176.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.8 m -75.26 58.73 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.515 0.674 . . . . 0.0 110.579 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.511 ' HG3' ' CZ2' ' A' ' 112' ' ' TRP . 81.5 mm-40 -129.65 -178.5 4.72 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.821 -176.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -84.71 -26.0 27.98 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -174.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.541 ' CZ2' ' HA ' ' A' ' 191' ' ' THR . 0.7 OUTLIER -85.71 -19.63 30.56 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -177.729 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.6 ' CG ' ' HB ' ' A' ' 108' ' ' THR . 72.2 t80 -81.45 123.76 28.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.012 0.434 . . . . 0.0 110.551 175.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -110.52 139.57 45.64 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.62 -88.87 0.03 OUTLIER Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.94 -0.648 . . . . 0.0 113.528 -174.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -100.52 106.63 18.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.03 0.443 . . . . 0.0 111.439 -175.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 64.0 mt -143.45 135.89 27.18 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.789 175.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.6 p -93.69 174.41 7.19 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -50.23 -54.3 20.17 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 121.558 -0.353 . . . . 0.0 113.856 -174.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 60.7 mmtt -77.99 -25.33 48.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 117.27 0.535 . . . . 0.0 111.87 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -65.33 -44.71 86.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.801 0.334 . . . . 0.0 110.627 175.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.553 ' HB2' ' HD3' ' A' ' 138' ' ' ARG . . . -64.11 -34.01 77.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.325 0.583 . . . . 0.0 110.494 176.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.546 ' HG3' ' HB ' ' A' ' 167' ' ' VAL . 16.3 tt0 -69.68 -48.36 59.99 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.962 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -56.47 -35.78 68.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.325 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.64 -51.52 69.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.273 177.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.549 ' CD2' HD12 ' A' ' 216' ' ' LEU . 27.7 mt -74.63 -46.41 38.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.687 -177.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.6 m -67.64 -33.01 74.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.029 -173.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -95.83 -48.27 5.81 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -100.14 -25.65 14.21 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -171.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -89.53 -159.75 35.76 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.573 -177.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -153.1 175.16 13.31 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -55.31 121.0 7.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.876 0.37 . . . . 0.0 111.275 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 99.54 -3.35 57.71 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.765 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 56.4 m -74.39 140.25 44.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.646 0.26 . . . . 0.0 110.503 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.508 ' CB ' HG12 ' A' ' 151' ' ' VAL . 52.3 p90 -137.45 149.02 46.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.165 177.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.534 HD21 ' HB2' ' A' ' 150' ' ' SER . 1.1 pt? -148.91 139.51 22.63 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 175.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.747 HG21 HD13 ' A' ' 190' ' ' LEU . 10.1 m -104.23 145.04 13.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.553 ' HD3' ' HB2' ' A' ' 122' ' ' ALA . 26.4 ptt85 -146.29 168.21 21.63 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.867 -178.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -76.74 131.41 38.72 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 123.247 0.342 . . . . 0.0 110.63 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.6 t -72.39 137.12 46.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.522 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -98.02 -28.78 13.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.845 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 39.0 m -78.8 -34.1 45.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.027 0.442 . . . . 0.0 109.862 175.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -117.82 78.04 12.11 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.876 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.26 123.1 12.16 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.088 1.859 . . . . 0.0 111.72 -177.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 113.97 -16.68 20.46 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.608 -176.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -109.37 171.68 7.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.06 0.457 . . . . 0.0 110.29 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -123.45 163.6 20.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.604 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 33.3 m -134.11 143.05 39.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.152 0.501 . . . . 0.0 111.401 177.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.907 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -101.86 111.09 23.22 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.225 177.516 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.573 ' HA ' ' HA ' ' A' ' 169' ' ' HIS . 1.2 m -104.17 131.71 51.18 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.592 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' A' ' 210' ' ' LEU . 32.7 m -130.57 152.08 36.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.456 -174.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.403 ' HB2' ' HB3' ' A' ' 126' ' ' LEU . 56.7 ttt180 -100.43 103.8 15.18 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.109 177.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 32.4 p -99.72 147.36 25.52 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.54 -177.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 75.57 161.82 10.52 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.15 -176.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.529 ' OD2' ' HE2' ' A' ' 157' ' ' LYS . 20.7 t70 -105.02 152.88 22.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.774 0.321 . . . . 0.0 110.908 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -90.03 -6.55 55.44 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -172.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.529 ' HE2' ' OD2' ' A' ' 155' ' ' ASP . 3.5 mppt? -91.15 -1.96 57.63 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.881 0.372 . . . . 0.0 110.925 178.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 161' ' ' ASN . . . 89.28 36.36 7.6 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.473 174.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -109.39 18.34 20.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.664 0.745 . . . . 0.0 110.37 174.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 21.5 m -154.11 -48.84 0.09 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.909 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.47 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 3.8 p-10 -149.46 165.44 32.13 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.753 176.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -110.55 163.53 13.62 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 82.12 58.39 2.48 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -175.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm 55.31 -167.15 0.1 Allowed 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 122.949 0.5 . . . . 0.0 111.176 -173.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 48.1 m -79.68 166.8 21.45 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.229 176.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.68 121.73 41.66 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.98 -175.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.546 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 56.1 t -100.01 133.32 43.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.364 0.602 . . . . 0.0 111.724 -177.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.65 HG21 HD11 ' A' ' 210' ' ' LEU . 1.1 m -119.18 141.41 48.89 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.763 171.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.656 ' CD2' ' HA ' ' B' ' -2' ' ' THR . 13.4 m-70 -108.24 138.17 44.97 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.907 HG22 ' HB3' ' A' ' 149' ' ' LEU . 1.2 m -114.35 138.62 43.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.513 ' HB2' ' HB2' ' B' ' 0' ' ' PTR . 41.2 tpp -81.91 126.71 32.23 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.878 0.37 . . . . 0.0 111.213 -178.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.514 HD13 HD21 ' A' ' 190' ' ' LEU . 32.6 mt -104.9 107.43 22.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 175.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.604 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 4.7 ptp180 -70.44 119.35 14.48 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.023 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.672 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 49.7 t -118.11 93.36 4.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.165 0.507 . . . . 0.0 110.469 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -116.62 125.65 52.11 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.769 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 57.18 39.15 29.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.9 -176.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 82.9 mt 63.16 31.75 15.49 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.324 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.672 ' O ' ' HA ' ' A' ' 174' ' ' CYS . 11.9 tppt? -110.99 132.23 54.39 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.471 ' CD2' ' HG ' ' A' ' 190' ' ' LEU . 81.8 m-85 -111.83 135.09 52.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.585 0.231 . . . . 0.0 111.176 -174.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.604 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 18.4 t0 -157.32 136.39 11.77 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.5 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.535 ' HB ' ' CZ ' ' A' ' 197' ' ' TYR . 56.0 t -90.65 -14.21 8.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.77 0.795 . . . . 0.0 109.031 174.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLY . . . . . 0.541 ' HA2' ' NH1' ' A' ' 173' ' ' ARG . . . 123.57 5.56 7.7 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.248 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -137.21 141.24 12.11 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.662 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 71.78 -158.45 53.47 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.241 -0.504 . . . . 0.0 113.083 174.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -74.08 150.73 40.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.894 0.378 . . . . 0.0 110.738 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 186' ' ' ARG . 54.2 mtt180 -99.26 132.89 44.27 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.67 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -110.9 150.56 29.02 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.138 -171.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -88.62 0.39 56.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.17 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.51 141.84 50.49 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.656 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.747 HD13 HG21 ' A' ' 137' ' ' VAL . 1.0 OUTLIER -77.28 -22.86 51.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.045 -175.476 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.541 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 16.4 m -61.97 -44.15 97.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.004 0.431 . . . . 0.0 110.275 177.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -66.41 -34.17 77.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.328 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.503 HD11 HG23 ' A' ' 181' ' ' VAL . 3.2 tm? -62.27 -54.64 37.77 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.199 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 27.2 m -66.39 -39.91 85.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.267 -175.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 191' ' ' THR . 27.8 mt-10 -68.17 -31.7 71.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.274 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -59.15 -47.26 85.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.087 0.47 . . . . 0.0 110.243 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.641 ' HB2' HD22 ' A' ' 212' ' ' LEU . 76.3 m-85 -85.73 -8.85 57.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.762 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.416 ' HA ' ' HB2' ' A' ' 212' ' ' LEU . 39.4 ttpt -70.95 -23.74 62.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.67 175.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -105.74 -22.85 12.86 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.564 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -126.42 89.0 53.22 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.523 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.69 132.29 51.22 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.236 2.624 . . . . 0.0 112.799 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' MET . . . . . 0.516 ' HB2' HG23 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -97.48 137.31 36.63 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.066 179.725 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.621 HG22 ' HB ' ' A' ' 209' ' ' VAL . 36.3 t -108.39 137.11 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -169.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.547 ' O ' HG12 ' A' ' 203' ' ' VAL . 27.4 mt-10 -81.71 163.99 22.08 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.817 0.341 . . . . 0.0 110.182 169.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.0 t -76.29 -10.62 59.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.796 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.9 mp -90.95 -1.23 57.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.452 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 103.89 -23.72 31.57 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.471 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 23.2 m -60.77 111.33 1.59 Allowed 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 120.882 0.372 . . . . 0.0 110.307 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.621 ' HB ' HG22 ' A' ' 203' ' ' VAL . 1.1 p -112.58 128.66 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-O 121.826 0.822 . . . . 0.0 110.833 175.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.65 HD11 HG21 ' A' ' 168' ' ' THR . 0.3 OUTLIER -81.55 105.31 12.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 113.987 -1.46 . . . . 0.0 110.219 -170.849 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -93.89 90.47 6.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.637 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.641 HD22 ' HB2' ' A' ' 197' ' ' TYR . 6.8 mp -73.85 106.65 5.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.768 178.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -114.6 -55.96 2.43 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.633 ' O ' ' HA ' ' A' ' 134' ' ' SER . 0.7 OUTLIER -134.46 142.22 41.98 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 121.076 0.465 . . . . 0.0 111.179 -179.139 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.413 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 78.7 Cg_endo -76.38 142.24 23.63 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.951 2.434 . . . . 0.0 112.963 -175.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.549 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.3 OUTLIER -76.6 110.06 10.85 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 175.667 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -57.58 139.67 52.92 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 123.384 0.428 . . . . 0.0 111.103 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 13.4 p -71.99 108.0 5.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.498 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 3.6 t -81.96 105.49 13.12 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.68 0.753 . . . . 0.0 109.92 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 . . . . . 0 C--O 1.247 0.923 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.024 -176.935 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' -4' ' ' GLU . . . . . 0.432 ' HB3' ' H ' ' B' ' -3' ' ' GLN . 12.8 mm-40 . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 111.558 0.207 . . . . 0.0 111.558 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' -3' ' ' GLN . . . . . 0.432 ' H ' ' HB3' ' B' ' -4' ' ' GLU . 9.7 mm100 -57.16 112.34 1.34 Allowed 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.273 0.358 . . . . 0.0 110.631 -175.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' -2' ' ' THR . . . . . 0.656 ' HA ' ' CD2' ' A' ' 169' ' ' HIS . 7.2 m 47.76 -113.89 0.55 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -165.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' -1' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 70.69 -35.37 0.32 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 167.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 0' ' ' PTR . . . . . 0.513 ' HB2' ' HB2' ' A' ' 171' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.481 ' HA ' ' OE1' ' A' ' 204' ' ' GLU . . . 57.46 146.48 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 O-C-N 125.005 1.44 . . . . 0.0 113.702 168.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.52 -44.58 28.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.283 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.516 HG23 ' HB2' ' A' ' 202' ' ' MET . 4.2 mm 55.36 73.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.566 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.42 ' O ' ' HD3' ' B' ' 6' ' ' PRO . 2.3 m -101.03 97.76 6.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.591 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' PHE . . . . . 0.449 ' CE2' HG22 ' B' ' 3' ' ' ILE . 93.3 m-85 -76.55 108.71 6.87 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.848 173.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' B' ' 4' ' ' VAL . 1.7 Cg_endo . . . . . 0 C--O 1.251 1.134 0 C-N-CA 122.354 2.036 . . . . 0.0 111.466 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.793 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.33 -23.62 65.44 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.777 2.318 . . . . 0.0 112.758 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.7 tpt -104.21 74.29 1.18 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.505 0.669 . . . . 0.0 109.929 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.23 83.81 5.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.414 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -65.1 110.72 4.58 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.188 0.518 . . . . 0.0 110.494 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.49 ' HB2' ' H ' ' A' ' 190' ' ' LEU . 84.2 Cg_endo -78.21 -9.28 16.48 Favored 'Trans proline' 0 CA--C 1.517 -0.365 0 C-N-CA 123.399 2.732 . . . . 0.0 111.964 -174.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.714 ' HB ' ' CG ' ' A' ' 113' ' ' PHE . 34.7 p -100.19 7.85 44.23 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.562 -171.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 26.7 m -74.68 49.12 0.39 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.169 0.509 . . . . 0.0 110.939 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.407 ' HG3' ' CZ2' ' A' ' 112' ' ' TRP . 70.4 mm-40 -127.04 174.11 9.13 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.662 -176.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -79.55 -20.05 47.99 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -173.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.503 ' HB3' ' CB ' ' A' ' 215' ' ' PRO . 1.8 p-90 -85.95 -19.81 29.89 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.875 -178.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.714 ' CG ' ' HB ' ' A' ' 108' ' ' THR . 75.4 t80 -77.92 124.67 28.29 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.151 0.5 . . . . 0.0 110.707 175.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -122.11 107.04 11.72 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -51.84 -72.09 0.56 Allowed Glycine 0 CA--C 1.519 0.307 0 N-CA-C 114.744 0.657 . . . . 0.0 114.744 -167.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -100.29 86.34 3.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.347 0.594 . . . . 0.0 112.156 -173.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.475 ' O ' ' HD2' ' A' ' 138' ' ' ARG . 33.1 mt -133.38 133.27 42.22 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.165 175.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 35.4 t -93.6 172.76 8.06 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 168.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 123' ' ' GLU . . . -51.77 -44.27 54.88 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.245 -0.502 . . . . 0.0 112.797 -177.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.408 ' HD3' ' N ' ' A' ' 120' ' ' LYS . 3.1 mppt? -69.36 -35.03 75.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.959 0.409 . . . . 0.0 110.607 -175.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -72.61 -47.26 49.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.402 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.492 ' HB2' ' HD3' ' A' ' 138' ' ' ARG . . . -62.56 -34.06 76.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.431 177.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.505 ' HG3' ' HB ' ' A' ' 167' ' ' VAL . 3.7 tt0 -65.36 -50.33 65.97 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.694 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -58.94 -36.22 74.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.418 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.475 HD12 HD13 ' A' ' 216' ' ' LEU . 0.7 OUTLIER -58.48 -53.66 55.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.768 178.368 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.542 ' CD2' HD12 ' A' ' 216' ' ' LEU . 61.3 mt -75.39 -48.44 22.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.759 -176.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.46 HG23 ' HB2' ' A' ' 165' ' ' SER . 5.7 m -61.9 -32.78 73.19 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.192 -172.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -97.44 -53.87 3.32 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.406 ' CD ' HG21 ' A' ' 219' ' ' THR . 96.9 mttt -91.58 -23.37 19.91 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -169.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -93.32 -160.24 35.2 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.057 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -152.3 175.73 12.35 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 175.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -58.54 125.15 22.18 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 177.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.505 ' HA2' ' O ' ' A' ' 211' ' ' GLN . . . 103.72 -10.98 53.22 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.113 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.708 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 27.8 m -78.65 139.59 38.51 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.658 0.266 . . . . 0.0 110.376 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.527 ' CB ' HG12 ' A' ' 151' ' ' VAL . 44.9 p90 -137.02 150.38 48.06 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.409 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.5 ' CD2' ' HB2' ' A' ' 150' ' ' SER . 1.1 pt? -149.04 136.41 20.17 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.697 HG21 HD13 ' A' ' 190' ' ' LEU . 5.6 m -100.42 139.99 20.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.547 178.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.492 ' HD3' ' HB2' ' A' ' 122' ' ' ALA . 17.6 ptt85 -141.8 167.73 21.45 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.459 -176.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -80.63 133.79 35.79 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.496 ' HB2' HG13 ' A' ' 148' ' ' VAL . 39.2 t -76.14 139.13 41.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.934 0.397 . . . . 0.0 110.048 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -99.87 -18.01 17.35 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.669 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.637 ' HG ' ' HE2' ' B' ' 0' ' ' PTR . 51.4 p -84.93 -26.67 27.08 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 171.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -123.34 78.63 53.51 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.178 176.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.97 124.55 15.94 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.869 2.379 . . . . 0.0 112.303 -178.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 106.79 -16.85 39.61 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.012 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -106.98 157.24 17.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.896 0.379 . . . . 0.0 110.351 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -110.58 158.64 18.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.657 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.551 HG11 ' CE1' ' B' ' 0' ' ' PTR . 35.1 m -136.47 139.36 45.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.339 0.59 . . . . 0.0 111.383 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.968 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -95.09 110.54 22.46 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.817 176.23 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.5 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 2.4 m -101.89 130.68 48.44 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.269 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.527 HG12 ' CB ' ' A' ' 135' ' ' PHE . 33.5 m -129.26 150.3 34.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.679 -174.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.402 ' HB2' ' HB3' ' A' ' 126' ' ' LEU . 70.0 ttt180 -93.04 102.4 14.74 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.425 0.631 . . . . 0.0 109.506 175.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.504 HG21 ' HA ' ' A' ' 210' ' ' LEU . 0.9 OUTLIER -115.0 97.78 6.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.722 178.758 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.465 ' HA2' ' HB2' ' A' ' 160' ' ' SER . . . 139.7 142.1 4.17 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -176.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.539 ' HB2' ' HB2' ' A' ' 159' ' ' GLU . 0.7 OUTLIER -104.82 146.17 29.35 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.38 0.609 . . . . 0.0 112.052 -172.621 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -72.49 4.21 4.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.576 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -99.57 12.83 35.42 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.781 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 88.12 38.23 7.41 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.908 176.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 155' ' ' ASP . 37.5 mt-10 -120.92 131.12 54.17 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.465 ' HB2' ' HA2' ' A' ' 154' ' ' GLY . 49.1 m 70.62 8.09 6.45 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 123.937 0.773 . . . . 0.0 111.178 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -171.37 163.64 6.96 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -81.02 79.09 7.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.941 0.4 . . . . 0.0 111.394 -176.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 92.63 -52.48 2.67 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 121.116 -0.564 . . . . 0.0 113.286 172.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -92.45 174.12 7.45 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.751 0.31 . . . . 0.0 110.791 -175.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.46 ' HB2' HG23 ' A' ' 127' ' ' THR . 19.4 m -76.03 169.11 18.79 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.447 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.502 ' HB3' ' O ' ' A' ' 153' ' ' THR . 0.0 OUTLIER -131.23 142.26 50.14 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.267 -176.667 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.505 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 60.1 t -123.39 115.98 47.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 121.086 0.469 . . . . 0.0 111.323 176.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.715 HG21 HD11 ' A' ' 210' ' ' LEU . 4.1 m -92.86 140.73 29.19 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.049 172.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.699 ' O ' ' HA ' ' B' ' 0' ' ' PTR . 37.8 m-70 -114.78 119.72 37.61 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.968 HG22 ' HB3' ' A' ' 149' ' ' LEU . 0.8 OUTLIER -98.4 140.14 18.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -177.028 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 40.2 tpp -87.02 117.88 26.03 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.253 -177.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.542 HD13 HD21 ' A' ' 190' ' ' LEU . 20.7 mt -97.02 107.04 19.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 175.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.567 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 17.9 ptp180 -69.16 122.42 18.76 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.917 0.389 . . . . 0.0 110.0 -177.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 49.5 t -113.88 93.42 4.36 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.805 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -125.92 122.4 35.9 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.158 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 58.63 41.75 21.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.124 -178.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.0 mt 60.49 45.42 10.77 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.165 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 174' ' ' CYS . 10.9 tppt? -131.46 139.11 49.29 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -116.04 129.95 56.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.585 0.231 . . . . 0.0 110.783 -175.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.567 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 13.8 t0 -157.01 129.25 7.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.79 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.557 ' HB ' ' CZ ' ' A' ' 197' ' ' TYR . 31.0 t -83.91 -12.27 11.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.773 0.797 . . . . 0.0 109.312 176.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 122.76 9.02 6.5 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.388 176.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.611 ' HA3' ' CE2' ' B' ' 5' ' ' PHE . . . -137.88 140.48 11.26 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.138 -1.029 . . . . 0.0 113.738 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 71.59 -154.8 51.74 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.266 -0.492 . . . . 0.0 112.998 174.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -73.97 142.73 45.84 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.64 0.257 . . . . 0.0 110.364 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -88.0 132.71 34.16 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -106.88 156.44 18.69 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.226 0.536 . . . . 0.0 112.019 -169.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -94.34 -11.52 29.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.24 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.6 m -129.4 142.71 50.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.123 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.697 HD13 HG21 ' A' ' 137' ' ' VAL . 0.9 OUTLIER -72.81 -22.71 60.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.28 -175.4 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 5.8 m -61.82 -46.23 90.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.894 0.378 . . . . 0.0 110.53 177.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -64.72 -34.17 77.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.057 178.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.502 HD11 HG23 ' A' ' 181' ' ' VAL . 3.1 tm? -60.25 -54.28 47.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.298 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 30.8 m -68.62 -43.75 83.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.934 -175.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -59.2 -35.57 73.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.001 0.429 . . . . 0.0 111.232 177.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -62.4 -45.28 93.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.102 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.557 ' CZ ' ' HB ' ' A' ' 181' ' ' VAL . 59.8 m-85 -85.76 -10.36 55.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.948 0.404 . . . . 0.0 111.448 -176.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.443 ' HD2' ' CZ ' ' A' ' 135' ' ' PHE . 47.0 mtpt -70.86 -34.81 72.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.155 0.502 . . . . 0.0 109.865 170.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 14.1 tptt -88.85 -36.17 16.16 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.036 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -113.49 101.57 53.8 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.432 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.28 126.17 21.62 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.845 2.363 . . . . 0.0 112.77 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' MET . . . . . 0.755 ' SD ' HG11 ' A' ' 170' ' ' VAL . 14.3 ptp -89.31 141.81 28.22 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 175.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.558 HG22 HG22 ' A' ' 209' ' ' VAL . 11.2 t -124.8 139.51 50.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.998 -173.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.671 ' HG2' ' HB1' ' B' ' 1' ' ' ALA . 26.0 mt-10 -82.01 161.24 23.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.898 171.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.3 t -74.32 -9.85 59.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.235 0.54 . . . . 0.0 110.006 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.5 mp -89.68 4.38 49.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.162 176.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.57 -1.27 83.79 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.629 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.414 HG22 HD13 ' A' ' 210' ' ' LEU . 23.1 m -73.16 113.51 10.3 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.011 0.434 . . . . 0.0 110.588 177.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.558 HG22 HG22 ' A' ' 203' ' ' VAL . 69.9 t -98.6 114.34 35.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.715 HD11 HG21 ' A' ' 168' ' ' THR . 0.4 OUTLIER -76.52 100.34 5.24 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.505 ' O ' ' HA2' ' A' ' 133' ' ' GLY . 47.1 mt-30 -84.68 92.96 8.31 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.382 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.505 HD22 ' HB2' ' A' ' 197' ' ' TYR . 9.2 mp -77.57 105.41 8.69 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.956 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -113.86 -57.07 2.33 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.708 ' O ' ' HA ' ' A' ' 134' ' ' SER . 4.6 pm0 -132.0 139.38 34.84 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-O 121.14 0.495 . . . . 0.0 111.209 -177.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.503 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 71.5 Cg_endo -74.37 138.45 24.71 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.982 2.455 . . . . 0.0 112.527 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.542 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.3 OUTLIER -72.5 106.28 4.52 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.053 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -56.15 133.62 52.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.083 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.6 p -58.02 111.6 1.23 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.436 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.406 HG21 ' CD ' ' A' ' 129' ' ' LYS . 2.0 t -104.02 110.7 22.95 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.288 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.467 -0.778 . . . . 0.0 109.57 -179.848 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' -4' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 63.38 -157.21 0.32 Allowed 'General case' 0 CA--C 1.532 0.277 0 O-C-N 123.583 0.552 . . . . 0.0 110.898 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' -2' ' ' THR . . . . . 0.552 ' HA ' ' CD2' ' A' ' 169' ' ' HIS . 25.2 m -71.08 -95.14 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 119.233 -0.413 . . . . 0.0 110.361 175.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' -1' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 71.0 -39.01 0.44 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.215 0.606 . . . . 0.0 111.745 175.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 0' ' ' PTR . . . . . 0.699 ' HA ' ' O ' ' A' ' 169' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.671 ' HB1' ' HG2' ' A' ' 204' ' ' GLU . . . -56.17 130.68 45.26 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.627 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 23.5 m -70.87 -38.0 73.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.295 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.512 HD12 ' SD ' ' A' ' 202' ' ' MET . 7.5 mm 70.03 88.0 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 121.613 0.721 . . . . 0.0 111.213 176.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 2.1 m -108.79 98.33 6.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.828 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' PHE . . . . . 0.611 ' CE2' ' HA3' ' A' ' 183' ' ' GLY . 92.2 m-85 -74.75 118.88 73.71 Favored Pre-proline 0 C--N 1.313 -0.983 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.452 173.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo . . . . . 0 C--O 1.252 1.179 0 C-N-CA 122.451 2.101 . . . . 0.0 112.168 -178.882 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.705 0 CA-C-O 119.657 -0.524 . . . . 0.0 111.881 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -56.34 -49.17 15.91 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.089 2.526 . . . . 0.0 112.902 -178.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 86.3 mtp -108.98 26.87 10.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.98 0.419 . . . . 0.0 110.57 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.88 69.32 10.74 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.312 0.577 . . . . 0.0 109.64 176.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.411 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 3.2 m-20 -74.73 128.82 84.77 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.046 -176.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 5.6 Cg_exo -76.09 -6.86 17.74 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.718 2.278 . . . . 0.0 109.597 172.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.536 HG22 HD12 ' A' ' 190' ' ' LEU . 25.5 p -98.13 7.41 46.32 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 113.628 -1.623 . . . . 0.0 111.153 -176.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.4 p -75.65 30.19 0.11 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.934 0.397 . . . . 0.0 111.755 -178.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.429 ' H ' ' C ' ' A' ' 108' ' ' THR . 10.8 mm-40 -109.88 171.26 7.56 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.434 ' O ' HG23 ' A' ' 218' ' ' THR . 25.3 mmt180 -85.47 -9.62 57.21 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -167.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.467 ' HB3' ' CB ' ' A' ' 215' ' ' PRO . 2.4 p-90 -87.31 -19.14 28.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.954 0.407 . . . . 0.0 110.621 175.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.516 ' CD1' ' HB ' ' A' ' 108' ' ' THR . 80.3 t80 -75.17 119.19 18.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.199 0.524 . . . . 0.0 110.241 173.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.411 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 13.9 m-70 -112.16 147.09 36.89 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 175.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -73.55 -123.99 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.731 -172.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -86.84 83.6 7.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.515 0.674 . . . . 0.0 111.168 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.401 ' HB2' ' NH1' ' A' ' 138' ' ' ARG . 77.9 mt -98.0 160.6 14.2 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.835 171.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.1 p -102.48 172.46 6.85 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 165.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.64 -50.1 44.08 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 121.312 -0.471 . . . . 0.0 112.619 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -64.64 -41.43 96.15 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 122.466 0.307 . . . . 0.0 111.425 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -61.08 -46.75 89.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.552 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.91 -35.05 79.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.972 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -64.87 -50.83 65.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.071 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -60.65 -34.58 74.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.419 176.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 129' ' ' LYS . 0.4 OUTLIER -57.01 -52.82 63.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.983 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.586 HD23 HD12 ' A' ' 216' ' ' LEU . 71.1 mt -75.96 -52.19 10.8 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -178.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 m -64.89 -33.2 75.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.785 -170.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -96.66 -49.81 4.95 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 125' ' ' LEU . 95.9 mttt -92.14 -23.51 19.39 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -169.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -98.54 -149.77 25.2 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.325 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.29 173.67 15.85 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 176.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 62.9 t60 -51.18 118.87 3.52 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.774 0.321 . . . . 0.0 110.825 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 211' ' ' GLN . . . 102.21 -3.21 51.09 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.314 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 33.8 p -72.24 139.67 48.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.276 0.538 . . . . 0.0 110.1 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.479 ' CB ' HG12 ' A' ' 151' ' ' VAL . 53.3 p90 -137.21 151.58 48.92 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.976 0.417 . . . . 0.0 110.636 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.558 HD21 ' HB2' ' A' ' 150' ' ' SER . 1.2 pt? -153.21 136.05 15.38 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.645 HG21 HD13 ' A' ' 190' ' ' LEU . 5.5 m -96.72 142.44 13.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 175.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.668 ' HB2' HH11 ' A' ' 138' ' ' ARG . 0.0 OUTLIER -147.36 160.08 42.95 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.703 -171.482 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -79.14 110.42 14.37 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.997 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.574 ' HB2' HG13 ' A' ' 148' ' ' VAL . 41.8 t -66.66 124.78 23.81 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -90.99 -15.35 29.8 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 28.0 t -72.83 -39.47 66.55 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 172.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 46.7 m-70 -119.57 81.39 24.07 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.544 172.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.22 134.47 59.45 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.042 2.495 . . . . 0.0 112.968 -172.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 100.0 -21.6 43.98 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.073 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.56 ' HA ' ' SG ' ' A' ' 174' ' ' CYS . 4.5 m-20 -102.56 170.32 8.11 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.243 0.544 . . . . 0.0 111.063 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -117.18 149.95 39.53 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.311 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.574 HG13 ' HB2' ' A' ' 140' ' ' SER . 27.1 m -131.91 138.71 52.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.173 0.511 . . . . 0.0 111.065 176.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.927 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -92.18 109.48 20.85 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.455 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.558 ' HB2' HD21 ' A' ' 136' ' ' LEU . 2.8 m -101.77 133.49 46.43 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.136 -179.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.56 HG21 ' HB3' ' A' ' 210' ' ' LEU . 28.1 m -132.9 153.84 38.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.923 0.392 . . . . 0.0 111.356 -173.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.487 HH21 ' HB2' ' A' ' 156' ' ' ASP . 73.6 ttt180 -99.69 103.98 15.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.2 178.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 14.8 p -108.36 147.66 31.21 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.456 -177.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 88.89 172.25 46.23 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.112 -178.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -102.32 151.42 22.27 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.789 0.328 . . . . 0.0 110.6 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.487 ' HB2' HH21 ' A' ' 152' ' ' ARG . 3.3 t70 -96.03 23.59 6.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.532 0.682 . . . . 0.0 110.293 -175.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -81.42 -5.73 58.2 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.987 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 163' ' ' GLY . . . 84.63 -64.01 4.32 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.048 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -64.82 -17.08 63.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.01 0.434 . . . . 0.0 111.586 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 5.4 m -87.09 -10.64 52.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.156 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -146.38 -161.52 1.34 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -173.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -63.97 -28.26 69.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.864 0.84 . . . . 0.0 109.902 175.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.421 ' O ' ' HA2' ' A' ' 158' ' ' GLY . . . 162.21 -34.23 0.34 Allowed Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.81 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -132.09 168.92 17.13 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 18.0 m -58.48 147.59 31.27 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 123.464 0.478 . . . . 0.0 110.637 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.413 ' HD2' ' HA ' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -96.39 124.91 40.55 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.751 -179.024 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 72.6 t -100.41 113.01 34.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.426 0.632 . . . . 0.0 110.626 176.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.639 HG21 HD11 ' A' ' 210' ' ' LEU . 1.4 m -98.21 137.73 36.54 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.726 175.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.754 ' O ' ' HA ' ' B' ' 0' ' ' PTR . 23.7 m-70 -105.97 122.48 46.22 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.927 HG22 ' HB3' ' A' ' 149' ' ' LEU . 0.8 OUTLIER -99.5 138.42 23.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.144 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.414 ' O ' ' HA ' ' A' ' 181' ' ' VAL . 39.8 tpp -82.22 121.28 26.43 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.636 -0.257 . . . . 0.0 111.018 -174.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.537 HD13 HD21 ' A' ' 190' ' ' LEU . 28.8 mt -101.64 107.5 21.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 177.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.581 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 4.4 ptp180 -73.8 107.66 6.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.064 0.459 . . . . 0.0 110.735 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.56 ' SG ' ' HA ' ' A' ' 146' ' ' ASP . 4.9 p -86.0 101.27 12.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.888 175.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -127.73 111.14 13.35 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.944 -176.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 56.24 43.67 26.17 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.577 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 91.5 mt 66.48 15.96 10.26 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.197 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -105.99 142.86 34.99 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 172.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -117.23 141.35 48.4 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.538 -175.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.581 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 5.9 t0 -158.71 136.25 10.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.59 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.472 HG22 ' CZ ' ' A' ' 197' ' ' TYR . 16.8 m -87.62 -11.01 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 121.051 0.453 . . . . 0.0 110.409 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLY . . . . . 0.519 ' HA2' ' NH1' ' A' ' 173' ' ' ARG . . . 123.31 34.74 0.75 Allowed Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -174.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.464 ' HA2' ' CE1' ' B' ' 5' ' ' PHE . . . -102.95 -157.69 25.33 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 121.514 -0.374 . . . . 0.0 112.448 -176.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -86.43 -40.91 7.13 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.031 -177.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -115.89 143.11 45.88 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.905 0.384 . . . . 0.0 111.279 -177.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -93.15 141.53 28.32 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -110.95 137.39 48.64 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.643 0.259 . . . . 0.0 110.677 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -82.86 0.9 41.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.229 0.538 . . . . 0.0 110.372 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.1 p -141.39 142.67 33.73 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.906 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.645 HD13 HG21 ' A' ' 137' ' ' VAL . 1.7 mt -76.52 -23.14 53.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.061 -176.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.462 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 97.6 m -62.02 -49.29 76.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.006 0.431 . . . . 0.0 109.938 174.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.65 -29.89 70.9 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.494 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.411 HD13 ' C ' ' A' ' 193' ' ' LEU . 3.2 tm? -64.34 -54.91 25.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.99 176.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.15 -42.1 79.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.348 -174.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -60.83 -31.76 71.17 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.388 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -67.29 -47.81 69.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.922 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.528 ' HB2' HD22 ' A' ' 212' ' ' LEU . 80.3 m-85 -82.8 -11.16 58.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.246 0.546 . . . . 0.0 110.639 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -68.96 -29.74 68.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.284 172.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -93.3 -37.76 11.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.375 176.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -119.31 98.06 50.41 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.344 -177.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -56.31 138.28 83.01 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.978 2.452 . . . . 0.0 112.449 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' MET . . . . . 0.704 ' HB2' HG23 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -100.4 135.54 41.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.772 178.803 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.575 HG22 ' HB ' ' A' ' 209' ' ' VAL . 39.3 t -103.55 141.18 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -171.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.573 ' HG2' ' HB1' ' B' ' 1' ' ' ALA . 38.7 mt-10 -86.82 161.98 18.04 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 169.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 13.7 t -74.59 -10.5 59.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.057 0.456 . . . . 0.0 110.346 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.6 mp -92.07 8.77 36.26 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.126 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.77 -29.0 7.74 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.776 177.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 53.4 m -57.98 112.5 1.52 Allowed 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 116.981 0.39 . . . . 0.0 110.164 176.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.575 ' HB ' HG22 ' A' ' 203' ' ' VAL . 1.1 p -111.6 129.35 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-O 121.548 0.689 . . . . 0.0 110.228 174.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.639 HD11 HG21 ' A' ' 168' ' ' THR . 0.4 OUTLIER -78.85 113.23 16.77 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.347 -1.297 . . . . 0.0 111.163 -168.854 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.404 ' O ' ' HA2' ' A' ' 133' ' ' GLY . 65.9 mt-30 -90.36 90.16 7.92 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.437 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.528 HD22 ' HB2' ' A' ' 197' ' ' TYR . 8.0 mp -79.17 104.94 10.14 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 175.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 47.5 mttp -112.73 -54.73 2.6 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -177.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.552 ' O ' ' HA ' ' A' ' 134' ' ' SER . 0.1 OUTLIER -142.03 144.7 33.06 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.112 0.482 . . . . 0.0 111.32 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.467 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 74.1 Cg_endo -73.88 144.6 34.89 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.097 2.531 . . . . 0.0 113.202 -176.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.586 HD12 HD23 ' A' ' 126' ' ' LEU . 0.4 OUTLIER -82.94 119.92 25.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.513 176.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -58.18 145.43 37.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.265 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 111' ' ' ARG . 4.2 p -74.25 108.22 6.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.532 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 2.8 t -109.81 115.6 30.12 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.708 176.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 69.8 mtp180 . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.523 -0.751 . . . . 0.0 110.239 -178.668 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' -4' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 58.26 24.54 11.61 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.483 0.658 . . . . 0.0 110.961 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' -2' ' ' THR . . . . . 0.575 HG23 ' O1P' ' B' ' 0' ' ' PTR . 6.6 m -137.94 -94.6 0.2 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' -1' ' ' GLU . . . . . 0.429 ' H ' ' HB ' ' B' ' -2' ' ' THR . 1.5 mp0 72.35 -47.05 0.66 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.371 0.669 . . . . 0.0 111.01 171.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 0' ' ' PTR . . . . . 0.754 ' HA ' ' O ' ' A' ' 169' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.573 ' HB1' ' HG2' ' A' ' 204' ' ' GLU . . . -40.92 125.12 2.28 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 113.59 -1.641 . . . . 0.0 112.365 -173.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 7.4 m -61.79 -52.26 64.91 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.189 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.704 HG23 ' HB2' ' A' ' 202' ' ' MET . 33.6 mm 82.74 82.25 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-O 121.853 0.835 . . . . 0.0 109.372 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.646 ' O ' ' HD3' ' B' ' 6' ' ' PRO . 28.7 m -106.84 130.16 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.629 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' PHE . . . . . 0.464 ' CE1' ' HA2' ' A' ' 183' ' ' GLY . 74.7 m-85 -98.97 92.55 1.68 Allowed Pre-proline 0 C--N 1.305 -1.327 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.074 175.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.646 ' HD3' ' O ' ' B' ' 4' ' ' VAL . 16.2 Cg_exo . . . . . 0 C--O 1.249 1.068 0 C-N-CA 122.912 2.408 . . . . 0.0 111.918 -176.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.8 0 CA-C-O 119.627 -0.54 . . . . 0.0 111.808 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -77.71 52.09 3.83 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.138 2.559 . . . . 0.0 112.405 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 24.5 ttt -135.97 -50.83 0.71 Allowed 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 173.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.67 20.06 9.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.857 175.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.444 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 8.7 p-10 -72.03 147.19 90.91 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.018 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 5.4 Cg_exo -76.02 -7.01 17.95 Favored 'Trans proline' 0 CA--C 1.515 -0.468 0 C-N-CA 123.058 2.505 . . . . 0.0 111.441 -175.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.506 ' HB ' ' CG ' ' A' ' 113' ' ' PHE . 40.4 p -100.44 6.26 44.37 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.154 -175.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.8 p -78.54 45.28 0.57 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.246 0.546 . . . . 0.0 111.09 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -125.9 168.34 14.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.89 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.434 ' O ' HG23 ' A' ' 218' ' ' THR . 14.3 mmt180 -82.82 -14.86 53.58 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -170.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.538 ' HB3' ' CB ' ' A' ' 215' ' ' PRO . 1.7 p-90 -85.17 -18.6 33.64 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.3 175.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.506 ' CG ' ' HB ' ' A' ' 108' ' ' THR . 87.2 t80 -78.98 118.05 20.62 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.215 173.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -115.11 113.36 23.9 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 174.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -64.31 -72.74 0.65 Allowed Glycine 0 N--CA 1.454 -0.163 0 CA-C-N 116.089 -0.505 . . . . 0.0 113.658 -173.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -84.41 89.46 7.4 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.642 -0.328 . . . . 0.0 110.996 -174.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 24.3 mt -143.73 137.15 27.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.661 174.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.1 t -101.05 173.59 6.4 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 169.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 123' ' ' GLU . . . -49.85 -52.87 24.24 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 121.527 -0.368 . . . . 0.0 113.796 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.56 -25.55 57.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.169 0.485 . . . . 0.0 111.229 -176.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -69.99 -47.27 62.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.156 0.503 . . . . 0.0 109.93 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.667 ' HB2' ' HD2' ' A' ' 138' ' ' ARG . . . -67.06 -34.11 76.97 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.597 177.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.474 ' HG3' ' HB ' ' A' ' 167' ' ' VAL . 3.3 tt0 -61.66 -49.08 77.98 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.847 177.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -59.67 -34.11 72.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.877 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.401 HD12 HD13 ' A' ' 216' ' ' LEU . 1.2 mm? -56.72 -53.53 56.7 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.119 0.485 . . . . 0.0 110.405 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.526 ' CD2' HD12 ' A' ' 216' ' ' LEU . 54.0 mt -76.15 -44.36 38.58 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.67 HG23 ' HB2' ' A' ' 165' ' ' SER . 6.9 m -61.61 -35.48 78.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 110.757 -175.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -95.6 -52.99 3.89 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -97.86 -22.73 16.2 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -170.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -90.08 177.51 42.96 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.307 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -135.59 175.14 9.87 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -57.98 117.59 4.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.781 0.324 . . . . 0.0 110.574 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 211' ' ' GLN . . . 104.02 -5.29 46.05 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.76 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 29.6 m -74.61 137.44 42.29 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.649 -0.324 . . . . 0.0 110.434 176.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.463 ' CB ' HG12 ' A' ' 151' ' ' VAL . 51.0 p90 -136.87 149.26 47.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.714 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.582 HD21 ' HB2' ' A' ' 150' ' ' SER . 1.2 pt? -150.56 134.15 16.51 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.71 HG21 HD13 ' A' ' 190' ' ' LEU . 11.9 m -97.44 141.09 16.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.667 ' HD2' ' HB2' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -140.19 162.94 34.06 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.903 -175.046 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -77.73 128.13 33.54 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.53 ' HB2' HG13 ' A' ' 148' ' ' VAL . 36.4 t -75.82 137.98 40.85 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -101.3 -21.51 14.85 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.033 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 33.5 m -86.12 -29.19 23.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.985 173.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -116.83 81.09 11.58 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 175.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.03 133.11 39.6 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.797 2.331 . . . . 0.0 112.369 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 94.52 -10.08 71.17 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.862 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -113.65 168.37 9.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.071 0.463 . . . . 0.0 110.356 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.475 ' CE1' ' HE1' ' A' ' 179' ' ' TYR . 74.0 m-85 -125.06 163.27 22.74 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.58 -177.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.532 ' CG2' ' HG3' ' A' ' 138' ' ' ARG . 26.7 m -134.62 136.99 51.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.228 0.537 . . . . 0.0 111.193 178.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.986 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -92.29 110.18 21.57 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.14 177.116 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.582 ' HB2' HD21 ' A' ' 136' ' ' LEU . 3.8 m -101.25 130.43 47.38 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.297 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.499 HG21 ' HB3' ' A' ' 210' ' ' LEU . 33.9 m -131.43 146.9 32.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.848 -174.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.409 ' HB2' ' HB3' ' A' ' 126' ' ' LEU . 39.5 ttt180 -91.55 104.89 17.32 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.17 0.51 . . . . 0.0 109.964 175.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.489 ' O ' ' HB3' ' A' ' 166' ' ' LYS . 3.7 p -104.11 146.58 28.53 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.977 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 76.14 172.9 34.72 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.876 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.492 ' OD1' ' HE2' ' A' ' 157' ' ' LYS . 25.0 t70 -106.98 172.79 6.63 Favored 'General case' 0 C--N 1.316 -0.857 0 O-C-N 122.869 -0.195 . . . . 0.0 110.587 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.487 ' HB3' ' OG ' ' A' ' 165' ' ' SER . 11.3 p-10 -95.4 -9.94 31.38 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.863 0.363 . . . . 0.0 111.232 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.492 ' HE2' ' OD1' ' A' ' 155' ' ' ASP . 3.9 mppt? -97.63 -19.79 18.06 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.392 0.615 . . . . 0.0 109.711 171.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 96.08 69.08 1.01 Allowed Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.304 -0.862 . . . . 0.0 113.129 175.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -76.2 -58.49 3.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.153 0.501 . . . . 0.0 110.025 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 36.5 t -123.28 30.49 6.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.465 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -163.04 -169.83 2.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.083 -177.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -77.11 -179.39 5.55 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -83.92 44.48 3.33 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.843 -175.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 10.8 mmmm -143.59 139.26 29.58 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.67 ' HB2' HG23 ' A' ' 127' ' ' THR . 7.4 m -70.01 124.07 23.13 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 178.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 153' ' ' THR . 51.9 tptt -95.77 137.45 34.81 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.247 -177.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.474 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 73.9 t -119.17 113.33 41.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.353 0.597 . . . . 0.0 110.319 174.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.822 HG21 HD11 ' A' ' 210' ' ' LEU . 18.9 m -97.95 133.59 42.23 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.905 176.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.699 ' O ' ' HA ' ' B' ' 0' ' ' PTR . 13.4 m-70 -110.9 117.91 34.66 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.986 HG22 ' HB3' ' A' ' 149' ' ' LEU . 0.7 OUTLIER -98.15 133.58 39.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -177.064 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 44.0 tpp -78.7 119.27 21.7 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.683 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.559 HD13 HD21 ' A' ' 190' ' ' LEU . 24.8 mt -99.58 107.22 20.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.644 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 4.5 ptp180 -69.98 125.51 26.98 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.673 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 49.4 t -118.53 115.5 24.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.72 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -141.44 112.8 7.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.164 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 60.16 49.94 6.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.974 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.0 mt 58.35 47.49 13.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.844 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.673 ' O ' ' HA ' ' A' ' 174' ' ' CYS . 11.3 tppt? -133.97 132.23 39.91 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.475 ' HE1' ' CE1' ' A' ' 147' ' ' PHE . 69.0 m-85 -117.71 134.08 55.27 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.161 0.288 . . . . 0.0 110.715 -175.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.644 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 12.5 t0 -156.12 131.46 9.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.952 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.561 ' HB ' ' CZ ' ' A' ' 197' ' ' TYR . 51.1 t -83.16 -15.69 11.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.701 0.762 . . . . 0.0 109.083 175.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLY . . . . . 0.411 ' HA2' ' NH1' ' A' ' 173' ' ' ARG . . . 122.57 8.49 6.91 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.83 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.417 ' HA3' ' CZ ' ' B' ' 5' ' ' PHE . . . -136.61 141.62 12.67 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.465 -175.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 71.44 -152.03 49.0 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.888 175.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -84.16 144.05 29.24 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.866 0.365 . . . . 0.0 110.835 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -78.98 137.17 37.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.576 177.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -110.74 149.95 29.77 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.193 0.52 . . . . 0.0 111.647 -175.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -84.06 -9.59 58.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.644 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.18 143.43 40.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.273 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.71 HD13 HG21 ' A' ' 137' ' ' VAL . 0.8 OUTLIER -70.85 -23.39 62.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.441 -174.63 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 20.6 m -61.35 -47.92 83.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.945 0.402 . . . . 0.0 110.15 175.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.21 -30.99 72.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.249 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.547 HD11 HG23 ' A' ' 181' ' ' VAL . 2.9 tm? -65.72 -54.64 24.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.44 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 34.5 m -66.77 -43.17 90.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.239 -173.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -62.25 -31.47 72.04 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.416 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -64.21 -52.1 60.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.817 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.561 ' CZ ' ' HB ' ' A' ' 181' ' ' VAL . 86.6 m-85 -80.92 -8.52 59.77 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.265 0.555 . . . . 0.0 110.393 -177.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -71.74 -23.17 61.56 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 172.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 8.3 tppt? -96.18 -36.5 10.93 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.682 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -121.86 103.72 39.78 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.001 0.429 . . . . 0.0 111.219 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -58.31 126.85 22.69 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 123.038 2.492 . . . . 0.0 112.475 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' MET . . . . . 0.464 ' HB2' ' CG2' ' B' ' 3' ' ' ILE . 0.0 OUTLIER -89.51 127.66 35.89 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.727 178.785 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.573 HG22 ' HB ' ' A' ' 209' ' ' VAL . 47.2 t -99.42 139.69 20.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.192 0.52 . . . . 0.0 111.63 -173.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.724 ' HB2' ' O ' ' A' ' 208' ' ' THR . 0.4 OUTLIER -85.6 155.95 20.92 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.946 171.592 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 9.2 t -72.41 -11.8 60.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.052 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.403 HD12 ' N ' ' A' ' 206' ' ' LEU . 5.5 mp -91.3 6.7 44.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.881 176.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.13 -17.93 53.57 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.788 178.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.724 ' O ' ' HB2' ' A' ' 204' ' ' GLU . 92.7 m -66.34 110.73 3.19 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-O 120.705 0.288 . . . . 0.0 110.239 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.573 ' HB ' HG22 ' A' ' 203' ' ' VAL . 1.4 p -111.8 127.43 68.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.695 0.759 . . . . 0.0 110.517 175.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.822 HD11 HG21 ' A' ' 168' ' ' THR . 0.3 OUTLIER -81.34 110.38 16.72 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.813 -169.377 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.434 ' O ' ' HA2' ' A' ' 133' ' ' GLY . 49.8 mt-30 -91.46 89.53 7.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.371 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.412 HD11 HD21 ' A' ' 149' ' ' LEU . 7.4 mp -75.45 111.7 11.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.195 176.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -113.92 -56.12 2.43 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.638 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.537 ' O ' ' HA ' ' A' ' 134' ' ' SER . 0.0 OUTLIER -145.77 149.2 38.92 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 121.096 0.474 . . . . 0.0 111.082 179.594 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.538 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 72.6 Cg_endo -72.94 149.44 47.21 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 123.55 2.833 . . . . 0.0 114.17 -173.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.526 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.2 OUTLIER -84.97 113.74 21.64 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 173.868 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -62.76 151.06 39.74 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.133 0.492 . . . . 0.0 111.198 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 111' ' ' ARG . 12.6 p -80.02 111.57 16.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.138 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 3.1 t -88.8 105.68 17.88 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.385 0.612 . . . . 0.0 109.474 176.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.527 -175.413 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' -4' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 121.02 0.438 . . . . 0.0 110.485 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' -3' ' ' GLN . . . . . 0.401 ' HB2' ' OE1' ' A' ' 123' ' ' GLU . 4.4 pt20 -100.75 160.13 14.61 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 176.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' -2' ' ' THR . . . . . 0.598 ' HA ' ' CD2' ' A' ' 169' ' ' HIS . 12.3 m 53.33 -109.52 0.48 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-O 118.675 -0.679 . . . . 0.0 109.427 -172.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' -1' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' B' ' 0' ' ' PTR . 11.3 tp10 70.88 -42.69 0.54 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.195 0.598 . . . . 0.0 111.535 174.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 0' ' ' PTR . . . . . 0.699 ' HA ' ' O ' ' A' ' 169' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.438 ' HB2' ' CG2' ' A' ' 168' ' ' THR . . . -55.23 132.08 46.89 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.09 -1.413 . . . . 0.0 111.357 -175.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 86.0 m -70.7 -47.29 60.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.008 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.464 ' CG2' ' HB2' ' A' ' 202' ' ' MET . 15.7 mm 78.54 89.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 123.318 0.647 . . . . 0.0 110.278 173.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.692 ' O ' ' HD3' ' B' ' 6' ' ' PRO . 5.9 m -98.66 124.31 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.435 177.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' PHE . . . . . 0.419 ' CE1' HG22 ' B' ' 3' ' ' ILE . 96.5 m-85 -102.23 82.37 0.42 Allowed Pre-proline 0 C--N 1.308 -1.215 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.925 170.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.692 ' HD3' ' O ' ' B' ' 4' ' ' VAL . 7.1 Cg_endo . . . . . 0 N--CA 1.448 -1.178 0 C-N-CA 122.875 2.384 . . . . 0.0 111.092 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.717 0 N-CA-C 112.132 -0.387 . . . . 0.0 112.132 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -86.77 -5.85 7.86 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.801 2.334 . . . . 0.0 112.959 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 86.8 mmm -93.34 4.51 53.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.4 0.619 . . . . 0.0 110.088 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.36 -164.58 2.05 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.703 176.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 1.3 t70 -78.63 138.43 58.55 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 173.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 6.3 Cg_exo -73.12 -5.49 17.27 Favored 'Trans proline' 0 CA--C 1.516 -0.416 0 C-N-CA 122.774 2.316 . . . . 0.0 111.294 -173.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.63 ' HB ' ' CD2' ' A' ' 113' ' ' PHE . 81.5 p -94.77 6.69 48.2 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.59 -176.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 51.3 m -76.64 59.24 1.5 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.299 0.571 . . . . 0.0 110.818 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.474 ' HG3' ' CZ2' ' A' ' 112' ' ' TRP . 76.8 mm-40 -134.39 156.35 48.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.513 -177.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -75.11 -13.76 60.5 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -171.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.492 ' HB3' ' CB ' ' A' ' 215' ' ' PRO . 2.5 p-90 -89.65 -14.16 35.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.947 0.403 . . . . 0.0 110.742 175.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.63 ' CD2' ' HB ' ' A' ' 108' ' ' THR . 76.3 t80 -80.73 120.94 25.27 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.088 0.47 . . . . 0.0 110.149 172.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -111.91 140.4 46.6 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -76.73 -90.3 0.26 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.037 -175.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -92.66 93.54 8.54 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.992 0.425 . . . . 0.0 111.51 -172.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.2 mt -134.38 128.46 33.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.301 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 24.5 m -83.68 173.25 11.51 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 173.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -50.84 -52.62 29.49 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 121.477 -0.392 . . . . 0.0 113.386 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -72.09 -31.75 66.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.491 0.186 . . . . 0.0 111.431 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -64.04 -47.13 81.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.968 0.413 . . . . 0.0 110.481 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.465 ' HB2' ' HD3' ' A' ' 138' ' ' ARG . . . -66.15 -34.03 77.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.723 178.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.444 ' HA ' HG11 ' A' ' 167' ' ' VAL . 0.2 OUTLIER -65.87 -50.77 63.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.51 176.274 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -58.55 -34.78 71.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.615 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.411 HD12 HD13 ' A' ' 216' ' ' LEU . 0.7 OUTLIER -56.81 -51.59 68.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.218 178.065 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.541 ' CD2' HD12 ' A' ' 216' ' ' LEU . 53.2 mt -75.48 -46.66 31.1 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 m -64.97 -28.32 69.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.098 -174.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -95.71 -53.03 3.86 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -103.48 11.65 36.13 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -170.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -127.05 -163.36 11.44 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.254 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -154.34 176.15 12.67 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -46.71 120.74 3.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.937 0.398 . . . . 0.0 111.004 176.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 211' ' ' GLN . . . 99.1 -9.63 61.51 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.797 177.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.658 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 69.0 m -70.41 135.67 48.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.218 0.509 . . . . 0.0 110.526 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.517 ' CB ' HG12 ' A' ' 151' ' ' VAL . 52.5 p90 -137.03 149.54 47.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.923 -178.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.551 ' CD2' ' HB2' ' A' ' 150' ' ' SER . 1.2 pt? -149.43 134.8 18.36 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 175.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.652 HG21 HD13 ' A' ' 190' ' ' LEU . 12.3 m -97.52 141.93 15.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.465 ' HD3' ' HB2' ' A' ' 122' ' ' ALA . 30.5 ptt85 -140.98 162.17 36.1 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.357 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -71.38 129.25 38.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.871 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.436 ' OG ' ' HB2' ' A' ' 143' ' ' HIS . 23.3 t -77.94 132.85 38.07 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.328 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -91.08 -40.86 11.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.819 -175.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.6 t -79.81 -12.99 59.74 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.057 0.456 . . . . 0.0 109.789 177.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.436 ' HB2' ' OG ' ' A' ' 140' ' ' SER . 54.3 m80 -126.19 75.04 72.82 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.951 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.5 126.87 21.91 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.847 2.364 . . . . 0.0 112.234 -176.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 106.09 -31.97 7.83 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.943 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -98.16 171.79 8.0 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.155 0.502 . . . . 0.0 110.732 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.412 ' CE2' ' HE1' ' A' ' 179' ' ' TYR . 85.8 m-85 -125.23 165.9 17.46 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.435 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.446 HG11 ' CE1' ' B' ' 0' ' ' PTR . 27.5 m -132.97 136.48 55.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.404 0.621 . . . . 0.0 111.456 176.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.973 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -92.74 110.02 21.45 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.806 174.907 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.551 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 1.2 m -101.9 128.98 48.05 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.709 -0.796 . . . . 0.0 109.254 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.517 HG12 ' CB ' ' A' ' 135' ' ' PHE . 33.7 m -130.46 147.7 33.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.581 -172.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.423 ' HB2' ' HB3' ' A' ' 126' ' ' LEU . 62.7 ttt180 -93.02 104.25 16.48 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.253 0.549 . . . . 0.0 109.879 176.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.7 p -104.08 146.93 28.01 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.092 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 86.51 -176.01 47.85 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.568 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -104.12 155.21 18.89 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 177.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -99.83 -1.08 38.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.042 0.449 . . . . 0.0 110.37 177.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -116.69 141.79 47.74 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.75 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 98.03 -18.47 57.09 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.647 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 59.58 47.08 11.2 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.273 0.559 . . . . 0.0 110.607 -178.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.6 p -77.15 -9.73 58.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.221 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -111.74 -133.44 0.34 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 174.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -78.39 -14.51 59.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.447 0.641 . . . . 0.0 109.973 176.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 163.2 -58.07 0.28 Allowed Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.877 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -100.26 -161.16 0.85 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 174.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 26.0 m -67.6 164.43 19.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.102 173.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 167' ' ' VAL . 0.0 OUTLIER -120.18 130.65 54.67 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.199 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.449 ' N ' ' HD2' ' A' ' 166' ' ' LYS . 74.9 t -99.41 116.2 42.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.475 0.655 . . . . 0.0 111.751 -177.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.745 HG21 HD11 ' A' ' 210' ' ' LEU . 4.4 m -97.26 141.19 30.67 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.35 176.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.588 ' O ' ' HA ' ' B' ' 0' ' ' PTR . 17.1 m-70 -117.76 117.47 29.41 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.973 HG22 ' HB3' ' A' ' 149' ' ' LEU . 0.7 OUTLIER -98.85 135.37 34.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -173.936 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 35.2 tpp -78.48 115.93 18.52 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.657 -176.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.582 HD13 HD21 ' A' ' 190' ' ' LEU . 29.6 mt -93.61 105.95 17.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 176.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.552 ' HB2' ' OE1' ' A' ' 175' ' ' GLN . 13.6 ptm180 -82.18 118.58 23.18 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.313 -175.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.666 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 38.5 t -104.42 110.0 22.09 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.112 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.552 ' OE1' ' HB2' ' A' ' 173' ' ' ARG . 1.8 mp0 -113.74 107.91 16.39 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 177.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 58.2 52.17 7.78 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 123.562 0.539 . . . . 0.0 111.094 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 93.6 mt 61.05 41.89 13.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.193 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.666 ' O ' ' HA ' ' A' ' 174' ' ' CYS . 5.8 tppt? -134.51 131.03 37.53 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.412 ' HE1' ' CE2' ' A' ' 147' ' ' PHE . 63.5 m-85 -105.52 138.19 42.12 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 122.91 0.131 . . . . 0.0 111.118 -171.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.549 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 24.7 t70 -152.11 139.49 19.48 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.355 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.551 HG12 ' O ' ' A' ' 181' ' ' VAL . 84.4 t -96.83 55.68 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 122.514 1.15 . . . . 0.0 109.127 173.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 82.52 -39.02 2.64 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 114.7 -1.136 . . . . 0.0 113.674 173.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.409 ' HA3' ' CD1' ' B' ' 5' ' ' PHE . . . -138.51 151.88 21.77 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.281 -176.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 110.16 -142.71 16.63 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.653 175.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -106.44 143.75 34.1 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 176.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.438 ' HG2' ' HB2' ' A' ' 180' ' ' ASP . 80.2 mtt180 -92.77 139.49 30.49 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.346 -176.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -113.95 147.86 37.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.184 -175.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -79.16 -16.9 55.95 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.169 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 19.8 m -129.78 143.37 50.78 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.795 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.652 HD13 HG21 ' A' ' 137' ' ' VAL . 0.8 OUTLIER -69.89 -22.55 63.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.039 -176.456 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.478 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 6.5 m -58.83 -47.36 85.1 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.992 0.425 . . . . 0.0 110.363 176.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -66.41 -31.52 72.32 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.298 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.52 ' HB3' HD23 ' A' ' 190' ' ' LEU . 3.0 tm? -62.84 -54.48 38.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.779 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 32.7 m -69.22 -41.35 81.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.032 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -62.26 -34.87 77.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.677 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -63.52 -50.01 71.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.739 0.304 . . . . 0.0 110.811 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.598 ' HB2' HD22 ' A' ' 212' ' ' LEU . 76.5 m-85 -82.04 -8.35 59.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.186 0.517 . . . . 0.0 111.014 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 212' ' ' LEU . 35.3 ttpt -73.53 -20.47 60.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.68 0.752 . . . . 0.0 109.358 173.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 9.5 tppt? -106.12 -36.21 6.99 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.554 175.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' A' ' 197' ' ' TYR . 18.7 m120 -112.68 93.99 26.3 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.834 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -58.22 130.09 36.12 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.99 2.46 . . . . 0.0 112.382 178.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' MET . . . . . 0.505 ' HG3' HD12 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -92.89 130.87 38.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.368 179.328 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.552 HG22 ' HB ' ' A' ' 209' ' ' VAL . 42.7 t -98.5 133.62 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.247 0.546 . . . . 0.0 112.091 -174.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.722 ' HB2' ' O ' ' A' ' 208' ' ' THR . 0.1 OUTLIER -81.56 159.07 24.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.974 170.848 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 9.0 t -74.06 -10.61 59.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.277 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 206' ' ' LEU . 5.4 mp -88.88 -2.29 58.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.373 176.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 95.5 -13.91 65.82 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.07 -177.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.722 ' O ' ' HB2' ' A' ' 204' ' ' GLU . 49.5 m -67.65 110.27 3.65 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 176.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.552 ' HB ' HG22 ' A' ' 203' ' ' VAL . 1.1 p -112.14 120.61 62.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.925 0.869 . . . . 0.0 110.504 175.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.745 HD11 HG21 ' A' ' 168' ' ' THR . 0.4 OUTLIER -76.7 103.55 6.73 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.354 -170.233 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.478 ' O ' ' HA2' ' A' ' 133' ' ' GLY . 44.8 mt-30 -90.09 89.3 7.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.851 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.598 HD22 ' HB2' ' A' ' 197' ' ' TYR . 7.6 mp -71.27 113.89 8.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.656 178.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -115.81 -56.6 2.31 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.658 ' O ' ' HA ' ' A' ' 134' ' ' SER . 4.2 pm0 -136.84 140.91 33.16 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.072 0.463 . . . . 0.0 110.898 -177.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.492 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 59.9 Cg_endo -73.68 146.05 37.95 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.645 2.23 . . . . 0.0 112.753 -178.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.541 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.2 OUTLIER -86.75 105.46 16.98 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 174.712 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -60.78 138.64 58.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.996 0.427 . . . . 0.0 110.953 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 7.0 p -61.83 114.14 3.16 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.671 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 2.6 t -89.84 106.41 18.45 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.446 0.641 . . . . 0.0 109.523 177.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 . . . . . 0 C--O 1.246 0.91 0 CA-C-O 118.366 -0.826 . . . . 0.0 110.241 -174.75 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' -4' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 120.812 0.339 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -94.89 141.58 28.47 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -176.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' -2' ' ' THR . . . . . 0.451 HG22 ' H ' ' B' ' -1' ' ' GLU . 1.3 m 69.04 -146.99 0.11 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.094 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' -1' ' ' GLU . . . . . 0.451 ' H ' HG22 ' B' ' -2' ' ' THR . 42.7 mt-10 75.21 -13.2 0.87 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.635 0.774 . . . . 0.0 110.198 -170.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 0' ' ' PTR . . . . . 0.588 ' HA ' ' O ' ' A' ' 169' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.533 ' HB2' ' CG2' ' A' ' 168' ' ' THR . . . -71.49 125.06 26.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.507 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 86.0 m -71.5 -42.3 68.19 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.877 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.505 HD12 ' HG3' ' A' ' 202' ' ' MET . 13.5 mm 73.68 99.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.113 0.565 . . . . 0.0 111.192 175.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 3.0 m -111.02 94.49 3.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.099 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' PHE . . . . . 0.409 ' CD1' ' HA3' ' A' ' 183' ' ' GLY . 93.8 m-85 -75.6 115.84 49.57 Favored Pre-proline 0 C--N 1.318 -0.777 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 172.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo . . . . . 0 C--O 1.249 1.063 0 C-N-CA 122.731 2.288 . . . . 0.0 111.936 178.861 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.427 ' HA2' ' HD3' ' A' ' 103' ' ' PRO . . . . . . . . 0 N--CA 1.481 1.676 0 N-CA-C 112.22 -0.352 . . . . 0.0 112.22 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.427 ' HD3' ' HA2' ' A' ' 102' ' ' GLY . 17.4 Cg_exo -66.56 -31.77 40.56 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.822 2.348 . . . . 0.0 112.44 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 90.2 mtp -87.67 -29.64 21.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.715 -178.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 52.63 67.93 0.91 Allowed 'General case' 0 C--O 1.238 0.454 0 O-C-N 123.699 0.625 . . . . 0.0 110.973 177.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.417 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 3.7 m-20 -59.0 126.0 79.89 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.478 -178.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 3.2 Cg_exo -77.03 -7.13 17.18 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.77 2.314 . . . . 0.0 110.108 172.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.526 ' HB ' ' CG ' ' A' ' 113' ' ' PHE . 42.1 p -98.39 8.05 45.38 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.609 -178.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 66.5 p -74.86 34.65 0.1 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.933 0.397 . . . . 0.0 111.563 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 108' ' ' THR . 60.7 mm-40 -115.8 157.22 24.72 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -75.65 -12.2 60.16 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -167.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.4 ' CZ2' ' HA ' ' A' ' 191' ' ' THR . 4.4 p-90 -85.29 -14.68 45.84 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.827 176.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.526 ' CG ' ' HB ' ' A' ' 108' ' ' THR . 68.4 t80 -77.59 120.25 22.28 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.125 0.488 . . . . 0.0 110.389 171.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.482 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 10.6 m170 -121.08 106.57 11.68 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 175.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -73.93 -45.96 24.83 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.541 -171.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -99.01 83.72 2.94 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.052 0.453 . . . . 0.0 111.139 -173.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.4 mt -148.44 138.07 22.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.493 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.8 p -90.62 173.25 8.15 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 169.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 123' ' ' GLU . . . -51.71 -48.9 49.1 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.862 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -76.48 -32.35 58.31 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -64.02 -46.79 82.91 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.026 176.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.612 ' HB2' ' HD2' ' A' ' 138' ' ' ARG . . . -66.64 -33.69 76.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.693 177.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.562 ' HG3' ' HB ' ' A' ' 167' ' ' VAL . 4.2 tt0 -62.51 -50.37 71.65 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.215 176.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.66 -34.49 72.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.22 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.453 HD12 HD13 ' A' ' 216' ' ' LEU . 0.7 OUTLIER -56.22 -52.9 62.74 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.332 0.587 . . . . 0.0 110.494 -178.069 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.569 ' CD2' HD12 ' A' ' 216' ' ' LEU . 54.2 mt -75.7 -46.72 29.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.514 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.6 m -61.28 -32.54 72.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.337 -172.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -97.36 -53.7 3.38 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 178.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -93.03 -21.35 19.79 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -170.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -89.1 -161.24 37.32 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.937 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -153.88 175.63 13.12 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 174.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -51.08 117.63 2.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.918 0.39 . . . . 0.0 110.891 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 99.93 -3.75 57.32 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.996 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 68.7 m -75.96 139.63 41.66 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.52 -0.4 . . . . 0.0 110.647 178.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.497 ' CB ' HG12 ' A' ' 151' ' ' VAL . 52.8 p90 -137.5 151.4 48.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.771 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.582 ' CD2' ' HB2' ' A' ' 150' ' ' SER . 1.2 pt? -151.71 138.02 18.47 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.693 HG21 HD13 ' A' ' 190' ' ' LEU . 14.2 m -97.62 137.94 23.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.308 176.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.612 ' HD2' ' HB2' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -137.64 162.14 34.61 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.053 -174.765 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -76.66 134.38 39.29 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.507 ' HB2' HG13 ' A' ' 148' ' ' VAL . 33.2 t -80.93 143.65 32.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.174 -175.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -101.15 -22.76 14.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.914 174.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 72.7 m -69.86 -40.35 75.82 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.439 0.637 . . . . 0.0 109.356 170.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -121.93 83.14 43.49 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.036 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -55.47 123.58 14.15 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.506 2.137 . . . . 0.0 111.553 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 106.7 -32.14 7.57 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.906 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -88.28 170.29 11.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.877 0.37 . . . . 0.0 110.431 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -121.65 153.96 37.45 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.151 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.536 ' CG2' ' HG3' ' A' ' 138' ' ' ARG . 30.2 m -129.38 138.86 53.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.159 0.504 . . . . 0.0 110.52 176.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.853 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -92.18 110.13 21.51 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.149 177.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.582 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 3.3 m -101.42 132.01 47.23 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.408 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.555 HG21 ' HB3' ' A' ' 210' ' ' LEU . 32.0 m -132.47 149.44 32.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.96 -174.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.527 HH21 ' HB2' ' A' ' 156' ' ' ASP . 72.9 ttt180 -96.0 104.16 16.09 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.031 0.443 . . . . 0.0 109.898 176.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -107.69 147.15 31.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.224 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 85.17 -178.52 50.79 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.405 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -96.12 176.42 6.09 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.762 0.315 . . . . 0.0 110.493 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.527 ' HB2' HH21 ' A' ' 152' ' ' ARG . 21.9 t70 -126.16 -3.94 6.86 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.238 0.542 . . . . 0.0 111.003 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -98.9 60.4 1.24 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.163 0.506 . . . . 0.0 111.575 -172.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 78.5 -72.26 2.39 Favored Glycine 0 C--N 1.318 -0.431 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.882 176.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -78.16 110.61 13.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.126 0.488 . . . . 0.0 110.439 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 45.5 t -168.36 -55.84 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.359 -176.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.505 HD21 ' HB2' ' A' ' 166' ' ' LYS . 4.9 p30 -168.07 -65.52 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.159 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -124.81 -10.9 7.24 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.105 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 152.1 -78.1 0.21 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.781 177.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -88.07 -176.1 5.31 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.473 ' OG ' ' HB2' ' A' ' 156' ' ' ASP . 58.9 m -67.71 154.5 41.36 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.25 0.548 . . . . 0.0 111.363 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.505 ' HB2' HD21 ' A' ' 161' ' ' ASN . 0.0 OUTLIER -110.72 126.27 54.38 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 176.379 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.562 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 71.4 t -99.96 112.52 32.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.396 0.617 . . . . 0.0 110.492 177.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.702 HG21 HD11 ' A' ' 210' ' ' LEU . 6.3 m -92.01 140.5 29.59 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.641 175.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.797 ' O ' ' HA ' ' B' ' 0' ' ' PTR . 7.5 m-70 -118.5 120.15 36.66 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.853 HG22 ' HB3' ' A' ' 149' ' ' LEU . 1.1 m -98.16 138.8 21.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -177.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 5.7 ttm -90.45 118.69 30.12 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.941 -174.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.485 HD13 HD21 ' A' ' 190' ' ' LEU . 25.6 mt -93.47 127.97 45.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.661 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.597 ' NH1' ' HA2' ' A' ' 182' ' ' GLY . 5.0 ptp180 -87.77 112.26 22.24 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.043 0.449 . . . . 0.0 109.942 177.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 47.0 t -96.89 92.6 6.2 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -113.77 113.78 25.42 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.48 -175.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 58.63 40.89 23.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.857 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 93.9 mt 67.1 18.78 10.49 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.82 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -109.95 139.05 45.48 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 172.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.452 ' CD1' ' HG ' ' A' ' 190' ' ' LEU . 51.5 m-85 -109.54 138.53 45.77 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.841 -175.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.586 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 9.6 t0 -155.73 140.99 17.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.028 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.53 ' HB ' ' CE1' ' A' ' 197' ' ' TYR . 14.4 t -94.62 -12.43 8.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.657 0.742 . . . . 0.0 109.342 176.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLY . . . . . 0.597 ' HA2' ' NH1' ' A' ' 173' ' ' ARG . . . 123.21 9.02 6.24 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.166 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.651 ' HA3' ' CE1' ' B' ' 5' ' ' PHE . . . -138.07 140.59 11.3 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.242 -0.98 . . . . 0.0 113.755 -176.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.67 -119.87 5.59 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.376 173.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -115.76 158.69 22.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.631 0.253 . . . . 0.0 110.564 -173.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -95.43 128.65 42.46 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -110.31 144.28 39.26 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.076 -173.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -79.8 -8.66 59.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.413 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 85.1 p -130.46 143.9 51.06 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.479 177.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.693 HD13 HG21 ' A' ' 137' ' ' VAL . 1.1 mt -70.65 -22.08 62.54 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.37 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.492 ' O ' ' HG3' ' A' ' 195' ' ' GLU . 4.0 m -60.42 -49.18 78.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.637 177.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -67.14 -30.52 70.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.705 0.288 . . . . 0.0 110.565 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.528 HD11 HG23 ' A' ' 181' ' ' VAL . 3.4 tm? -62.15 -54.83 35.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.836 177.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 35.7 m -68.97 -39.69 80.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.999 -175.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 191' ' ' THR . 22.7 mt-10 -66.67 -35.27 79.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.414 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -60.26 -42.78 96.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.818 0.342 . . . . 0.0 110.414 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.53 ' CE1' ' HB ' ' A' ' 181' ' ' VAL . 40.5 m-85 -85.44 -11.62 53.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.376 0.608 . . . . 0.0 110.649 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.408 ' HE2' ' HA ' ' A' ' 195' ' ' GLU . 38.4 ttpt -73.67 -27.67 61.35 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 173.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -90.29 -35.99 14.95 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.442 175.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -116.38 102.78 53.42 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.511 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -57.93 126.43 21.64 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.603 2.202 . . . . 0.0 111.974 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' MET . . . . . 0.729 ' SD ' HD23 ' A' ' 210' ' ' LEU . 9.5 ptp -89.11 120.48 30.54 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.633 -177.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.591 HG22 ' HB ' ' A' ' 209' ' ' VAL . 28.7 t -97.91 136.55 28.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.662 0.268 . . . . 0.0 111.72 -175.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.558 ' O ' HG12 ' A' ' 203' ' ' VAL . 22.6 mt-10 -85.79 167.09 15.53 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.877 0.37 . . . . 0.0 110.063 169.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 12.1 t -75.16 -14.83 60.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.276 0.56 . . . . 0.0 109.978 177.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.469 HD12 ' N ' ' A' ' 206' ' ' LEU . 5.1 mp -81.73 -7.44 59.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.153 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 99.82 -21.23 45.87 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.869 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 89.8 m -62.94 112.13 2.44 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.591 ' HB ' HG22 ' A' ' 203' ' ' VAL . 0.8 OUTLIER -112.82 121.82 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 CA-C-O 121.616 0.722 . . . . 0.0 110.574 173.836 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.729 HD23 ' SD ' ' A' ' 202' ' ' MET . 0.4 OUTLIER -77.12 107.94 9.84 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.767 -174.708 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -93.54 90.23 6.59 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.008 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.488 HD22 ' HB2' ' A' ' 197' ' ' TYR . 7.8 mp -74.02 103.4 4.49 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.242 -177.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -115.47 -55.79 2.41 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.633 ' O ' ' HA ' ' A' ' 134' ' ' SER . 0.1 OUTLIER -115.09 132.89 22.8 Favored Pre-proline 0 C--O 1.223 -0.305 0 CA-C-O 120.483 0.182 . . . . 0.0 111.323 -173.706 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.09 132.78 11.81 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.315 2.01 . . . . 0.0 111.817 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.569 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.3 OUTLIER -78.88 102.02 8.0 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.173 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -58.13 140.24 53.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.705 178.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.3 p -62.58 125.54 24.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.335 0.588 . . . . 0.0 111.554 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.2 t -118.08 116.38 26.74 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.076 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.696 -0.669 . . . . 0.0 110.639 179.536 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' -4' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 121.088 0.47 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' -3' ' ' GLN . . . . . 0.46 ' HB3' ' OE1' ' A' ' 123' ' ' GLU . 92.4 mt-30 -116.59 158.78 23.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.703 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' -2' ' ' THR . . . . . 0.636 ' HA ' ' CD2' ' A' ' 169' ' ' HIS . 6.9 m 54.13 -110.57 0.56 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.471 -0.776 . . . . 0.0 109.279 -172.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' -1' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' B' ' -2' ' ' THR . 43.2 tt0 74.37 -42.51 0.5 Allowed 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.369 0.531 . . . . 0.0 111.195 171.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 0' ' ' PTR . . . . . 0.797 ' HA ' ' O ' ' A' ' 169' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.599 ' HB2' ' CG2' ' A' ' 168' ' ' THR . . . -51.03 141.67 13.47 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 113.584 -1.644 . . . . 0.0 113.1 -169.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 63.4 m -73.48 -47.03 44.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.443 -1.253 . . . . 0.0 111.521 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.56 HD12 ' SD ' ' A' ' 202' ' ' MET . 6.4 mm 66.32 105.25 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 123.224 0.61 . . . . 0.0 111.63 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -129.97 86.0 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.333 175.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' PHE . . . . . 0.651 ' CE1' ' HA3' ' A' ' 183' ' ' GLY . 77.0 m-85 -58.07 114.15 7.98 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.143 174.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo . . . . . 0 C--O 1.249 1.073 0 C-N-CA 122.764 2.309 . . . . 0.0 112.094 178.892 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.678 0 N-CA-C 111.729 -0.549 . . . . 0.0 111.729 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -66.49 -41.33 11.94 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.742 2.295 . . . . 0.0 112.426 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 64.9 mtt -86.83 -47.26 9.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.896 0.379 . . . . 0.0 110.923 -177.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -105.67 125.89 51.51 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.735 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -63.77 150.29 91.26 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.421 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -75.32 -12.61 20.9 Favored 'Trans proline' 0 CA--C 1.508 -0.816 0 C-N-CA 122.693 2.262 . . . . 0.0 110.741 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 190' ' ' LEU . 8.9 t -101.07 5.94 43.14 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.348 175.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.7 t -71.74 65.54 0.51 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 121.792 0.805 . . . . 0.0 110.035 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -130.27 169.89 14.83 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.033 -175.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -64.83 -17.1 63.95 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -167.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.436 ' CZ2' ' HA ' ' A' ' 191' ' ' THR . 1.3 p-90 -92.93 -13.33 29.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.858 0.361 . . . . 0.0 111.467 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.494 ' HA ' ' O ' ' A' ' 137' ' ' VAL . 24.6 t80 -89.37 118.57 29.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.175 0.512 . . . . 0.0 110.806 177.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -109.65 119.26 38.84 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -49.8 -86.02 0.01 OUTLIER Glycine 0 C--N 1.331 0.256 0 O-C-N 123.98 0.8 . . . . 0.0 114.213 -170.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -100.4 107.2 18.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.521 0.677 . . . . 0.0 111.227 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 33.9 mt -129.57 140.92 51.08 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.951 174.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.422 ' H ' ' HB2' ' A' ' 121' ' ' GLU . 18.1 t -90.0 171.31 9.65 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 173.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.34 -53.18 42.58 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.835 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 20.9 mmtm -76.73 -25.45 53.54 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.422 ' HB2' ' H ' ' A' ' 118' ' ' SER . 15.2 mm-40 -65.29 -47.03 78.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.948 0.404 . . . . 0.0 110.225 175.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.596 ' HB2' ' HD2' ' A' ' 138' ' ' ARG . . . -65.59 -34.26 77.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.282 0.563 . . . . 0.0 110.492 178.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -67.94 -50.14 57.73 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.851 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -56.97 -34.65 68.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.788 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.453 HD12 HD13 ' A' ' 216' ' ' LEU . 0.7 OUTLIER -57.14 -52.69 64.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.275 178.484 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.558 ' CD2' HD12 ' A' ' 216' ' ' LEU . 55.1 mt -76.04 -51.88 11.38 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.5 m -61.07 -35.84 78.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.75 -171.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -97.68 -46.63 5.92 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 125' ' ' LEU . 89.0 mttt -91.23 -28.88 17.52 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.668 -0.413 . . . . 0.0 112.015 -171.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -93.17 -158.98 34.56 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.831 -176.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.432 ' C ' ' HD3' ' A' ' 152' ' ' ARG . 14.9 ptmm? -148.08 176.0 10.56 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -51.92 123.85 11.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.707 0.289 . . . . 0.0 110.513 176.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 94.87 -3.64 67.66 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.239 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.624 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 69.0 m -73.61 139.15 45.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.059 0.429 . . . . 0.0 110.313 178.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.501 ' CB ' HG12 ' A' ' 151' ' ' VAL . 50.4 p90 -136.93 149.38 47.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.71 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.593 HD21 ' HB2' ' A' ' 150' ' ' SER . 1.2 pt? -150.64 140.4 21.77 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.657 HG21 HD13 ' A' ' 190' ' ' LEU . 11.4 m -99.73 144.1 12.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.186 175.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.596 ' HD2' ' HB2' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -146.0 156.69 43.67 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.845 -173.682 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -70.31 132.73 46.13 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 175.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.645 ' HB2' HG13 ' A' ' 148' ' ' VAL . 37.9 t -86.22 143.43 27.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.916 0.389 . . . . 0.0 110.38 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -100.63 -20.25 15.74 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.691 178.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 65.9 m -78.75 -30.56 45.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.141 0.496 . . . . 0.0 109.789 172.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.403 ' HB3' ' HB2' ' A' ' 146' ' ' ASP . 27.1 m-70 -120.55 86.16 39.26 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.858 173.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -61.49 123.19 12.28 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.241 1.96 . . . . 0.0 111.892 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 101.35 -14.82 57.99 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.166 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.403 ' HB2' ' HB3' ' A' ' 143' ' ' HIS . 4.2 m-20 -105.61 164.08 12.17 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.168 0.509 . . . . 0.0 110.865 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -119.24 153.89 34.28 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.721 -177.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.645 HG13 ' HB2' ' A' ' 140' ' ' SER . 34.5 m -130.31 139.94 50.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.393 0.616 . . . . 0.0 111.371 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.779 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -92.64 110.37 21.79 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.256 178.17 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.593 ' HB2' HD21 ' A' ' 136' ' ' LEU . 1.5 m -102.97 131.27 50.05 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.115 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.538 HG21 ' HB3' ' A' ' 210' ' ' LEU . 35.3 m -132.12 146.81 32.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.166 -173.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.432 ' HD3' ' C ' ' A' ' 131' ' ' LYS . 75.0 ttt180 -90.56 104.67 17.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.339 0.59 . . . . 0.0 109.968 176.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.429 HG21 HD12 ' A' ' 210' ' ' LEU . 8.8 p -102.23 147.43 26.66 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.392 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 83.0 173.47 49.68 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.76 -177.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -102.89 177.51 4.82 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.082 0.468 . . . . 0.0 110.744 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.676 ' HA ' ' ND2' ' A' ' 161' ' ' ASN . 34.6 t70 -123.86 14.12 9.25 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.725 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -98.13 -44.2 6.71 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.027 -176.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 144.12 19.37 0.2 Allowed Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.304 -0.95 . . . . 0.0 114.235 177.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.67 -57.3 3.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.526 0.663 . . . . 0.0 109.514 175.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 10.1 t -129.04 46.61 2.6 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 176.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.676 ' ND2' ' HA ' ' A' ' 156' ' ' ASP . 26.4 t-20 -118.58 109.89 16.7 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.612 -175.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -92.29 66.36 4.74 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.21 0.529 . . . . 0.0 110.528 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 84.76 -50.54 4.42 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -129.36 161.94 29.14 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 28.1 m -76.78 164.54 25.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.932 -177.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.442 ' HD2' ' HA ' ' A' ' 166' ' ' LYS . 25.6 mmmt -95.89 139.14 32.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.846 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 71.3 t -125.73 113.32 34.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.71 170.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.69 HG21 HD11 ' A' ' 210' ' ' LEU . 1.8 m -97.83 138.18 35.57 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.898 175.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.746 ' O ' ' HA ' ' B' ' 0' ' ' PTR . 14.2 m-70 -112.73 117.99 33.74 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.779 HG22 ' HB3' ' A' ' 149' ' ' LEU . 1.3 m -98.35 135.72 32.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -175.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 40.1 tpp -81.3 116.78 21.32 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.893 -174.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.562 HG21 HD21 ' A' ' 190' ' ' LEU . 16.6 mt -97.03 107.67 20.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 3.9 ptp180 -70.11 117.73 12.05 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.617 -178.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 36.6 t -93.02 94.59 8.97 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -113.78 109.59 18.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.47 -174.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 53.01 40.52 31.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.802 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 96.1 mt 72.66 15.13 4.97 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.169 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.88 142.94 34.74 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 170.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -110.8 140.99 44.74 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.53 -176.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.582 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 10.6 t0 -156.02 137.95 14.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.753 0.311 . . . . 0.0 111.048 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.483 HG23 HD11 ' A' ' 193' ' ' LEU . 48.6 t -90.11 -13.16 9.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.724 0.773 . . . . 0.0 109.322 175.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLY . . . . . 0.57 ' HA2' ' NH1' ' A' ' 173' ' ' ARG . . . 124.09 5.23 7.5 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.763 178.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -137.14 140.41 11.37 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 119.807 -1.187 . . . . 0.0 113.918 -174.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 79.45 -116.46 4.31 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.088 -0.577 . . . . 0.0 113.18 174.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -115.92 150.18 37.53 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 122.291 0.236 . . . . 0.0 110.436 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -80.96 126.96 32.03 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 171.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -105.62 138.69 41.4 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.099 0.476 . . . . 0.0 111.326 -172.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -70.13 -22.77 62.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.788 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 82.2 p -130.71 144.62 51.56 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.517 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.657 HD13 HG21 ' A' ' 137' ' ' VAL . 8.8 mt -65.66 -20.92 66.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.11 176.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.436 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 3.7 m -55.89 -48.91 74.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.694 0.283 . . . . 0.0 110.538 176.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -69.24 -34.73 75.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.764 0.316 . . . . 0.0 110.334 176.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.483 HD11 HG23 ' A' ' 181' ' ' VAL . 2.9 tm? -59.75 -54.0 51.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.987 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 30.5 m -69.58 -41.86 80.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.389 -174.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -66.68 -36.37 82.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.447 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -61.03 -44.9 96.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.751 0.31 . . . . 0.0 110.752 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.498 ' HB2' HD22 ' A' ' 212' ' ' LEU . 55.6 m-85 -85.23 -10.48 56.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.008 0.432 . . . . 0.0 110.799 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.492 ' HA ' ' HB2' ' A' ' 212' ' ' LEU . 38.9 ttpt -70.13 -34.03 72.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.608 0.718 . . . . 0.0 109.228 174.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -88.01 -25.75 22.96 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.043 176.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -128.31 90.78 45.97 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.801 -174.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -55.17 127.98 28.57 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.177 2.584 . . . . 0.0 112.587 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' MET . . . . . 0.519 ' HG3' HD12 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -91.63 123.78 35.28 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.956 0.408 . . . . 0.0 110.415 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.579 HG22 ' HB ' ' A' ' 209' ' ' VAL . 36.3 t -93.87 134.89 29.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 120.85 0.357 . . . . 0.0 111.871 -176.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.54 ' O ' HG12 ' A' ' 203' ' ' VAL . 0.7 OUTLIER -79.2 163.64 24.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.49 169.245 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 7.7 t -76.33 -10.0 59.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.452 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.415 HD12 ' N ' ' A' ' 206' ' ' LEU . 5.4 mp -92.2 5.03 51.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.432 178.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 90.99 -14.5 63.27 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.703 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.486 ' O ' ' HB2' ' A' ' 204' ' ' GLU . 88.2 m -71.6 111.42 6.88 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.579 ' HB ' HG22 ' A' ' 203' ' ' VAL . 1.4 p -111.81 128.27 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-O 121.82 0.819 . . . . 0.0 110.854 176.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.69 HD11 HG21 ' A' ' 168' ' ' THR . 0.3 OUTLIER -84.8 103.49 13.93 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.83 -172.884 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -90.88 89.41 7.45 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.216 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.498 HD22 ' HB2' ' A' ' 197' ' ' TYR . 7.6 mp -71.79 108.55 5.15 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.314 177.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -115.11 -56.01 2.41 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -177.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.624 ' O ' ' HA ' ' A' ' 134' ' ' SER . 5.0 pm0 -131.95 136.46 28.32 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 121.068 0.461 . . . . 0.0 110.746 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.01 137.54 26.75 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.918 2.412 . . . . 0.0 112.798 -178.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.558 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.2 OUTLIER -76.7 98.88 4.89 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 175.792 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -63.77 139.18 58.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.905 0.384 . . . . 0.0 110.574 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 7.5 p -61.66 110.49 1.51 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.394 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 2.0 t -87.28 105.22 17.08 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.463 0.649 . . . . 0.0 109.517 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.658 -0.686 . . . . 0.0 110.138 -175.245 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' -4' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 120.944 0.402 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -145.57 -160.7 1.18 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' -2' ' ' THR . . . . . 0.705 ' HA ' ' CD2' ' A' ' 169' ' ' HIS . 0.5 OUTLIER -51.66 -69.64 0.11 Allowed 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 120.883 0.373 . . . . 0.0 110.578 170.901 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' -1' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 60.49 50.86 5.56 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 173.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 0' ' ' PTR . . . . . 0.746 ' HA ' ' O ' ' A' ' 169' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.538 ' HB2' ' CG2' ' A' ' 168' ' ' THR . . . -55.97 133.33 51.56 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.746 -172.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 71.8 m -76.05 -41.81 49.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.742 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.519 HD12 ' HG3' ' A' ' 202' ' ' MET . 8.5 mm 68.48 120.54 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.291 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 1.3 m -120.32 -17.88 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 48.02 71.29 1.64 Allowed Pre-proline 0 C--N 1.317 -0.832 0 O-C-N 123.373 0.421 . . . . 0.0 111.544 -175.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.564 ' CD ' ' HB ' ' A' ' 203' ' ' VAL . 5.5 Cg_exo . . . . . 0 C--O 1.248 0.99 0 C-N-CA 122.856 2.37 . . . . 0.0 111.445 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.785 0 N-CA-C 112.014 -0.434 . . . . 0.0 112.014 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -62.21 -24.33 76.11 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.083 2.522 . . . . 0.0 113.194 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 64.5 mtt -97.99 21.2 11.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.082 0.468 . . . . 0.0 110.891 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -118.98 98.51 6.22 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 175.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -65.68 117.22 39.25 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.925 -173.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -76.9 -9.51 18.13 Favored 'Trans proline' 0 CA--C 1.515 -0.471 0 C-N-CA 122.811 2.341 . . . . 0.0 109.29 169.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.703 ' HB ' ' CG ' ' A' ' 113' ' ' PHE . 22.9 p -88.12 7.37 31.92 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 113.619 -1.628 . . . . 0.0 110.738 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.4 p -71.26 47.07 0.11 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.483 0.659 . . . . 0.0 111.258 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.43 ' HG3' ' CZ2' ' A' ' 112' ' ' TRP . 70.8 mm-40 -122.03 -176.9 3.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.84 -176.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -85.92 -23.43 27.0 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -176.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.452 ' HE3' HG22 ' A' ' 137' ' ' VAL . 2.8 p-90 -85.16 -20.34 30.4 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.812 -177.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.703 ' CG ' ' HB ' ' A' ' 108' ' ' THR . 60.2 t80 -80.27 127.15 32.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.98 0.419 . . . . 0.0 110.405 173.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -118.56 113.09 20.74 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.436 ' HA2' ' CZ ' ' A' ' 113' ' ' PHE . . . -50.44 -82.4 0.04 OUTLIER Glycine 0 C--O 1.237 0.315 0 O-C-N 123.971 0.794 . . . . 0.0 114.599 -169.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -99.83 90.59 4.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.185 0.517 . . . . 0.0 111.393 -173.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.414 HD13 ' HA ' ' A' ' 122' ' ' ALA . 44.5 mt -126.21 130.56 51.19 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.164 173.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.4 m -81.85 170.82 15.22 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 171.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -54.66 -47.45 70.69 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.45 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -64.71 -44.39 90.4 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 122.704 0.402 . . . . 0.0 110.974 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -62.7 -46.75 86.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.238 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.685 ' HB2' ' HD2' ' A' ' 138' ' ' ARG . . . -60.32 -34.32 73.64 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.945 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.665 ' OE1' ' HA ' ' B' ' -3' ' ' GLN . 3.7 tt0 -69.93 -46.64 64.91 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.529 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -56.92 -36.21 69.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.647 175.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.64 -52.59 64.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.601 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.559 ' CD2' HD12 ' A' ' 216' ' ' LEU . 58.2 mt -75.12 -49.43 19.62 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.568 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.7 m -61.95 -29.58 70.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.326 -172.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -95.56 -51.97 4.32 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 177.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.415 ' HD3' HG21 ' A' ' 219' ' ' THR . 55.5 mttp -105.77 -0.81 25.06 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -163.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -106.09 -161.52 22.72 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.169 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -149.86 173.8 13.36 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 174.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 55.0 t60 -53.61 117.39 3.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.964 0.411 . . . . 0.0 111.025 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 100.95 -3.76 55.83 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.985 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.692 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 68.5 m -72.57 139.87 47.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.99 0.395 . . . . 0.0 110.608 178.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.488 ' HB3' HG12 ' A' ' 151' ' ' VAL . 52.1 p90 -136.92 150.82 48.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.612 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.586 HD21 ' HB2' ' A' ' 150' ' ' SER . 1.3 pt? -151.22 138.04 18.94 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.627 HG21 HD13 ' A' ' 190' ' ' LEU . 11.2 m -100.55 140.23 20.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 120.231 -0.588 . . . . 0.0 109.441 177.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.685 ' HD2' ' HB2' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -141.04 161.56 37.55 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.311 -174.683 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -72.84 132.83 44.05 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.579 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.48 ' HB2' HG13 ' A' ' 148' ' ' VAL . 29.5 t -77.37 143.46 38.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.531 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -100.6 -30.1 11.96 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.145 178.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 72.6 m -74.32 -30.73 62.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.02 0.438 . . . . 0.0 110.256 173.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -121.49 85.53 43.27 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.193 175.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.66 123.73 14.21 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.525 2.15 . . . . 0.0 111.808 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 105.94 -27.69 16.6 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.701 -176.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -89.99 171.65 9.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.247 0.546 . . . . 0.0 110.614 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -124.36 157.52 34.84 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.314 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.504 ' CG2' ' HG3' ' A' ' 138' ' ' ARG . 32.1 m -128.13 136.58 59.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.298 0.571 . . . . 0.0 110.717 174.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.906 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -91.77 109.61 20.94 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.318 -0.856 . . . . 0.0 108.848 176.81 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.586 ' HB2' HD21 ' A' ' 136' ' ' LEU . 2.1 m -102.46 132.38 48.53 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.212 -178.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.505 HG21 ' HB3' ' A' ' 210' ' ' LEU . 34.7 m -130.43 147.8 33.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.128 -172.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -92.84 105.08 17.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.744 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.422 ' O ' ' HB3' ' A' ' 166' ' ' LYS . 1.2 p -108.52 148.43 30.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.777 -175.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 93.66 169.14 38.51 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.883 177.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -101.45 140.83 35.2 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.844 0.354 . . . . 0.0 111.107 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -123.59 -3.87 8.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.399 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -96.18 -24.49 16.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.599 -176.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -100.1 23.88 34.27 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.962 178.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 55.75 37.34 28.75 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 122.682 0.393 . . . . 0.0 111.398 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 46.9 m -73.36 -20.53 60.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.155 0.502 . . . . 0.0 110.437 177.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -152.19 62.27 0.83 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 52.55 -100.01 0.09 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.751 -175.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -135.46 17.14 4.03 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.596 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -114.41 143.35 45.06 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.764 0.316 . . . . 0.0 110.395 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 14.8 m -95.96 165.41 12.28 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 174.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.422 ' HB3' ' O ' ' A' ' 153' ' ' THR . 46.1 tptt -94.65 143.09 26.72 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.5 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 69.2 t -126.62 112.61 29.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.51 0.671 . . . . 0.0 110.503 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.717 HG21 HD11 ' A' ' 210' ' ' LEU . 3.9 m -96.38 140.3 31.24 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.623 174.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.769 ' O ' ' HA ' ' B' ' 0' ' ' PTR . 18.9 m-70 -115.57 119.16 35.24 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.906 HG22 ' HB3' ' A' ' 149' ' ' LEU . 1.0 OUTLIER -98.37 134.91 35.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -178.835 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 9.8 ttm -88.6 119.04 28.69 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.395 -176.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.492 HD13 HD21 ' A' ' 190' ' ' LEU . 12.5 mt -94.05 113.73 29.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.072 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.608 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 19.9 ptp180 -74.21 118.28 16.98 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.146 0.498 . . . . 0.0 110.189 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 46.1 t -102.56 93.07 4.94 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -114.73 108.5 16.86 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.364 -176.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 57.64 48.39 14.22 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.704 0.628 . . . . 0.0 110.573 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 88.9 mt 64.82 24.88 12.85 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.768 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 10.4 tppt? -115.08 133.46 56.02 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -113.38 130.87 56.18 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 123.012 0.195 . . . . 0.0 111.026 -173.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.608 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 34.6 t0 -156.42 136.15 12.51 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.945 0.402 . . . . 0.0 110.796 175.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.544 ' HB ' ' CZ ' ' A' ' 197' ' ' TYR . 25.9 t -85.41 -15.64 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 123.69 4.23 8.16 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.251 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.483 ' HA3' ' CE1' ' B' ' 5' ' ' PHE . . . -136.19 141.14 12.18 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.812 -177.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 80.42 -158.09 41.21 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.685 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -85.76 155.16 21.15 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -84.94 130.58 34.61 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -105.89 153.54 21.8 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.031 0.443 . . . . 0.0 111.58 -172.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -91.61 -7.39 50.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.379 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 49.3 m -130.12 142.56 50.58 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.59 176.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.627 HD13 HG21 ' A' ' 137' ' ' VAL . 2.0 mt -72.87 -22.69 60.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.622 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.445 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 3.7 m -59.71 -46.28 89.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.671 176.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -66.3 -35.5 80.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.123 177.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.517 HD11 HG23 ' A' ' 181' ' ' VAL . 3.2 tm? -61.76 -54.96 35.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.306 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 34.6 m -66.69 -42.9 90.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.224 -173.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' A' ' 199' ' ' LYS . 27.7 mt-10 -70.38 -30.75 67.74 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.557 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -59.89 -42.93 94.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.775 0.321 . . . . 0.0 110.441 176.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.544 ' CZ ' ' HB ' ' A' ' 181' ' ' VAL . 56.3 m-85 -85.1 -13.29 50.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.207 0.527 . . . . 0.0 110.619 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 212' ' ' LEU . 39.8 ttpt -72.68 -25.33 61.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.546 0.689 . . . . 0.0 109.487 174.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.422 ' HA ' ' HE2' ' A' ' 199' ' ' LYS . 11.8 mmpt? -91.65 -36.0 13.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.903 175.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -120.78 102.15 44.78 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.623 -176.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.11 133.47 58.29 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.853 2.369 . . . . 0.0 112.58 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' MET . . . . . 0.709 ' SD ' HD12 ' B' ' 3' ' ' ILE . 7.3 ptp -96.65 128.15 43.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.493 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.612 HG22 ' HB ' ' A' ' 209' ' ' VAL . 40.6 t -101.52 137.87 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -175.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.563 ' O ' HG12 ' A' ' 203' ' ' VAL . 35.8 mt-10 -84.39 166.07 17.67 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.209 0.528 . . . . 0.0 110.382 170.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 12.1 t -77.21 -10.37 59.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.761 174.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.6 mp -91.43 8.91 34.05 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.402 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 86.77 -21.36 19.37 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.87 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 65.6 m -65.58 113.2 4.03 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.612 ' HB ' HG22 ' A' ' 203' ' ' VAL . 0.8 OUTLIER -111.64 124.66 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-O 121.785 0.802 . . . . 0.0 110.505 174.477 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.717 HD11 HG21 ' A' ' 168' ' ' THR . 0.4 OUTLIER -78.84 107.39 11.53 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.215 -172.523 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -92.3 89.43 6.84 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.836 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.528 HD22 ' HB2' ' A' ' 197' ' ' TYR . 7.4 mp -74.57 110.8 9.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.767 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -114.27 -56.21 2.41 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.692 ' O ' ' HA ' ' A' ' 134' ' ' SER . 4.3 pm0 -135.69 142.56 41.3 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 121.024 0.44 . . . . 0.0 111.103 -176.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.444 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 74.4 Cg_endo -74.27 138.1 24.45 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.992 2.461 . . . . 0.0 112.728 -178.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.559 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.3 OUTLIER -74.12 108.39 6.9 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.787 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -55.75 131.42 46.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.9 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 2.6 p -61.68 126.85 28.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.342 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.415 HG21 ' HD3' ' A' ' 129' ' ' LYS . 3.1 t -123.77 110.93 15.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.362 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.634 -0.698 . . . . 0.0 109.903 178.165 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' -4' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 120.56 0.219 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' -3' ' ' GLN . . . . . 0.665 ' HA ' ' OE1' ' A' ' 123' ' ' GLU . 4.6 pm0 -164.7 149.06 9.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.788 174.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' -2' ' ' THR . . . . . 0.581 ' HA ' ' CD2' ' A' ' 169' ' ' HIS . 3.2 p 57.32 179.69 0.05 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.743 0.782 . . . . 0.0 112.782 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' -1' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 170.57 -39.25 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -172.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 0' ' ' PTR . . . . . 0.769 ' HA ' ' O ' ' A' ' 169' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.639 ' HB2' ' CG2' ' A' ' 168' ' ' THR . . . -52.99 135.34 37.05 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 113.3 -1.773 . . . . 0.0 112.774 -170.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 22.8 m -63.78 -44.47 93.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.045 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.709 HD12 ' SD ' ' A' ' 202' ' ' MET . 4.4 mm 60.06 96.84 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 123.267 0.627 . . . . 0.0 111.017 -177.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 3.7 m -114.78 86.02 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.459 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' PHE . . . . . 0.483 ' CE1' ' HA3' ' A' ' 183' ' ' GLY . 96.0 m-85 -67.83 114.8 22.23 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.504 173.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' B' ' 5' ' ' PHE . 24.1 Cg_exo . . . . . 0 C--O 1.249 1.049 0 C-N-CA 122.67 2.246 . . . . 0.0 111.804 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.4 ' HA2' ' HD3' ' A' ' 103' ' ' PRO . . . . . . . . 0 N--CA 1.481 1.675 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.4 ' HD3' ' HA2' ' A' ' 102' ' ' GLY . 34.0 Cg_exo -60.03 -63.26 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.691 2.26 . . . . 0.0 112.415 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 90.1 mtp -130.14 21.9 5.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.16 0.505 . . . . 0.0 110.33 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.44 97.55 11.25 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.535 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -92.3 158.8 38.39 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.297 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -75.06 -7.27 18.96 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.622 2.215 . . . . 0.0 109.543 174.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.749 ' HB ' ' CG ' ' A' ' 113' ' ' PHE . 48.2 p -100.26 4.3 44.1 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 114.018 -1.447 . . . . 0.0 111.098 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 44.4 m -75.57 45.31 0.31 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.609 0.718 . . . . 0.0 110.667 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -117.11 -170.46 1.85 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.625 -175.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.527 ' O ' HG23 ' A' ' 218' ' ' THR . 33.9 mtm180 -83.05 -28.05 29.85 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -176.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.484 ' CZ2' ' HA ' ' A' ' 191' ' ' THR . 2.2 p-90 -85.66 -21.53 28.34 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -174.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.749 ' CG ' ' HB ' ' A' ' 108' ' ' THR . 80.9 t80 -79.62 121.0 24.74 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.282 0.563 . . . . 0.0 111.067 177.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.492 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 11.8 m170 -116.88 124.56 49.77 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 173.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -68.5 -95.29 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.479 -173.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -76.46 93.09 3.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.139 0.495 . . . . 0.0 111.257 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.3 mt -131.37 139.16 49.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.424 174.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.451 ' HB3' ' HG2' ' A' ' 121' ' ' GLU . 21.1 t -94.57 172.58 8.09 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 172.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.44 -52.95 46.82 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.011 -176.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.414 ' HE2' ' HB3' ' B' ' -3' ' ' GLN . 67.6 mmtt -75.71 -25.51 56.7 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.568 0.21 . . . . 0.0 111.568 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.451 ' HG2' ' HB3' ' A' ' 118' ' ' SER . 52.5 mm-40 -66.45 -47.5 72.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.108 0.48 . . . . 0.0 109.72 177.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.64 ' HB2' ' HD2' ' A' ' 138' ' ' ARG . . . -67.62 -34.16 76.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.68 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.546 ' HG3' ' HB ' ' A' ' 167' ' ' VAL . 5.9 tt0 -63.53 -47.28 82.26 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.198 177.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.82 -34.86 75.18 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.774 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.487 HD12 HD13 ' A' ' 216' ' ' LEU . 0.8 OUTLIER -56.71 -53.25 59.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.516 -179.667 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.533 ' CD2' HD12 ' A' ' 216' ' ' LEU . 58.7 mt -75.75 -44.04 43.66 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.627 -177.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 9.5 m -61.0 -35.01 75.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.29 -173.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -95.68 -52.85 3.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.073 0.463 . . . . 0.0 111.862 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -96.85 -11.33 24.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.325 -166.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -96.32 -164.15 33.35 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.82 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -153.76 173.88 15.28 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -55.13 116.02 2.56 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.928 0.394 . . . . 0.0 110.5 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 100.8 -3.27 55.89 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.525 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 42.6 p -71.12 137.48 48.88 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 117.494 0.647 . . . . 0.0 110.317 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.462 ' CB ' HG12 ' A' ' 151' ' ' VAL . 45.8 p90 -136.85 150.64 48.4 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.438 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.568 HD21 ' HB2' ' A' ' 150' ' ' SER . 1.2 pt? -153.2 134.19 14.0 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.367 176.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.642 HG21 HD13 ' A' ' 190' ' ' LEU . 10.6 m -96.89 138.75 21.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 176.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.64 ' HD2' ' HB2' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -139.55 162.81 34.16 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.869 -173.403 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -71.0 132.76 45.64 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 121.089 -0.244 . . . . 0.0 110.343 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.472 ' HB2' HG13 ' A' ' 148' ' ' VAL . 41.3 t -77.11 136.68 38.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.357 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -100.39 -26.18 13.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.826 0.346 . . . . 0.0 110.163 176.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.459 ' HB2' ' O3P' ' B' ' 0' ' ' PTR . 23.1 t -72.49 -36.0 68.3 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 172.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 47.6 m-70 -121.41 81.51 38.64 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.018 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.94 123.49 13.92 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.524 2.149 . . . . 0.0 112.267 -178.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 107.32 -26.66 17.89 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.915 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -89.99 170.64 10.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.95 0.405 . . . . 0.0 110.518 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -122.13 153.56 38.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.825 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.517 ' CG2' ' HG3' ' A' ' 138' ' ' ARG . 21.9 m -127.86 137.47 57.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.105 0.479 . . . . 0.0 110.668 176.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.912 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -92.63 110.11 21.53 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.407 178.353 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.568 ' HB2' HD21 ' A' ' 136' ' ' LEU . 2.3 m -101.65 132.63 47.23 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.517 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.497 HG21 ' HB3' ' A' ' 210' ' ' LEU . 35.1 m -131.25 149.79 33.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.988 -174.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.476 ' NH2' ' HB3' ' A' ' 156' ' ' ASP . 41.6 ttt180 -96.38 104.7 16.69 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.289 0.566 . . . . 0.0 109.925 176.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.521 ' O ' ' HB3' ' A' ' 166' ' ' LYS . 5.0 p -101.51 147.32 26.52 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.877 -178.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 85.64 173.65 49.61 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 119.942 -1.123 . . . . 0.0 112.05 -176.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -104.81 164.92 11.43 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 176.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.476 ' HB3' ' NH2' ' A' ' 152' ' ' ARG . 6.3 p-10 -96.09 -5.17 41.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.628 0.251 . . . . 0.0 111.475 -176.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -122.37 127.39 49.69 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.842 0.353 . . . . 0.0 111.03 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 96.04 14.2 46.58 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.953 176.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 55.5 92.35 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.185 0.594 . . . . 0.0 112.016 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 29.4 t -61.24 -69.77 0.22 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.515 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -122.2 -38.49 2.69 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -125.89 -169.22 1.97 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.062 173.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -65.09 -37.2 93.89 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.145 -177.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.434 ' HD2' ' N ' ' A' ' 164' ' ' LYS . 12.5 mptt -100.88 -171.49 2.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.181 0.515 . . . . 0.0 111.345 -174.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 9.6 m -76.47 147.02 38.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.481 174.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 153' ' ' THR . 47.6 tptt -96.42 137.83 34.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.013 0.435 . . . . 0.0 111.073 -177.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.546 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 70.6 t -124.68 114.42 40.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.267 173.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.72 HG21 HD11 ' A' ' 210' ' ' LEU . 18.6 m -98.96 137.51 37.39 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.965 175.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.79 ' O ' ' HA ' ' B' ' 0' ' ' PTR . 21.1 m-70 -112.29 118.83 36.35 Favored 'General case' 0 C--O 1.211 -0.922 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.912 HG22 ' HB3' ' A' ' 149' ' ' LEU . 1.0 OUTLIER -99.02 138.05 24.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.362 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.407 ' SD ' HG12 ' A' ' 148' ' ' VAL . 44.6 tpp -85.56 120.11 26.65 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.723 0.297 . . . . 0.0 110.756 -175.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 32.4 mt -94.04 107.08 18.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.623 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 3.6 ptp180 -67.55 107.1 2.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.211 0.529 . . . . 0.0 110.034 -178.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 36.8 m -98.46 93.13 6.0 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.647 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -114.31 108.91 17.55 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.005 -176.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 58.93 46.29 13.91 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 123.446 0.466 . . . . 0.0 110.698 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 91.5 mt 64.58 21.98 12.55 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.589 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 174' ' ' CYS . 1.7 tppp? -106.89 137.92 44.04 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 175.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -119.14 132.78 56.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.768 0.318 . . . . 0.0 111.454 -172.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.623 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 10.5 t70 -156.0 139.35 15.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.201 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.596 ' HB ' ' CZ ' ' A' ' 197' ' ' TYR . 37.9 t -89.23 -16.19 8.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.853 0.835 . . . . 0.0 109.075 175.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLY . . . . . 0.562 ' HA2' ' NH1' ' A' ' 173' ' ' ARG . . . 123.36 10.23 5.64 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.163 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.485 ' HA3' ' CE2' ' B' ' 5' ' ' PHE . . . -136.61 140.27 11.34 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 119.943 -1.123 . . . . 0.0 113.676 -176.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 67.13 -148.99 50.82 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 121.286 -0.483 . . . . 0.0 113.184 175.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -79.31 145.08 33.68 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.546 -0.327 . . . . 0.0 110.517 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.415 ' HG2' ' HB2' ' A' ' 180' ' ' ASP . 79.0 mtt180 -85.55 133.21 34.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.972 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -108.18 149.88 27.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.329 0.585 . . . . 0.0 111.723 -173.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.448 ' OD1' ' HE2' ' A' ' 178' ' ' LYS . 3.2 m-20 -87.55 -15.28 37.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.984 -178.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.4 p -130.64 142.4 50.44 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.231 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.642 HD13 HG21 ' A' ' 137' ' ' VAL . 9.1 mt -71.47 -22.99 61.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.232 -175.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.484 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 18.0 m -61.74 -43.52 98.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.018 0.437 . . . . 0.0 110.321 177.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -72.98 -32.92 65.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.932 177.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.487 HD11 HG23 ' A' ' 181' ' ' VAL . 3.2 tm? -61.02 -54.44 44.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.294 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 26.9 m -66.78 -43.08 90.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.629 -173.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.489 ' HA ' ' HE2' ' A' ' 198' ' ' LYS . 9.5 mt-10 -70.08 -30.46 67.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.511 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -59.02 -41.89 88.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.716 0.294 . . . . 0.0 110.498 176.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.596 ' CZ ' ' HB ' ' A' ' 181' ' ' VAL . 69.1 m-85 -86.15 -7.16 58.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.834 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.489 ' HE2' ' HA ' ' A' ' 195' ' ' GLU . 40.8 mtmt -69.27 -32.53 71.76 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 170.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.409 ' O ' ' HD3' ' A' ' 201' ' ' PRO . 1.9 tppp? -92.28 -36.2 13.34 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.856 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -111.57 96.28 31.42 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.229 -178.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 199' ' ' LYS . 25.3 Cg_exo -62.34 126.96 19.68 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.648 2.232 . . . . 0.0 112.001 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' MET . . . . . 0.662 ' HB2' HG23 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -89.1 118.11 28.58 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.07 0.462 . . . . 0.0 110.356 179.125 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.577 HG22 ' HB ' ' A' ' 209' ' ' VAL . 51.7 t -96.6 129.89 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.72 -175.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.613 ' HB2' ' O ' ' A' ' 208' ' ' THR . 2.4 mm-40 -78.63 159.98 27.79 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.668 0.747 . . . . 0.0 112.83 168.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.568 ' HB ' HG21 ' B' ' 4' ' ' VAL . 4.1 t -72.94 -10.96 60.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.024 177.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 206' ' ' LEU . 5.3 mp -88.88 -2.28 58.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.968 177.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 96.98 -26.65 21.7 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.212 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.613 ' O ' ' HB2' ' A' ' 204' ' ' GLU . 99.0 m -60.44 111.23 1.49 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.999 0.428 . . . . 0.0 110.207 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.577 ' HB ' HG22 ' A' ' 203' ' ' VAL . 0.8 OUTLIER -112.08 127.66 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-O 121.57 0.7 . . . . 0.0 110.287 175.146 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.72 HD11 HG21 ' A' ' 168' ' ' THR . 0.4 OUTLIER -82.55 111.03 18.17 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.783 -170.553 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -96.15 91.23 5.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.412 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.492 HD22 ' HB2' ' A' ' 197' ' ' TYR . 7.1 mp -74.81 109.83 8.6 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.983 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -114.58 -57.12 2.31 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.63 -0.428 . . . . 0.0 112.154 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.528 ' O ' ' HA ' ' A' ' 134' ' ' SER . 4.6 pm0 -133.16 142.83 45.88 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 121.099 0.476 . . . . 0.0 111.196 -176.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.477 ' HB3' ' HB3' ' A' ' 112' ' ' TRP . 74.5 Cg_endo -74.12 135.67 21.22 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.923 2.415 . . . . 0.0 112.479 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.533 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.4 OUTLIER -71.09 114.37 9.08 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.056 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -52.18 131.57 32.5 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 123.621 0.576 . . . . 0.0 110.863 -178.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 111' ' ' ARG . 18.1 p -73.49 107.9 6.04 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.064 0.459 . . . . 0.0 110.918 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 6.1 t -93.17 105.35 17.45 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 30.2 mtt180 . . . . . 0 C--O 1.247 0.949 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.17 -171.885 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' -4' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 . . . . . 0 N--CA 1.478 0.96 0 CA-C-O 120.957 0.408 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' -3' ' ' GLN . . . . . 0.414 ' HB3' ' HE2' ' A' ' 120' ' ' LYS . 14.0 pt20 -133.56 138.0 45.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.775 -175.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' -2' ' ' THR . . . . . 0.551 ' HA ' ' CD2' ' A' ' 169' ' ' HIS . 0.8 OUTLIER 43.56 -90.82 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 O-C-N 124.293 0.995 . . . . 0.0 113.611 176.339 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' -1' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 75.05 -41.73 0.47 Allowed 'General case' 0 N--CA 1.47 0.567 0 O-C-N 123.987 0.805 . . . . 0.0 109.957 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 0' ' ' PTR . . . . . 0.79 ' HA ' ' O ' ' A' ' 169' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.502 ' HA ' ' OE1' ' A' ' 204' ' ' GLU . . . -50.18 128.23 18.76 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 113.981 -1.463 . . . . 0.0 111.292 -175.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 13.3 m -69.35 -44.02 72.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.171 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.662 HG23 ' HB2' ' A' ' 202' ' ' MET . 15.5 mm 75.27 103.55 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 123.206 0.602 . . . . 0.0 111.398 175.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.568 HG21 ' HB ' ' A' ' 205' ' ' THR . 2.8 m -131.51 86.78 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.508 177.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' PHE . . . . . 0.485 ' CE2' ' HA3' ' A' ' 183' ' ' GLY . 67.5 m-85 -57.2 106.77 0.73 Allowed Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.502 177.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo . . . . . 0 C--O 1.246 0.906 0 C-N-CA 122.76 2.307 . . . . 0.0 112.067 -175.489 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.699 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.83 -166.76 0.36 Allowed 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.864 2.376 . . . . 0.0 112.166 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 97.1 mmm -81.39 78.14 8.19 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.19 0.519 . . . . 0.0 110.479 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -114.62 57.15 0.71 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.285 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.482 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 3.0 m-20 -64.99 127.23 92.59 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.859 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 4.1 Cg_exo -75.63 -5.44 16.5 Favored 'Trans proline' 0 CA--C 1.515 -0.437 0 C-N-CA 123.114 2.542 . . . . 0.0 110.46 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.614 ' HB ' ' CD1' ' A' ' 113' ' ' PHE . 40.6 p -92.49 6.79 45.82 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.079 -1.419 . . . . 0.0 111.121 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.7 t -75.31 52.7 0.62 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.521 0.676 . . . . 0.0 110.588 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.477 ' HG3' ' CZ2' ' A' ' 112' ' ' TRP . 65.3 mm-40 -130.92 169.6 15.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.292 -177.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.423 ' O ' HG23 ' A' ' 218' ' ' THR . 18.7 mmt180 -83.67 -11.61 57.0 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -170.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.518 ' HE3' HG22 ' A' ' 137' ' ' VAL . 1.5 p-90 -92.96 -12.04 31.77 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.054 177.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.614 ' CD1' ' HB ' ' A' ' 108' ' ' THR . 57.5 t80 -84.69 119.5 25.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.385 0.612 . . . . 0.0 110.843 174.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -111.94 117.03 31.61 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -65.11 -66.57 2.39 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.739 -0.664 . . . . 0.0 113.261 -174.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -100.23 104.99 16.52 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.288 0.566 . . . . 0.0 111.34 -175.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 17.4 mt -154.56 130.74 10.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.598 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 68.3 p -84.03 173.06 11.45 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 172.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.73 -49.84 63.82 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.65 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.0 mmtm -61.24 -45.64 93.69 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 123.942 0.436 . . . . 0.0 111.526 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -66.79 -47.22 72.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.677 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.488 ' HB3' ' NH1' ' A' ' 138' ' ' ARG . . . -63.85 -33.87 76.65 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.088 0.47 . . . . 0.0 110.771 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.537 ' HG3' ' HB ' ' A' ' 167' ' ' VAL . 9.1 tt0 -67.26 -46.43 73.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.426 176.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -60.76 -33.25 72.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.757 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.581 HD12 HD13 ' A' ' 216' ' ' LEU . 0.5 OUTLIER -55.69 -52.32 64.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.178 0.514 . . . . 0.0 110.154 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.571 ' CD2' HD12 ' A' ' 216' ' ' LEU . 42.5 mt -75.62 -47.29 27.15 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.5 m -64.18 -33.29 75.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.294 -172.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -96.99 -53.28 3.56 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -91.35 -31.97 15.86 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -171.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -86.95 -163.27 38.61 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.191 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.518 ' C ' ' HD3' ' A' ' 152' ' ' ARG . 0.5 OUTLIER -146.4 174.41 11.4 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 177.813 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -50.86 120.25 4.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.85 0.357 . . . . 0.0 110.937 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.462 ' HA3' ' HD3' ' A' ' 213' ' ' LYS . . . 98.39 -4.51 60.21 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.199 178.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.628 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 66.9 m -72.84 138.51 46.38 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 176.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.448 ' CB ' HG12 ' A' ' 151' ' ' VAL . 49.4 p90 -136.63 149.12 47.82 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.986 0.422 . . . . 0.0 110.62 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.558 ' CD2' ' HB3' ' A' ' 150' ' ' SER . 1.2 pt? -149.99 136.66 19.21 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.655 HG21 HD13 ' A' ' 190' ' ' LEU . 16.2 m -99.5 133.96 40.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.488 ' NH1' ' HB3' ' A' ' 122' ' ' ALA . 10.7 ptt-85 -129.81 172.09 12.02 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -178.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -76.98 127.27 32.4 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.416 ' HB2' HG23 ' A' ' 148' ' ' VAL . 46.2 t -69.55 133.3 47.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.39 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -96.19 -26.03 15.6 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.552 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 41.6 m -81.0 -25.67 37.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.924 0.393 . . . . 0.0 109.94 174.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -126.04 87.23 56.45 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.983 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.0 124.18 15.11 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.342 2.028 . . . . 0.0 111.255 176.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.529 ' O ' ' HB3' ' A' ' 174' ' ' CYS . . . 101.77 -10.44 57.38 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.079 -177.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -114.36 171.9 7.34 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.405 ' CE1' ' HE2' ' A' ' 179' ' ' TYR . 96.6 m-85 -125.8 163.99 21.66 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.832 0.349 . . . . 0.0 110.347 -177.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 4.7 t -125.37 127.27 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.923 -177.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.893 ' HB3' HG22 ' A' ' 170' ' ' VAL . 1.2 tp -91.46 109.36 20.65 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.558 ' HB3' ' CD2' ' A' ' 136' ' ' LEU . 40.3 t -101.89 124.88 48.27 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.541 HG21 ' HB3' ' A' ' 210' ' ' LEU . 34.8 m -128.28 142.95 42.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.829 -173.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.518 ' HD3' ' C ' ' A' ' 131' ' ' LYS . 73.2 ttt180 -90.04 103.14 15.84 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.369 0.604 . . . . 0.0 109.688 176.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.504 HG21 HD12 ' A' ' 210' ' ' LEU . 1.5 p -107.42 148.62 28.89 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.799 -1.092 . . . . 0.0 110.162 -177.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 93.57 143.16 12.8 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 119.67 -1.252 . . . . 0.0 111.21 -175.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -104.78 111.13 23.75 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.586 0.708 . . . . 0.0 110.828 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -68.79 -39.2 80.29 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 122.324 1.059 . . . . 0.0 108.878 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -84.36 93.1 8.18 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.069 176.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 143.1 -5.81 1.96 Allowed Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.496 -171.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.485 ' HA ' ' HB3' ' A' ' 162' ' ' ASP . 46.4 mt-10 72.43 26.61 2.56 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.196 0.599 . . . . 0.0 111.927 173.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 12.5 m -90.59 76.16 6.57 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 8.0 t30 61.8 68.4 0.7 Allowed 'General case' 0 C--O 1.231 0.105 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -170.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.485 ' HB3' ' HA ' ' A' ' 159' ' ' GLU . 4.8 p-10 -86.33 169.7 12.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.278 -174.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 94.32 -50.73 2.13 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -131.04 121.81 25.67 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 172.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 41.6 m -81.66 149.93 28.3 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.858 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -82.41 138.15 34.51 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.262 0.554 . . . . 0.0 111.893 -177.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.537 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 69.8 t -120.84 113.76 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.768 169.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.771 HG21 HD11 ' A' ' 210' ' ' LEU . 21.6 m -90.2 140.65 29.47 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.462 172.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.8 ' O ' ' HA ' ' B' ' 0' ' ' PTR . 19.4 m-70 -118.47 116.4 26.6 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.893 HG22 ' HB3' ' A' ' 149' ' ' LEU . 0.8 OUTLIER -98.53 138.95 21.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -177.143 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 38.8 tpp -84.91 116.51 23.38 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.995 0.426 . . . . 0.0 110.792 -175.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.567 HD13 HD21 ' A' ' 190' ' ' LEU . 24.5 mt -97.4 108.12 21.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.184 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.682 ' O ' ' HA ' ' A' ' 179' ' ' TYR . 77.3 mtm180 -65.56 123.24 19.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.487 176.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.529 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 48.3 t -116.82 91.6 3.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.459 0.647 . . . . 0.0 109.562 174.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -114.51 114.53 25.91 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.235 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 57.16 45.12 21.19 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.661 0.601 . . . . 0.0 111.116 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 95.7 mt 63.79 22.57 13.11 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.943 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -113.43 132.24 55.71 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 172.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.682 ' HA ' ' O ' ' A' ' 173' ' ' ARG . 71.1 m-85 -110.16 137.57 47.73 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.206 -173.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -152.91 127.35 9.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.121 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.44 HG23 HD11 ' A' ' 193' ' ' LEU . 3.1 t -77.58 -0.64 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-O 121.707 0.765 . . . . 0.0 111.567 -176.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 124.99 -19.44 6.89 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.067 177.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.556 ' HA3' ' CE2' ' B' ' 5' ' ' PHE . . . -137.56 159.6 24.92 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 121.024 -0.607 . . . . 0.0 112.032 177.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 89.32 -135.31 12.9 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.055 175.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -116.06 145.03 43.33 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.56 0.219 . . . . 0.0 110.831 -176.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -75.69 128.79 35.96 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 175.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -105.92 144.04 33.22 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.808 0.337 . . . . 0.0 110.725 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -76.01 -9.81 58.91 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.752 -174.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 35.4 p -140.74 143.9 35.24 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.655 HD13 HG21 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -67.35 -23.08 65.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.914 179.674 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.49 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 13.9 m -61.1 -49.01 79.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.355 175.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -65.63 -30.88 71.65 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.833 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.456 ' HB3' HD23 ' A' ' 190' ' ' LEU . 3.3 tm? -64.32 -54.78 27.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.404 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 27.8 m -70.19 -42.21 79.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.558 -174.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -61.42 -39.11 89.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.91 0.386 . . . . 0.0 111.051 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -59.99 -42.27 93.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.823 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.501 ' HB2' HD22 ' A' ' 212' ' ' LEU . 36.6 m-85 -85.24 -13.59 49.37 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.124 0.488 . . . . 0.0 110.951 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -74.2 -27.3 60.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.446 0.641 . . . . 0.0 109.351 176.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -88.79 -36.5 16.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.477 175.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -119.92 105.33 42.98 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.425 -176.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.28 128.96 32.68 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.884 2.389 . . . . 0.0 112.474 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' MET . . . . . 0.784 ' SD ' HD23 ' A' ' 210' ' ' LEU . 7.4 ptp -89.6 122.81 33.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.261 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.595 HG22 ' HB ' ' A' ' 209' ' ' VAL . 44.7 t -101.53 139.8 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 120.703 0.287 . . . . 0.0 111.59 -176.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.497 ' O ' HG12 ' A' ' 203' ' ' VAL . 25.6 mt-10 -89.22 162.35 15.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.37 . . . . 0.0 110.245 170.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.429 ' HB ' HG11 ' B' ' 4' ' ' VAL . 14.9 t -74.08 -11.91 60.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.324 0.583 . . . . 0.0 110.024 177.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.434 HD12 ' N ' ' A' ' 206' ' ' LEU . 5.0 mp -83.98 -8.31 59.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.018 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 101.04 -18.89 53.93 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.007 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 58.9 m -65.65 111.76 3.33 Favored 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 175.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.595 ' HB ' HG22 ' A' ' 203' ' ' VAL . 0.9 OUTLIER -112.22 126.99 69.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.6 0.714 . . . . 0.0 110.348 173.68 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.784 HD23 ' SD ' ' A' ' 202' ' ' MET . 0.4 OUTLIER -82.03 110.06 16.93 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.336 -172.188 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -85.17 89.51 7.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.584 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.501 HD22 ' HB2' ' A' ' 197' ' ' TYR . 8.2 mp -77.87 99.19 5.88 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 175.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.462 ' HD3' ' HA3' ' A' ' 133' ' ' GLY . 28.6 mtpp -109.61 -48.84 3.17 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.141 -173.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.628 ' O ' ' HA ' ' A' ' 134' ' ' SER . 0.4 OUTLIER -147.45 147.19 27.33 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 121.081 0.467 . . . . 0.0 111.007 178.006 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.458 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 93.0 Cg_endo -78.39 147.27 22.69 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.958 2.439 . . . . 0.0 113.222 -175.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.581 HD13 HD12 ' A' ' 125' ' ' LEU . 0.3 OUTLIER -83.86 109.88 17.92 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.726 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -56.55 145.98 26.42 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.43 0.456 . . . . 0.0 111.29 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 111' ' ' ARG . 4.8 p -82.13 136.02 35.22 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.58 -177.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.8 t -114.15 118.08 33.01 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.288 173.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 . . . . . 0 C--O 1.246 0.91 0 CA-C-O 118.411 -0.804 . . . . 0.0 110.484 -176.377 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' -4' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 120.949 0.404 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -92.3 158.79 15.92 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' -2' ' ' THR . . . . . 0.688 ' HA ' ' CD2' ' A' ' 169' ' ' HIS . 4.4 m 55.66 -110.68 0.57 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 118.932 -0.556 . . . . 0.0 109.715 -175.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' -1' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 76.84 -38.19 0.3 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.006 0.522 . . . . 0.0 111.225 169.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 0' ' ' PTR . . . . . 0.8 ' HA ' ' O ' ' A' ' 169' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.588 ' HB2' ' CG2' ' A' ' 168' ' ' THR . . . -56.63 141.33 43.86 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 113.929 -1.487 . . . . 0.0 112.384 -171.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 46.2 m -76.02 -49.44 17.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.176 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.576 HD12 ' SD ' ' A' ' 202' ' ' MET . 8.0 mm 73.32 94.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 123.244 0.617 . . . . 0.0 110.732 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.605 ' O ' ' HD3' ' B' ' 6' ' ' PRO . 13.8 m -103.64 113.46 40.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.624 0.726 . . . . 0.0 109.991 176.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' PHE . . . . . 0.556 ' CE2' ' HA3' ' A' ' 183' ' ' GLY . 89.4 m-85 -85.87 100.36 1.3 Allowed Pre-proline 0 C--N 1.308 -1.227 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.8 171.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.605 ' HD3' ' O ' ' B' ' 4' ' ' VAL . 6.9 Cg_endo . . . . . 0 C--O 1.251 1.131 0 C-N-CA 122.929 2.419 . . . . 0.0 111.516 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo . . . . . 0 CA--C 1.516 -0.38 0 CA-C-O 122.061 0.775 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.6 ' HB ' ' CG ' ' A' ' 113' ' ' PHE . 35.7 p -100.27 5.58 44.59 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.21 -176.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.8 m -75.26 58.73 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.515 0.674 . . . . 0.0 110.579 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.511 ' HG3' ' CZ2' ' A' ' 112' ' ' TRP . 81.5 mm-40 -129.65 -178.5 4.72 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.821 -176.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -84.71 -26.0 27.98 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -174.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.541 ' CZ2' ' HA ' ' A' ' 191' ' ' THR . 0.7 OUTLIER -85.71 -19.63 30.56 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -177.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.6 ' CG ' ' HB ' ' A' ' 108' ' ' THR . 72.2 t80 -81.45 123.76 28.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.012 0.434 . . . . 0.0 110.551 175.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -110.52 139.57 45.64 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.62 -88.87 0.03 OUTLIER Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.94 -0.648 . . . . 0.0 113.528 -174.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -100.52 106.63 18.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.03 0.443 . . . . 0.0 111.439 -175.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 64.0 mt -143.45 135.89 27.18 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.789 175.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.6 p -93.69 174.41 7.19 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -50.23 -54.3 20.17 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 121.558 -0.353 . . . . 0.0 113.856 -174.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 60.7 mmtt -77.99 -25.33 48.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 117.27 0.535 . . . . 0.0 111.87 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -65.33 -44.71 86.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.801 0.334 . . . . 0.0 110.627 175.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.553 ' HB2' ' HD3' ' A' ' 138' ' ' ARG . . . -64.11 -34.01 77.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.325 0.583 . . . . 0.0 110.494 176.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.546 ' HG3' ' HB ' ' A' ' 167' ' ' VAL . 16.3 tt0 -69.68 -48.36 59.99 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.962 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -56.47 -35.78 68.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.325 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.64 -51.52 69.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.273 177.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.549 ' CD2' HD12 ' A' ' 216' ' ' LEU . 27.7 mt -74.63 -46.41 38.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.687 -177.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.6 m -67.64 -33.01 74.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.029 -173.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -95.83 -48.27 5.81 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -100.14 -25.65 14.21 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -171.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -89.53 -159.75 35.76 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.573 -177.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -153.1 175.16 13.31 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -55.31 121.0 7.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.876 0.37 . . . . 0.0 111.275 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 99.54 -3.35 57.71 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.765 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 56.4 m -74.39 140.25 44.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.646 0.26 . . . . 0.0 110.503 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.508 ' CB ' HG12 ' A' ' 151' ' ' VAL . 52.3 p90 -137.45 149.02 46.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.165 177.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.534 HD21 ' HB2' ' A' ' 150' ' ' SER . 1.1 pt? -148.91 139.51 22.63 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 175.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.747 HG21 HD13 ' A' ' 190' ' ' LEU . 10.1 m -104.23 145.04 13.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.553 ' HD3' ' HB2' ' A' ' 122' ' ' ALA . 26.4 ptt85 -146.29 168.21 21.63 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.867 -178.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -76.74 131.41 38.72 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 123.247 0.342 . . . . 0.0 110.63 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.6 t -72.39 137.12 46.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.522 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -98.02 -28.78 13.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.845 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 39.0 m -78.8 -34.1 45.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.027 0.442 . . . . 0.0 109.862 175.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -117.82 78.04 12.11 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.876 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.26 123.1 12.16 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.088 1.859 . . . . 0.0 111.72 -177.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 113.97 -16.68 20.46 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.608 -176.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -109.37 171.68 7.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.06 0.457 . . . . 0.0 110.29 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -123.45 163.6 20.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.604 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 33.3 m -134.11 143.05 39.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.152 0.501 . . . . 0.0 111.401 177.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.907 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -101.86 111.09 23.22 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.225 177.516 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.573 ' HA ' ' HA ' ' A' ' 169' ' ' HIS . 1.2 m -104.17 131.71 51.18 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.592 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' A' ' 210' ' ' LEU . 32.7 m -130.57 152.08 36.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.456 -174.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.403 ' HB2' ' HB3' ' A' ' 126' ' ' LEU . 56.7 ttt180 -100.43 103.8 15.18 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.109 177.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 32.4 p -99.72 147.36 25.52 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.54 -177.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.502 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.15 -176.627 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.681 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.546 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 56.1 t -100.01 133.32 43.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.364 0.602 . . . . 0.0 111.724 -177.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.65 HG21 HD11 ' A' ' 210' ' ' LEU . 1.1 m -119.18 141.41 48.89 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.763 171.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 150' ' ' SER . 13.4 m-70 -108.24 138.17 44.97 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.907 HG22 ' HB3' ' A' ' 149' ' ' LEU . 1.2 m -114.35 138.62 43.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 41.2 tpp -81.91 126.71 32.23 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.878 0.37 . . . . 0.0 111.213 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.514 HD13 HD21 ' A' ' 190' ' ' LEU . 32.6 mt -104.9 107.43 22.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 175.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.604 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 4.7 ptp180 -70.44 119.35 14.48 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.023 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . 0.672 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 49.7 t -118.11 93.36 4.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.165 0.507 . . . . 0.0 110.469 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -116.62 125.65 52.11 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.769 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 57.18 39.15 29.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.9 -176.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 82.9 mt 63.16 31.75 15.49 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.324 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.672 ' O ' ' HA ' ' A' ' 174' ' ' CYS . 11.9 tppt? -110.99 132.23 54.39 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.471 ' CD2' ' HG ' ' A' ' 190' ' ' LEU . 81.8 m-85 -111.83 135.09 52.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.585 0.231 . . . . 0.0 111.176 -174.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.604 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 18.4 t0 -157.32 136.39 11.77 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.5 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.535 ' HB ' ' CZ ' ' A' ' 197' ' ' TYR . 56.0 t -90.65 -14.21 8.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.77 0.795 . . . . 0.0 109.031 174.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . 0.541 ' HA2' ' NH1' ' A' ' 173' ' ' ARG . . . 123.57 5.56 7.7 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.248 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -137.21 141.24 12.11 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.662 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 71.78 -158.45 53.47 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.241 -0.504 . . . . 0.0 113.083 174.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -74.08 150.73 40.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.894 0.378 . . . . 0.0 110.738 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 186' ' ' ARG . 54.2 mtt180 -99.26 132.89 44.27 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.67 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -110.9 150.56 29.02 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.138 -171.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -88.62 0.39 56.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.17 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.51 141.84 50.49 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.656 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.747 HD13 HG21 ' A' ' 137' ' ' VAL . 1.0 OUTLIER -77.28 -22.86 51.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.045 -175.476 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.541 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 16.4 m -61.97 -44.15 97.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.004 0.431 . . . . 0.0 110.275 177.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -66.41 -34.17 77.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.328 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.503 HD11 HG23 ' A' ' 181' ' ' VAL . 3.2 tm? -62.27 -54.64 37.77 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.199 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 27.2 m -66.39 -39.91 85.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.267 -175.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 191' ' ' THR . 27.8 mt-10 -68.17 -31.7 71.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.274 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -59.15 -47.26 85.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.087 0.47 . . . . 0.0 110.243 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.641 ' HB2' HD22 ' A' ' 212' ' ' LEU . 76.3 m-85 -85.73 -8.85 57.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.762 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.416 ' HA ' ' HB2' ' A' ' 212' ' ' LEU . 39.4 ttpt -70.95 -23.74 62.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.67 175.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -105.74 -22.85 12.86 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.564 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -126.42 89.0 53.22 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.523 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.69 132.29 51.22 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.236 2.624 . . . . 0.0 112.799 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . 0.516 ' HB2' HG23 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -97.48 137.31 36.63 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.066 179.725 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.621 HG22 ' HB ' ' A' ' 209' ' ' VAL . 36.3 t -108.39 137.11 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -169.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.547 ' O ' HG12 ' A' ' 203' ' ' VAL . 27.4 mt-10 -81.71 163.99 22.08 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.817 0.341 . . . . 0.0 110.182 169.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.0 t -76.29 -10.62 59.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.796 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.9 mp -90.95 -1.23 57.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.452 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 103.89 -23.72 31.57 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.471 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 23.2 m -60.77 111.33 1.59 Allowed 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 120.882 0.372 . . . . 0.0 110.307 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.621 ' HB ' HG22 ' A' ' 203' ' ' VAL . 1.1 p -112.58 128.66 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-O 121.826 0.822 . . . . 0.0 110.833 175.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.65 HD11 HG21 ' A' ' 168' ' ' THR . 0.3 OUTLIER -81.55 105.31 12.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 113.987 -1.46 . . . . 0.0 110.219 -170.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -93.89 90.47 6.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.637 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.641 HD22 ' HB2' ' A' ' 197' ' ' TYR . 6.8 mp -73.85 106.65 5.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.768 178.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -114.6 -55.96 2.43 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.633 ' O ' ' HA ' ' A' ' 134' ' ' SER . 0.7 OUTLIER -134.46 142.22 41.98 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 121.076 0.465 . . . . 0.0 111.179 -179.139 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.413 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 78.7 Cg_endo -76.38 142.24 23.63 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.951 2.434 . . . . 0.0 112.963 -175.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.549 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.3 OUTLIER -76.6 110.06 10.85 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 175.667 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -57.58 139.67 52.92 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 123.384 0.428 . . . . 0.0 111.103 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 13.4 p -71.99 108.0 5.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.498 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 3.6 t . . . . . 0 C--N 1.318 -0.774 0 CA-C-O 121.68 0.753 . . . . 0.0 109.92 179.344 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.481 ' HA ' ' OE1' ' A' ' 204' ' ' GLU . . . . . . . . 0 N--CA 1.476 0.869 0 CA-C-O 122.503 1.145 . . . . 0.0 113.702 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.52 -44.58 28.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.283 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.516 HG23 ' HB2' ' A' ' 202' ' ' MET . 4.2 mm 55.36 73.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.566 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 2.3 m . . . . . 0 C--N 1.32 -0.694 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.591 179.917 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.49 ' HB2' ' H ' ' A' ' 190' ' ' LEU . 84.2 Cg_endo . . . . . 0 CA--C 1.517 -0.365 0 CA-C-O 121.478 0.533 . . . . 0.0 111.964 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.714 ' HB ' ' CG ' ' A' ' 113' ' ' PHE . 34.7 p -100.19 7.85 44.23 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.562 -171.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 26.7 m -74.68 49.12 0.39 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.169 0.509 . . . . 0.0 110.939 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.407 ' HG3' ' CZ2' ' A' ' 112' ' ' TRP . 70.4 mm-40 -127.04 174.11 9.13 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.662 -176.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -79.55 -20.05 47.99 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -173.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.503 ' HB3' ' CB ' ' A' ' 215' ' ' PRO . 1.8 p-90 -85.95 -19.81 29.89 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.875 -178.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.714 ' CG ' ' HB ' ' A' ' 108' ' ' THR . 75.4 t80 -77.92 124.67 28.29 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.151 0.5 . . . . 0.0 110.707 175.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -122.11 107.04 11.72 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -51.84 -72.09 0.56 Allowed Glycine 0 CA--C 1.519 0.307 0 N-CA-C 114.744 0.657 . . . . 0.0 114.744 -167.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -100.29 86.34 3.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.347 0.594 . . . . 0.0 112.156 -173.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.475 ' O ' ' HD2' ' A' ' 138' ' ' ARG . 33.1 mt -133.38 133.27 42.22 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.165 175.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 35.4 t -93.6 172.76 8.06 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 168.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 123' ' ' GLU . . . -51.77 -44.27 54.88 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.245 -0.502 . . . . 0.0 112.797 -177.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.408 ' HD3' ' N ' ' A' ' 120' ' ' LYS . 3.1 mppt? -69.36 -35.03 75.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.959 0.409 . . . . 0.0 110.607 -175.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -72.61 -47.26 49.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.402 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.492 ' HB2' ' HD3' ' A' ' 138' ' ' ARG . . . -62.56 -34.06 76.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.431 177.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.505 ' HG3' ' HB ' ' A' ' 167' ' ' VAL . 3.7 tt0 -65.36 -50.33 65.97 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.694 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -58.94 -36.22 74.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.418 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.475 HD12 HD13 ' A' ' 216' ' ' LEU . 0.7 OUTLIER -58.48 -53.66 55.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.768 178.368 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.542 ' CD2' HD12 ' A' ' 216' ' ' LEU . 61.3 mt -75.39 -48.44 22.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.759 -176.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.7 m -61.9 -32.78 73.19 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.192 -172.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -97.44 -53.87 3.32 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.406 ' CD ' HG21 ' A' ' 219' ' ' THR . 96.9 mttt -91.58 -23.37 19.91 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -169.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -93.32 -160.24 35.2 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.057 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -152.3 175.73 12.35 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 175.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -58.54 125.15 22.18 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 177.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.505 ' HA2' ' O ' ' A' ' 211' ' ' GLN . . . 103.72 -10.98 53.22 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.113 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.708 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 27.8 m -78.65 139.59 38.51 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.658 0.266 . . . . 0.0 110.376 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.527 ' CB ' HG12 ' A' ' 151' ' ' VAL . 44.9 p90 -137.02 150.38 48.06 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.409 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.5 ' CD2' ' HB2' ' A' ' 150' ' ' SER . 1.1 pt? -149.04 136.41 20.17 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.697 HG21 HD13 ' A' ' 190' ' ' LEU . 5.6 m -100.42 139.99 20.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.547 178.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.492 ' HD3' ' HB2' ' A' ' 122' ' ' ALA . 17.6 ptt85 -141.8 167.73 21.45 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.459 -176.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -80.63 133.79 35.79 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.496 ' HB2' HG13 ' A' ' 148' ' ' VAL . 39.2 t -76.14 139.13 41.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.934 0.397 . . . . 0.0 110.048 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -99.87 -18.01 17.35 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.669 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.4 p -84.93 -26.67 27.08 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 171.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -123.34 78.63 53.51 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.178 176.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.97 124.55 15.94 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.869 2.379 . . . . 0.0 112.303 -178.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 106.79 -16.85 39.61 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.012 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -106.98 157.24 17.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.896 0.379 . . . . 0.0 110.351 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -110.58 158.64 18.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.657 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.496 HG13 ' HB2' ' A' ' 140' ' ' SER . 35.1 m -136.47 139.36 45.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.339 0.59 . . . . 0.0 111.383 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.968 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -95.09 110.54 22.46 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.817 176.23 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.5 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 2.4 m -101.89 130.68 48.44 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.269 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.527 HG12 ' CB ' ' A' ' 135' ' ' PHE . 33.5 m -129.26 150.3 34.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.679 -174.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.402 ' HB2' ' HB3' ' A' ' 126' ' ' LEU . 70.0 ttt180 -93.04 102.4 14.74 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.425 0.631 . . . . 0.0 109.506 175.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.504 HG21 ' HA ' ' A' ' 210' ' ' LEU . 0.9 OUTLIER -115.0 97.78 6.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.722 178.758 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.975 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -176.115 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.502 ' HB3' ' O ' ' A' ' 153' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.405 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.505 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 60.1 t -123.39 115.98 47.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 121.086 0.469 . . . . 0.0 111.323 176.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.715 HG21 HD11 ' A' ' 210' ' ' LEU . 4.1 m -92.86 140.73 29.19 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.049 172.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 150' ' ' SER . 37.8 m-70 -114.78 119.72 37.61 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.968 HG22 ' HB3' ' A' ' 149' ' ' LEU . 0.8 OUTLIER -98.4 140.14 18.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -177.028 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 40.2 tpp -87.02 117.88 26.03 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.253 -177.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.542 HD13 HD21 ' A' ' 190' ' ' LEU . 20.7 mt -97.02 107.04 19.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 175.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.567 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 17.9 ptp180 -69.16 122.42 18.76 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.917 0.389 . . . . 0.0 110.0 -177.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 49.5 t -113.88 93.42 4.36 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.805 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -125.92 122.4 35.9 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.158 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 58.63 41.75 21.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.124 -178.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.0 mt 60.49 45.42 10.77 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.165 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 174' ' ' CYS . 10.9 tppt? -131.46 139.11 49.29 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -116.04 129.95 56.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.585 0.231 . . . . 0.0 110.783 -175.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.567 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 13.8 t0 -157.01 129.25 7.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.79 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.557 ' HB ' ' CZ ' ' A' ' 197' ' ' TYR . 31.0 t -83.91 -12.27 11.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.773 0.797 . . . . 0.0 109.312 176.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 122.76 9.02 6.5 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.388 176.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -137.88 140.48 11.26 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.138 -1.029 . . . . 0.0 113.738 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 71.59 -154.8 51.74 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.266 -0.492 . . . . 0.0 112.998 174.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -73.97 142.73 45.84 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.64 0.257 . . . . 0.0 110.364 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -88.0 132.71 34.16 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -106.88 156.44 18.69 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.226 0.536 . . . . 0.0 112.019 -169.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -94.34 -11.52 29.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.24 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.6 m -129.4 142.71 50.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.123 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.697 HD13 HG21 ' A' ' 137' ' ' VAL . 0.9 OUTLIER -72.81 -22.71 60.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.28 -175.4 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 5.8 m -61.82 -46.23 90.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.894 0.378 . . . . 0.0 110.53 177.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -64.72 -34.17 77.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.057 178.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.502 HD11 HG23 ' A' ' 181' ' ' VAL . 3.1 tm? -60.25 -54.28 47.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.298 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 30.8 m -68.62 -43.75 83.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.934 -175.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -59.2 -35.57 73.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.001 0.429 . . . . 0.0 111.232 177.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -62.4 -45.28 93.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.102 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.557 ' CZ ' ' HB ' ' A' ' 181' ' ' VAL . 59.8 m-85 -85.76 -10.36 55.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.948 0.404 . . . . 0.0 111.448 -176.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.443 ' HD2' ' CZ ' ' A' ' 135' ' ' PHE . 47.0 mtpt -70.86 -34.81 72.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.155 0.502 . . . . 0.0 109.865 170.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.459 ' HG3' ' ND2' ' A' ' 200' ' ' ASN . 14.1 tptt -88.85 -36.17 16.16 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.036 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . 0.459 ' ND2' ' HG3' ' A' ' 199' ' ' LYS . 55.4 m-80 -113.49 101.57 53.8 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.432 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.28 126.17 21.62 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.845 2.363 . . . . 0.0 112.77 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . 0.755 ' SD ' HG11 ' A' ' 170' ' ' VAL . 14.3 ptp -89.31 141.81 28.22 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 175.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.558 HG22 HG22 ' A' ' 209' ' ' VAL . 11.2 t -124.8 139.51 50.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.998 -173.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.671 ' HG2' ' HB1' ' B' ' 1' ' ' ALA . 26.0 mt-10 -82.01 161.24 23.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.898 171.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.3 t -74.32 -9.85 59.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.235 0.54 . . . . 0.0 110.006 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.5 mp -89.68 4.38 49.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.162 176.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.57 -1.27 83.79 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.629 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.414 HG22 HD13 ' A' ' 210' ' ' LEU . 23.1 m -73.16 113.51 10.3 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.011 0.434 . . . . 0.0 110.588 177.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.558 HG22 HG22 ' A' ' 203' ' ' VAL . 69.9 t -98.6 114.34 35.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.715 HD11 HG21 ' A' ' 168' ' ' THR . 0.4 OUTLIER -76.52 100.34 5.24 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.505 ' O ' ' HA2' ' A' ' 133' ' ' GLY . 47.1 mt-30 -84.68 92.96 8.31 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.382 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.505 HD22 ' HB2' ' A' ' 197' ' ' TYR . 9.2 mp -77.57 105.41 8.69 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.956 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -113.86 -57.07 2.33 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.708 ' O ' ' HA ' ' A' ' 134' ' ' SER . 4.6 pm0 -132.0 139.38 34.84 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-O 121.14 0.495 . . . . 0.0 111.209 -177.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.503 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 71.5 Cg_endo -74.37 138.45 24.71 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.982 2.455 . . . . 0.0 112.527 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.542 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.3 OUTLIER -72.5 106.28 4.52 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.053 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -56.15 133.62 52.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.083 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.6 p -58.02 111.6 1.23 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.436 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.406 HG21 ' CD ' ' A' ' 129' ' ' LYS . 2.0 t . . . . . 0 C--N 1.318 -0.772 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.288 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.671 ' HB1' ' HG2' ' A' ' 204' ' ' GLU . . . . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.931 0.396 . . . . 0.0 110.627 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 23.5 m -70.87 -38.0 73.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.295 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.512 HD12 ' SD ' ' A' ' 202' ' ' MET . 7.5 mm 70.03 88.0 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 121.613 0.721 . . . . 0.0 111.213 176.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 2.1 m . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.828 179.359 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo . . . . . 0 N--CA 1.462 -0.371 0 N-CA-C 109.597 -0.963 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.536 HG22 HD12 ' A' ' 190' ' ' LEU . 25.5 p -98.13 7.41 46.32 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 113.628 -1.623 . . . . 0.0 111.153 -176.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.4 p -75.65 30.19 0.11 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.934 0.397 . . . . 0.0 111.755 -178.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.429 ' H ' ' C ' ' A' ' 108' ' ' THR . 10.8 mm-40 -109.88 171.26 7.56 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.434 ' O ' HG23 ' A' ' 218' ' ' THR . 25.3 mmt180 -85.47 -9.62 57.21 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -167.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.467 ' HB3' ' CB ' ' A' ' 215' ' ' PRO . 2.4 p-90 -87.31 -19.14 28.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.954 0.407 . . . . 0.0 110.621 175.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.516 ' CD1' ' HB ' ' A' ' 108' ' ' THR . 80.3 t80 -75.17 119.19 18.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.199 0.524 . . . . 0.0 110.241 173.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.411 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 13.9 m-70 -112.16 147.09 36.89 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 175.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -73.55 -123.99 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.731 -172.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -86.84 83.6 7.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.515 0.674 . . . . 0.0 111.168 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.401 ' HB2' ' NH1' ' A' ' 138' ' ' ARG . 77.9 mt -98.0 160.6 14.2 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.835 171.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.1 p -102.48 172.46 6.85 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 165.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.64 -50.1 44.08 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 121.312 -0.471 . . . . 0.0 112.619 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -64.64 -41.43 96.15 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 122.466 0.307 . . . . 0.0 111.425 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -61.08 -46.75 89.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.552 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.91 -35.05 79.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.972 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -64.87 -50.83 65.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.071 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -60.65 -34.58 74.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.419 176.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 129' ' ' LYS . 0.4 OUTLIER -57.01 -52.82 63.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.983 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.586 HD23 HD12 ' A' ' 216' ' ' LEU . 71.1 mt -75.96 -52.19 10.8 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -178.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 m -64.89 -33.2 75.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.785 -170.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -96.66 -49.81 4.95 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 125' ' ' LEU . 95.9 mttt -92.14 -23.51 19.39 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -169.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -98.54 -149.77 25.2 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.325 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.29 173.67 15.85 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 176.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 62.9 t60 -51.18 118.87 3.52 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.774 0.321 . . . . 0.0 110.825 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 211' ' ' GLN . . . 102.21 -3.21 51.09 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.314 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 33.8 p -72.24 139.67 48.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.276 0.538 . . . . 0.0 110.1 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.479 ' CB ' HG12 ' A' ' 151' ' ' VAL . 53.3 p90 -137.21 151.58 48.92 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.976 0.417 . . . . 0.0 110.636 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.558 HD21 ' HB2' ' A' ' 150' ' ' SER . 1.2 pt? -153.21 136.05 15.38 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.645 HG21 HD13 ' A' ' 190' ' ' LEU . 5.5 m -96.72 142.44 13.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 175.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.668 ' HB2' HH11 ' A' ' 138' ' ' ARG . 0.0 OUTLIER -147.36 160.08 42.95 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.703 -171.482 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -79.14 110.42 14.37 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.997 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.574 ' HB2' HG13 ' A' ' 148' ' ' VAL . 41.8 t -66.66 124.78 23.81 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -90.99 -15.35 29.8 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 28.0 t -72.83 -39.47 66.55 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 172.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 46.7 m-70 -119.57 81.39 24.07 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.544 172.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.22 134.47 59.45 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.042 2.495 . . . . 0.0 112.968 -172.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 100.0 -21.6 43.98 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.073 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.56 ' HA ' ' SG ' ' A' ' 174' ' ' CYS . 4.5 m-20 -102.56 170.32 8.11 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.243 0.544 . . . . 0.0 111.063 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -117.18 149.95 39.53 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.311 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.574 HG13 ' HB2' ' A' ' 140' ' ' SER . 27.1 m -131.91 138.71 52.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.173 0.511 . . . . 0.0 111.065 176.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.927 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -92.18 109.48 20.85 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.455 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.558 ' HB2' HD21 ' A' ' 136' ' ' LEU . 2.8 m -101.77 133.49 46.43 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.136 -179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.56 HG21 ' HB3' ' A' ' 210' ' ' LEU . 28.1 m -132.9 153.84 38.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.923 0.392 . . . . 0.0 111.356 -173.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.458 ' HB2' ' HB3' ' A' ' 126' ' ' LEU . 73.6 ttt180 -99.69 103.98 15.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.2 178.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 14.8 p -108.36 147.66 31.21 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.456 -177.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.506 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.112 -178.364 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.413 ' HD2' ' HA ' ' A' ' 166' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.448 -0.53 0 CA-C-O 120.55 0.214 . . . . 0.0 110.751 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 72.6 t -100.41 113.01 34.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.426 0.632 . . . . 0.0 110.626 176.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.639 HG21 HD11 ' A' ' 210' ' ' LEU . 1.4 m -98.21 137.73 36.54 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.726 175.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 150' ' ' SER . 23.7 m-70 -105.97 122.48 46.22 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.927 HG22 ' HB3' ' A' ' 149' ' ' LEU . 0.8 OUTLIER -99.5 138.42 23.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.144 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . 0.414 ' O ' ' HA ' ' A' ' 181' ' ' VAL . 39.8 tpp -82.22 121.28 26.43 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.636 -0.257 . . . . 0.0 111.018 -174.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.537 HD13 HD21 ' A' ' 190' ' ' LEU . 28.8 mt -101.64 107.5 21.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 177.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.581 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 4.4 ptp180 -73.8 107.66 6.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.064 0.459 . . . . 0.0 110.735 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . 0.56 ' SG ' ' HA ' ' A' ' 146' ' ' ASP . 4.9 p -86.0 101.27 12.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.888 175.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -127.73 111.14 13.35 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.944 -176.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 56.24 43.67 26.17 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.577 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 91.5 mt 66.48 15.96 10.26 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.197 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -105.99 142.86 34.99 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 172.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -117.23 141.35 48.4 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.538 -175.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.581 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 5.9 t0 -158.71 136.25 10.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.59 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.472 HG22 ' CZ ' ' A' ' 197' ' ' TYR . 16.8 m -87.62 -11.01 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 121.051 0.453 . . . . 0.0 110.409 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . 0.519 ' HA2' ' NH1' ' A' ' 173' ' ' ARG . . . 123.31 34.74 0.75 Allowed Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -174.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -102.95 -157.69 25.33 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 121.514 -0.374 . . . . 0.0 112.448 -176.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -86.43 -40.91 7.13 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.031 -177.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -115.89 143.11 45.88 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.905 0.384 . . . . 0.0 111.279 -177.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -93.15 141.53 28.32 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -110.95 137.39 48.64 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.643 0.259 . . . . 0.0 110.677 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -82.86 0.9 41.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.229 0.538 . . . . 0.0 110.372 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.1 p -141.39 142.67 33.73 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.906 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.645 HD13 HG21 ' A' ' 137' ' ' VAL . 1.7 mt -76.52 -23.14 53.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.061 -176.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.462 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 97.6 m -62.02 -49.29 76.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.006 0.431 . . . . 0.0 109.938 174.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.65 -29.89 70.9 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.494 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.411 HD13 ' C ' ' A' ' 193' ' ' LEU . 3.2 tm? -64.34 -54.91 25.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.99 176.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.15 -42.1 79.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.348 -174.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -60.83 -31.76 71.17 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.388 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -67.29 -47.81 69.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.922 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.528 ' HB2' HD22 ' A' ' 212' ' ' LEU . 80.3 m-85 -82.8 -11.16 58.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.246 0.546 . . . . 0.0 110.639 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -68.96 -29.74 68.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.284 172.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -93.3 -37.76 11.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.375 176.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -119.31 98.06 50.41 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.344 -177.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -56.31 138.28 83.01 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.978 2.452 . . . . 0.0 112.449 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . 0.704 ' HB2' HG23 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -100.4 135.54 41.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.772 178.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.575 HG22 ' HB ' ' A' ' 209' ' ' VAL . 39.3 t -103.55 141.18 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -171.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.573 ' HG2' ' HB1' ' B' ' 1' ' ' ALA . 38.7 mt-10 -86.82 161.98 18.04 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 169.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 13.7 t -74.59 -10.5 59.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.057 0.456 . . . . 0.0 110.346 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.6 mp -92.07 8.77 36.26 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.126 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.77 -29.0 7.74 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.776 177.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 53.4 m -57.98 112.5 1.52 Allowed 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 116.981 0.39 . . . . 0.0 110.164 176.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.575 ' HB ' HG22 ' A' ' 203' ' ' VAL . 1.1 p -111.6 129.35 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-O 121.548 0.689 . . . . 0.0 110.228 174.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.639 HD11 HG21 ' A' ' 168' ' ' THR . 0.4 OUTLIER -78.85 113.23 16.77 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.347 -1.297 . . . . 0.0 111.163 -168.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.404 ' O ' ' HA2' ' A' ' 133' ' ' GLY . 65.9 mt-30 -90.36 90.16 7.92 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.437 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.528 HD22 ' HB2' ' A' ' 197' ' ' TYR . 8.0 mp -79.17 104.94 10.14 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 175.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 47.5 mttp -112.73 -54.73 2.6 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -177.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.552 ' O ' ' HA ' ' A' ' 134' ' ' SER . 0.1 OUTLIER -142.03 144.7 33.06 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.112 0.482 . . . . 0.0 111.32 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.467 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 74.1 Cg_endo -73.88 144.6 34.89 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.097 2.531 . . . . 0.0 113.202 -176.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.586 HD12 HD23 ' A' ' 126' ' ' LEU . 0.4 OUTLIER -82.94 119.92 25.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.513 176.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -58.18 145.43 37.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.265 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 111' ' ' ARG . 4.2 p -74.25 108.22 6.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.532 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 2.8 t . . . . . 0 C--N 1.318 -0.802 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.708 176.694 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.573 ' HB1' ' HG2' ' A' ' 204' ' ' GLU . . . . . . . . 0 N--CA 1.463 0.206 0 CA-C-O 121.459 0.647 . . . . 0.0 112.365 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 7.4 m -61.79 -52.26 64.91 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.189 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.704 HG23 ' HB2' ' A' ' 202' ' ' MET . 33.6 mm 82.74 82.25 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-O 121.853 0.835 . . . . 0.0 109.372 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.438 -1.064 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.629 178.83 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.416 ' HB2' ' H ' ' A' ' 190' ' ' LEU . 5.4 Cg_exo . . . . . 0 CA--C 1.515 -0.468 0 CA-C-O 121.474 0.531 . . . . 0.0 111.441 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.506 ' HB ' ' CG ' ' A' ' 113' ' ' PHE . 40.4 p -100.44 6.26 44.37 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.154 -175.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.8 p -78.54 45.28 0.57 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.246 0.546 . . . . 0.0 111.09 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -125.9 168.34 14.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.89 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.434 ' O ' HG23 ' A' ' 218' ' ' THR . 14.3 mmt180 -82.82 -14.86 53.58 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -170.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.538 ' HB3' ' CB ' ' A' ' 215' ' ' PRO . 1.7 p-90 -85.17 -18.6 33.64 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.3 175.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.506 ' CG ' ' HB ' ' A' ' 108' ' ' THR . 87.2 t80 -78.98 118.05 20.62 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.215 173.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -115.11 113.36 23.9 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 174.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -64.31 -72.74 0.65 Allowed Glycine 0 N--CA 1.454 -0.163 0 CA-C-N 116.089 -0.505 . . . . 0.0 113.658 -173.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -84.41 89.46 7.4 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.642 -0.328 . . . . 0.0 110.996 -174.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 24.3 mt -143.73 137.15 27.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.661 174.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.1 t -101.05 173.59 6.4 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 169.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 123' ' ' GLU . . . -49.85 -52.87 24.24 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 121.527 -0.368 . . . . 0.0 113.796 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.56 -25.55 57.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.169 0.485 . . . . 0.0 111.229 -176.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -69.99 -47.27 62.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.156 0.503 . . . . 0.0 109.93 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.667 ' HB2' ' HD2' ' A' ' 138' ' ' ARG . . . -67.06 -34.11 76.97 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.597 177.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.474 ' HG3' ' HB ' ' A' ' 167' ' ' VAL . 3.3 tt0 -61.66 -49.08 77.98 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.847 177.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -59.67 -34.11 72.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.877 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.401 HD12 HD13 ' A' ' 216' ' ' LEU . 1.2 mm? -56.72 -53.53 56.7 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.119 0.485 . . . . 0.0 110.405 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.526 ' CD2' HD12 ' A' ' 216' ' ' LEU . 54.0 mt -76.15 -44.36 38.58 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.9 m -61.61 -35.48 78.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 110.757 -175.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -95.6 -52.99 3.89 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -97.86 -22.73 16.2 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -170.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -90.08 177.51 42.96 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.307 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -135.59 175.14 9.87 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -57.98 117.59 4.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.781 0.324 . . . . 0.0 110.574 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 211' ' ' GLN . . . 104.02 -5.29 46.05 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.76 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 29.6 m -74.61 137.44 42.29 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.649 -0.324 . . . . 0.0 110.434 176.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.463 ' CB ' HG12 ' A' ' 151' ' ' VAL . 51.0 p90 -136.87 149.26 47.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.714 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.582 HD21 ' HB2' ' A' ' 150' ' ' SER . 1.2 pt? -150.56 134.15 16.51 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.71 HG21 HD13 ' A' ' 190' ' ' LEU . 11.9 m -97.44 141.09 16.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.667 ' HD2' ' HB2' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -140.19 162.94 34.06 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.903 -175.046 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -77.73 128.13 33.54 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.53 ' HB2' HG13 ' A' ' 148' ' ' VAL . 36.4 t -75.82 137.98 40.85 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -101.3 -21.51 14.85 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.033 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 33.5 m -86.12 -29.19 23.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.985 173.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -116.83 81.09 11.58 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 175.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.03 133.11 39.6 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.797 2.331 . . . . 0.0 112.369 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 94.52 -10.08 71.17 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.862 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -113.65 168.37 9.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.071 0.463 . . . . 0.0 110.356 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.475 ' CE1' ' HE1' ' A' ' 179' ' ' TYR . 74.0 m-85 -125.06 163.27 22.74 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.58 -177.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.532 ' CG2' ' HG3' ' A' ' 138' ' ' ARG . 26.7 m -134.62 136.99 51.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.228 0.537 . . . . 0.0 111.193 178.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.986 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -92.29 110.18 21.57 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.14 177.116 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.582 ' HB2' HD21 ' A' ' 136' ' ' LEU . 3.8 m -101.25 130.43 47.38 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.297 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.499 HG21 ' HB3' ' A' ' 210' ' ' LEU . 33.9 m -131.43 146.9 32.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.848 -174.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.409 ' HB2' ' HB3' ' A' ' 126' ' ' LEU . 39.5 ttt180 -91.55 104.89 17.32 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.17 0.51 . . . . 0.0 109.964 175.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.489 ' O ' ' HB3' ' A' ' 166' ' ' LYS . 3.7 p -104.11 146.58 28.53 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.977 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.752 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.876 -176.201 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 153' ' ' THR . 51.9 tptt . . . . . 0 N--CA 1.446 -0.662 0 CA-C-O 120.734 0.302 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.474 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 73.9 t -119.17 113.33 41.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.353 0.597 . . . . 0.0 110.319 174.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.822 HG21 HD11 ' A' ' 210' ' ' LEU . 18.9 m -97.95 133.59 42.23 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.905 176.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 150' ' ' SER . 13.4 m-70 -110.9 117.91 34.66 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.986 HG22 ' HB3' ' A' ' 149' ' ' LEU . 0.7 OUTLIER -98.15 133.58 39.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -177.064 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 44.0 tpp -78.7 119.27 21.7 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.683 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.559 HD13 HD21 ' A' ' 190' ' ' LEU . 24.8 mt -99.58 107.22 20.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.644 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 4.5 ptp180 -69.98 125.51 26.98 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . 0.673 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 49.4 t -118.53 115.5 24.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.72 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -141.44 112.8 7.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.164 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 60.16 49.94 6.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.974 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.0 mt 58.35 47.49 13.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.844 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.673 ' O ' ' HA ' ' A' ' 174' ' ' CYS . 11.3 tppt? -133.97 132.23 39.91 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.475 ' HE1' ' CE1' ' A' ' 147' ' ' PHE . 69.0 m-85 -117.71 134.08 55.27 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.161 0.288 . . . . 0.0 110.715 -175.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.644 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 12.5 t0 -156.12 131.46 9.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.952 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.561 ' HB ' ' CZ ' ' A' ' 197' ' ' TYR . 51.1 t -83.16 -15.69 11.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.701 0.762 . . . . 0.0 109.083 175.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . 0.411 ' HA2' ' NH1' ' A' ' 173' ' ' ARG . . . 122.57 8.49 6.91 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.83 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -136.61 141.62 12.67 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.465 -175.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 71.44 -152.03 49.0 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.888 175.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -84.16 144.05 29.24 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.866 0.365 . . . . 0.0 110.835 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -78.98 137.17 37.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.576 177.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -110.74 149.95 29.77 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.193 0.52 . . . . 0.0 111.647 -175.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -84.06 -9.59 58.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.644 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.18 143.43 40.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.273 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.71 HD13 HG21 ' A' ' 137' ' ' VAL . 0.8 OUTLIER -70.85 -23.39 62.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.441 -174.63 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 20.6 m -61.35 -47.92 83.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.945 0.402 . . . . 0.0 110.15 175.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.21 -30.99 72.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.249 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.547 HD11 HG23 ' A' ' 181' ' ' VAL . 2.9 tm? -65.72 -54.64 24.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.44 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 34.5 m -66.77 -43.17 90.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.239 -173.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -62.25 -31.47 72.04 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.416 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -64.21 -52.1 60.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.817 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.561 ' CZ ' ' HB ' ' A' ' 181' ' ' VAL . 86.6 m-85 -80.92 -8.52 59.77 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.265 0.555 . . . . 0.0 110.393 -177.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -71.74 -23.17 61.56 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 172.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 8.3 tppt? -96.18 -36.5 10.93 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.682 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -121.86 103.72 39.78 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.001 0.429 . . . . 0.0 111.219 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -58.31 126.85 22.69 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 123.038 2.492 . . . . 0.0 112.475 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . 0.464 ' HB2' ' CG2' ' B' ' 3' ' ' ILE . 0.0 OUTLIER -89.51 127.66 35.89 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.727 178.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.573 HG22 ' HB ' ' A' ' 209' ' ' VAL . 47.2 t -99.42 139.69 20.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.192 0.52 . . . . 0.0 111.63 -173.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.724 ' HB2' ' O ' ' A' ' 208' ' ' THR . 0.4 OUTLIER -85.6 155.95 20.92 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.946 171.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 9.2 t -72.41 -11.8 60.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.052 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.403 HD12 ' N ' ' A' ' 206' ' ' LEU . 5.5 mp -91.3 6.7 44.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.881 176.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.13 -17.93 53.57 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.788 178.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.724 ' O ' ' HB2' ' A' ' 204' ' ' GLU . 92.7 m -66.34 110.73 3.19 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-O 120.705 0.288 . . . . 0.0 110.239 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.573 ' HB ' HG22 ' A' ' 203' ' ' VAL . 1.4 p -111.8 127.43 68.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.695 0.759 . . . . 0.0 110.517 175.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.822 HD11 HG21 ' A' ' 168' ' ' THR . 0.3 OUTLIER -81.34 110.38 16.72 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.813 -169.377 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.434 ' O ' ' HA2' ' A' ' 133' ' ' GLY . 49.8 mt-30 -91.46 89.53 7.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.371 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.412 HD11 HD21 ' A' ' 149' ' ' LEU . 7.4 mp -75.45 111.7 11.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.195 176.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -113.92 -56.12 2.43 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.638 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.537 ' O ' ' HA ' ' A' ' 134' ' ' SER . 0.9 OUTLIER -145.77 149.2 38.92 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 121.096 0.474 . . . . 0.0 111.082 179.594 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.538 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 72.6 Cg_endo -72.94 149.44 47.21 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 123.55 2.833 . . . . 0.0 114.17 -173.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.526 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.2 OUTLIER -84.97 113.74 21.64 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 173.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -62.76 151.06 39.74 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.133 0.492 . . . . 0.0 111.198 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 111' ' ' ARG . 12.6 p -80.02 111.57 16.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.138 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 3.1 t . . . . . 0 C--N 1.321 -0.654 0 CA-C-O 121.385 0.612 . . . . 0.0 109.474 176.069 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.438 ' HB2' ' CG2' ' A' ' 168' ' ' THR . . . . . . . . 0 C--O 1.234 0.244 0 CA-C-O 121.37 0.605 . . . . 0.0 111.357 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 86.0 m -70.7 -47.29 60.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.008 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.464 ' CG2' ' HB2' ' A' ' 202' ' ' MET . 15.7 mm 78.54 89.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 123.318 0.647 . . . . 0.0 110.278 173.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.441 -0.899 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.435 177.639 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 CA--C 1.516 -0.416 0 CA-C-O 121.635 0.598 . . . . 0.0 111.294 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.63 ' HB ' ' CD2' ' A' ' 113' ' ' PHE . 81.5 p -94.77 6.69 48.2 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.59 -176.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 51.3 m -76.64 59.24 1.5 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.299 0.571 . . . . 0.0 110.818 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.474 ' HG3' ' CZ2' ' A' ' 112' ' ' TRP . 76.8 mm-40 -134.39 156.35 48.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.513 -177.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -75.11 -13.76 60.5 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -171.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.492 ' HB3' ' CB ' ' A' ' 215' ' ' PRO . 2.5 p-90 -89.65 -14.16 35.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.947 0.403 . . . . 0.0 110.742 175.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.63 ' CD2' ' HB ' ' A' ' 108' ' ' THR . 76.3 t80 -80.73 120.94 25.27 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.088 0.47 . . . . 0.0 110.149 172.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -111.91 140.4 46.6 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -76.73 -90.3 0.26 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.037 -175.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -92.66 93.54 8.54 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.992 0.425 . . . . 0.0 111.51 -172.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.2 mt -134.38 128.46 33.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.301 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 24.5 m -83.68 173.25 11.51 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 173.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -50.84 -52.62 29.49 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 121.477 -0.392 . . . . 0.0 113.386 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -72.09 -31.75 66.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.491 0.186 . . . . 0.0 111.431 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -64.04 -47.13 81.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.968 0.413 . . . . 0.0 110.481 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.465 ' HB2' ' HD3' ' A' ' 138' ' ' ARG . . . -66.15 -34.03 77.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.723 178.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.444 ' HA ' HG11 ' A' ' 167' ' ' VAL . 0.2 OUTLIER -65.87 -50.77 63.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.51 176.274 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -58.55 -34.78 71.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.615 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.411 HD12 HD13 ' A' ' 216' ' ' LEU . 0.7 OUTLIER -56.81 -51.59 68.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.218 178.065 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.541 ' CD2' HD12 ' A' ' 216' ' ' LEU . 53.2 mt -75.48 -46.66 31.1 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 m -64.97 -28.32 69.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.098 -174.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -95.71 -53.03 3.86 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -103.48 11.65 36.13 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -170.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -127.05 -163.36 11.44 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.254 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -154.34 176.15 12.67 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -46.71 120.74 3.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.937 0.398 . . . . 0.0 111.004 176.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 211' ' ' GLN . . . 99.1 -9.63 61.51 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.797 177.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.658 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 69.0 m -70.41 135.67 48.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.218 0.509 . . . . 0.0 110.526 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.517 ' CB ' HG12 ' A' ' 151' ' ' VAL . 52.5 p90 -137.03 149.54 47.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.923 -178.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.551 ' CD2' ' HB2' ' A' ' 150' ' ' SER . 1.2 pt? -149.43 134.8 18.36 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 175.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.652 HG21 HD13 ' A' ' 190' ' ' LEU . 12.3 m -97.52 141.93 15.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.465 ' HD3' ' HB2' ' A' ' 122' ' ' ALA . 30.5 ptt85 -140.98 162.17 36.1 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.357 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -71.38 129.25 38.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.871 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.436 ' OG ' ' HB2' ' A' ' 143' ' ' HIS . 23.3 t -77.94 132.85 38.07 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.328 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -91.08 -40.86 11.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.819 -175.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.6 t -79.81 -12.99 59.74 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.057 0.456 . . . . 0.0 109.789 177.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . 0.436 ' HB2' ' OG ' ' A' ' 140' ' ' SER . 54.3 m80 -126.19 75.04 72.82 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.951 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.5 126.87 21.91 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.847 2.364 . . . . 0.0 112.234 -176.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 106.09 -31.97 7.83 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.943 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -98.16 171.79 8.0 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.155 0.502 . . . . 0.0 110.732 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.412 ' CE2' ' HE1' ' A' ' 179' ' ' TYR . 85.8 m-85 -125.23 165.9 17.46 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.435 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 27.5 m -132.97 136.48 55.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.404 0.621 . . . . 0.0 111.456 176.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.973 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -92.74 110.02 21.45 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.806 174.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.551 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 1.2 m -101.9 128.98 48.05 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.709 -0.796 . . . . 0.0 109.254 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.517 HG12 ' CB ' ' A' ' 135' ' ' PHE . 33.7 m -130.46 147.7 33.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.581 -172.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.423 ' HB2' ' HB3' ' A' ' 126' ' ' LEU . 62.7 ttt180 -93.02 104.25 16.48 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.253 0.549 . . . . 0.0 109.879 176.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.7 p -104.08 146.93 28.01 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.092 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.666 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.568 179.169 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 167' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.638 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.449 ' N ' ' HD2' ' A' ' 166' ' ' LYS . 74.9 t -99.41 116.2 42.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.475 0.655 . . . . 0.0 111.751 -177.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.745 HG21 HD11 ' A' ' 210' ' ' LEU . 4.4 m -97.26 141.19 30.67 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.35 176.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 150' ' ' SER . 17.1 m-70 -117.76 117.47 29.41 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.973 HG22 ' HB3' ' A' ' 149' ' ' LEU . 0.7 OUTLIER -98.85 135.37 34.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -173.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 35.2 tpp -78.48 115.93 18.52 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.657 -176.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.582 HD13 HD21 ' A' ' 190' ' ' LEU . 29.6 mt -93.61 105.95 17.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 176.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.552 ' HB2' ' OE1' ' A' ' 175' ' ' GLN . 13.6 ptm180 -82.18 118.58 23.18 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.313 -175.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . 0.666 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 38.5 t -104.42 110.0 22.09 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.112 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.552 ' OE1' ' HB2' ' A' ' 173' ' ' ARG . 1.8 mp0 -113.74 107.91 16.39 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 177.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 58.2 52.17 7.78 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 123.562 0.539 . . . . 0.0 111.094 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 93.6 mt 61.05 41.89 13.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.193 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.666 ' O ' ' HA ' ' A' ' 174' ' ' CYS . 5.8 tppt? -134.51 131.03 37.53 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.412 ' HE1' ' CE2' ' A' ' 147' ' ' PHE . 63.5 m-85 -105.52 138.19 42.12 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 122.91 0.131 . . . . 0.0 111.118 -171.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.549 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 24.7 t70 -152.11 139.49 19.48 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.355 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.551 HG12 ' O ' ' A' ' 181' ' ' VAL . 84.4 t -96.83 55.68 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 122.514 1.15 . . . . 0.0 109.127 173.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 82.52 -39.02 2.64 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 114.7 -1.136 . . . . 0.0 113.674 173.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -138.51 151.88 21.77 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.281 -176.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 110.16 -142.71 16.63 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.653 175.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -106.44 143.75 34.1 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 176.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.438 ' HG2' ' HB2' ' A' ' 180' ' ' ASP . 80.2 mtt180 -92.77 139.49 30.49 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.346 -176.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -113.95 147.86 37.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.184 -175.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -79.16 -16.9 55.95 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.169 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 19.8 m -129.78 143.37 50.78 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.795 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.652 HD13 HG21 ' A' ' 137' ' ' VAL . 0.8 OUTLIER -69.89 -22.55 63.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.039 -176.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.478 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 6.5 m -58.83 -47.36 85.1 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.992 0.425 . . . . 0.0 110.363 176.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -66.41 -31.52 72.32 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.298 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.52 ' HB3' HD23 ' A' ' 190' ' ' LEU . 3.0 tm? -62.84 -54.48 38.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.779 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 32.7 m -69.22 -41.35 81.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.032 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -62.26 -34.87 77.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.677 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -63.52 -50.01 71.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.739 0.304 . . . . 0.0 110.811 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.598 ' HB2' HD22 ' A' ' 212' ' ' LEU . 76.5 m-85 -82.04 -8.35 59.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.186 0.517 . . . . 0.0 111.014 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 212' ' ' LEU . 35.3 ttpt -73.53 -20.47 60.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.68 0.752 . . . . 0.0 109.358 173.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.423 ' HG3' ' ND2' ' A' ' 200' ' ' ASN . 9.5 tppt? -106.12 -36.21 6.99 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.554 175.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . 0.423 ' ND2' ' HG3' ' A' ' 199' ' ' LYS . 40.7 m-80 -112.68 93.99 26.3 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.834 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -58.22 130.09 36.12 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.99 2.46 . . . . 0.0 112.382 178.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . 0.505 ' HG3' HD12 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -92.89 130.87 38.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.368 179.328 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.552 HG22 ' HB ' ' A' ' 209' ' ' VAL . 42.7 t -98.5 133.62 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.247 0.546 . . . . 0.0 112.091 -174.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.722 ' HB2' ' O ' ' A' ' 208' ' ' THR . 0.1 OUTLIER -81.56 159.07 24.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.974 170.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 9.0 t -74.06 -10.61 59.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.277 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 206' ' ' LEU . 5.4 mp -88.88 -2.29 58.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.373 176.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 95.5 -13.91 65.82 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.07 -177.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.722 ' O ' ' HB2' ' A' ' 204' ' ' GLU . 49.5 m -67.65 110.27 3.65 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 176.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.552 ' HB ' HG22 ' A' ' 203' ' ' VAL . 1.1 p -112.14 120.61 62.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.925 0.869 . . . . 0.0 110.504 175.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.745 HD11 HG21 ' A' ' 168' ' ' THR . 0.4 OUTLIER -76.7 103.55 6.73 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.354 -170.233 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.478 ' O ' ' HA2' ' A' ' 133' ' ' GLY . 44.8 mt-30 -90.09 89.3 7.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.851 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.598 HD22 ' HB2' ' A' ' 197' ' ' TYR . 7.6 mp -71.27 113.89 8.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.656 178.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -115.81 -56.6 2.31 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.658 ' O ' ' HA ' ' A' ' 134' ' ' SER . 4.2 pm0 -136.84 140.91 33.16 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.072 0.463 . . . . 0.0 110.898 -177.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.492 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 59.9 Cg_endo -73.68 146.05 37.95 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.645 2.23 . . . . 0.0 112.753 -178.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.541 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.2 OUTLIER -86.75 105.46 16.98 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 174.712 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -60.78 138.64 58.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.996 0.427 . . . . 0.0 110.953 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 7.0 p -61.83 114.14 3.16 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.671 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.446 -0.669 0 CA-C-O 121.446 0.641 . . . . 0.0 109.523 177.052 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.533 ' HB2' ' CG2' ' A' ' 168' ' ' THR . . . . . . . . 0 N--CA 1.451 -0.416 0 CA-C-O 121.268 0.556 . . . . 0.0 110.507 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 86.0 m -71.5 -42.3 68.19 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.877 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.505 HD12 ' HG3' ' A' ' 202' ' ' MET . 13.5 mm 73.68 99.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.113 0.565 . . . . 0.0 111.192 175.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 C--N 1.32 -0.678 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.099 -179.892 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo . . . . . 0 N--CA 1.463 -0.321 0 N-CA-C 110.108 -0.766 . . . . 0.0 110.108 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.526 ' HB ' ' CG ' ' A' ' 113' ' ' PHE . 42.1 p -98.39 8.05 45.38 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.609 -178.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 66.5 p -74.86 34.65 0.1 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.933 0.397 . . . . 0.0 111.563 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 108' ' ' THR . 60.7 mm-40 -115.8 157.22 24.72 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -75.65 -12.2 60.16 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -167.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.4 ' CZ2' ' HA ' ' A' ' 191' ' ' THR . 4.4 p-90 -85.29 -14.68 45.84 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.827 176.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.526 ' CG ' ' HB ' ' A' ' 108' ' ' THR . 68.4 t80 -77.59 120.25 22.28 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.125 0.488 . . . . 0.0 110.389 171.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.482 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 10.6 m170 -121.08 106.57 11.68 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 175.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -73.93 -45.96 24.83 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.541 -171.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -99.01 83.72 2.94 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.052 0.453 . . . . 0.0 111.139 -173.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.4 mt -148.44 138.07 22.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.493 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.8 p -90.62 173.25 8.15 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 169.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 123' ' ' GLU . . . -51.71 -48.9 49.1 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.862 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -76.48 -32.35 58.31 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -64.02 -46.79 82.91 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.026 176.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.612 ' HB2' ' HD2' ' A' ' 138' ' ' ARG . . . -66.64 -33.69 76.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.693 177.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.562 ' HG3' ' HB ' ' A' ' 167' ' ' VAL . 4.2 tt0 -62.51 -50.37 71.65 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.215 176.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.66 -34.49 72.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.22 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.453 HD12 HD13 ' A' ' 216' ' ' LEU . 0.7 OUTLIER -56.22 -52.9 62.74 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.332 0.587 . . . . 0.0 110.494 -178.069 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.569 ' CD2' HD12 ' A' ' 216' ' ' LEU . 54.2 mt -75.7 -46.72 29.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.514 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.6 m -61.28 -32.54 72.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.337 -172.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -97.36 -53.7 3.38 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 178.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -93.03 -21.35 19.79 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -170.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -89.1 -161.24 37.32 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.937 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -153.88 175.63 13.12 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 174.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -51.08 117.63 2.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.918 0.39 . . . . 0.0 110.891 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 99.93 -3.75 57.32 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.996 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 68.7 m -75.96 139.63 41.66 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.52 -0.4 . . . . 0.0 110.647 178.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.497 ' CB ' HG12 ' A' ' 151' ' ' VAL . 52.8 p90 -137.5 151.4 48.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.771 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.582 ' CD2' ' HB2' ' A' ' 150' ' ' SER . 1.2 pt? -151.71 138.02 18.47 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.693 HG21 HD13 ' A' ' 190' ' ' LEU . 14.2 m -97.62 137.94 23.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.308 176.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.612 ' HD2' ' HB2' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -137.64 162.14 34.61 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.053 -174.765 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -76.66 134.38 39.29 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.507 ' HB2' HG13 ' A' ' 148' ' ' VAL . 33.2 t -80.93 143.65 32.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.174 -175.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -101.15 -22.76 14.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.914 174.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 72.7 m -69.86 -40.35 75.82 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.439 0.637 . . . . 0.0 109.356 170.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -121.93 83.14 43.49 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.036 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -55.47 123.58 14.15 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.506 2.137 . . . . 0.0 111.553 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 106.7 -32.14 7.57 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.906 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -88.28 170.29 11.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.877 0.37 . . . . 0.0 110.431 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -121.65 153.96 37.45 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.151 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.536 ' CG2' ' HG3' ' A' ' 138' ' ' ARG . 30.2 m -129.38 138.86 53.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.159 0.504 . . . . 0.0 110.52 176.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.853 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -92.18 110.13 21.51 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.149 177.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.582 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 3.3 m -101.42 132.01 47.23 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.408 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.555 HG21 ' HB3' ' A' ' 210' ' ' LEU . 32.0 m -132.47 149.44 32.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.96 -174.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.486 ' HB2' ' HB3' ' A' ' 126' ' ' LEU . 72.9 ttt180 -96.0 104.16 16.09 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.031 0.443 . . . . 0.0 109.898 176.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -107.69 147.15 31.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.224 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.648 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.405 -178.77 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.889 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.562 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 71.4 t -99.96 112.52 32.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.396 0.617 . . . . 0.0 110.492 177.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.702 HG21 HD11 ' A' ' 210' ' ' LEU . 6.3 m -92.01 140.5 29.59 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.641 175.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 150' ' ' SER . 7.5 m-70 -118.5 120.15 36.66 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.853 HG22 ' HB3' ' A' ' 149' ' ' LEU . 1.1 m -98.16 138.8 21.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -177.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 5.7 ttm -90.45 118.69 30.12 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.941 -174.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.485 HD13 HD21 ' A' ' 190' ' ' LEU . 25.6 mt -93.47 127.97 45.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.661 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.597 ' NH1' ' HA2' ' A' ' 182' ' ' GLY . 5.0 ptp180 -87.77 112.26 22.24 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.043 0.449 . . . . 0.0 109.942 177.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 47.0 t -96.89 92.6 6.2 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -113.77 113.78 25.42 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.48 -175.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 58.63 40.89 23.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.857 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 93.9 mt 67.1 18.78 10.49 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.82 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -109.95 139.05 45.48 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 172.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.452 ' CD1' ' HG ' ' A' ' 190' ' ' LEU . 51.5 m-85 -109.54 138.53 45.77 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.841 -175.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.586 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 9.6 t0 -155.73 140.99 17.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.028 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.53 ' HB ' ' CE1' ' A' ' 197' ' ' TYR . 14.4 t -94.62 -12.43 8.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.657 0.742 . . . . 0.0 109.342 176.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . 0.597 ' HA2' ' NH1' ' A' ' 173' ' ' ARG . . . 123.21 9.02 6.24 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.166 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -138.07 140.59 11.3 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.242 -0.98 . . . . 0.0 113.755 -176.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.67 -119.87 5.59 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.376 173.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -115.76 158.69 22.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.631 0.253 . . . . 0.0 110.564 -173.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -95.43 128.65 42.46 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -110.31 144.28 39.26 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.076 -173.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -79.8 -8.66 59.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.413 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 85.1 p -130.46 143.9 51.06 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.479 177.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.693 HD13 HG21 ' A' ' 137' ' ' VAL . 1.1 mt -70.65 -22.08 62.54 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.37 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.492 ' O ' ' HG3' ' A' ' 195' ' ' GLU . 4.0 m -60.42 -49.18 78.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.637 177.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -67.14 -30.52 70.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.705 0.288 . . . . 0.0 110.565 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.528 HD11 HG23 ' A' ' 181' ' ' VAL . 3.4 tm? -62.15 -54.83 35.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.836 177.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 35.7 m -68.97 -39.69 80.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.999 -175.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 191' ' ' THR . 22.7 mt-10 -66.67 -35.27 79.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.414 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -60.26 -42.78 96.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.818 0.342 . . . . 0.0 110.414 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.53 ' CE1' ' HB ' ' A' ' 181' ' ' VAL . 40.5 m-85 -85.44 -11.62 53.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.376 0.608 . . . . 0.0 110.649 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.408 ' HE2' ' HA ' ' A' ' 195' ' ' GLU . 38.4 ttpt -73.67 -27.67 61.35 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 173.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -90.29 -35.99 14.95 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.442 175.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -116.38 102.78 53.42 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.511 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -57.93 126.43 21.64 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.603 2.202 . . . . 0.0 111.974 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . 0.729 ' SD ' HD23 ' A' ' 210' ' ' LEU . 9.5 ptp -89.11 120.48 30.54 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.633 -177.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.591 HG22 ' HB ' ' A' ' 209' ' ' VAL . 28.7 t -97.91 136.55 28.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.662 0.268 . . . . 0.0 111.72 -175.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.558 ' O ' HG12 ' A' ' 203' ' ' VAL . 22.6 mt-10 -85.79 167.09 15.53 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.877 0.37 . . . . 0.0 110.063 169.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 12.1 t -75.16 -14.83 60.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.276 0.56 . . . . 0.0 109.978 177.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.469 HD12 ' N ' ' A' ' 206' ' ' LEU . 5.1 mp -81.73 -7.44 59.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.153 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 99.82 -21.23 45.87 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.869 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 89.8 m -62.94 112.13 2.44 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.591 ' HB ' HG22 ' A' ' 203' ' ' VAL . 0.8 OUTLIER -112.82 121.82 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 CA-C-O 121.616 0.722 . . . . 0.0 110.574 173.836 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.729 HD23 ' SD ' ' A' ' 202' ' ' MET . 0.4 OUTLIER -77.12 107.94 9.84 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.767 -174.708 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -93.54 90.23 6.59 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.008 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.488 HD22 ' HB2' ' A' ' 197' ' ' TYR . 7.8 mp -74.02 103.4 4.49 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.242 -177.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -115.47 -55.79 2.41 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.633 ' O ' ' HA ' ' A' ' 134' ' ' SER . 0.1 OUTLIER -115.09 132.89 22.8 Favored Pre-proline 0 C--O 1.223 -0.305 0 CA-C-O 120.483 0.182 . . . . 0.0 111.323 -173.706 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.09 132.78 11.81 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.315 2.01 . . . . 0.0 111.817 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.569 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.3 OUTLIER -78.88 102.02 8.0 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.173 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -58.13 140.24 53.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.705 178.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.3 p -62.58 125.54 24.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.335 0.588 . . . . 0.0 111.554 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.318 -0.763 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.076 -179.85 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.599 ' HB2' ' CG2' ' A' ' 168' ' ' THR . . . . . . . . 0 N--CA 1.465 0.287 0 CA-C-O 121.797 0.808 . . . . 0.0 113.1 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 63.4 m -73.48 -47.03 44.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.443 -1.253 . . . . 0.0 111.521 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.56 HD12 ' SD ' ' A' ' 202' ' ' MET . 6.4 mm 66.32 105.25 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 123.224 0.61 . . . . 0.0 111.63 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.323 -0.555 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.333 175.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo . . . . . 0 CA--C 1.508 -0.816 0 CA-C-O 121.807 0.67 . . . . 0.0 110.741 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 190' ' ' LEU . 8.9 t -101.07 5.94 43.14 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.348 175.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.7 t -71.74 65.54 0.51 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 121.792 0.805 . . . . 0.0 110.035 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -130.27 169.89 14.83 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.033 -175.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -64.83 -17.1 63.95 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -167.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.436 ' CZ2' ' HA ' ' A' ' 191' ' ' THR . 1.3 p-90 -92.93 -13.33 29.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.858 0.361 . . . . 0.0 111.467 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.494 ' HA ' ' O ' ' A' ' 137' ' ' VAL . 24.6 t80 -89.37 118.57 29.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.175 0.512 . . . . 0.0 110.806 177.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -109.65 119.26 38.84 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -49.8 -86.02 0.01 OUTLIER Glycine 0 C--N 1.331 0.256 0 O-C-N 123.98 0.8 . . . . 0.0 114.213 -170.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -100.4 107.2 18.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.521 0.677 . . . . 0.0 111.227 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 33.9 mt -129.57 140.92 51.08 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.951 174.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.422 ' H ' ' HB2' ' A' ' 121' ' ' GLU . 18.1 t -90.0 171.31 9.65 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 173.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.34 -53.18 42.58 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.835 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 20.9 mmtm -76.73 -25.45 53.54 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.422 ' HB2' ' H ' ' A' ' 118' ' ' SER . 15.2 mm-40 -65.29 -47.03 78.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.948 0.404 . . . . 0.0 110.225 175.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.596 ' HB2' ' HD2' ' A' ' 138' ' ' ARG . . . -65.59 -34.26 77.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.282 0.563 . . . . 0.0 110.492 178.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -67.94 -50.14 57.73 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.851 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -56.97 -34.65 68.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.788 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.453 HD12 HD13 ' A' ' 216' ' ' LEU . 0.7 OUTLIER -57.14 -52.69 64.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.275 178.484 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.558 ' CD2' HD12 ' A' ' 216' ' ' LEU . 55.1 mt -76.04 -51.88 11.38 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.5 m -61.07 -35.84 78.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.75 -171.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -97.68 -46.63 5.92 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 125' ' ' LEU . 89.0 mttt -91.23 -28.88 17.52 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.668 -0.413 . . . . 0.0 112.015 -171.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -93.17 -158.98 34.56 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.831 -176.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.432 ' C ' ' HD3' ' A' ' 152' ' ' ARG . 14.9 ptmm? -148.08 176.0 10.56 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -51.92 123.85 11.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.707 0.289 . . . . 0.0 110.513 176.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 94.87 -3.64 67.66 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.239 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.624 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 69.0 m -73.61 139.15 45.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.059 0.429 . . . . 0.0 110.313 178.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.501 ' CB ' HG12 ' A' ' 151' ' ' VAL . 50.4 p90 -136.93 149.38 47.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.71 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.593 HD21 ' HB2' ' A' ' 150' ' ' SER . 1.2 pt? -150.64 140.4 21.77 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.657 HG21 HD13 ' A' ' 190' ' ' LEU . 11.4 m -99.73 144.1 12.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.186 175.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.596 ' HD2' ' HB2' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -146.0 156.69 43.67 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.845 -173.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -70.31 132.73 46.13 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 175.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.645 ' HB2' HG13 ' A' ' 148' ' ' VAL . 37.9 t -86.22 143.43 27.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.916 0.389 . . . . 0.0 110.38 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -100.63 -20.25 15.74 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.691 178.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 65.9 m -78.75 -30.56 45.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.141 0.496 . . . . 0.0 109.789 172.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . 0.403 ' HB3' ' HB2' ' A' ' 146' ' ' ASP . 27.1 m-70 -120.55 86.16 39.26 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.858 173.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -61.49 123.19 12.28 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.241 1.96 . . . . 0.0 111.892 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 101.35 -14.82 57.99 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.166 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.403 ' HB2' ' HB3' ' A' ' 143' ' ' HIS . 4.2 m-20 -105.61 164.08 12.17 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.168 0.509 . . . . 0.0 110.865 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -119.24 153.89 34.28 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.721 -177.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.645 HG13 ' HB2' ' A' ' 140' ' ' SER . 34.5 m -130.31 139.94 50.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.393 0.616 . . . . 0.0 111.371 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.779 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -92.64 110.37 21.79 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.256 178.17 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.593 ' HB2' HD21 ' A' ' 136' ' ' LEU . 1.5 m -102.97 131.27 50.05 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.115 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.538 HG21 ' HB3' ' A' ' 210' ' ' LEU . 35.3 m -132.12 146.81 32.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.166 -173.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.432 ' HD3' ' C ' ' A' ' 131' ' ' LYS . 75.0 ttt180 -90.56 104.67 17.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.339 0.59 . . . . 0.0 109.968 176.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.429 HG21 HD12 ' A' ' 210' ' ' LEU . 8.8 p -102.23 147.43 26.66 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.392 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.603 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.76 -177.671 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.442 ' HD2' ' HA ' ' A' ' 166' ' ' LYS . 25.6 mmmt . . . . . 0 N--CA 1.448 -0.541 0 CA-C-O 121.09 0.471 . . . . 0.0 111.846 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 71.3 t -125.73 113.32 34.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.71 170.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.69 HG21 HD11 ' A' ' 210' ' ' LEU . 1.8 m -97.83 138.18 35.57 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.898 175.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 150' ' ' SER . 14.2 m-70 -112.73 117.99 33.74 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.779 HG22 ' HB3' ' A' ' 149' ' ' LEU . 1.3 m -98.35 135.72 32.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -175.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 40.1 tpp -81.3 116.78 21.32 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.893 -174.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.562 HG21 HD21 ' A' ' 190' ' ' LEU . 16.6 mt -97.03 107.67 20.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 3.9 ptp180 -70.11 117.73 12.05 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.617 -178.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 36.6 t -93.02 94.59 8.97 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -113.78 109.59 18.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.47 -174.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 53.01 40.52 31.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.802 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 96.1 mt 72.66 15.13 4.97 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.169 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.88 142.94 34.74 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 170.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -110.8 140.99 44.74 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.53 -176.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.582 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 10.6 t0 -156.02 137.95 14.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.753 0.311 . . . . 0.0 111.048 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.483 HG23 HD11 ' A' ' 193' ' ' LEU . 48.6 t -90.11 -13.16 9.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.724 0.773 . . . . 0.0 109.322 175.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . 0.57 ' HA2' ' NH1' ' A' ' 173' ' ' ARG . . . 124.09 5.23 7.5 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.763 178.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -137.14 140.41 11.37 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 119.807 -1.187 . . . . 0.0 113.918 -174.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 79.45 -116.46 4.31 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.088 -0.577 . . . . 0.0 113.18 174.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -115.92 150.18 37.53 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 122.291 0.236 . . . . 0.0 110.436 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -80.96 126.96 32.03 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 171.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -105.62 138.69 41.4 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.099 0.476 . . . . 0.0 111.326 -172.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -70.13 -22.77 62.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.788 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 82.2 p -130.71 144.62 51.56 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.517 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.657 HD13 HG21 ' A' ' 137' ' ' VAL . 8.8 mt -65.66 -20.92 66.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.11 176.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.436 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 3.7 m -55.89 -48.91 74.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.694 0.283 . . . . 0.0 110.538 176.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -69.24 -34.73 75.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.764 0.316 . . . . 0.0 110.334 176.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.483 HD11 HG23 ' A' ' 181' ' ' VAL . 2.9 tm? -59.75 -54.0 51.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.987 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 30.5 m -69.58 -41.86 80.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.389 -174.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -66.68 -36.37 82.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.447 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -61.03 -44.9 96.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.751 0.31 . . . . 0.0 110.752 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.498 ' HB2' HD22 ' A' ' 212' ' ' LEU . 55.6 m-85 -85.23 -10.48 56.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.008 0.432 . . . . 0.0 110.799 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.492 ' HA ' ' HB2' ' A' ' 212' ' ' LEU . 38.9 ttpt -70.13 -34.03 72.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.608 0.718 . . . . 0.0 109.228 174.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -88.01 -25.75 22.96 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.043 176.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -128.31 90.78 45.97 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.801 -174.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -55.17 127.98 28.57 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.177 2.584 . . . . 0.0 112.587 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . 0.519 ' HG3' HD12 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -91.63 123.78 35.28 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.956 0.408 . . . . 0.0 110.415 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.579 HG22 ' HB ' ' A' ' 209' ' ' VAL . 36.3 t -93.87 134.89 29.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 120.85 0.357 . . . . 0.0 111.871 -176.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.54 ' O ' HG12 ' A' ' 203' ' ' VAL . 0.7 OUTLIER -79.2 163.64 24.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.49 169.245 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 7.7 t -76.33 -10.0 59.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.452 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.415 HD12 ' N ' ' A' ' 206' ' ' LEU . 5.4 mp -92.2 5.03 51.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.432 178.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 90.99 -14.5 63.27 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.703 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.486 ' O ' ' HB2' ' A' ' 204' ' ' GLU . 88.2 m -71.6 111.42 6.88 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.579 ' HB ' HG22 ' A' ' 203' ' ' VAL . 1.4 p -111.81 128.27 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-O 121.82 0.819 . . . . 0.0 110.854 176.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.69 HD11 HG21 ' A' ' 168' ' ' THR . 0.3 OUTLIER -84.8 103.49 13.93 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.83 -172.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -90.88 89.41 7.45 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.216 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.498 HD22 ' HB2' ' A' ' 197' ' ' TYR . 7.6 mp -71.79 108.55 5.15 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.314 177.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -115.11 -56.01 2.41 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -177.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.624 ' O ' ' HA ' ' A' ' 134' ' ' SER . 5.0 pm0 -131.95 136.46 28.32 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 121.068 0.461 . . . . 0.0 110.746 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.01 137.54 26.75 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.918 2.412 . . . . 0.0 112.798 -178.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.558 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.2 OUTLIER -76.7 98.88 4.89 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 175.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -63.77 139.18 58.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.905 0.384 . . . . 0.0 110.574 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 7.5 p -61.66 110.49 1.51 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.394 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 C--N 1.319 -0.74 0 CA-C-O 121.463 0.649 . . . . 0.0 109.517 177.474 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.538 ' HB2' ' CG2' ' A' ' 168' ' ' THR . . . . . . . . 0 C--O 1.232 0.157 0 CA-C-O 121.305 0.574 . . . . 0.0 111.746 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 71.8 m -76.05 -41.81 49.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.742 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.519 HD12 ' HG3' ' A' ' 202' ' ' MET . 8.5 mm 68.48 120.54 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.291 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.466 0.355 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.224 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo . . . . . 0 CA--C 1.515 -0.471 0 N-CA-C 109.29 -1.081 . . . . 0.0 109.29 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.703 ' HB ' ' CG ' ' A' ' 113' ' ' PHE . 22.9 p -88.12 7.37 31.92 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 113.619 -1.628 . . . . 0.0 110.738 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.4 p -71.26 47.07 0.11 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.483 0.659 . . . . 0.0 111.258 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.43 ' HG3' ' CZ2' ' A' ' 112' ' ' TRP . 70.8 mm-40 -122.03 -176.9 3.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.84 -176.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -85.92 -23.43 27.0 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -176.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.452 ' HE3' HG22 ' A' ' 137' ' ' VAL . 2.8 p-90 -85.16 -20.34 30.4 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.812 -177.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.703 ' CG ' ' HB ' ' A' ' 108' ' ' THR . 60.2 t80 -80.27 127.15 32.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.98 0.419 . . . . 0.0 110.405 173.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -118.56 113.09 20.74 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.436 ' HA2' ' CZ ' ' A' ' 113' ' ' PHE . . . -50.44 -82.4 0.04 OUTLIER Glycine 0 C--O 1.237 0.315 0 O-C-N 123.971 0.794 . . . . 0.0 114.599 -169.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -99.83 90.59 4.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.185 0.517 . . . . 0.0 111.393 -173.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.414 HD13 ' HA ' ' A' ' 122' ' ' ALA . 44.5 mt -126.21 130.56 51.19 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.164 173.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.4 m -81.85 170.82 15.22 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 171.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -54.66 -47.45 70.69 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.45 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -64.71 -44.39 90.4 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 122.704 0.402 . . . . 0.0 110.974 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -62.7 -46.75 86.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.238 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.685 ' HB2' ' HD2' ' A' ' 138' ' ' ARG . . . -60.32 -34.32 73.64 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.945 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.5 ' HG3' ' HB ' ' A' ' 167' ' ' VAL . 3.7 tt0 -69.93 -46.64 64.91 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.529 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -56.92 -36.21 69.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.647 175.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.64 -52.59 64.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.601 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.559 ' CD2' HD12 ' A' ' 216' ' ' LEU . 58.2 mt -75.12 -49.43 19.62 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.568 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.7 m -61.95 -29.58 70.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.326 -172.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -95.56 -51.97 4.32 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 177.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.415 ' HD3' HG21 ' A' ' 219' ' ' THR . 55.5 mttp -105.77 -0.81 25.06 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -163.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -106.09 -161.52 22.72 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.169 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -149.86 173.8 13.36 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 174.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 55.0 t60 -53.61 117.39 3.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.964 0.411 . . . . 0.0 111.025 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 100.95 -3.76 55.83 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.985 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.692 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 68.5 m -72.57 139.87 47.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.99 0.395 . . . . 0.0 110.608 178.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.488 ' HB3' HG12 ' A' ' 151' ' ' VAL . 52.1 p90 -136.92 150.82 48.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.612 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.586 HD21 ' HB2' ' A' ' 150' ' ' SER . 1.3 pt? -151.22 138.04 18.94 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.627 HG21 HD13 ' A' ' 190' ' ' LEU . 11.2 m -100.55 140.23 20.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 120.231 -0.588 . . . . 0.0 109.441 177.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.685 ' HD2' ' HB2' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -141.04 161.56 37.55 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.311 -174.683 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -72.84 132.83 44.05 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.579 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.48 ' HB2' HG13 ' A' ' 148' ' ' VAL . 29.5 t -77.37 143.46 38.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.531 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -100.6 -30.1 11.96 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.145 178.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 72.6 m -74.32 -30.73 62.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.02 0.438 . . . . 0.0 110.256 173.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -121.49 85.53 43.27 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.193 175.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.66 123.73 14.21 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.525 2.15 . . . . 0.0 111.808 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 105.94 -27.69 16.6 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.701 -176.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -89.99 171.65 9.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.247 0.546 . . . . 0.0 110.614 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -124.36 157.52 34.84 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.314 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.504 ' CG2' ' HG3' ' A' ' 138' ' ' ARG . 32.1 m -128.13 136.58 59.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.298 0.571 . . . . 0.0 110.717 174.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.906 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -91.77 109.61 20.94 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.318 -0.856 . . . . 0.0 108.848 176.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.586 ' HB2' HD21 ' A' ' 136' ' ' LEU . 2.1 m -102.46 132.38 48.53 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.212 -178.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.505 HG21 ' HB3' ' A' ' 210' ' ' LEU . 34.7 m -130.43 147.8 33.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.128 -172.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -92.84 105.08 17.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.744 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.422 ' O ' ' HB3' ' A' ' 166' ' ' LYS . 1.2 p -108.52 148.43 30.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.777 -175.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.738 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.883 177.221 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.422 ' HB3' ' O ' ' A' ' 153' ' ' THR . 46.1 tptt . . . . . 0 N--CA 1.446 -0.637 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.5 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 69.2 t -126.62 112.61 29.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.51 0.671 . . . . 0.0 110.503 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.717 HG21 HD11 ' A' ' 210' ' ' LEU . 3.9 m -96.38 140.3 31.24 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.623 174.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 150' ' ' SER . 18.9 m-70 -115.57 119.16 35.24 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.906 HG22 ' HB3' ' A' ' 149' ' ' LEU . 1.0 OUTLIER -98.37 134.91 35.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -178.835 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 9.8 ttm -88.6 119.04 28.69 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.395 -176.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.492 HD13 HD21 ' A' ' 190' ' ' LEU . 12.5 mt -94.05 113.73 29.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.072 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.608 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 19.9 ptp180 -74.21 118.28 16.98 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.146 0.498 . . . . 0.0 110.189 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 46.1 t -102.56 93.07 4.94 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -114.73 108.5 16.86 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.364 -176.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 57.64 48.39 14.22 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.704 0.628 . . . . 0.0 110.573 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 88.9 mt 64.82 24.88 12.85 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.768 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 10.4 tppt? -115.08 133.46 56.02 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -113.38 130.87 56.18 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 123.012 0.195 . . . . 0.0 111.026 -173.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.608 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 34.6 t0 -156.42 136.15 12.51 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.945 0.402 . . . . 0.0 110.796 175.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.544 ' HB ' ' CZ ' ' A' ' 197' ' ' TYR . 25.9 t -85.41 -15.64 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 123.69 4.23 8.16 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.251 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -136.19 141.14 12.18 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.812 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 80.42 -158.09 41.21 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.685 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -85.76 155.16 21.15 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -84.94 130.58 34.61 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -105.89 153.54 21.8 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.031 0.443 . . . . 0.0 111.58 -172.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -91.61 -7.39 50.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.379 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 49.3 m -130.12 142.56 50.58 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.59 176.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.627 HD13 HG21 ' A' ' 137' ' ' VAL . 2.0 mt -72.87 -22.69 60.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.622 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.445 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 3.7 m -59.71 -46.28 89.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.671 176.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -66.3 -35.5 80.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.123 177.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.517 HD11 HG23 ' A' ' 181' ' ' VAL . 3.2 tm? -61.76 -54.96 35.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.306 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 34.6 m -66.69 -42.9 90.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.224 -173.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' A' ' 199' ' ' LYS . 27.7 mt-10 -70.38 -30.75 67.74 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.557 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -59.89 -42.93 94.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.775 0.321 . . . . 0.0 110.441 176.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.544 ' CZ ' ' HB ' ' A' ' 181' ' ' VAL . 56.3 m-85 -85.1 -13.29 50.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.207 0.527 . . . . 0.0 110.619 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 212' ' ' LEU . 39.8 ttpt -72.68 -25.33 61.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.546 0.689 . . . . 0.0 109.487 174.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.422 ' HA ' ' HE2' ' A' ' 199' ' ' LYS . 11.8 mmpt? -91.65 -36.0 13.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.903 175.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -120.78 102.15 44.78 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.623 -176.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.11 133.47 58.29 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.853 2.369 . . . . 0.0 112.58 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . 0.709 ' SD ' HD12 ' B' ' 3' ' ' ILE . 7.3 ptp -96.65 128.15 43.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.493 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.612 HG22 ' HB ' ' A' ' 209' ' ' VAL . 40.6 t -101.52 137.87 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -175.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.563 ' O ' HG12 ' A' ' 203' ' ' VAL . 35.8 mt-10 -84.39 166.07 17.67 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.209 0.528 . . . . 0.0 110.382 170.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 12.1 t -77.21 -10.37 59.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.761 174.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.6 mp -91.43 8.91 34.05 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.402 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 86.77 -21.36 19.37 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.87 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 65.6 m -65.58 113.2 4.03 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.612 ' HB ' HG22 ' A' ' 203' ' ' VAL . 0.8 OUTLIER -111.64 124.66 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-O 121.785 0.802 . . . . 0.0 110.505 174.477 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.717 HD11 HG21 ' A' ' 168' ' ' THR . 0.4 OUTLIER -78.84 107.39 11.53 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.215 -172.523 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -92.3 89.43 6.84 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.836 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.528 HD22 ' HB2' ' A' ' 197' ' ' TYR . 7.4 mp -74.57 110.8 9.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.767 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -114.27 -56.21 2.41 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.692 ' O ' ' HA ' ' A' ' 134' ' ' SER . 4.3 pm0 -135.69 142.56 41.3 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 121.024 0.44 . . . . 0.0 111.103 -176.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.444 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 74.4 Cg_endo -74.27 138.1 24.45 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.992 2.461 . . . . 0.0 112.728 -178.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.559 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.3 OUTLIER -74.12 108.39 6.9 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.787 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -55.75 131.42 46.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.9 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 2.6 p -61.68 126.85 28.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.342 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.415 HG21 ' HD3' ' A' ' 129' ' ' LYS . 3.1 t . . . . . 0 C--N 1.323 -0.579 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.362 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.639 ' HB2' ' CG2' ' A' ' 168' ' ' THR . . . . . . . . 0 CA--C 1.52 -0.178 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 22.8 m -63.78 -44.47 93.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.045 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.709 HD12 ' SD ' ' A' ' 202' ' ' MET . 4.4 mm 60.06 96.84 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 123.267 0.627 . . . . 0.0 111.017 -177.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.459 -178.552 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo . . . . . 0 N--CA 1.457 -0.641 0 N-CA-C 109.543 -0.983 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.749 ' HB ' ' CG ' ' A' ' 113' ' ' PHE . 48.2 p -100.26 4.3 44.1 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 114.018 -1.447 . . . . 0.0 111.098 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 44.4 m -75.57 45.31 0.31 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.609 0.718 . . . . 0.0 110.667 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -117.11 -170.46 1.85 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.625 -175.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.527 ' O ' HG23 ' A' ' 218' ' ' THR . 33.9 mtm180 -83.05 -28.05 29.85 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -176.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.484 ' CZ2' ' HA ' ' A' ' 191' ' ' THR . 2.2 p-90 -85.66 -21.53 28.34 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -174.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.749 ' CG ' ' HB ' ' A' ' 108' ' ' THR . 80.9 t80 -79.62 121.0 24.74 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.282 0.563 . . . . 0.0 111.067 177.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.492 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 11.8 m170 -116.88 124.56 49.77 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 173.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -68.5 -95.29 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.479 -173.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -76.46 93.09 3.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.139 0.495 . . . . 0.0 111.257 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.3 mt -131.37 139.16 49.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.424 174.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.451 ' HB3' ' HG2' ' A' ' 121' ' ' GLU . 21.1 t -94.57 172.58 8.09 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 172.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.44 -52.95 46.82 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.011 -176.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -75.71 -25.51 56.7 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.568 0.21 . . . . 0.0 111.568 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.451 ' HG2' ' HB3' ' A' ' 118' ' ' SER . 52.5 mm-40 -66.45 -47.5 72.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.108 0.48 . . . . 0.0 109.72 177.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.64 ' HB2' ' HD2' ' A' ' 138' ' ' ARG . . . -67.62 -34.16 76.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.68 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.546 ' HG3' ' HB ' ' A' ' 167' ' ' VAL . 5.9 tt0 -63.53 -47.28 82.26 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.198 177.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.82 -34.86 75.18 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.774 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.487 HD12 HD13 ' A' ' 216' ' ' LEU . 0.8 OUTLIER -56.71 -53.25 59.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.516 -179.667 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.533 ' CD2' HD12 ' A' ' 216' ' ' LEU . 58.7 mt -75.75 -44.04 43.66 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.627 -177.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 9.5 m -61.0 -35.01 75.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.29 -173.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -95.68 -52.85 3.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.073 0.463 . . . . 0.0 111.862 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -96.85 -11.33 24.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.325 -166.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -96.32 -164.15 33.35 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.82 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -153.76 173.88 15.28 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -55.13 116.02 2.56 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.928 0.394 . . . . 0.0 110.5 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 100.8 -3.27 55.89 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.525 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 42.6 p -71.12 137.48 48.88 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 117.494 0.647 . . . . 0.0 110.317 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.462 ' CB ' HG12 ' A' ' 151' ' ' VAL . 45.8 p90 -136.85 150.64 48.4 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.438 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.568 HD21 ' HB2' ' A' ' 150' ' ' SER . 1.2 pt? -153.2 134.19 14.0 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.367 176.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.642 HG21 HD13 ' A' ' 190' ' ' LEU . 10.6 m -96.89 138.75 21.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 176.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.64 ' HD2' ' HB2' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -139.55 162.81 34.16 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.869 -173.403 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -71.0 132.76 45.64 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 121.089 -0.244 . . . . 0.0 110.343 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.472 ' HB2' HG13 ' A' ' 148' ' ' VAL . 41.3 t -77.11 136.68 38.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.357 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -100.39 -26.18 13.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.826 0.346 . . . . 0.0 110.163 176.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.1 t -72.49 -36.0 68.3 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 172.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 47.6 m-70 -121.41 81.51 38.64 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.018 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.94 123.49 13.92 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.524 2.149 . . . . 0.0 112.267 -178.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 107.32 -26.66 17.89 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.915 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -89.99 170.64 10.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.95 0.405 . . . . 0.0 110.518 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -122.13 153.56 38.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.825 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.517 ' CG2' ' HG3' ' A' ' 138' ' ' ARG . 21.9 m -127.86 137.47 57.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.105 0.479 . . . . 0.0 110.668 176.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.912 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -92.63 110.11 21.53 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.407 178.353 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.568 ' HB2' HD21 ' A' ' 136' ' ' LEU . 2.3 m -101.65 132.63 47.23 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.517 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.497 HG21 ' HB3' ' A' ' 210' ' ' LEU . 35.1 m -131.25 149.79 33.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.988 -174.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.437 ' HB2' ' HB3' ' A' ' 126' ' ' LEU . 41.6 ttt180 -96.38 104.7 16.69 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.289 0.566 . . . . 0.0 109.925 176.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.521 ' O ' ' HB3' ' A' ' 166' ' ' LYS . 5.0 p -101.51 147.32 26.52 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.877 -178.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.912 0 C-N-CA 119.942 -1.123 . . . . 0.0 112.05 -176.814 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 153' ' ' THR . 47.6 tptt . . . . . 0 N--CA 1.45 -0.466 0 CA-C-O 121.013 0.435 . . . . 0.0 111.073 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.546 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 70.6 t -124.68 114.42 40.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.267 173.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.72 HG21 HD11 ' A' ' 210' ' ' LEU . 18.6 m -98.96 137.51 37.39 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.965 175.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 150' ' ' SER . 21.1 m-70 -112.29 118.83 36.35 Favored 'General case' 0 C--O 1.211 -0.922 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.912 HG22 ' HB3' ' A' ' 149' ' ' LEU . 1.0 OUTLIER -99.02 138.05 24.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.362 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . 0.407 ' SD ' HG12 ' A' ' 148' ' ' VAL . 44.6 tpp -85.56 120.11 26.65 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.723 0.297 . . . . 0.0 110.756 -175.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 32.4 mt -94.04 107.08 18.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.623 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 3.6 ptp180 -67.55 107.1 2.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.211 0.529 . . . . 0.0 110.034 -178.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 36.8 m -98.46 93.13 6.0 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.647 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -114.31 108.91 17.55 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.005 -176.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 58.93 46.29 13.91 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 123.446 0.466 . . . . 0.0 110.698 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 91.5 mt 64.58 21.98 12.55 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.589 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 174' ' ' CYS . 1.7 tppp? -106.89 137.92 44.04 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 175.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -119.14 132.78 56.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.768 0.318 . . . . 0.0 111.454 -172.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.623 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 10.5 t70 -156.0 139.35 15.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.201 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.596 ' HB ' ' CZ ' ' A' ' 197' ' ' TYR . 37.9 t -89.23 -16.19 8.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.853 0.835 . . . . 0.0 109.075 175.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . 0.562 ' HA2' ' NH1' ' A' ' 173' ' ' ARG . . . 123.36 10.23 5.64 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.163 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -136.61 140.27 11.34 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 119.943 -1.123 . . . . 0.0 113.676 -176.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 67.13 -148.99 50.82 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 121.286 -0.483 . . . . 0.0 113.184 175.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -79.31 145.08 33.68 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.546 -0.327 . . . . 0.0 110.517 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.415 ' HG2' ' HB2' ' A' ' 180' ' ' ASP . 79.0 mtt180 -85.55 133.21 34.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.972 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -108.18 149.88 27.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.329 0.585 . . . . 0.0 111.723 -173.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.448 ' OD1' ' HE2' ' A' ' 178' ' ' LYS . 3.2 m-20 -87.55 -15.28 37.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.984 -178.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.4 p -130.64 142.4 50.44 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.231 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.642 HD13 HG21 ' A' ' 137' ' ' VAL . 9.1 mt -71.47 -22.99 61.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.232 -175.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.484 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 18.0 m -61.74 -43.52 98.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.018 0.437 . . . . 0.0 110.321 177.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -72.98 -32.92 65.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.932 177.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.487 HD11 HG23 ' A' ' 181' ' ' VAL . 3.2 tm? -61.02 -54.44 44.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.294 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 26.9 m -66.78 -43.08 90.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.629 -173.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.489 ' HA ' ' HE2' ' A' ' 198' ' ' LYS . 9.5 mt-10 -70.08 -30.46 67.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.511 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -59.02 -41.89 88.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.716 0.294 . . . . 0.0 110.498 176.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.596 ' CZ ' ' HB ' ' A' ' 181' ' ' VAL . 69.1 m-85 -86.15 -7.16 58.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.834 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.489 ' HE2' ' HA ' ' A' ' 195' ' ' GLU . 40.8 mtmt -69.27 -32.53 71.76 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 170.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.409 ' O ' ' HD3' ' A' ' 201' ' ' PRO . 1.9 tppp? -92.28 -36.2 13.34 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.856 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -111.57 96.28 31.42 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.229 -178.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 199' ' ' LYS . 25.3 Cg_exo -62.34 126.96 19.68 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.648 2.232 . . . . 0.0 112.001 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . 0.662 ' HB2' HG23 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -89.1 118.11 28.58 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.07 0.462 . . . . 0.0 110.356 179.125 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.577 HG22 ' HB ' ' A' ' 209' ' ' VAL . 51.7 t -96.6 129.89 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.72 -175.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.613 ' HB2' ' O ' ' A' ' 208' ' ' THR . 2.4 mm-40 -78.63 159.98 27.79 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.668 0.747 . . . . 0.0 112.83 168.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.568 ' HB ' HG21 ' B' ' 4' ' ' VAL . 4.1 t -72.94 -10.96 60.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.024 177.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 206' ' ' LEU . 5.3 mp -88.88 -2.28 58.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.968 177.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 96.98 -26.65 21.7 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.212 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.613 ' O ' ' HB2' ' A' ' 204' ' ' GLU . 99.0 m -60.44 111.23 1.49 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.999 0.428 . . . . 0.0 110.207 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.577 ' HB ' HG22 ' A' ' 203' ' ' VAL . 0.8 OUTLIER -112.08 127.66 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-O 121.57 0.7 . . . . 0.0 110.287 175.146 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.72 HD11 HG21 ' A' ' 168' ' ' THR . 0.4 OUTLIER -82.55 111.03 18.17 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.783 -170.553 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -96.15 91.23 5.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.412 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.492 HD22 ' HB2' ' A' ' 197' ' ' TYR . 7.1 mp -74.81 109.83 8.6 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.983 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -114.58 -57.12 2.31 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.63 -0.428 . . . . 0.0 112.154 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.528 ' O ' ' HA ' ' A' ' 134' ' ' SER . 4.6 pm0 -133.16 142.83 45.88 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 121.099 0.476 . . . . 0.0 111.196 -176.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.477 ' HB3' ' HB3' ' A' ' 112' ' ' TRP . 74.5 Cg_endo -74.12 135.67 21.22 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.923 2.415 . . . . 0.0 112.479 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.533 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.4 OUTLIER -71.09 114.37 9.08 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.056 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -52.18 131.57 32.5 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 123.621 0.576 . . . . 0.0 110.863 -178.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 111' ' ' ARG . 18.1 p -73.49 107.9 6.04 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.064 0.459 . . . . 0.0 110.918 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 6.1 t . . . . . 0 C--N 1.317 -0.826 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.849 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.502 ' HA ' ' OE1' ' A' ' 204' ' ' GLU . . . . . . . . 0 C--O 1.233 0.228 0 CA-C-O 121.48 0.657 . . . . 0.0 111.292 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 13.3 m -69.35 -44.02 72.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.171 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.662 HG23 ' HB2' ' A' ' 202' ' ' MET . 15.5 mm 75.27 103.55 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 123.206 0.602 . . . . 0.0 111.398 175.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.568 HG21 ' HB ' ' A' ' 205' ' ' THR . 2.8 m . . . . . 0 C--N 1.323 -0.565 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.508 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo . . . . . 0 CA--C 1.515 -0.437 0 CA-C-O 122.124 0.802 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.614 ' HB ' ' CD1' ' A' ' 113' ' ' PHE . 40.6 p -92.49 6.79 45.82 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.079 -1.419 . . . . 0.0 111.121 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.7 t -75.31 52.7 0.62 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.521 0.676 . . . . 0.0 110.588 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.477 ' HG3' ' CZ2' ' A' ' 112' ' ' TRP . 65.3 mm-40 -130.92 169.6 15.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.292 -177.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.423 ' O ' HG23 ' A' ' 218' ' ' THR . 18.7 mmt180 -83.67 -11.61 57.0 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -170.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.518 ' HE3' HG22 ' A' ' 137' ' ' VAL . 1.5 p-90 -92.96 -12.04 31.77 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.054 177.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.614 ' CD1' ' HB ' ' A' ' 108' ' ' THR . 57.5 t80 -84.69 119.5 25.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.385 0.612 . . . . 0.0 110.843 174.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -111.94 117.03 31.61 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -65.11 -66.57 2.39 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.739 -0.664 . . . . 0.0 113.261 -174.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -100.23 104.99 16.52 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.288 0.566 . . . . 0.0 111.34 -175.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 17.4 mt -154.56 130.74 10.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.598 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 68.3 p -84.03 173.06 11.45 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 172.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.73 -49.84 63.82 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.65 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.0 mmtm -61.24 -45.64 93.69 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 123.942 0.436 . . . . 0.0 111.526 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -66.79 -47.22 72.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.677 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.488 ' HB3' ' NH1' ' A' ' 138' ' ' ARG . . . -63.85 -33.87 76.65 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.088 0.47 . . . . 0.0 110.771 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.537 ' HG3' ' HB ' ' A' ' 167' ' ' VAL . 9.1 tt0 -67.26 -46.43 73.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.426 176.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -60.76 -33.25 72.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.757 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.581 HD12 HD13 ' A' ' 216' ' ' LEU . 0.5 OUTLIER -55.69 -52.32 64.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.178 0.514 . . . . 0.0 110.154 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.571 ' CD2' HD12 ' A' ' 216' ' ' LEU . 42.5 mt -75.62 -47.29 27.15 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.5 m -64.18 -33.29 75.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.294 -172.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -96.99 -53.28 3.56 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -91.35 -31.97 15.86 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -171.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -86.95 -163.27 38.61 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.191 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.518 ' C ' ' HD3' ' A' ' 152' ' ' ARG . 0.5 OUTLIER -146.4 174.41 11.4 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 177.813 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -50.86 120.25 4.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.85 0.357 . . . . 0.0 110.937 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.462 ' HA3' ' HD3' ' A' ' 213' ' ' LYS . . . 98.39 -4.51 60.21 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.199 178.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.628 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 66.9 m -72.84 138.51 46.38 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 176.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.448 ' CB ' HG12 ' A' ' 151' ' ' VAL . 49.4 p90 -136.63 149.12 47.82 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.986 0.422 . . . . 0.0 110.62 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.558 ' CD2' ' HB3' ' A' ' 150' ' ' SER . 1.2 pt? -149.99 136.66 19.21 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.655 HG21 HD13 ' A' ' 190' ' ' LEU . 16.2 m -99.5 133.96 40.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.488 ' NH1' ' HB3' ' A' ' 122' ' ' ALA . 10.7 ptt-85 -129.81 172.09 12.02 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -178.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -76.98 127.27 32.4 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.416 ' HB2' HG23 ' A' ' 148' ' ' VAL . 46.2 t -69.55 133.3 47.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.39 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -96.19 -26.03 15.6 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.552 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 41.6 m -81.0 -25.67 37.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.924 0.393 . . . . 0.0 109.94 174.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -126.04 87.23 56.45 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.983 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.0 124.18 15.11 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.342 2.028 . . . . 0.0 111.255 176.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.529 ' O ' ' HB3' ' A' ' 174' ' ' CYS . . . 101.77 -10.44 57.38 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.079 -177.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -114.36 171.9 7.34 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.405 ' CE1' ' HE2' ' A' ' 179' ' ' TYR . 96.6 m-85 -125.8 163.99 21.66 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.832 0.349 . . . . 0.0 110.347 -177.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 4.7 t -125.37 127.27 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.923 -177.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.893 ' HB3' HG22 ' A' ' 170' ' ' VAL . 1.2 tp -91.46 109.36 20.65 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.558 ' HB3' ' CD2' ' A' ' 136' ' ' LEU . 40.3 t -101.89 124.88 48.27 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.541 HG21 ' HB3' ' A' ' 210' ' ' LEU . 34.8 m -128.28 142.95 42.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.829 -173.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.518 ' HD3' ' C ' ' A' ' 131' ' ' LYS . 73.2 ttt180 -90.04 103.14 15.84 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.369 0.604 . . . . 0.0 109.688 176.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.504 HG21 HD12 ' A' ' 210' ' ' LEU . 1.5 p -107.42 148.62 28.89 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.799 -1.092 . . . . 0.0 110.162 -177.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.088 0 C-N-CA 119.67 -1.252 . . . . 0.0 111.21 -175.697 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm . . . . . 0 N--CA 1.442 -0.834 0 CA-C-O 121.262 0.554 . . . . 0.0 111.893 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.537 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 69.8 t -120.84 113.76 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.768 169.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.771 HG21 HD11 ' A' ' 210' ' ' LEU . 21.6 m -90.2 140.65 29.47 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.462 172.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -118.47 116.4 26.6 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.893 HG22 ' HB3' ' A' ' 149' ' ' LEU . 0.8 OUTLIER -98.53 138.95 21.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -177.143 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 38.8 tpp -84.91 116.51 23.38 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.995 0.426 . . . . 0.0 110.792 -175.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.567 HD13 HD21 ' A' ' 190' ' ' LEU . 24.5 mt -97.4 108.12 21.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.184 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.682 ' O ' ' HA ' ' A' ' 179' ' ' TYR . 77.3 mtm180 -65.56 123.24 19.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.487 176.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . 0.529 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 48.3 t -116.82 91.6 3.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.459 0.647 . . . . 0.0 109.562 174.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -114.51 114.53 25.91 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.235 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 57.16 45.12 21.19 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.661 0.601 . . . . 0.0 111.116 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 95.7 mt 63.79 22.57 13.11 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.943 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -113.43 132.24 55.71 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 172.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.682 ' HA ' ' O ' ' A' ' 173' ' ' ARG . 71.1 m-85 -110.16 137.57 47.73 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.206 -173.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -152.91 127.35 9.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.121 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.44 HG23 HD11 ' A' ' 193' ' ' LEU . 3.1 t -77.58 -0.64 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-O 121.707 0.765 . . . . 0.0 111.567 -176.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 124.99 -19.44 6.89 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.067 177.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -137.56 159.6 24.92 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 121.024 -0.607 . . . . 0.0 112.032 177.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 89.32 -135.31 12.9 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.055 175.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -116.06 145.03 43.33 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.56 0.219 . . . . 0.0 110.831 -176.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -75.69 128.79 35.96 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 175.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -105.92 144.04 33.22 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.808 0.337 . . . . 0.0 110.725 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -76.01 -9.81 58.91 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.752 -174.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 35.4 p -140.74 143.9 35.24 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.655 HD13 HG21 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -67.35 -23.08 65.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.914 179.674 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.49 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 13.9 m -61.1 -49.01 79.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.355 175.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -65.63 -30.88 71.65 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.833 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.456 ' HB3' HD23 ' A' ' 190' ' ' LEU . 3.3 tm? -64.32 -54.78 27.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.404 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 27.8 m -70.19 -42.21 79.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.558 -174.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -61.42 -39.11 89.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.91 0.386 . . . . 0.0 111.051 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -59.99 -42.27 93.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.823 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.501 ' HB2' HD22 ' A' ' 212' ' ' LEU . 36.6 m-85 -85.24 -13.59 49.37 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.124 0.488 . . . . 0.0 110.951 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -74.2 -27.3 60.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.446 0.641 . . . . 0.0 109.351 176.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -88.79 -36.5 16.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.477 175.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -119.92 105.33 42.98 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.425 -176.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.28 128.96 32.68 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.884 2.389 . . . . 0.0 112.474 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . 0.784 ' SD ' HD23 ' A' ' 210' ' ' LEU . 7.4 ptp -89.6 122.81 33.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.261 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.595 HG22 ' HB ' ' A' ' 209' ' ' VAL . 44.7 t -101.53 139.8 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 120.703 0.287 . . . . 0.0 111.59 -176.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.497 ' O ' HG12 ' A' ' 203' ' ' VAL . 25.6 mt-10 -89.22 162.35 15.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.37 . . . . 0.0 110.245 170.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.429 ' HB ' HG11 ' B' ' 4' ' ' VAL . 14.9 t -74.08 -11.91 60.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.324 0.583 . . . . 0.0 110.024 177.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.434 HD12 ' N ' ' A' ' 206' ' ' LEU . 5.0 mp -83.98 -8.31 59.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.018 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 101.04 -18.89 53.93 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.007 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 58.9 m -65.65 111.76 3.33 Favored 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 175.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.595 ' HB ' HG22 ' A' ' 203' ' ' VAL . 0.9 OUTLIER -112.22 126.99 69.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.6 0.714 . . . . 0.0 110.348 173.68 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.784 HD23 ' SD ' ' A' ' 202' ' ' MET . 0.4 OUTLIER -82.03 110.06 16.93 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.336 -172.188 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -85.17 89.51 7.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.584 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.501 HD22 ' HB2' ' A' ' 197' ' ' TYR . 8.2 mp -77.87 99.19 5.88 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 175.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.462 ' HD3' ' HA3' ' A' ' 133' ' ' GLY . 28.6 mtpp -109.61 -48.84 3.17 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.141 -173.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.628 ' O ' ' HA ' ' A' ' 134' ' ' SER . 0.4 OUTLIER -147.45 147.19 27.33 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 121.081 0.467 . . . . 0.0 111.007 178.006 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.458 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 93.0 Cg_endo -78.39 147.27 22.69 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.958 2.439 . . . . 0.0 113.222 -175.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.581 HD13 HD12 ' A' ' 125' ' ' LEU . 0.3 OUTLIER -83.86 109.88 17.92 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -56.55 145.98 26.42 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.43 0.456 . . . . 0.0 111.29 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 111' ' ' ARG . 4.8 p -82.13 136.02 35.22 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.58 -177.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.319 -0.743 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.288 173.603 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.588 ' HB2' ' CG2' ' A' ' 168' ' ' THR . . . . . . . . 0 C--O 1.231 0.096 0 CA-C-O 121.505 0.669 . . . . 0.0 112.384 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 46.2 m -76.02 -49.44 17.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.176 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.576 HD12 ' SD ' ' A' ' 202' ' ' MET . 8.0 mm 73.32 94.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 123.244 0.617 . . . . 0.0 110.732 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.429 HG11 ' HB ' ' A' ' 205' ' ' THR . 13.8 m . . . . . 0 C--N 1.32 -0.678 0 CA-C-O 121.624 0.726 . . . . 0.0 109.991 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.838 0 N-CA-C 112.058 -0.417 . . . . 0.0 112.058 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.45 -33.12 23.83 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.872 2.381 . . . . 0.0 112.815 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 58.5 ttp -76.21 -31.72 58.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.198 0.523 . . . . 0.0 109.9 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.91 82.66 8.05 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.346 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.409 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 5.4 m-20 -62.77 129.94 93.4 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.728 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 6.0 Cg_exo -75.43 -7.26 18.63 Favored 'Trans proline' 0 CA--C 1.516 -0.38 0 C-N-CA 122.636 2.224 . . . . 0.0 110.275 177.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.6 ' HB ' ' CG ' ' A' ' 113' ' ' PHE . 35.7 p -100.27 5.58 44.59 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.21 -176.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.8 m -75.26 58.73 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.515 0.674 . . . . 0.0 110.579 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.511 ' HG3' ' CZ2' ' A' ' 112' ' ' TRP . 81.5 mm-40 -129.65 -178.5 4.72 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.821 -176.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -84.71 -26.0 27.98 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -174.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.541 ' CZ2' ' HA ' ' A' ' 191' ' ' THR . 0.7 OUTLIER -85.71 -19.63 30.56 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -177.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.6 ' CG ' ' HB ' ' A' ' 108' ' ' THR . 72.2 t80 -81.45 123.76 28.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.012 0.434 . . . . 0.0 110.551 175.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -110.52 139.57 45.64 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.62 -88.87 0.03 OUTLIER Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.94 -0.648 . . . . 0.0 113.528 -174.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -100.52 106.63 18.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.03 0.443 . . . . 0.0 111.439 -175.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 64.0 mt -143.45 135.89 27.18 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.789 175.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.6 p -93.69 174.41 7.19 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -50.23 -54.3 20.17 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 121.558 -0.353 . . . . 0.0 113.856 -174.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 60.7 mmtt -77.99 -25.33 48.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 117.27 0.535 . . . . 0.0 111.87 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -65.33 -44.71 86.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.801 0.334 . . . . 0.0 110.627 175.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.553 ' HB2' ' HD3' ' A' ' 138' ' ' ARG . . . -64.11 -34.01 77.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.325 0.583 . . . . 0.0 110.494 176.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.546 ' HG3' ' HB ' ' A' ' 167' ' ' VAL . 16.3 tt0 -69.68 -48.36 59.99 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.962 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -56.47 -35.78 68.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.325 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.64 -51.52 69.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.273 177.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.549 ' CD2' HD12 ' A' ' 216' ' ' LEU . 27.7 mt -74.63 -46.41 38.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.687 -177.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.6 m -67.64 -33.01 74.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.029 -173.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -95.83 -48.27 5.81 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -100.14 -25.65 14.21 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -171.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -89.53 -159.75 35.76 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.573 -177.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -153.1 175.16 13.31 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -55.31 121.0 7.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.876 0.37 . . . . 0.0 111.275 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 99.54 -3.35 57.71 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.765 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 56.4 m -74.39 140.25 44.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.646 0.26 . . . . 0.0 110.503 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.508 ' CB ' HG12 ' A' ' 151' ' ' VAL . 52.3 p90 -137.45 149.02 46.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.165 177.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.534 HD21 ' HB2' ' A' ' 150' ' ' SER . 1.1 pt? -148.91 139.51 22.63 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 175.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.747 HG21 HD13 ' A' ' 190' ' ' LEU . 10.1 m -104.23 145.04 13.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.553 ' HD3' ' HB2' ' A' ' 122' ' ' ALA . 26.4 ptt85 -146.29 168.21 21.63 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.867 -178.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -76.74 131.41 38.72 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 123.247 0.342 . . . . 0.0 110.63 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.6 t -72.39 137.12 46.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.522 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -98.02 -28.78 13.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.845 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 39.0 m -78.8 -34.1 45.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.027 0.442 . . . . 0.0 109.862 175.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -117.82 78.04 12.11 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.876 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.26 123.1 12.16 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.088 1.859 . . . . 0.0 111.72 -177.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 113.97 -16.68 20.46 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.608 -176.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -109.37 171.68 7.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.06 0.457 . . . . 0.0 110.29 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -123.45 163.6 20.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.604 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 33.3 m -134.11 143.05 39.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.152 0.501 . . . . 0.0 111.401 177.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.907 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -101.86 111.09 23.22 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.225 177.516 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.573 ' HA ' ' HA ' ' A' ' 169' ' ' HIS . 1.2 m -104.17 131.71 51.18 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.592 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' A' ' 210' ' ' LEU . 32.7 m -130.57 152.08 36.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.456 -174.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.403 ' HB2' ' HB3' ' A' ' 126' ' ' LEU . 56.7 ttt180 -100.43 103.8 15.18 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.109 177.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 32.4 p -99.72 147.36 25.52 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.54 -177.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 75.57 161.82 10.52 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.15 -176.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.529 ' OD2' ' HE2' ' A' ' 157' ' ' LYS . 20.7 t70 -105.02 152.88 22.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.774 0.321 . . . . 0.0 110.908 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -90.03 -6.55 55.44 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -172.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.529 ' HE2' ' OD2' ' A' ' 155' ' ' ASP . 3.5 mppt? -91.15 -1.96 57.63 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.881 0.372 . . . . 0.0 110.925 178.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 161' ' ' ASN . . . 89.28 36.36 7.6 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.473 174.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -109.39 18.34 20.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.664 0.745 . . . . 0.0 110.37 174.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 21.5 m -154.11 -48.84 0.09 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.909 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.47 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 3.8 p-10 -149.46 165.44 32.13 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.753 176.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -110.55 163.53 13.62 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 82.12 58.39 2.48 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -175.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm 55.31 -167.15 0.1 Allowed 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 122.949 0.5 . . . . 0.0 111.176 -173.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 48.1 m -79.68 166.8 21.45 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.229 176.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.68 121.73 41.66 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.98 -175.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.546 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 56.1 t -100.01 133.32 43.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.364 0.602 . . . . 0.0 111.724 -177.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.65 HG21 HD11 ' A' ' 210' ' ' LEU . 1.1 m -119.18 141.41 48.89 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.763 171.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.656 ' CD2' ' HA ' ' B' ' -2' ' ' THR . 13.4 m-70 -108.24 138.17 44.97 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.907 HG22 ' HB3' ' A' ' 149' ' ' LEU . 1.2 m -114.35 138.62 43.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.513 ' HB2' ' HB2' ' B' ' 0' ' ' PTR . 41.2 tpp -81.91 126.71 32.23 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.878 0.37 . . . . 0.0 111.213 -178.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.514 HD13 HD21 ' A' ' 190' ' ' LEU . 32.6 mt -104.9 107.43 22.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 175.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.604 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 4.7 ptp180 -70.44 119.35 14.48 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.023 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.672 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 49.7 t -118.11 93.36 4.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.165 0.507 . . . . 0.0 110.469 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -116.62 125.65 52.11 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.769 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 57.18 39.15 29.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.9 -176.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 82.9 mt 63.16 31.75 15.49 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.324 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.672 ' O ' ' HA ' ' A' ' 174' ' ' CYS . 11.9 tppt? -110.99 132.23 54.39 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.471 ' CD2' ' HG ' ' A' ' 190' ' ' LEU . 81.8 m-85 -111.83 135.09 52.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.585 0.231 . . . . 0.0 111.176 -174.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.604 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 18.4 t0 -157.32 136.39 11.77 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.5 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.535 ' HB ' ' CZ ' ' A' ' 197' ' ' TYR . 56.0 t -90.65 -14.21 8.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.77 0.795 . . . . 0.0 109.031 174.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . 0.541 ' HA2' ' NH1' ' A' ' 173' ' ' ARG . . . 123.57 5.56 7.7 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.248 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -137.21 141.24 12.11 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.662 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 71.78 -158.45 53.47 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.241 -0.504 . . . . 0.0 113.083 174.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -74.08 150.73 40.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.894 0.378 . . . . 0.0 110.738 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 186' ' ' ARG . 54.2 mtt180 -99.26 132.89 44.27 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.67 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -110.9 150.56 29.02 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.138 -171.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -88.62 0.39 56.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.17 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.51 141.84 50.49 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.656 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.747 HD13 HG21 ' A' ' 137' ' ' VAL . 1.0 OUTLIER -77.28 -22.86 51.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.045 -175.476 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.541 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 16.4 m -61.97 -44.15 97.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.004 0.431 . . . . 0.0 110.275 177.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -66.41 -34.17 77.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.328 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.503 HD11 HG23 ' A' ' 181' ' ' VAL . 3.2 tm? -62.27 -54.64 37.77 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.199 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 27.2 m -66.39 -39.91 85.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.267 -175.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 191' ' ' THR . 27.8 mt-10 -68.17 -31.7 71.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.274 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -59.15 -47.26 85.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.087 0.47 . . . . 0.0 110.243 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.641 ' HB2' HD22 ' A' ' 212' ' ' LEU . 76.3 m-85 -85.73 -8.85 57.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.762 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.416 ' HA ' ' HB2' ' A' ' 212' ' ' LEU . 39.4 ttpt -70.95 -23.74 62.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.67 175.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -105.74 -22.85 12.86 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.564 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -126.42 89.0 53.22 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.523 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.69 132.29 51.22 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.236 2.624 . . . . 0.0 112.799 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . 0.516 ' HB2' HG23 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -97.48 137.31 36.63 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.066 179.725 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.621 HG22 ' HB ' ' A' ' 209' ' ' VAL . 36.3 t -108.39 137.11 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -169.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.547 ' O ' HG12 ' A' ' 203' ' ' VAL . 27.4 mt-10 -81.71 163.99 22.08 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.817 0.341 . . . . 0.0 110.182 169.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.0 t -76.29 -10.62 59.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.796 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.9 mp -90.95 -1.23 57.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.452 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 103.89 -23.72 31.57 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.471 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 23.2 m -60.77 111.33 1.59 Allowed 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 120.882 0.372 . . . . 0.0 110.307 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.621 ' HB ' HG22 ' A' ' 203' ' ' VAL . 1.1 p -112.58 128.66 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-O 121.826 0.822 . . . . 0.0 110.833 175.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.65 HD11 HG21 ' A' ' 168' ' ' THR . 0.3 OUTLIER -81.55 105.31 12.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 113.987 -1.46 . . . . 0.0 110.219 -170.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -93.89 90.47 6.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.637 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.641 HD22 ' HB2' ' A' ' 197' ' ' TYR . 6.8 mp -73.85 106.65 5.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.768 178.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -114.6 -55.96 2.43 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.633 ' O ' ' HA ' ' A' ' 134' ' ' SER . 0.7 OUTLIER -134.46 142.22 41.98 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 121.076 0.465 . . . . 0.0 111.179 -179.139 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.413 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 78.7 Cg_endo -76.38 142.24 23.63 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.951 2.434 . . . . 0.0 112.963 -175.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.549 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.3 OUTLIER -76.6 110.06 10.85 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 175.667 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -57.58 139.67 52.92 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 123.384 0.428 . . . . 0.0 111.103 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 13.4 p -71.99 108.0 5.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.498 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 3.6 t -81.96 105.49 13.12 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.68 0.753 . . . . 0.0 109.92 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 . . . . . 0 C--O 1.247 0.923 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.024 -176.935 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' -4' ' ' GLU . . . . . 0.432 ' HB3' ' H ' ' B' ' -3' ' ' GLN . 12.8 mm-40 . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 111.558 0.207 . . . . 0.0 111.558 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' -3' ' ' GLN . . . . . 0.432 ' H ' ' HB3' ' B' ' -4' ' ' GLU . 9.7 mm100 -57.16 112.34 1.34 Allowed 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.273 0.358 . . . . 0.0 110.631 -175.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' -2' ' ' THR . . . . . 0.656 ' HA ' ' CD2' ' A' ' 169' ' ' HIS . 7.2 m 47.76 -113.89 0.55 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -165.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' -1' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 70.69 -35.37 0.32 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 167.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 0' ' ' PTR . . . . . 0.513 ' HB2' ' HB2' ' A' ' 171' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.481 ' HA ' ' OE1' ' A' ' 204' ' ' GLU . . . 57.46 146.48 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 O-C-N 125.005 1.44 . . . . 0.0 113.702 168.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.52 -44.58 28.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.283 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.516 HG23 ' HB2' ' A' ' 202' ' ' MET . 4.2 mm 55.36 73.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.566 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.42 ' O ' ' HD3' ' B' ' 6' ' ' PRO . 2.3 m -101.03 97.76 6.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.591 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' PHE . . . . . 0.449 ' CE2' HG22 ' B' ' 3' ' ' ILE . 93.3 m-85 -76.55 108.71 6.87 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.848 173.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' B' ' 4' ' ' VAL . 1.7 Cg_endo . . . . . 0 C--O 1.251 1.134 0 C-N-CA 122.354 2.036 . . . . 0.0 111.466 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.793 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.33 -23.62 65.44 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.777 2.318 . . . . 0.0 112.758 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.7 tpt -104.21 74.29 1.18 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.505 0.669 . . . . 0.0 109.929 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.23 83.81 5.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.414 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -65.1 110.72 4.58 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.188 0.518 . . . . 0.0 110.494 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.49 ' HB2' ' H ' ' A' ' 190' ' ' LEU . 84.2 Cg_endo -78.21 -9.28 16.48 Favored 'Trans proline' 0 CA--C 1.517 -0.365 0 C-N-CA 123.399 2.732 . . . . 0.0 111.964 -174.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.714 ' HB ' ' CG ' ' A' ' 113' ' ' PHE . 34.7 p -100.19 7.85 44.23 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.562 -171.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 26.7 m -74.68 49.12 0.39 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.169 0.509 . . . . 0.0 110.939 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.407 ' HG3' ' CZ2' ' A' ' 112' ' ' TRP . 70.4 mm-40 -127.04 174.11 9.13 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.662 -176.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -79.55 -20.05 47.99 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -173.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.503 ' HB3' ' CB ' ' A' ' 215' ' ' PRO . 1.8 p-90 -85.95 -19.81 29.89 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.875 -178.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.714 ' CG ' ' HB ' ' A' ' 108' ' ' THR . 75.4 t80 -77.92 124.67 28.29 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.151 0.5 . . . . 0.0 110.707 175.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -122.11 107.04 11.72 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -51.84 -72.09 0.56 Allowed Glycine 0 CA--C 1.519 0.307 0 N-CA-C 114.744 0.657 . . . . 0.0 114.744 -167.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -100.29 86.34 3.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.347 0.594 . . . . 0.0 112.156 -173.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.475 ' O ' ' HD2' ' A' ' 138' ' ' ARG . 33.1 mt -133.38 133.27 42.22 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.165 175.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 35.4 t -93.6 172.76 8.06 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 168.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 123' ' ' GLU . . . -51.77 -44.27 54.88 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.245 -0.502 . . . . 0.0 112.797 -177.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.408 ' HD3' ' N ' ' A' ' 120' ' ' LYS . 3.1 mppt? -69.36 -35.03 75.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.959 0.409 . . . . 0.0 110.607 -175.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -72.61 -47.26 49.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.402 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.492 ' HB2' ' HD3' ' A' ' 138' ' ' ARG . . . -62.56 -34.06 76.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.431 177.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.505 ' HG3' ' HB ' ' A' ' 167' ' ' VAL . 3.7 tt0 -65.36 -50.33 65.97 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.694 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -58.94 -36.22 74.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.418 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.475 HD12 HD13 ' A' ' 216' ' ' LEU . 0.7 OUTLIER -58.48 -53.66 55.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.768 178.368 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.542 ' CD2' HD12 ' A' ' 216' ' ' LEU . 61.3 mt -75.39 -48.44 22.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.759 -176.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.46 HG23 ' HB2' ' A' ' 165' ' ' SER . 5.7 m -61.9 -32.78 73.19 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.192 -172.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -97.44 -53.87 3.32 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.406 ' CD ' HG21 ' A' ' 219' ' ' THR . 96.9 mttt -91.58 -23.37 19.91 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -169.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -93.32 -160.24 35.2 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.057 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -152.3 175.73 12.35 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 175.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -58.54 125.15 22.18 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 177.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.505 ' HA2' ' O ' ' A' ' 211' ' ' GLN . . . 103.72 -10.98 53.22 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.113 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.708 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 27.8 m -78.65 139.59 38.51 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.658 0.266 . . . . 0.0 110.376 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.527 ' CB ' HG12 ' A' ' 151' ' ' VAL . 44.9 p90 -137.02 150.38 48.06 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.409 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.5 ' CD2' ' HB2' ' A' ' 150' ' ' SER . 1.1 pt? -149.04 136.41 20.17 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.697 HG21 HD13 ' A' ' 190' ' ' LEU . 5.6 m -100.42 139.99 20.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.547 178.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.492 ' HD3' ' HB2' ' A' ' 122' ' ' ALA . 17.6 ptt85 -141.8 167.73 21.45 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.459 -176.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -80.63 133.79 35.79 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.496 ' HB2' HG13 ' A' ' 148' ' ' VAL . 39.2 t -76.14 139.13 41.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.934 0.397 . . . . 0.0 110.048 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -99.87 -18.01 17.35 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.669 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.637 ' HG ' ' HE2' ' B' ' 0' ' ' PTR . 51.4 p -84.93 -26.67 27.08 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 171.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -123.34 78.63 53.51 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.178 176.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.97 124.55 15.94 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.869 2.379 . . . . 0.0 112.303 -178.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 106.79 -16.85 39.61 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.012 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -106.98 157.24 17.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.896 0.379 . . . . 0.0 110.351 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -110.58 158.64 18.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.657 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.551 HG11 ' CE1' ' B' ' 0' ' ' PTR . 35.1 m -136.47 139.36 45.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.339 0.59 . . . . 0.0 111.383 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.968 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -95.09 110.54 22.46 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.817 176.23 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.5 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 2.4 m -101.89 130.68 48.44 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.269 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.527 HG12 ' CB ' ' A' ' 135' ' ' PHE . 33.5 m -129.26 150.3 34.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.679 -174.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.402 ' HB2' ' HB3' ' A' ' 126' ' ' LEU . 70.0 ttt180 -93.04 102.4 14.74 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.425 0.631 . . . . 0.0 109.506 175.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.504 HG21 ' HA ' ' A' ' 210' ' ' LEU . 0.9 OUTLIER -115.0 97.78 6.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.722 178.758 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.465 ' HA2' ' HB2' ' A' ' 160' ' ' SER . . . 139.7 142.1 4.17 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -176.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.539 ' HB2' ' HB2' ' A' ' 159' ' ' GLU . 0.7 OUTLIER -104.82 146.17 29.35 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.38 0.609 . . . . 0.0 112.052 -172.621 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -72.49 4.21 4.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.576 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -99.57 12.83 35.42 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.781 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 88.12 38.23 7.41 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.908 176.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 155' ' ' ASP . 37.5 mt-10 -120.92 131.12 54.17 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.465 ' HB2' ' HA2' ' A' ' 154' ' ' GLY . 49.1 m 70.62 8.09 6.45 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 123.937 0.773 . . . . 0.0 111.178 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -171.37 163.64 6.96 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -81.02 79.09 7.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.941 0.4 . . . . 0.0 111.394 -176.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 92.63 -52.48 2.67 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 121.116 -0.564 . . . . 0.0 113.286 172.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -92.45 174.12 7.45 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.751 0.31 . . . . 0.0 110.791 -175.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.46 ' HB2' HG23 ' A' ' 127' ' ' THR . 19.4 m -76.03 169.11 18.79 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.447 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.502 ' HB3' ' O ' ' A' ' 153' ' ' THR . 0.0 OUTLIER -131.23 142.26 50.14 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.267 -176.667 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.505 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 60.1 t -123.39 115.98 47.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 121.086 0.469 . . . . 0.0 111.323 176.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.715 HG21 HD11 ' A' ' 210' ' ' LEU . 4.1 m -92.86 140.73 29.19 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.049 172.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.699 ' O ' ' HA ' ' B' ' 0' ' ' PTR . 37.8 m-70 -114.78 119.72 37.61 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.968 HG22 ' HB3' ' A' ' 149' ' ' LEU . 0.8 OUTLIER -98.4 140.14 18.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -177.028 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 40.2 tpp -87.02 117.88 26.03 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.253 -177.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.542 HD13 HD21 ' A' ' 190' ' ' LEU . 20.7 mt -97.02 107.04 19.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 175.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.567 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 17.9 ptp180 -69.16 122.42 18.76 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.917 0.389 . . . . 0.0 110.0 -177.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 49.5 t -113.88 93.42 4.36 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.805 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -125.92 122.4 35.9 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.158 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 58.63 41.75 21.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.124 -178.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.0 mt 60.49 45.42 10.77 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.165 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 174' ' ' CYS . 10.9 tppt? -131.46 139.11 49.29 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -116.04 129.95 56.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.585 0.231 . . . . 0.0 110.783 -175.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.567 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 13.8 t0 -157.01 129.25 7.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.79 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.557 ' HB ' ' CZ ' ' A' ' 197' ' ' TYR . 31.0 t -83.91 -12.27 11.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.773 0.797 . . . . 0.0 109.312 176.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 122.76 9.02 6.5 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.388 176.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.611 ' HA3' ' CE2' ' B' ' 5' ' ' PHE . . . -137.88 140.48 11.26 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.138 -1.029 . . . . 0.0 113.738 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 71.59 -154.8 51.74 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.266 -0.492 . . . . 0.0 112.998 174.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -73.97 142.73 45.84 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.64 0.257 . . . . 0.0 110.364 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -88.0 132.71 34.16 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -106.88 156.44 18.69 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.226 0.536 . . . . 0.0 112.019 -169.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -94.34 -11.52 29.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.24 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.6 m -129.4 142.71 50.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.123 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.697 HD13 HG21 ' A' ' 137' ' ' VAL . 0.9 OUTLIER -72.81 -22.71 60.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.28 -175.4 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 5.8 m -61.82 -46.23 90.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.894 0.378 . . . . 0.0 110.53 177.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -64.72 -34.17 77.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.057 178.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.502 HD11 HG23 ' A' ' 181' ' ' VAL . 3.1 tm? -60.25 -54.28 47.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.298 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 30.8 m -68.62 -43.75 83.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.934 -175.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -59.2 -35.57 73.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.001 0.429 . . . . 0.0 111.232 177.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -62.4 -45.28 93.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.102 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.557 ' CZ ' ' HB ' ' A' ' 181' ' ' VAL . 59.8 m-85 -85.76 -10.36 55.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.948 0.404 . . . . 0.0 111.448 -176.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.443 ' HD2' ' CZ ' ' A' ' 135' ' ' PHE . 47.0 mtpt -70.86 -34.81 72.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.155 0.502 . . . . 0.0 109.865 170.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.459 ' HG3' ' ND2' ' A' ' 200' ' ' ASN . 14.1 tptt -88.85 -36.17 16.16 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.036 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . 0.459 ' ND2' ' HG3' ' A' ' 199' ' ' LYS . 55.4 m-80 -113.49 101.57 53.8 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.432 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.28 126.17 21.62 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.845 2.363 . . . . 0.0 112.77 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . 0.755 ' SD ' HG11 ' A' ' 170' ' ' VAL . 14.3 ptp -89.31 141.81 28.22 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 175.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.558 HG22 HG22 ' A' ' 209' ' ' VAL . 11.2 t -124.8 139.51 50.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.998 -173.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.671 ' HG2' ' HB1' ' B' ' 1' ' ' ALA . 26.0 mt-10 -82.01 161.24 23.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.898 171.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.3 t -74.32 -9.85 59.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.235 0.54 . . . . 0.0 110.006 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.5 mp -89.68 4.38 49.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.162 176.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.57 -1.27 83.79 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.629 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.414 HG22 HD13 ' A' ' 210' ' ' LEU . 23.1 m -73.16 113.51 10.3 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.011 0.434 . . . . 0.0 110.588 177.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.558 HG22 HG22 ' A' ' 203' ' ' VAL . 69.9 t -98.6 114.34 35.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.715 HD11 HG21 ' A' ' 168' ' ' THR . 0.4 OUTLIER -76.52 100.34 5.24 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.505 ' O ' ' HA2' ' A' ' 133' ' ' GLY . 47.1 mt-30 -84.68 92.96 8.31 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.382 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.505 HD22 ' HB2' ' A' ' 197' ' ' TYR . 9.2 mp -77.57 105.41 8.69 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.956 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -113.86 -57.07 2.33 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.708 ' O ' ' HA ' ' A' ' 134' ' ' SER . 4.6 pm0 -132.0 139.38 34.84 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-O 121.14 0.495 . . . . 0.0 111.209 -177.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.503 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 71.5 Cg_endo -74.37 138.45 24.71 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.982 2.455 . . . . 0.0 112.527 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.542 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.3 OUTLIER -72.5 106.28 4.52 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.053 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -56.15 133.62 52.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.083 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.6 p -58.02 111.6 1.23 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.436 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.406 HG21 ' CD ' ' A' ' 129' ' ' LYS . 2.0 t -104.02 110.7 22.95 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.288 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.467 -0.778 . . . . 0.0 109.57 -179.848 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' -4' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 63.38 -157.21 0.32 Allowed 'General case' 0 CA--C 1.532 0.277 0 O-C-N 123.583 0.552 . . . . 0.0 110.898 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' -2' ' ' THR . . . . . 0.552 ' HA ' ' CD2' ' A' ' 169' ' ' HIS . 25.2 m -71.08 -95.14 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 119.233 -0.413 . . . . 0.0 110.361 175.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' -1' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 71.0 -39.01 0.44 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.215 0.606 . . . . 0.0 111.745 175.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 0' ' ' PTR . . . . . 0.699 ' HA ' ' O ' ' A' ' 169' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.671 ' HB1' ' HG2' ' A' ' 204' ' ' GLU . . . -56.17 130.68 45.26 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.627 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 23.5 m -70.87 -38.0 73.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.295 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.512 HD12 ' SD ' ' A' ' 202' ' ' MET . 7.5 mm 70.03 88.0 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 121.613 0.721 . . . . 0.0 111.213 176.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 2.1 m -108.79 98.33 6.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.828 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' PHE . . . . . 0.611 ' CE2' ' HA3' ' A' ' 183' ' ' GLY . 92.2 m-85 -74.75 118.88 73.71 Favored Pre-proline 0 C--N 1.313 -0.983 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.452 173.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo . . . . . 0 C--O 1.252 1.179 0 C-N-CA 122.451 2.101 . . . . 0.0 112.168 -178.882 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.705 0 CA-C-O 119.657 -0.524 . . . . 0.0 111.881 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -56.34 -49.17 15.91 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.089 2.526 . . . . 0.0 112.902 -178.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 86.3 mtp -108.98 26.87 10.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.98 0.419 . . . . 0.0 110.57 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.88 69.32 10.74 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.312 0.577 . . . . 0.0 109.64 176.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.411 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 3.2 m-20 -74.73 128.82 84.77 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.046 -176.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 5.6 Cg_exo -76.09 -6.86 17.74 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.718 2.278 . . . . 0.0 109.597 172.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.536 HG22 HD12 ' A' ' 190' ' ' LEU . 25.5 p -98.13 7.41 46.32 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 113.628 -1.623 . . . . 0.0 111.153 -176.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.4 p -75.65 30.19 0.11 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.934 0.397 . . . . 0.0 111.755 -178.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.429 ' H ' ' C ' ' A' ' 108' ' ' THR . 10.8 mm-40 -109.88 171.26 7.56 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.434 ' O ' HG23 ' A' ' 218' ' ' THR . 25.3 mmt180 -85.47 -9.62 57.21 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -167.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.467 ' HB3' ' CB ' ' A' ' 215' ' ' PRO . 2.4 p-90 -87.31 -19.14 28.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.954 0.407 . . . . 0.0 110.621 175.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.516 ' CD1' ' HB ' ' A' ' 108' ' ' THR . 80.3 t80 -75.17 119.19 18.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.199 0.524 . . . . 0.0 110.241 173.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.411 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 13.9 m-70 -112.16 147.09 36.89 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 175.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -73.55 -123.99 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.731 -172.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -86.84 83.6 7.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.515 0.674 . . . . 0.0 111.168 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.401 ' HB2' ' NH1' ' A' ' 138' ' ' ARG . 77.9 mt -98.0 160.6 14.2 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.835 171.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.1 p -102.48 172.46 6.85 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 165.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.64 -50.1 44.08 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 121.312 -0.471 . . . . 0.0 112.619 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -64.64 -41.43 96.15 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 122.466 0.307 . . . . 0.0 111.425 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -61.08 -46.75 89.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.552 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.91 -35.05 79.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.972 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -64.87 -50.83 65.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.071 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -60.65 -34.58 74.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.419 176.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 129' ' ' LYS . 0.4 OUTLIER -57.01 -52.82 63.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.983 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.586 HD23 HD12 ' A' ' 216' ' ' LEU . 71.1 mt -75.96 -52.19 10.8 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -178.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 m -64.89 -33.2 75.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.785 -170.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -96.66 -49.81 4.95 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 125' ' ' LEU . 95.9 mttt -92.14 -23.51 19.39 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -169.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -98.54 -149.77 25.2 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.325 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.29 173.67 15.85 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 176.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 62.9 t60 -51.18 118.87 3.52 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.774 0.321 . . . . 0.0 110.825 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 211' ' ' GLN . . . 102.21 -3.21 51.09 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.314 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 33.8 p -72.24 139.67 48.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.276 0.538 . . . . 0.0 110.1 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.479 ' CB ' HG12 ' A' ' 151' ' ' VAL . 53.3 p90 -137.21 151.58 48.92 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.976 0.417 . . . . 0.0 110.636 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.558 HD21 ' HB2' ' A' ' 150' ' ' SER . 1.2 pt? -153.21 136.05 15.38 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.645 HG21 HD13 ' A' ' 190' ' ' LEU . 5.5 m -96.72 142.44 13.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 175.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.668 ' HB2' HH11 ' A' ' 138' ' ' ARG . 0.0 OUTLIER -147.36 160.08 42.95 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.703 -171.482 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -79.14 110.42 14.37 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.997 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.574 ' HB2' HG13 ' A' ' 148' ' ' VAL . 41.8 t -66.66 124.78 23.81 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -90.99 -15.35 29.8 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 28.0 t -72.83 -39.47 66.55 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 172.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 46.7 m-70 -119.57 81.39 24.07 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.544 172.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.22 134.47 59.45 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.042 2.495 . . . . 0.0 112.968 -172.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 100.0 -21.6 43.98 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.073 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.56 ' HA ' ' SG ' ' A' ' 174' ' ' CYS . 4.5 m-20 -102.56 170.32 8.11 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.243 0.544 . . . . 0.0 111.063 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -117.18 149.95 39.53 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.311 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.574 HG13 ' HB2' ' A' ' 140' ' ' SER . 27.1 m -131.91 138.71 52.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.173 0.511 . . . . 0.0 111.065 176.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.927 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -92.18 109.48 20.85 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.455 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.558 ' HB2' HD21 ' A' ' 136' ' ' LEU . 2.8 m -101.77 133.49 46.43 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.136 -179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.56 HG21 ' HB3' ' A' ' 210' ' ' LEU . 28.1 m -132.9 153.84 38.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.923 0.392 . . . . 0.0 111.356 -173.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.487 HH21 ' HB2' ' A' ' 156' ' ' ASP . 73.6 ttt180 -99.69 103.98 15.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.2 178.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 14.8 p -108.36 147.66 31.21 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.456 -177.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 88.89 172.25 46.23 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.112 -178.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -102.32 151.42 22.27 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.789 0.328 . . . . 0.0 110.6 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.487 ' HB2' HH21 ' A' ' 152' ' ' ARG . 3.3 t70 -96.03 23.59 6.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.532 0.682 . . . . 0.0 110.293 -175.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -81.42 -5.73 58.2 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.987 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 163' ' ' GLY . . . 84.63 -64.01 4.32 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.048 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -64.82 -17.08 63.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.01 0.434 . . . . 0.0 111.586 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 5.4 m -87.09 -10.64 52.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.156 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -146.38 -161.52 1.34 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -173.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -63.97 -28.26 69.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.864 0.84 . . . . 0.0 109.902 175.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.421 ' O ' ' HA2' ' A' ' 158' ' ' GLY . . . 162.21 -34.23 0.34 Allowed Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.81 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -132.09 168.92 17.13 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 18.0 m -58.48 147.59 31.27 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 123.464 0.478 . . . . 0.0 110.637 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.413 ' HD2' ' HA ' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -96.39 124.91 40.55 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.751 -179.024 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 72.6 t -100.41 113.01 34.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.426 0.632 . . . . 0.0 110.626 176.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.639 HG21 HD11 ' A' ' 210' ' ' LEU . 1.4 m -98.21 137.73 36.54 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.726 175.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.754 ' O ' ' HA ' ' B' ' 0' ' ' PTR . 23.7 m-70 -105.97 122.48 46.22 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.927 HG22 ' HB3' ' A' ' 149' ' ' LEU . 0.8 OUTLIER -99.5 138.42 23.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.144 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.414 ' O ' ' HA ' ' A' ' 181' ' ' VAL . 39.8 tpp -82.22 121.28 26.43 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.636 -0.257 . . . . 0.0 111.018 -174.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.537 HD13 HD21 ' A' ' 190' ' ' LEU . 28.8 mt -101.64 107.5 21.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 177.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.581 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 4.4 ptp180 -73.8 107.66 6.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.064 0.459 . . . . 0.0 110.735 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.56 ' SG ' ' HA ' ' A' ' 146' ' ' ASP . 4.9 p -86.0 101.27 12.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.888 175.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -127.73 111.14 13.35 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.944 -176.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 56.24 43.67 26.17 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.577 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 91.5 mt 66.48 15.96 10.26 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.197 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -105.99 142.86 34.99 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 172.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -117.23 141.35 48.4 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.538 -175.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.581 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 5.9 t0 -158.71 136.25 10.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.59 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.472 HG22 ' CZ ' ' A' ' 197' ' ' TYR . 16.8 m -87.62 -11.01 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 121.051 0.453 . . . . 0.0 110.409 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . 0.519 ' HA2' ' NH1' ' A' ' 173' ' ' ARG . . . 123.31 34.74 0.75 Allowed Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -174.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.464 ' HA2' ' CE1' ' B' ' 5' ' ' PHE . . . -102.95 -157.69 25.33 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 121.514 -0.374 . . . . 0.0 112.448 -176.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -86.43 -40.91 7.13 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.031 -177.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -115.89 143.11 45.88 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.905 0.384 . . . . 0.0 111.279 -177.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -93.15 141.53 28.32 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -110.95 137.39 48.64 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.643 0.259 . . . . 0.0 110.677 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -82.86 0.9 41.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.229 0.538 . . . . 0.0 110.372 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.1 p -141.39 142.67 33.73 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.906 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.645 HD13 HG21 ' A' ' 137' ' ' VAL . 1.7 mt -76.52 -23.14 53.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.061 -176.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.462 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 97.6 m -62.02 -49.29 76.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.006 0.431 . . . . 0.0 109.938 174.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.65 -29.89 70.9 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.494 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.411 HD13 ' C ' ' A' ' 193' ' ' LEU . 3.2 tm? -64.34 -54.91 25.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.99 176.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.15 -42.1 79.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.348 -174.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -60.83 -31.76 71.17 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.388 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -67.29 -47.81 69.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.922 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.528 ' HB2' HD22 ' A' ' 212' ' ' LEU . 80.3 m-85 -82.8 -11.16 58.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.246 0.546 . . . . 0.0 110.639 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -68.96 -29.74 68.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.284 172.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -93.3 -37.76 11.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.375 176.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -119.31 98.06 50.41 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.344 -177.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -56.31 138.28 83.01 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.978 2.452 . . . . 0.0 112.449 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . 0.704 ' HB2' HG23 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -100.4 135.54 41.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.772 178.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.575 HG22 ' HB ' ' A' ' 209' ' ' VAL . 39.3 t -103.55 141.18 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -171.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.573 ' HG2' ' HB1' ' B' ' 1' ' ' ALA . 38.7 mt-10 -86.82 161.98 18.04 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 169.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 13.7 t -74.59 -10.5 59.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.057 0.456 . . . . 0.0 110.346 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.6 mp -92.07 8.77 36.26 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.126 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.77 -29.0 7.74 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.776 177.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 53.4 m -57.98 112.5 1.52 Allowed 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 116.981 0.39 . . . . 0.0 110.164 176.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.575 ' HB ' HG22 ' A' ' 203' ' ' VAL . 1.1 p -111.6 129.35 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-O 121.548 0.689 . . . . 0.0 110.228 174.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.639 HD11 HG21 ' A' ' 168' ' ' THR . 0.4 OUTLIER -78.85 113.23 16.77 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.347 -1.297 . . . . 0.0 111.163 -168.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.404 ' O ' ' HA2' ' A' ' 133' ' ' GLY . 65.9 mt-30 -90.36 90.16 7.92 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.437 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.528 HD22 ' HB2' ' A' ' 197' ' ' TYR . 8.0 mp -79.17 104.94 10.14 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 175.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 47.5 mttp -112.73 -54.73 2.6 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -177.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.552 ' O ' ' HA ' ' A' ' 134' ' ' SER . 0.1 OUTLIER -142.03 144.7 33.06 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.112 0.482 . . . . 0.0 111.32 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.467 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 74.1 Cg_endo -73.88 144.6 34.89 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.097 2.531 . . . . 0.0 113.202 -176.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.586 HD12 HD23 ' A' ' 126' ' ' LEU . 0.4 OUTLIER -82.94 119.92 25.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.513 176.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -58.18 145.43 37.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.265 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 111' ' ' ARG . 4.2 p -74.25 108.22 6.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.532 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 2.8 t -109.81 115.6 30.12 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.708 176.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 69.8 mtp180 . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.523 -0.751 . . . . 0.0 110.239 -178.668 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' -4' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 58.26 24.54 11.61 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.483 0.658 . . . . 0.0 110.961 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' -2' ' ' THR . . . . . 0.575 HG23 ' O1P' ' B' ' 0' ' ' PTR . 6.6 m -137.94 -94.6 0.2 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' -1' ' ' GLU . . . . . 0.429 ' H ' ' HB ' ' B' ' -2' ' ' THR . 1.5 mp0 72.35 -47.05 0.66 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.371 0.669 . . . . 0.0 111.01 171.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 0' ' ' PTR . . . . . 0.754 ' HA ' ' O ' ' A' ' 169' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.573 ' HB1' ' HG2' ' A' ' 204' ' ' GLU . . . -40.92 125.12 2.28 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 113.59 -1.641 . . . . 0.0 112.365 -173.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 7.4 m -61.79 -52.26 64.91 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.189 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.704 HG23 ' HB2' ' A' ' 202' ' ' MET . 33.6 mm 82.74 82.25 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-O 121.853 0.835 . . . . 0.0 109.372 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.646 ' O ' ' HD3' ' B' ' 6' ' ' PRO . 28.7 m -106.84 130.16 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.629 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' PHE . . . . . 0.464 ' CE1' ' HA2' ' A' ' 183' ' ' GLY . 74.7 m-85 -98.97 92.55 1.68 Allowed Pre-proline 0 C--N 1.305 -1.327 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.074 175.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.646 ' HD3' ' O ' ' B' ' 4' ' ' VAL . 16.2 Cg_exo . . . . . 0 C--O 1.249 1.068 0 C-N-CA 122.912 2.408 . . . . 0.0 111.918 -176.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.8 0 CA-C-O 119.627 -0.54 . . . . 0.0 111.808 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -77.71 52.09 3.83 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.138 2.559 . . . . 0.0 112.405 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 24.5 ttt -135.97 -50.83 0.71 Allowed 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 173.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.67 20.06 9.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.857 175.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.444 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 8.7 p-10 -72.03 147.19 90.91 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.018 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 5.4 Cg_exo -76.02 -7.01 17.95 Favored 'Trans proline' 0 CA--C 1.515 -0.468 0 C-N-CA 123.058 2.505 . . . . 0.0 111.441 -175.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.506 ' HB ' ' CG ' ' A' ' 113' ' ' PHE . 40.4 p -100.44 6.26 44.37 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.154 -175.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.8 p -78.54 45.28 0.57 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.246 0.546 . . . . 0.0 111.09 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -125.9 168.34 14.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.89 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.434 ' O ' HG23 ' A' ' 218' ' ' THR . 14.3 mmt180 -82.82 -14.86 53.58 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -170.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.538 ' HB3' ' CB ' ' A' ' 215' ' ' PRO . 1.7 p-90 -85.17 -18.6 33.64 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.3 175.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.506 ' CG ' ' HB ' ' A' ' 108' ' ' THR . 87.2 t80 -78.98 118.05 20.62 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.215 173.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -115.11 113.36 23.9 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 174.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -64.31 -72.74 0.65 Allowed Glycine 0 N--CA 1.454 -0.163 0 CA-C-N 116.089 -0.505 . . . . 0.0 113.658 -173.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -84.41 89.46 7.4 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.642 -0.328 . . . . 0.0 110.996 -174.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 24.3 mt -143.73 137.15 27.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.661 174.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.1 t -101.05 173.59 6.4 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 169.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 123' ' ' GLU . . . -49.85 -52.87 24.24 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 121.527 -0.368 . . . . 0.0 113.796 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.56 -25.55 57.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.169 0.485 . . . . 0.0 111.229 -176.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -69.99 -47.27 62.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.156 0.503 . . . . 0.0 109.93 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.667 ' HB2' ' HD2' ' A' ' 138' ' ' ARG . . . -67.06 -34.11 76.97 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.597 177.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.474 ' HG3' ' HB ' ' A' ' 167' ' ' VAL . 3.3 tt0 -61.66 -49.08 77.98 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.847 177.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -59.67 -34.11 72.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.877 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.401 HD12 HD13 ' A' ' 216' ' ' LEU . 1.2 mm? -56.72 -53.53 56.7 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.119 0.485 . . . . 0.0 110.405 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.526 ' CD2' HD12 ' A' ' 216' ' ' LEU . 54.0 mt -76.15 -44.36 38.58 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.67 HG23 ' HB2' ' A' ' 165' ' ' SER . 6.9 m -61.61 -35.48 78.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 110.757 -175.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -95.6 -52.99 3.89 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -97.86 -22.73 16.2 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -170.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -90.08 177.51 42.96 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.307 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -135.59 175.14 9.87 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -57.98 117.59 4.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.781 0.324 . . . . 0.0 110.574 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 211' ' ' GLN . . . 104.02 -5.29 46.05 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.76 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 29.6 m -74.61 137.44 42.29 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.649 -0.324 . . . . 0.0 110.434 176.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.463 ' CB ' HG12 ' A' ' 151' ' ' VAL . 51.0 p90 -136.87 149.26 47.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.714 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.582 HD21 ' HB2' ' A' ' 150' ' ' SER . 1.2 pt? -150.56 134.15 16.51 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.71 HG21 HD13 ' A' ' 190' ' ' LEU . 11.9 m -97.44 141.09 16.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.667 ' HD2' ' HB2' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -140.19 162.94 34.06 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.903 -175.046 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -77.73 128.13 33.54 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.53 ' HB2' HG13 ' A' ' 148' ' ' VAL . 36.4 t -75.82 137.98 40.85 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -101.3 -21.51 14.85 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.033 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 33.5 m -86.12 -29.19 23.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.985 173.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -116.83 81.09 11.58 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 175.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.03 133.11 39.6 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.797 2.331 . . . . 0.0 112.369 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 94.52 -10.08 71.17 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.862 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -113.65 168.37 9.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.071 0.463 . . . . 0.0 110.356 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.475 ' CE1' ' HE1' ' A' ' 179' ' ' TYR . 74.0 m-85 -125.06 163.27 22.74 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.58 -177.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.532 ' CG2' ' HG3' ' A' ' 138' ' ' ARG . 26.7 m -134.62 136.99 51.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.228 0.537 . . . . 0.0 111.193 178.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.986 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -92.29 110.18 21.57 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.14 177.116 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.582 ' HB2' HD21 ' A' ' 136' ' ' LEU . 3.8 m -101.25 130.43 47.38 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.297 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.499 HG21 ' HB3' ' A' ' 210' ' ' LEU . 33.9 m -131.43 146.9 32.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.848 -174.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.409 ' HB2' ' HB3' ' A' ' 126' ' ' LEU . 39.5 ttt180 -91.55 104.89 17.32 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.17 0.51 . . . . 0.0 109.964 175.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.489 ' O ' ' HB3' ' A' ' 166' ' ' LYS . 3.7 p -104.11 146.58 28.53 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.977 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 76.14 172.9 34.72 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.876 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.492 ' OD1' ' HE2' ' A' ' 157' ' ' LYS . 25.0 t70 -106.98 172.79 6.63 Favored 'General case' 0 C--N 1.316 -0.857 0 O-C-N 122.869 -0.195 . . . . 0.0 110.587 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.487 ' HB3' ' OG ' ' A' ' 165' ' ' SER . 11.3 p-10 -95.4 -9.94 31.38 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.863 0.363 . . . . 0.0 111.232 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.492 ' HE2' ' OD1' ' A' ' 155' ' ' ASP . 3.9 mppt? -97.63 -19.79 18.06 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.392 0.615 . . . . 0.0 109.711 171.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 96.08 69.08 1.01 Allowed Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.304 -0.862 . . . . 0.0 113.129 175.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -76.2 -58.49 3.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.153 0.501 . . . . 0.0 110.025 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 36.5 t -123.28 30.49 6.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.465 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -163.04 -169.83 2.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.083 -177.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -77.11 -179.39 5.55 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -83.92 44.48 3.33 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.843 -175.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 10.8 mmmm -143.59 139.26 29.58 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.67 ' HB2' HG23 ' A' ' 127' ' ' THR . 7.4 m -70.01 124.07 23.13 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 178.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 153' ' ' THR . 51.9 tptt -95.77 137.45 34.81 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.247 -177.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.474 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 73.9 t -119.17 113.33 41.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.353 0.597 . . . . 0.0 110.319 174.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.822 HG21 HD11 ' A' ' 210' ' ' LEU . 18.9 m -97.95 133.59 42.23 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.905 176.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.699 ' O ' ' HA ' ' B' ' 0' ' ' PTR . 13.4 m-70 -110.9 117.91 34.66 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.986 HG22 ' HB3' ' A' ' 149' ' ' LEU . 0.7 OUTLIER -98.15 133.58 39.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -177.064 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 44.0 tpp -78.7 119.27 21.7 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.683 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.559 HD13 HD21 ' A' ' 190' ' ' LEU . 24.8 mt -99.58 107.22 20.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.644 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 4.5 ptp180 -69.98 125.51 26.98 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.673 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 49.4 t -118.53 115.5 24.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.72 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -141.44 112.8 7.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.164 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 60.16 49.94 6.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.974 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.0 mt 58.35 47.49 13.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.844 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.673 ' O ' ' HA ' ' A' ' 174' ' ' CYS . 11.3 tppt? -133.97 132.23 39.91 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.475 ' HE1' ' CE1' ' A' ' 147' ' ' PHE . 69.0 m-85 -117.71 134.08 55.27 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.161 0.288 . . . . 0.0 110.715 -175.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.644 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 12.5 t0 -156.12 131.46 9.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.952 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.561 ' HB ' ' CZ ' ' A' ' 197' ' ' TYR . 51.1 t -83.16 -15.69 11.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.701 0.762 . . . . 0.0 109.083 175.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . 0.411 ' HA2' ' NH1' ' A' ' 173' ' ' ARG . . . 122.57 8.49 6.91 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.83 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.417 ' HA3' ' CZ ' ' B' ' 5' ' ' PHE . . . -136.61 141.62 12.67 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.465 -175.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 71.44 -152.03 49.0 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.888 175.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -84.16 144.05 29.24 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.866 0.365 . . . . 0.0 110.835 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -78.98 137.17 37.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.576 177.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -110.74 149.95 29.77 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.193 0.52 . . . . 0.0 111.647 -175.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -84.06 -9.59 58.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.644 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.18 143.43 40.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.273 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.71 HD13 HG21 ' A' ' 137' ' ' VAL . 0.8 OUTLIER -70.85 -23.39 62.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.441 -174.63 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 20.6 m -61.35 -47.92 83.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.945 0.402 . . . . 0.0 110.15 175.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.21 -30.99 72.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.249 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.547 HD11 HG23 ' A' ' 181' ' ' VAL . 2.9 tm? -65.72 -54.64 24.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.44 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 34.5 m -66.77 -43.17 90.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.239 -173.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -62.25 -31.47 72.04 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.416 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -64.21 -52.1 60.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.817 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.561 ' CZ ' ' HB ' ' A' ' 181' ' ' VAL . 86.6 m-85 -80.92 -8.52 59.77 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.265 0.555 . . . . 0.0 110.393 -177.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -71.74 -23.17 61.56 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 172.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 8.3 tppt? -96.18 -36.5 10.93 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.682 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -121.86 103.72 39.78 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.001 0.429 . . . . 0.0 111.219 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -58.31 126.85 22.69 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 123.038 2.492 . . . . 0.0 112.475 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . 0.464 ' HB2' ' CG2' ' B' ' 3' ' ' ILE . 0.0 OUTLIER -89.51 127.66 35.89 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.727 178.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.573 HG22 ' HB ' ' A' ' 209' ' ' VAL . 47.2 t -99.42 139.69 20.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.192 0.52 . . . . 0.0 111.63 -173.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.724 ' HB2' ' O ' ' A' ' 208' ' ' THR . 0.4 OUTLIER -85.6 155.95 20.92 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.946 171.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 9.2 t -72.41 -11.8 60.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.052 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.403 HD12 ' N ' ' A' ' 206' ' ' LEU . 5.5 mp -91.3 6.7 44.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.881 176.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.13 -17.93 53.57 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.788 178.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.724 ' O ' ' HB2' ' A' ' 204' ' ' GLU . 92.7 m -66.34 110.73 3.19 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-O 120.705 0.288 . . . . 0.0 110.239 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.573 ' HB ' HG22 ' A' ' 203' ' ' VAL . 1.4 p -111.8 127.43 68.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.695 0.759 . . . . 0.0 110.517 175.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.822 HD11 HG21 ' A' ' 168' ' ' THR . 0.3 OUTLIER -81.34 110.38 16.72 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.813 -169.377 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.434 ' O ' ' HA2' ' A' ' 133' ' ' GLY . 49.8 mt-30 -91.46 89.53 7.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.371 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.412 HD11 HD21 ' A' ' 149' ' ' LEU . 7.4 mp -75.45 111.7 11.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.195 176.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -113.92 -56.12 2.43 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.638 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.537 ' O ' ' HA ' ' A' ' 134' ' ' SER . 0.9 OUTLIER -145.77 149.2 38.92 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 121.096 0.474 . . . . 0.0 111.082 179.594 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.538 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 72.6 Cg_endo -72.94 149.44 47.21 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 123.55 2.833 . . . . 0.0 114.17 -173.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.526 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.2 OUTLIER -84.97 113.74 21.64 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 173.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -62.76 151.06 39.74 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.133 0.492 . . . . 0.0 111.198 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 111' ' ' ARG . 12.6 p -80.02 111.57 16.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.138 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 3.1 t -88.8 105.68 17.88 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.385 0.612 . . . . 0.0 109.474 176.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.527 -175.413 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' -4' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 121.02 0.438 . . . . 0.0 110.485 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' -3' ' ' GLN . . . . . 0.401 ' HB2' ' OE1' ' A' ' 123' ' ' GLU . 4.4 pt20 -100.75 160.13 14.61 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 176.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' -2' ' ' THR . . . . . 0.598 ' HA ' ' CD2' ' A' ' 169' ' ' HIS . 12.3 m 53.33 -109.52 0.48 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-O 118.675 -0.679 . . . . 0.0 109.427 -172.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' -1' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' B' ' 0' ' ' PTR . 11.3 tp10 70.88 -42.69 0.54 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.195 0.598 . . . . 0.0 111.535 174.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 0' ' ' PTR . . . . . 0.699 ' HA ' ' O ' ' A' ' 169' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.438 ' HB2' ' CG2' ' A' ' 168' ' ' THR . . . -55.23 132.08 46.89 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.09 -1.413 . . . . 0.0 111.357 -175.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 86.0 m -70.7 -47.29 60.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.008 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.464 ' CG2' ' HB2' ' A' ' 202' ' ' MET . 15.7 mm 78.54 89.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 123.318 0.647 . . . . 0.0 110.278 173.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.692 ' O ' ' HD3' ' B' ' 6' ' ' PRO . 5.9 m -98.66 124.31 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.435 177.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' PHE . . . . . 0.419 ' CE1' HG22 ' B' ' 3' ' ' ILE . 96.5 m-85 -102.23 82.37 0.42 Allowed Pre-proline 0 C--N 1.308 -1.215 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.925 170.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.692 ' HD3' ' O ' ' B' ' 4' ' ' VAL . 7.1 Cg_endo . . . . . 0 N--CA 1.448 -1.178 0 C-N-CA 122.875 2.384 . . . . 0.0 111.092 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.717 0 N-CA-C 112.132 -0.387 . . . . 0.0 112.132 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -86.77 -5.85 7.86 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.801 2.334 . . . . 0.0 112.959 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 86.8 mmm -93.34 4.51 53.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.4 0.619 . . . . 0.0 110.088 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.36 -164.58 2.05 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.703 176.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 1.3 t70 -78.63 138.43 58.55 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 173.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 6.3 Cg_exo -73.12 -5.49 17.27 Favored 'Trans proline' 0 CA--C 1.516 -0.416 0 C-N-CA 122.774 2.316 . . . . 0.0 111.294 -173.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.63 ' HB ' ' CD2' ' A' ' 113' ' ' PHE . 81.5 p -94.77 6.69 48.2 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.59 -176.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 51.3 m -76.64 59.24 1.5 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.299 0.571 . . . . 0.0 110.818 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.474 ' HG3' ' CZ2' ' A' ' 112' ' ' TRP . 76.8 mm-40 -134.39 156.35 48.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.513 -177.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -75.11 -13.76 60.5 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -171.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.492 ' HB3' ' CB ' ' A' ' 215' ' ' PRO . 2.5 p-90 -89.65 -14.16 35.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.947 0.403 . . . . 0.0 110.742 175.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.63 ' CD2' ' HB ' ' A' ' 108' ' ' THR . 76.3 t80 -80.73 120.94 25.27 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.088 0.47 . . . . 0.0 110.149 172.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -111.91 140.4 46.6 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -76.73 -90.3 0.26 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.037 -175.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -92.66 93.54 8.54 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.992 0.425 . . . . 0.0 111.51 -172.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.2 mt -134.38 128.46 33.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.301 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 24.5 m -83.68 173.25 11.51 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 173.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -50.84 -52.62 29.49 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 121.477 -0.392 . . . . 0.0 113.386 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -72.09 -31.75 66.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.491 0.186 . . . . 0.0 111.431 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -64.04 -47.13 81.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.968 0.413 . . . . 0.0 110.481 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.465 ' HB2' ' HD3' ' A' ' 138' ' ' ARG . . . -66.15 -34.03 77.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.723 178.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.444 ' HA ' HG11 ' A' ' 167' ' ' VAL . 0.2 OUTLIER -65.87 -50.77 63.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.51 176.274 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -58.55 -34.78 71.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.615 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.411 HD12 HD13 ' A' ' 216' ' ' LEU . 0.7 OUTLIER -56.81 -51.59 68.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.218 178.065 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.541 ' CD2' HD12 ' A' ' 216' ' ' LEU . 53.2 mt -75.48 -46.66 31.1 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 m -64.97 -28.32 69.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.098 -174.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -95.71 -53.03 3.86 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -103.48 11.65 36.13 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -170.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -127.05 -163.36 11.44 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.254 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -154.34 176.15 12.67 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -46.71 120.74 3.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.937 0.398 . . . . 0.0 111.004 176.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 211' ' ' GLN . . . 99.1 -9.63 61.51 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.797 177.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.658 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 69.0 m -70.41 135.67 48.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.218 0.509 . . . . 0.0 110.526 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.517 ' CB ' HG12 ' A' ' 151' ' ' VAL . 52.5 p90 -137.03 149.54 47.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.923 -178.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.551 ' CD2' ' HB2' ' A' ' 150' ' ' SER . 1.2 pt? -149.43 134.8 18.36 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 175.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.652 HG21 HD13 ' A' ' 190' ' ' LEU . 12.3 m -97.52 141.93 15.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.465 ' HD3' ' HB2' ' A' ' 122' ' ' ALA . 30.5 ptt85 -140.98 162.17 36.1 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.357 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -71.38 129.25 38.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.871 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.436 ' OG ' ' HB2' ' A' ' 143' ' ' HIS . 23.3 t -77.94 132.85 38.07 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.328 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -91.08 -40.86 11.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.819 -175.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.6 t -79.81 -12.99 59.74 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.057 0.456 . . . . 0.0 109.789 177.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.436 ' HB2' ' OG ' ' A' ' 140' ' ' SER . 54.3 m80 -126.19 75.04 72.82 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.951 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.5 126.87 21.91 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.847 2.364 . . . . 0.0 112.234 -176.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 106.09 -31.97 7.83 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.943 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -98.16 171.79 8.0 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.155 0.502 . . . . 0.0 110.732 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.412 ' CE2' ' HE1' ' A' ' 179' ' ' TYR . 85.8 m-85 -125.23 165.9 17.46 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.435 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.446 HG11 ' CE1' ' B' ' 0' ' ' PTR . 27.5 m -132.97 136.48 55.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.404 0.621 . . . . 0.0 111.456 176.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.973 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -92.74 110.02 21.45 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.806 174.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.551 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 1.2 m -101.9 128.98 48.05 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.709 -0.796 . . . . 0.0 109.254 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.517 HG12 ' CB ' ' A' ' 135' ' ' PHE . 33.7 m -130.46 147.7 33.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.581 -172.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.423 ' HB2' ' HB3' ' A' ' 126' ' ' LEU . 62.7 ttt180 -93.02 104.25 16.48 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.253 0.549 . . . . 0.0 109.879 176.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.7 p -104.08 146.93 28.01 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.092 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 86.51 -176.01 47.85 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.568 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -104.12 155.21 18.89 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 177.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -99.83 -1.08 38.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.042 0.449 . . . . 0.0 110.37 177.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -116.69 141.79 47.74 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.75 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 98.03 -18.47 57.09 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.647 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 59.58 47.08 11.2 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.273 0.559 . . . . 0.0 110.607 -178.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.6 p -77.15 -9.73 58.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.221 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -111.74 -133.44 0.34 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 174.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -78.39 -14.51 59.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.447 0.641 . . . . 0.0 109.973 176.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 163.2 -58.07 0.28 Allowed Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.877 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -100.26 -161.16 0.85 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 174.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 26.0 m -67.6 164.43 19.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.102 173.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 167' ' ' VAL . 0.0 OUTLIER -120.18 130.65 54.67 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.199 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.449 ' N ' ' HD2' ' A' ' 166' ' ' LYS . 74.9 t -99.41 116.2 42.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.475 0.655 . . . . 0.0 111.751 -177.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.745 HG21 HD11 ' A' ' 210' ' ' LEU . 4.4 m -97.26 141.19 30.67 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.35 176.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.588 ' O ' ' HA ' ' B' ' 0' ' ' PTR . 17.1 m-70 -117.76 117.47 29.41 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.973 HG22 ' HB3' ' A' ' 149' ' ' LEU . 0.7 OUTLIER -98.85 135.37 34.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -173.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 35.2 tpp -78.48 115.93 18.52 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.657 -176.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.582 HD13 HD21 ' A' ' 190' ' ' LEU . 29.6 mt -93.61 105.95 17.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 176.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.552 ' HB2' ' OE1' ' A' ' 175' ' ' GLN . 13.6 ptm180 -82.18 118.58 23.18 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.313 -175.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.666 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 38.5 t -104.42 110.0 22.09 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.112 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.552 ' OE1' ' HB2' ' A' ' 173' ' ' ARG . 1.8 mp0 -113.74 107.91 16.39 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 177.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 58.2 52.17 7.78 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 123.562 0.539 . . . . 0.0 111.094 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 93.6 mt 61.05 41.89 13.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.193 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.666 ' O ' ' HA ' ' A' ' 174' ' ' CYS . 5.8 tppt? -134.51 131.03 37.53 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.412 ' HE1' ' CE2' ' A' ' 147' ' ' PHE . 63.5 m-85 -105.52 138.19 42.12 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 122.91 0.131 . . . . 0.0 111.118 -171.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.549 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 24.7 t70 -152.11 139.49 19.48 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.355 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.551 HG12 ' O ' ' A' ' 181' ' ' VAL . 84.4 t -96.83 55.68 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 122.514 1.15 . . . . 0.0 109.127 173.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 82.52 -39.02 2.64 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 114.7 -1.136 . . . . 0.0 113.674 173.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.409 ' HA3' ' CD1' ' B' ' 5' ' ' PHE . . . -138.51 151.88 21.77 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.281 -176.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 110.16 -142.71 16.63 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.653 175.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -106.44 143.75 34.1 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 176.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.438 ' HG2' ' HB2' ' A' ' 180' ' ' ASP . 80.2 mtt180 -92.77 139.49 30.49 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.346 -176.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -113.95 147.86 37.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.184 -175.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -79.16 -16.9 55.95 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.169 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 19.8 m -129.78 143.37 50.78 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.795 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.652 HD13 HG21 ' A' ' 137' ' ' VAL . 0.8 OUTLIER -69.89 -22.55 63.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.039 -176.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.478 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 6.5 m -58.83 -47.36 85.1 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.992 0.425 . . . . 0.0 110.363 176.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -66.41 -31.52 72.32 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.298 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.52 ' HB3' HD23 ' A' ' 190' ' ' LEU . 3.0 tm? -62.84 -54.48 38.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.779 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 32.7 m -69.22 -41.35 81.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.032 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -62.26 -34.87 77.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.677 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -63.52 -50.01 71.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.739 0.304 . . . . 0.0 110.811 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.598 ' HB2' HD22 ' A' ' 212' ' ' LEU . 76.5 m-85 -82.04 -8.35 59.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.186 0.517 . . . . 0.0 111.014 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 212' ' ' LEU . 35.3 ttpt -73.53 -20.47 60.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.68 0.752 . . . . 0.0 109.358 173.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.423 ' HG3' ' ND2' ' A' ' 200' ' ' ASN . 9.5 tppt? -106.12 -36.21 6.99 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.554 175.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . 0.423 ' ND2' ' HG3' ' A' ' 199' ' ' LYS . 40.7 m-80 -112.68 93.99 26.3 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.834 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -58.22 130.09 36.12 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.99 2.46 . . . . 0.0 112.382 178.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . 0.505 ' HG3' HD12 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -92.89 130.87 38.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.368 179.328 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.552 HG22 ' HB ' ' A' ' 209' ' ' VAL . 42.7 t -98.5 133.62 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.247 0.546 . . . . 0.0 112.091 -174.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.722 ' HB2' ' O ' ' A' ' 208' ' ' THR . 0.1 OUTLIER -81.56 159.07 24.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.974 170.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 9.0 t -74.06 -10.61 59.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.277 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 206' ' ' LEU . 5.4 mp -88.88 -2.29 58.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.373 176.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 95.5 -13.91 65.82 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.07 -177.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.722 ' O ' ' HB2' ' A' ' 204' ' ' GLU . 49.5 m -67.65 110.27 3.65 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 176.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.552 ' HB ' HG22 ' A' ' 203' ' ' VAL . 1.1 p -112.14 120.61 62.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.925 0.869 . . . . 0.0 110.504 175.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.745 HD11 HG21 ' A' ' 168' ' ' THR . 0.4 OUTLIER -76.7 103.55 6.73 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.354 -170.233 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.478 ' O ' ' HA2' ' A' ' 133' ' ' GLY . 44.8 mt-30 -90.09 89.3 7.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.851 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.598 HD22 ' HB2' ' A' ' 197' ' ' TYR . 7.6 mp -71.27 113.89 8.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.656 178.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -115.81 -56.6 2.31 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.658 ' O ' ' HA ' ' A' ' 134' ' ' SER . 4.2 pm0 -136.84 140.91 33.16 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.072 0.463 . . . . 0.0 110.898 -177.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.492 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 59.9 Cg_endo -73.68 146.05 37.95 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.645 2.23 . . . . 0.0 112.753 -178.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.541 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.2 OUTLIER -86.75 105.46 16.98 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 174.712 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -60.78 138.64 58.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.996 0.427 . . . . 0.0 110.953 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 7.0 p -61.83 114.14 3.16 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.671 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 2.6 t -89.84 106.41 18.45 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.446 0.641 . . . . 0.0 109.523 177.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 . . . . . 0 C--O 1.246 0.91 0 CA-C-O 118.366 -0.826 . . . . 0.0 110.241 -174.75 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' -4' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 120.812 0.339 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -94.89 141.58 28.47 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -176.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' -2' ' ' THR . . . . . 0.451 HG22 ' H ' ' B' ' -1' ' ' GLU . 1.3 m 69.04 -146.99 0.11 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.094 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' -1' ' ' GLU . . . . . 0.451 ' H ' HG22 ' B' ' -2' ' ' THR . 42.7 mt-10 75.21 -13.2 0.87 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.635 0.774 . . . . 0.0 110.198 -170.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 0' ' ' PTR . . . . . 0.588 ' HA ' ' O ' ' A' ' 169' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.533 ' HB2' ' CG2' ' A' ' 168' ' ' THR . . . -71.49 125.06 26.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.507 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 86.0 m -71.5 -42.3 68.19 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.877 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.505 HD12 ' HG3' ' A' ' 202' ' ' MET . 13.5 mm 73.68 99.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.113 0.565 . . . . 0.0 111.192 175.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 3.0 m -111.02 94.49 3.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.099 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' PHE . . . . . 0.409 ' CD1' ' HA3' ' A' ' 183' ' ' GLY . 93.8 m-85 -75.6 115.84 49.57 Favored Pre-proline 0 C--N 1.318 -0.777 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 172.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo . . . . . 0 C--O 1.249 1.063 0 C-N-CA 122.731 2.288 . . . . 0.0 111.936 178.861 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.427 ' HA2' ' HD3' ' A' ' 103' ' ' PRO . . . . . . . . 0 N--CA 1.481 1.676 0 N-CA-C 112.22 -0.352 . . . . 0.0 112.22 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.427 ' HD3' ' HA2' ' A' ' 102' ' ' GLY . 17.4 Cg_exo -66.56 -31.77 40.56 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.822 2.348 . . . . 0.0 112.44 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 90.2 mtp -87.67 -29.64 21.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.715 -178.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 52.63 67.93 0.91 Allowed 'General case' 0 C--O 1.238 0.454 0 O-C-N 123.699 0.625 . . . . 0.0 110.973 177.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.417 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 3.7 m-20 -59.0 126.0 79.89 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.478 -178.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 3.2 Cg_exo -77.03 -7.13 17.18 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.77 2.314 . . . . 0.0 110.108 172.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.526 ' HB ' ' CG ' ' A' ' 113' ' ' PHE . 42.1 p -98.39 8.05 45.38 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.609 -178.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 66.5 p -74.86 34.65 0.1 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.933 0.397 . . . . 0.0 111.563 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 108' ' ' THR . 60.7 mm-40 -115.8 157.22 24.72 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -75.65 -12.2 60.16 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -167.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.4 ' CZ2' ' HA ' ' A' ' 191' ' ' THR . 4.4 p-90 -85.29 -14.68 45.84 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.827 176.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.526 ' CG ' ' HB ' ' A' ' 108' ' ' THR . 68.4 t80 -77.59 120.25 22.28 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.125 0.488 . . . . 0.0 110.389 171.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.482 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 10.6 m170 -121.08 106.57 11.68 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 175.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -73.93 -45.96 24.83 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.541 -171.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -99.01 83.72 2.94 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.052 0.453 . . . . 0.0 111.139 -173.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.4 mt -148.44 138.07 22.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.493 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.8 p -90.62 173.25 8.15 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 169.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 123' ' ' GLU . . . -51.71 -48.9 49.1 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.862 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -76.48 -32.35 58.31 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -64.02 -46.79 82.91 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.026 176.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.612 ' HB2' ' HD2' ' A' ' 138' ' ' ARG . . . -66.64 -33.69 76.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.693 177.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.562 ' HG3' ' HB ' ' A' ' 167' ' ' VAL . 4.2 tt0 -62.51 -50.37 71.65 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.215 176.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.66 -34.49 72.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.22 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.453 HD12 HD13 ' A' ' 216' ' ' LEU . 0.7 OUTLIER -56.22 -52.9 62.74 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.332 0.587 . . . . 0.0 110.494 -178.069 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.569 ' CD2' HD12 ' A' ' 216' ' ' LEU . 54.2 mt -75.7 -46.72 29.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.514 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.6 m -61.28 -32.54 72.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.337 -172.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -97.36 -53.7 3.38 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 178.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -93.03 -21.35 19.79 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -170.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -89.1 -161.24 37.32 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.937 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -153.88 175.63 13.12 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 174.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -51.08 117.63 2.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.918 0.39 . . . . 0.0 110.891 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 99.93 -3.75 57.32 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.996 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 68.7 m -75.96 139.63 41.66 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.52 -0.4 . . . . 0.0 110.647 178.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.497 ' CB ' HG12 ' A' ' 151' ' ' VAL . 52.8 p90 -137.5 151.4 48.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.771 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.582 ' CD2' ' HB2' ' A' ' 150' ' ' SER . 1.2 pt? -151.71 138.02 18.47 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.693 HG21 HD13 ' A' ' 190' ' ' LEU . 14.2 m -97.62 137.94 23.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.308 176.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.612 ' HD2' ' HB2' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -137.64 162.14 34.61 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.053 -174.765 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -76.66 134.38 39.29 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.507 ' HB2' HG13 ' A' ' 148' ' ' VAL . 33.2 t -80.93 143.65 32.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.174 -175.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -101.15 -22.76 14.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.914 174.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 72.7 m -69.86 -40.35 75.82 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.439 0.637 . . . . 0.0 109.356 170.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -121.93 83.14 43.49 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.036 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -55.47 123.58 14.15 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.506 2.137 . . . . 0.0 111.553 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 106.7 -32.14 7.57 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.906 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -88.28 170.29 11.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.877 0.37 . . . . 0.0 110.431 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -121.65 153.96 37.45 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.151 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.536 ' CG2' ' HG3' ' A' ' 138' ' ' ARG . 30.2 m -129.38 138.86 53.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.159 0.504 . . . . 0.0 110.52 176.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.853 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -92.18 110.13 21.51 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.149 177.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.582 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 3.3 m -101.42 132.01 47.23 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.408 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.555 HG21 ' HB3' ' A' ' 210' ' ' LEU . 32.0 m -132.47 149.44 32.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.96 -174.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.527 HH21 ' HB2' ' A' ' 156' ' ' ASP . 72.9 ttt180 -96.0 104.16 16.09 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.031 0.443 . . . . 0.0 109.898 176.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -107.69 147.15 31.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.224 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 85.17 -178.52 50.79 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.405 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -96.12 176.42 6.09 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.762 0.315 . . . . 0.0 110.493 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.527 ' HB2' HH21 ' A' ' 152' ' ' ARG . 21.9 t70 -126.16 -3.94 6.86 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.238 0.542 . . . . 0.0 111.003 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -98.9 60.4 1.24 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.163 0.506 . . . . 0.0 111.575 -172.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 78.5 -72.26 2.39 Favored Glycine 0 C--N 1.318 -0.431 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.882 176.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -78.16 110.61 13.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.126 0.488 . . . . 0.0 110.439 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 45.5 t -168.36 -55.84 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.359 -176.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.505 HD21 ' HB2' ' A' ' 166' ' ' LYS . 4.9 p30 -168.07 -65.52 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.159 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -124.81 -10.9 7.24 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.105 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 152.1 -78.1 0.21 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.781 177.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -88.07 -176.1 5.31 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.473 ' OG ' ' HB2' ' A' ' 156' ' ' ASP . 58.9 m -67.71 154.5 41.36 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.25 0.548 . . . . 0.0 111.363 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.505 ' HB2' HD21 ' A' ' 161' ' ' ASN . 0.0 OUTLIER -110.72 126.27 54.38 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 176.379 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.562 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 71.4 t -99.96 112.52 32.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.396 0.617 . . . . 0.0 110.492 177.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.702 HG21 HD11 ' A' ' 210' ' ' LEU . 6.3 m -92.01 140.5 29.59 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.641 175.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.797 ' O ' ' HA ' ' B' ' 0' ' ' PTR . 7.5 m-70 -118.5 120.15 36.66 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.853 HG22 ' HB3' ' A' ' 149' ' ' LEU . 1.1 m -98.16 138.8 21.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -177.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 5.7 ttm -90.45 118.69 30.12 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.941 -174.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.485 HD13 HD21 ' A' ' 190' ' ' LEU . 25.6 mt -93.47 127.97 45.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.661 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.597 ' NH1' ' HA2' ' A' ' 182' ' ' GLY . 5.0 ptp180 -87.77 112.26 22.24 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.043 0.449 . . . . 0.0 109.942 177.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 47.0 t -96.89 92.6 6.2 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -113.77 113.78 25.42 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.48 -175.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 58.63 40.89 23.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.857 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 93.9 mt 67.1 18.78 10.49 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.82 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -109.95 139.05 45.48 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 172.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.452 ' CD1' ' HG ' ' A' ' 190' ' ' LEU . 51.5 m-85 -109.54 138.53 45.77 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.841 -175.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.586 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 9.6 t0 -155.73 140.99 17.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.028 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.53 ' HB ' ' CE1' ' A' ' 197' ' ' TYR . 14.4 t -94.62 -12.43 8.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.657 0.742 . . . . 0.0 109.342 176.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . 0.597 ' HA2' ' NH1' ' A' ' 173' ' ' ARG . . . 123.21 9.02 6.24 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.166 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.651 ' HA3' ' CE1' ' B' ' 5' ' ' PHE . . . -138.07 140.59 11.3 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.242 -0.98 . . . . 0.0 113.755 -176.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.67 -119.87 5.59 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.376 173.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -115.76 158.69 22.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.631 0.253 . . . . 0.0 110.564 -173.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -95.43 128.65 42.46 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -110.31 144.28 39.26 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.076 -173.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -79.8 -8.66 59.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.413 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 85.1 p -130.46 143.9 51.06 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.479 177.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.693 HD13 HG21 ' A' ' 137' ' ' VAL . 1.1 mt -70.65 -22.08 62.54 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.37 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.492 ' O ' ' HG3' ' A' ' 195' ' ' GLU . 4.0 m -60.42 -49.18 78.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.637 177.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -67.14 -30.52 70.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.705 0.288 . . . . 0.0 110.565 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.528 HD11 HG23 ' A' ' 181' ' ' VAL . 3.4 tm? -62.15 -54.83 35.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.836 177.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 35.7 m -68.97 -39.69 80.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.999 -175.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 191' ' ' THR . 22.7 mt-10 -66.67 -35.27 79.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.414 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -60.26 -42.78 96.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.818 0.342 . . . . 0.0 110.414 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.53 ' CE1' ' HB ' ' A' ' 181' ' ' VAL . 40.5 m-85 -85.44 -11.62 53.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.376 0.608 . . . . 0.0 110.649 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.408 ' HE2' ' HA ' ' A' ' 195' ' ' GLU . 38.4 ttpt -73.67 -27.67 61.35 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 173.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -90.29 -35.99 14.95 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.442 175.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -116.38 102.78 53.42 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.511 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -57.93 126.43 21.64 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.603 2.202 . . . . 0.0 111.974 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . 0.729 ' SD ' HD23 ' A' ' 210' ' ' LEU . 9.5 ptp -89.11 120.48 30.54 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.633 -177.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.591 HG22 ' HB ' ' A' ' 209' ' ' VAL . 28.7 t -97.91 136.55 28.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.662 0.268 . . . . 0.0 111.72 -175.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.558 ' O ' HG12 ' A' ' 203' ' ' VAL . 22.6 mt-10 -85.79 167.09 15.53 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.877 0.37 . . . . 0.0 110.063 169.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 12.1 t -75.16 -14.83 60.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.276 0.56 . . . . 0.0 109.978 177.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.469 HD12 ' N ' ' A' ' 206' ' ' LEU . 5.1 mp -81.73 -7.44 59.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.153 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 99.82 -21.23 45.87 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.869 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 89.8 m -62.94 112.13 2.44 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.591 ' HB ' HG22 ' A' ' 203' ' ' VAL . 0.8 OUTLIER -112.82 121.82 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 CA-C-O 121.616 0.722 . . . . 0.0 110.574 173.836 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.729 HD23 ' SD ' ' A' ' 202' ' ' MET . 0.4 OUTLIER -77.12 107.94 9.84 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.767 -174.708 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -93.54 90.23 6.59 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.008 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.488 HD22 ' HB2' ' A' ' 197' ' ' TYR . 7.8 mp -74.02 103.4 4.49 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.242 -177.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -115.47 -55.79 2.41 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.633 ' O ' ' HA ' ' A' ' 134' ' ' SER . 0.1 OUTLIER -115.09 132.89 22.8 Favored Pre-proline 0 C--O 1.223 -0.305 0 CA-C-O 120.483 0.182 . . . . 0.0 111.323 -173.706 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.09 132.78 11.81 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.315 2.01 . . . . 0.0 111.817 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.569 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.3 OUTLIER -78.88 102.02 8.0 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.173 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -58.13 140.24 53.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.705 178.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.3 p -62.58 125.54 24.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.335 0.588 . . . . 0.0 111.554 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.2 t -118.08 116.38 26.74 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.076 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.696 -0.669 . . . . 0.0 110.639 179.536 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' -4' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 121.088 0.47 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' -3' ' ' GLN . . . . . 0.46 ' HB3' ' OE1' ' A' ' 123' ' ' GLU . 92.4 mt-30 -116.59 158.78 23.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.703 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' -2' ' ' THR . . . . . 0.636 ' HA ' ' CD2' ' A' ' 169' ' ' HIS . 6.9 m 54.13 -110.57 0.56 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.471 -0.776 . . . . 0.0 109.279 -172.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' -1' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' B' ' -2' ' ' THR . 43.2 tt0 74.37 -42.51 0.5 Allowed 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.369 0.531 . . . . 0.0 111.195 171.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 0' ' ' PTR . . . . . 0.797 ' HA ' ' O ' ' A' ' 169' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.599 ' HB2' ' CG2' ' A' ' 168' ' ' THR . . . -51.03 141.67 13.47 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 113.584 -1.644 . . . . 0.0 113.1 -169.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 63.4 m -73.48 -47.03 44.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.443 -1.253 . . . . 0.0 111.521 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.56 HD12 ' SD ' ' A' ' 202' ' ' MET . 6.4 mm 66.32 105.25 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 123.224 0.61 . . . . 0.0 111.63 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -129.97 86.0 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.333 175.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' PHE . . . . . 0.651 ' CE1' ' HA3' ' A' ' 183' ' ' GLY . 77.0 m-85 -58.07 114.15 7.98 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.143 174.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo . . . . . 0 C--O 1.249 1.073 0 C-N-CA 122.764 2.309 . . . . 0.0 112.094 178.892 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.678 0 N-CA-C 111.729 -0.549 . . . . 0.0 111.729 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -66.49 -41.33 11.94 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.742 2.295 . . . . 0.0 112.426 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 64.9 mtt -86.83 -47.26 9.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.896 0.379 . . . . 0.0 110.923 -177.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -105.67 125.89 51.51 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.735 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -63.77 150.29 91.26 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.421 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -75.32 -12.61 20.9 Favored 'Trans proline' 0 CA--C 1.508 -0.816 0 C-N-CA 122.693 2.262 . . . . 0.0 110.741 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 190' ' ' LEU . 8.9 t -101.07 5.94 43.14 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.348 175.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.7 t -71.74 65.54 0.51 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 121.792 0.805 . . . . 0.0 110.035 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -130.27 169.89 14.83 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.033 -175.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -64.83 -17.1 63.95 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -167.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.436 ' CZ2' ' HA ' ' A' ' 191' ' ' THR . 1.3 p-90 -92.93 -13.33 29.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.858 0.361 . . . . 0.0 111.467 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.494 ' HA ' ' O ' ' A' ' 137' ' ' VAL . 24.6 t80 -89.37 118.57 29.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.175 0.512 . . . . 0.0 110.806 177.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -109.65 119.26 38.84 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -49.8 -86.02 0.01 OUTLIER Glycine 0 C--N 1.331 0.256 0 O-C-N 123.98 0.8 . . . . 0.0 114.213 -170.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -100.4 107.2 18.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.521 0.677 . . . . 0.0 111.227 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 33.9 mt -129.57 140.92 51.08 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.951 174.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.422 ' H ' ' HB2' ' A' ' 121' ' ' GLU . 18.1 t -90.0 171.31 9.65 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 173.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.34 -53.18 42.58 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.835 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 20.9 mmtm -76.73 -25.45 53.54 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.422 ' HB2' ' H ' ' A' ' 118' ' ' SER . 15.2 mm-40 -65.29 -47.03 78.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.948 0.404 . . . . 0.0 110.225 175.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.596 ' HB2' ' HD2' ' A' ' 138' ' ' ARG . . . -65.59 -34.26 77.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.282 0.563 . . . . 0.0 110.492 178.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -67.94 -50.14 57.73 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.851 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -56.97 -34.65 68.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.788 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.453 HD12 HD13 ' A' ' 216' ' ' LEU . 0.7 OUTLIER -57.14 -52.69 64.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.275 178.484 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.558 ' CD2' HD12 ' A' ' 216' ' ' LEU . 55.1 mt -76.04 -51.88 11.38 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.5 m -61.07 -35.84 78.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.75 -171.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -97.68 -46.63 5.92 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 125' ' ' LEU . 89.0 mttt -91.23 -28.88 17.52 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.668 -0.413 . . . . 0.0 112.015 -171.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -93.17 -158.98 34.56 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.831 -176.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.432 ' C ' ' HD3' ' A' ' 152' ' ' ARG . 14.9 ptmm? -148.08 176.0 10.56 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -51.92 123.85 11.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.707 0.289 . . . . 0.0 110.513 176.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 94.87 -3.64 67.66 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.239 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.624 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 69.0 m -73.61 139.15 45.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.059 0.429 . . . . 0.0 110.313 178.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.501 ' CB ' HG12 ' A' ' 151' ' ' VAL . 50.4 p90 -136.93 149.38 47.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.71 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.593 HD21 ' HB2' ' A' ' 150' ' ' SER . 1.2 pt? -150.64 140.4 21.77 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.657 HG21 HD13 ' A' ' 190' ' ' LEU . 11.4 m -99.73 144.1 12.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.186 175.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.596 ' HD2' ' HB2' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -146.0 156.69 43.67 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.845 -173.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -70.31 132.73 46.13 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 175.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.645 ' HB2' HG13 ' A' ' 148' ' ' VAL . 37.9 t -86.22 143.43 27.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.916 0.389 . . . . 0.0 110.38 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -100.63 -20.25 15.74 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.691 178.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 65.9 m -78.75 -30.56 45.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.141 0.496 . . . . 0.0 109.789 172.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.403 ' HB3' ' HB2' ' A' ' 146' ' ' ASP . 27.1 m-70 -120.55 86.16 39.26 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.858 173.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -61.49 123.19 12.28 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.241 1.96 . . . . 0.0 111.892 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 101.35 -14.82 57.99 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.166 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.403 ' HB2' ' HB3' ' A' ' 143' ' ' HIS . 4.2 m-20 -105.61 164.08 12.17 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.168 0.509 . . . . 0.0 110.865 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -119.24 153.89 34.28 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.721 -177.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.645 HG13 ' HB2' ' A' ' 140' ' ' SER . 34.5 m -130.31 139.94 50.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.393 0.616 . . . . 0.0 111.371 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.779 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -92.64 110.37 21.79 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.256 178.17 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.593 ' HB2' HD21 ' A' ' 136' ' ' LEU . 1.5 m -102.97 131.27 50.05 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.115 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.538 HG21 ' HB3' ' A' ' 210' ' ' LEU . 35.3 m -132.12 146.81 32.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.166 -173.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.432 ' HD3' ' C ' ' A' ' 131' ' ' LYS . 75.0 ttt180 -90.56 104.67 17.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.339 0.59 . . . . 0.0 109.968 176.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.429 HG21 HD12 ' A' ' 210' ' ' LEU . 8.8 p -102.23 147.43 26.66 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.392 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 83.0 173.47 49.68 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.76 -177.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -102.89 177.51 4.82 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.082 0.468 . . . . 0.0 110.744 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.676 ' HA ' ' ND2' ' A' ' 161' ' ' ASN . 34.6 t70 -123.86 14.12 9.25 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.725 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -98.13 -44.2 6.71 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.027 -176.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 144.12 19.37 0.2 Allowed Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.304 -0.95 . . . . 0.0 114.235 177.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.67 -57.3 3.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.526 0.663 . . . . 0.0 109.514 175.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 10.1 t -129.04 46.61 2.6 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 176.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.676 ' ND2' ' HA ' ' A' ' 156' ' ' ASP . 26.4 t-20 -118.58 109.89 16.7 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.612 -175.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -92.29 66.36 4.74 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.21 0.529 . . . . 0.0 110.528 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 84.76 -50.54 4.42 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -129.36 161.94 29.14 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 28.1 m -76.78 164.54 25.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.932 -177.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.442 ' HD2' ' HA ' ' A' ' 166' ' ' LYS . 25.6 mmmt -95.89 139.14 32.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.846 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 71.3 t -125.73 113.32 34.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.71 170.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.69 HG21 HD11 ' A' ' 210' ' ' LEU . 1.8 m -97.83 138.18 35.57 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.898 175.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.746 ' O ' ' HA ' ' B' ' 0' ' ' PTR . 14.2 m-70 -112.73 117.99 33.74 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.779 HG22 ' HB3' ' A' ' 149' ' ' LEU . 1.3 m -98.35 135.72 32.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -175.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 40.1 tpp -81.3 116.78 21.32 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.893 -174.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.562 HG21 HD21 ' A' ' 190' ' ' LEU . 16.6 mt -97.03 107.67 20.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 3.9 ptp180 -70.11 117.73 12.05 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.617 -178.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 36.6 t -93.02 94.59 8.97 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -113.78 109.59 18.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.47 -174.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 53.01 40.52 31.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.802 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 96.1 mt 72.66 15.13 4.97 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.169 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.88 142.94 34.74 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 170.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -110.8 140.99 44.74 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.53 -176.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.582 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 10.6 t0 -156.02 137.95 14.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.753 0.311 . . . . 0.0 111.048 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.483 HG23 HD11 ' A' ' 193' ' ' LEU . 48.6 t -90.11 -13.16 9.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.724 0.773 . . . . 0.0 109.322 175.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . 0.57 ' HA2' ' NH1' ' A' ' 173' ' ' ARG . . . 124.09 5.23 7.5 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.763 178.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -137.14 140.41 11.37 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 119.807 -1.187 . . . . 0.0 113.918 -174.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 79.45 -116.46 4.31 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.088 -0.577 . . . . 0.0 113.18 174.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -115.92 150.18 37.53 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 122.291 0.236 . . . . 0.0 110.436 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -80.96 126.96 32.03 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 171.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -105.62 138.69 41.4 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.099 0.476 . . . . 0.0 111.326 -172.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -70.13 -22.77 62.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.788 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 82.2 p -130.71 144.62 51.56 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.517 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.657 HD13 HG21 ' A' ' 137' ' ' VAL . 8.8 mt -65.66 -20.92 66.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.11 176.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.436 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 3.7 m -55.89 -48.91 74.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.694 0.283 . . . . 0.0 110.538 176.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -69.24 -34.73 75.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.764 0.316 . . . . 0.0 110.334 176.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.483 HD11 HG23 ' A' ' 181' ' ' VAL . 2.9 tm? -59.75 -54.0 51.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.987 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 30.5 m -69.58 -41.86 80.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.389 -174.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -66.68 -36.37 82.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.447 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -61.03 -44.9 96.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.751 0.31 . . . . 0.0 110.752 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.498 ' HB2' HD22 ' A' ' 212' ' ' LEU . 55.6 m-85 -85.23 -10.48 56.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.008 0.432 . . . . 0.0 110.799 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.492 ' HA ' ' HB2' ' A' ' 212' ' ' LEU . 38.9 ttpt -70.13 -34.03 72.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.608 0.718 . . . . 0.0 109.228 174.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -88.01 -25.75 22.96 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.043 176.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -128.31 90.78 45.97 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.801 -174.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -55.17 127.98 28.57 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.177 2.584 . . . . 0.0 112.587 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . 0.519 ' HG3' HD12 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -91.63 123.78 35.28 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.956 0.408 . . . . 0.0 110.415 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.579 HG22 ' HB ' ' A' ' 209' ' ' VAL . 36.3 t -93.87 134.89 29.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 120.85 0.357 . . . . 0.0 111.871 -176.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.54 ' O ' HG12 ' A' ' 203' ' ' VAL . 0.7 OUTLIER -79.2 163.64 24.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.49 169.245 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 7.7 t -76.33 -10.0 59.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.452 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.415 HD12 ' N ' ' A' ' 206' ' ' LEU . 5.4 mp -92.2 5.03 51.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.432 178.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 90.99 -14.5 63.27 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.703 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.486 ' O ' ' HB2' ' A' ' 204' ' ' GLU . 88.2 m -71.6 111.42 6.88 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.579 ' HB ' HG22 ' A' ' 203' ' ' VAL . 1.4 p -111.81 128.27 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-O 121.82 0.819 . . . . 0.0 110.854 176.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.69 HD11 HG21 ' A' ' 168' ' ' THR . 0.3 OUTLIER -84.8 103.49 13.93 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.83 -172.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -90.88 89.41 7.45 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.216 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.498 HD22 ' HB2' ' A' ' 197' ' ' TYR . 7.6 mp -71.79 108.55 5.15 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.314 177.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -115.11 -56.01 2.41 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -177.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.624 ' O ' ' HA ' ' A' ' 134' ' ' SER . 5.0 pm0 -131.95 136.46 28.32 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 121.068 0.461 . . . . 0.0 110.746 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.01 137.54 26.75 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.918 2.412 . . . . 0.0 112.798 -178.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.558 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.2 OUTLIER -76.7 98.88 4.89 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 175.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -63.77 139.18 58.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.905 0.384 . . . . 0.0 110.574 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 7.5 p -61.66 110.49 1.51 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.394 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 2.0 t -87.28 105.22 17.08 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.463 0.649 . . . . 0.0 109.517 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.658 -0.686 . . . . 0.0 110.138 -175.245 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' -4' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 120.944 0.402 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -145.57 -160.7 1.18 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' -2' ' ' THR . . . . . 0.705 ' HA ' ' CD2' ' A' ' 169' ' ' HIS . 0.5 OUTLIER -51.66 -69.64 0.11 Allowed 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 120.883 0.373 . . . . 0.0 110.578 170.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' -1' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 60.49 50.86 5.56 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 173.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 0' ' ' PTR . . . . . 0.746 ' HA ' ' O ' ' A' ' 169' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.538 ' HB2' ' CG2' ' A' ' 168' ' ' THR . . . -55.97 133.33 51.56 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.746 -172.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 71.8 m -76.05 -41.81 49.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.742 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.519 HD12 ' HG3' ' A' ' 202' ' ' MET . 8.5 mm 68.48 120.54 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.291 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 1.3 m -120.32 -17.88 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 48.02 71.29 1.64 Allowed Pre-proline 0 C--N 1.317 -0.832 0 O-C-N 123.373 0.421 . . . . 0.0 111.544 -175.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.564 ' CD ' ' HB ' ' A' ' 203' ' ' VAL . 5.5 Cg_exo . . . . . 0 C--O 1.248 0.99 0 C-N-CA 122.856 2.37 . . . . 0.0 111.445 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.785 0 N-CA-C 112.014 -0.434 . . . . 0.0 112.014 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -62.21 -24.33 76.11 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.083 2.522 . . . . 0.0 113.194 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 64.5 mtt -97.99 21.2 11.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.082 0.468 . . . . 0.0 110.891 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -118.98 98.51 6.22 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 175.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -65.68 117.22 39.25 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.925 -173.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -76.9 -9.51 18.13 Favored 'Trans proline' 0 CA--C 1.515 -0.471 0 C-N-CA 122.811 2.341 . . . . 0.0 109.29 169.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.703 ' HB ' ' CG ' ' A' ' 113' ' ' PHE . 22.9 p -88.12 7.37 31.92 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 113.619 -1.628 . . . . 0.0 110.738 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.4 p -71.26 47.07 0.11 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.483 0.659 . . . . 0.0 111.258 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.43 ' HG3' ' CZ2' ' A' ' 112' ' ' TRP . 70.8 mm-40 -122.03 -176.9 3.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.84 -176.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -85.92 -23.43 27.0 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -176.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.452 ' HE3' HG22 ' A' ' 137' ' ' VAL . 2.8 p-90 -85.16 -20.34 30.4 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.812 -177.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.703 ' CG ' ' HB ' ' A' ' 108' ' ' THR . 60.2 t80 -80.27 127.15 32.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.98 0.419 . . . . 0.0 110.405 173.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -118.56 113.09 20.74 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.436 ' HA2' ' CZ ' ' A' ' 113' ' ' PHE . . . -50.44 -82.4 0.04 OUTLIER Glycine 0 C--O 1.237 0.315 0 O-C-N 123.971 0.794 . . . . 0.0 114.599 -169.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -99.83 90.59 4.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.185 0.517 . . . . 0.0 111.393 -173.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.414 HD13 ' HA ' ' A' ' 122' ' ' ALA . 44.5 mt -126.21 130.56 51.19 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.164 173.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.4 m -81.85 170.82 15.22 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 171.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -54.66 -47.45 70.69 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.45 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -64.71 -44.39 90.4 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 122.704 0.402 . . . . 0.0 110.974 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -62.7 -46.75 86.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.238 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.685 ' HB2' ' HD2' ' A' ' 138' ' ' ARG . . . -60.32 -34.32 73.64 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.945 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.665 ' OE1' ' HA ' ' B' ' -3' ' ' GLN . 3.7 tt0 -69.93 -46.64 64.91 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.529 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -56.92 -36.21 69.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.647 175.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.64 -52.59 64.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.601 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.559 ' CD2' HD12 ' A' ' 216' ' ' LEU . 58.2 mt -75.12 -49.43 19.62 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.568 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.7 m -61.95 -29.58 70.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.326 -172.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -95.56 -51.97 4.32 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 177.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.415 ' HD3' HG21 ' A' ' 219' ' ' THR . 55.5 mttp -105.77 -0.81 25.06 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -163.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -106.09 -161.52 22.72 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.169 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -149.86 173.8 13.36 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 174.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 55.0 t60 -53.61 117.39 3.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.964 0.411 . . . . 0.0 111.025 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 100.95 -3.76 55.83 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.985 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.692 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 68.5 m -72.57 139.87 47.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.99 0.395 . . . . 0.0 110.608 178.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.488 ' HB3' HG12 ' A' ' 151' ' ' VAL . 52.1 p90 -136.92 150.82 48.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.612 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.586 HD21 ' HB2' ' A' ' 150' ' ' SER . 1.3 pt? -151.22 138.04 18.94 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.627 HG21 HD13 ' A' ' 190' ' ' LEU . 11.2 m -100.55 140.23 20.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 120.231 -0.588 . . . . 0.0 109.441 177.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.685 ' HD2' ' HB2' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -141.04 161.56 37.55 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.311 -174.683 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -72.84 132.83 44.05 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.579 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.48 ' HB2' HG13 ' A' ' 148' ' ' VAL . 29.5 t -77.37 143.46 38.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.531 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -100.6 -30.1 11.96 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.145 178.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 72.6 m -74.32 -30.73 62.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.02 0.438 . . . . 0.0 110.256 173.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -121.49 85.53 43.27 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.193 175.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.66 123.73 14.21 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.525 2.15 . . . . 0.0 111.808 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 105.94 -27.69 16.6 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.701 -176.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -89.99 171.65 9.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.247 0.546 . . . . 0.0 110.614 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -124.36 157.52 34.84 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.314 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.504 ' CG2' ' HG3' ' A' ' 138' ' ' ARG . 32.1 m -128.13 136.58 59.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.298 0.571 . . . . 0.0 110.717 174.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.906 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -91.77 109.61 20.94 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.318 -0.856 . . . . 0.0 108.848 176.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.586 ' HB2' HD21 ' A' ' 136' ' ' LEU . 2.1 m -102.46 132.38 48.53 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.212 -178.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.505 HG21 ' HB3' ' A' ' 210' ' ' LEU . 34.7 m -130.43 147.8 33.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.128 -172.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -92.84 105.08 17.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.744 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.422 ' O ' ' HB3' ' A' ' 166' ' ' LYS . 1.2 p -108.52 148.43 30.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.777 -175.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 93.66 169.14 38.51 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.883 177.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -101.45 140.83 35.2 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.844 0.354 . . . . 0.0 111.107 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -123.59 -3.87 8.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.399 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -96.18 -24.49 16.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.599 -176.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -100.1 23.88 34.27 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.962 178.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 55.75 37.34 28.75 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 122.682 0.393 . . . . 0.0 111.398 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 46.9 m -73.36 -20.53 60.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.155 0.502 . . . . 0.0 110.437 177.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -152.19 62.27 0.83 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 52.55 -100.01 0.09 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.751 -175.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -135.46 17.14 4.03 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.596 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -114.41 143.35 45.06 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.764 0.316 . . . . 0.0 110.395 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 14.8 m -95.96 165.41 12.28 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 174.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.422 ' HB3' ' O ' ' A' ' 153' ' ' THR . 46.1 tptt -94.65 143.09 26.72 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.5 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 69.2 t -126.62 112.61 29.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.51 0.671 . . . . 0.0 110.503 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.717 HG21 HD11 ' A' ' 210' ' ' LEU . 3.9 m -96.38 140.3 31.24 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.623 174.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.769 ' O ' ' HA ' ' B' ' 0' ' ' PTR . 18.9 m-70 -115.57 119.16 35.24 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.906 HG22 ' HB3' ' A' ' 149' ' ' LEU . 1.0 OUTLIER -98.37 134.91 35.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -178.835 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 9.8 ttm -88.6 119.04 28.69 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.395 -176.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.492 HD13 HD21 ' A' ' 190' ' ' LEU . 12.5 mt -94.05 113.73 29.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.072 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.608 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 19.9 ptp180 -74.21 118.28 16.98 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.146 0.498 . . . . 0.0 110.189 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 46.1 t -102.56 93.07 4.94 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -114.73 108.5 16.86 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.364 -176.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 57.64 48.39 14.22 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.704 0.628 . . . . 0.0 110.573 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 88.9 mt 64.82 24.88 12.85 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.768 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 10.4 tppt? -115.08 133.46 56.02 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -113.38 130.87 56.18 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 123.012 0.195 . . . . 0.0 111.026 -173.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.608 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 34.6 t0 -156.42 136.15 12.51 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.945 0.402 . . . . 0.0 110.796 175.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.544 ' HB ' ' CZ ' ' A' ' 197' ' ' TYR . 25.9 t -85.41 -15.64 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 123.69 4.23 8.16 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.251 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.483 ' HA3' ' CE1' ' B' ' 5' ' ' PHE . . . -136.19 141.14 12.18 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.812 -177.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 80.42 -158.09 41.21 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.685 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -85.76 155.16 21.15 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -84.94 130.58 34.61 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -105.89 153.54 21.8 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.031 0.443 . . . . 0.0 111.58 -172.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -91.61 -7.39 50.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.379 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 49.3 m -130.12 142.56 50.58 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.59 176.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.627 HD13 HG21 ' A' ' 137' ' ' VAL . 2.0 mt -72.87 -22.69 60.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.622 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.445 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 3.7 m -59.71 -46.28 89.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.671 176.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -66.3 -35.5 80.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.123 177.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.517 HD11 HG23 ' A' ' 181' ' ' VAL . 3.2 tm? -61.76 -54.96 35.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.306 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 34.6 m -66.69 -42.9 90.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.224 -173.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' A' ' 199' ' ' LYS . 27.7 mt-10 -70.38 -30.75 67.74 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.557 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -59.89 -42.93 94.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.775 0.321 . . . . 0.0 110.441 176.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.544 ' CZ ' ' HB ' ' A' ' 181' ' ' VAL . 56.3 m-85 -85.1 -13.29 50.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.207 0.527 . . . . 0.0 110.619 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 212' ' ' LEU . 39.8 ttpt -72.68 -25.33 61.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.546 0.689 . . . . 0.0 109.487 174.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.422 ' HA ' ' HE2' ' A' ' 199' ' ' LYS . 11.8 mmpt? -91.65 -36.0 13.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.903 175.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -120.78 102.15 44.78 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.623 -176.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.11 133.47 58.29 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.853 2.369 . . . . 0.0 112.58 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . 0.709 ' SD ' HD12 ' B' ' 3' ' ' ILE . 7.3 ptp -96.65 128.15 43.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.493 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.612 HG22 ' HB ' ' A' ' 209' ' ' VAL . 40.6 t -101.52 137.87 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -175.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.563 ' O ' HG12 ' A' ' 203' ' ' VAL . 35.8 mt-10 -84.39 166.07 17.67 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.209 0.528 . . . . 0.0 110.382 170.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 12.1 t -77.21 -10.37 59.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.761 174.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.6 mp -91.43 8.91 34.05 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.402 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 86.77 -21.36 19.37 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.87 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 65.6 m -65.58 113.2 4.03 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.612 ' HB ' HG22 ' A' ' 203' ' ' VAL . 0.8 OUTLIER -111.64 124.66 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-O 121.785 0.802 . . . . 0.0 110.505 174.477 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.717 HD11 HG21 ' A' ' 168' ' ' THR . 0.4 OUTLIER -78.84 107.39 11.53 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.215 -172.523 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -92.3 89.43 6.84 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.836 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.528 HD22 ' HB2' ' A' ' 197' ' ' TYR . 7.4 mp -74.57 110.8 9.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.767 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -114.27 -56.21 2.41 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.692 ' O ' ' HA ' ' A' ' 134' ' ' SER . 4.3 pm0 -135.69 142.56 41.3 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 121.024 0.44 . . . . 0.0 111.103 -176.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.444 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 74.4 Cg_endo -74.27 138.1 24.45 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.992 2.461 . . . . 0.0 112.728 -178.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.559 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.3 OUTLIER -74.12 108.39 6.9 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.787 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -55.75 131.42 46.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.9 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 2.6 p -61.68 126.85 28.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.342 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.415 HG21 ' HD3' ' A' ' 129' ' ' LYS . 3.1 t -123.77 110.93 15.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.362 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.634 -0.698 . . . . 0.0 109.903 178.165 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' -4' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 120.56 0.219 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' -3' ' ' GLN . . . . . 0.665 ' HA ' ' OE1' ' A' ' 123' ' ' GLU . 4.6 pm0 -164.7 149.06 9.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.788 174.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' -2' ' ' THR . . . . . 0.581 ' HA ' ' CD2' ' A' ' 169' ' ' HIS . 3.2 p 57.32 179.69 0.05 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.743 0.782 . . . . 0.0 112.782 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' -1' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 170.57 -39.25 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -172.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 0' ' ' PTR . . . . . 0.769 ' HA ' ' O ' ' A' ' 169' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.639 ' HB2' ' CG2' ' A' ' 168' ' ' THR . . . -52.99 135.34 37.05 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 113.3 -1.773 . . . . 0.0 112.774 -170.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 22.8 m -63.78 -44.47 93.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.045 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.709 HD12 ' SD ' ' A' ' 202' ' ' MET . 4.4 mm 60.06 96.84 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 123.267 0.627 . . . . 0.0 111.017 -177.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 3.7 m -114.78 86.02 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.459 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' PHE . . . . . 0.483 ' CE1' ' HA3' ' A' ' 183' ' ' GLY . 96.0 m-85 -67.83 114.8 22.23 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.504 173.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' B' ' 5' ' ' PHE . 24.1 Cg_exo . . . . . 0 C--O 1.249 1.049 0 C-N-CA 122.67 2.246 . . . . 0.0 111.804 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.4 ' HA2' ' HD3' ' A' ' 103' ' ' PRO . . . . . . . . 0 N--CA 1.481 1.675 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.4 ' HD3' ' HA2' ' A' ' 102' ' ' GLY . 34.0 Cg_exo -60.03 -63.26 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.691 2.26 . . . . 0.0 112.415 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 90.1 mtp -130.14 21.9 5.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.16 0.505 . . . . 0.0 110.33 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.44 97.55 11.25 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.535 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -92.3 158.8 38.39 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.297 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -75.06 -7.27 18.96 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.622 2.215 . . . . 0.0 109.543 174.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.749 ' HB ' ' CG ' ' A' ' 113' ' ' PHE . 48.2 p -100.26 4.3 44.1 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 114.018 -1.447 . . . . 0.0 111.098 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 44.4 m -75.57 45.31 0.31 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.609 0.718 . . . . 0.0 110.667 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -117.11 -170.46 1.85 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.625 -175.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.527 ' O ' HG23 ' A' ' 218' ' ' THR . 33.9 mtm180 -83.05 -28.05 29.85 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -176.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.484 ' CZ2' ' HA ' ' A' ' 191' ' ' THR . 2.2 p-90 -85.66 -21.53 28.34 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -174.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.749 ' CG ' ' HB ' ' A' ' 108' ' ' THR . 80.9 t80 -79.62 121.0 24.74 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.282 0.563 . . . . 0.0 111.067 177.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.492 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 11.8 m170 -116.88 124.56 49.77 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 173.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -68.5 -95.29 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.479 -173.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -76.46 93.09 3.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.139 0.495 . . . . 0.0 111.257 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.3 mt -131.37 139.16 49.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.424 174.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.451 ' HB3' ' HG2' ' A' ' 121' ' ' GLU . 21.1 t -94.57 172.58 8.09 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 172.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.44 -52.95 46.82 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.011 -176.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.414 ' HE2' ' HB3' ' B' ' -3' ' ' GLN . 67.6 mmtt -75.71 -25.51 56.7 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.568 0.21 . . . . 0.0 111.568 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.451 ' HG2' ' HB3' ' A' ' 118' ' ' SER . 52.5 mm-40 -66.45 -47.5 72.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.108 0.48 . . . . 0.0 109.72 177.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.64 ' HB2' ' HD2' ' A' ' 138' ' ' ARG . . . -67.62 -34.16 76.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.68 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.546 ' HG3' ' HB ' ' A' ' 167' ' ' VAL . 5.9 tt0 -63.53 -47.28 82.26 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.198 177.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.82 -34.86 75.18 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.774 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.487 HD12 HD13 ' A' ' 216' ' ' LEU . 0.8 OUTLIER -56.71 -53.25 59.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.516 -179.667 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.533 ' CD2' HD12 ' A' ' 216' ' ' LEU . 58.7 mt -75.75 -44.04 43.66 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.627 -177.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 9.5 m -61.0 -35.01 75.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.29 -173.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -95.68 -52.85 3.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.073 0.463 . . . . 0.0 111.862 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -96.85 -11.33 24.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.325 -166.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -96.32 -164.15 33.35 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.82 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -153.76 173.88 15.28 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -55.13 116.02 2.56 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.928 0.394 . . . . 0.0 110.5 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 100.8 -3.27 55.89 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.525 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 42.6 p -71.12 137.48 48.88 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 117.494 0.647 . . . . 0.0 110.317 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.462 ' CB ' HG12 ' A' ' 151' ' ' VAL . 45.8 p90 -136.85 150.64 48.4 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.438 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.568 HD21 ' HB2' ' A' ' 150' ' ' SER . 1.2 pt? -153.2 134.19 14.0 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.367 176.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.642 HG21 HD13 ' A' ' 190' ' ' LEU . 10.6 m -96.89 138.75 21.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 176.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.64 ' HD2' ' HB2' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -139.55 162.81 34.16 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.869 -173.403 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -71.0 132.76 45.64 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 121.089 -0.244 . . . . 0.0 110.343 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.472 ' HB2' HG13 ' A' ' 148' ' ' VAL . 41.3 t -77.11 136.68 38.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.357 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -100.39 -26.18 13.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.826 0.346 . . . . 0.0 110.163 176.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.459 ' HB2' ' O3P' ' B' ' 0' ' ' PTR . 23.1 t -72.49 -36.0 68.3 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 172.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 47.6 m-70 -121.41 81.51 38.64 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.018 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.94 123.49 13.92 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.524 2.149 . . . . 0.0 112.267 -178.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 107.32 -26.66 17.89 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.915 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -89.99 170.64 10.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.95 0.405 . . . . 0.0 110.518 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -122.13 153.56 38.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.825 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.517 ' CG2' ' HG3' ' A' ' 138' ' ' ARG . 21.9 m -127.86 137.47 57.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.105 0.479 . . . . 0.0 110.668 176.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.912 ' HB3' HG22 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -92.63 110.11 21.53 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.407 178.353 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.568 ' HB2' HD21 ' A' ' 136' ' ' LEU . 2.3 m -101.65 132.63 47.23 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.517 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.497 HG21 ' HB3' ' A' ' 210' ' ' LEU . 35.1 m -131.25 149.79 33.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.988 -174.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.476 ' NH2' ' HB3' ' A' ' 156' ' ' ASP . 41.6 ttt180 -96.38 104.7 16.69 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.289 0.566 . . . . 0.0 109.925 176.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.521 ' O ' ' HB3' ' A' ' 166' ' ' LYS . 5.0 p -101.51 147.32 26.52 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.877 -178.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 85.64 173.65 49.61 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 119.942 -1.123 . . . . 0.0 112.05 -176.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -104.81 164.92 11.43 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 176.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.476 ' HB3' ' NH2' ' A' ' 152' ' ' ARG . 6.3 p-10 -96.09 -5.17 41.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.628 0.251 . . . . 0.0 111.475 -176.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -122.37 127.39 49.69 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.842 0.353 . . . . 0.0 111.03 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 96.04 14.2 46.58 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.953 176.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 55.5 92.35 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.185 0.594 . . . . 0.0 112.016 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 29.4 t -61.24 -69.77 0.22 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.515 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -122.2 -38.49 2.69 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -125.89 -169.22 1.97 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.062 173.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -65.09 -37.2 93.89 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.145 -177.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.434 ' HD2' ' N ' ' A' ' 164' ' ' LYS . 12.5 mptt -100.88 -171.49 2.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.181 0.515 . . . . 0.0 111.345 -174.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 9.6 m -76.47 147.02 38.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.481 174.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 153' ' ' THR . 47.6 tptt -96.42 137.83 34.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.013 0.435 . . . . 0.0 111.073 -177.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.546 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 70.6 t -124.68 114.42 40.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.267 173.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.72 HG21 HD11 ' A' ' 210' ' ' LEU . 18.6 m -98.96 137.51 37.39 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.965 175.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.79 ' O ' ' HA ' ' B' ' 0' ' ' PTR . 21.1 m-70 -112.29 118.83 36.35 Favored 'General case' 0 C--O 1.211 -0.922 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.912 HG22 ' HB3' ' A' ' 149' ' ' LEU . 1.0 OUTLIER -99.02 138.05 24.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.362 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.407 ' SD ' HG12 ' A' ' 148' ' ' VAL . 44.6 tpp -85.56 120.11 26.65 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.723 0.297 . . . . 0.0 110.756 -175.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 32.4 mt -94.04 107.08 18.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.623 ' HG2' ' O ' ' A' ' 180' ' ' ASP . 3.6 ptp180 -67.55 107.1 2.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.211 0.529 . . . . 0.0 110.034 -178.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 36.8 m -98.46 93.13 6.0 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.647 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -114.31 108.91 17.55 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.005 -176.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 58.93 46.29 13.91 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 123.446 0.466 . . . . 0.0 110.698 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 91.5 mt 64.58 21.98 12.55 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.589 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 174' ' ' CYS . 1.7 tppp? -106.89 137.92 44.04 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 175.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -119.14 132.78 56.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.768 0.318 . . . . 0.0 111.454 -172.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.623 ' O ' ' HG2' ' A' ' 173' ' ' ARG . 10.5 t70 -156.0 139.35 15.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.201 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.596 ' HB ' ' CZ ' ' A' ' 197' ' ' TYR . 37.9 t -89.23 -16.19 8.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.853 0.835 . . . . 0.0 109.075 175.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . 0.562 ' HA2' ' NH1' ' A' ' 173' ' ' ARG . . . 123.36 10.23 5.64 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.163 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.485 ' HA3' ' CE2' ' B' ' 5' ' ' PHE . . . -136.61 140.27 11.34 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 119.943 -1.123 . . . . 0.0 113.676 -176.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 67.13 -148.99 50.82 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 121.286 -0.483 . . . . 0.0 113.184 175.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -79.31 145.08 33.68 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.546 -0.327 . . . . 0.0 110.517 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.415 ' HG2' ' HB2' ' A' ' 180' ' ' ASP . 79.0 mtt180 -85.55 133.21 34.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.972 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -108.18 149.88 27.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.329 0.585 . . . . 0.0 111.723 -173.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.448 ' OD1' ' HE2' ' A' ' 178' ' ' LYS . 3.2 m-20 -87.55 -15.28 37.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.984 -178.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.4 p -130.64 142.4 50.44 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.231 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.642 HD13 HG21 ' A' ' 137' ' ' VAL . 9.1 mt -71.47 -22.99 61.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.232 -175.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.484 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 18.0 m -61.74 -43.52 98.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.018 0.437 . . . . 0.0 110.321 177.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -72.98 -32.92 65.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.932 177.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.487 HD11 HG23 ' A' ' 181' ' ' VAL . 3.2 tm? -61.02 -54.44 44.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.294 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 26.9 m -66.78 -43.08 90.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.629 -173.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.489 ' HA ' ' HE2' ' A' ' 198' ' ' LYS . 9.5 mt-10 -70.08 -30.46 67.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.511 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -59.02 -41.89 88.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.716 0.294 . . . . 0.0 110.498 176.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.596 ' CZ ' ' HB ' ' A' ' 181' ' ' VAL . 69.1 m-85 -86.15 -7.16 58.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.834 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.489 ' HE2' ' HA ' ' A' ' 195' ' ' GLU . 40.8 mtmt -69.27 -32.53 71.76 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 170.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.409 ' O ' ' HD3' ' A' ' 201' ' ' PRO . 1.9 tppp? -92.28 -36.2 13.34 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.856 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -111.57 96.28 31.42 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.229 -178.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 199' ' ' LYS . 25.3 Cg_exo -62.34 126.96 19.68 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.648 2.232 . . . . 0.0 112.001 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . 0.662 ' HB2' HG23 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -89.1 118.11 28.58 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.07 0.462 . . . . 0.0 110.356 179.125 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.577 HG22 ' HB ' ' A' ' 209' ' ' VAL . 51.7 t -96.6 129.89 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.72 -175.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.613 ' HB2' ' O ' ' A' ' 208' ' ' THR . 2.4 mm-40 -78.63 159.98 27.79 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.668 0.747 . . . . 0.0 112.83 168.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.568 ' HB ' HG21 ' B' ' 4' ' ' VAL . 4.1 t -72.94 -10.96 60.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.024 177.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 206' ' ' LEU . 5.3 mp -88.88 -2.28 58.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.968 177.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 96.98 -26.65 21.7 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.212 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.613 ' O ' ' HB2' ' A' ' 204' ' ' GLU . 99.0 m -60.44 111.23 1.49 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.999 0.428 . . . . 0.0 110.207 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.577 ' HB ' HG22 ' A' ' 203' ' ' VAL . 0.8 OUTLIER -112.08 127.66 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-O 121.57 0.7 . . . . 0.0 110.287 175.146 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.72 HD11 HG21 ' A' ' 168' ' ' THR . 0.4 OUTLIER -82.55 111.03 18.17 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.783 -170.553 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -96.15 91.23 5.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.412 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.492 HD22 ' HB2' ' A' ' 197' ' ' TYR . 7.1 mp -74.81 109.83 8.6 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.983 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -114.58 -57.12 2.31 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.63 -0.428 . . . . 0.0 112.154 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.528 ' O ' ' HA ' ' A' ' 134' ' ' SER . 4.6 pm0 -133.16 142.83 45.88 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 121.099 0.476 . . . . 0.0 111.196 -176.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.477 ' HB3' ' HB3' ' A' ' 112' ' ' TRP . 74.5 Cg_endo -74.12 135.67 21.22 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.923 2.415 . . . . 0.0 112.479 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.533 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.4 OUTLIER -71.09 114.37 9.08 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.056 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -52.18 131.57 32.5 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 123.621 0.576 . . . . 0.0 110.863 -178.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 111' ' ' ARG . 18.1 p -73.49 107.9 6.04 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.064 0.459 . . . . 0.0 110.918 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 6.1 t -93.17 105.35 17.45 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 30.2 mtt180 . . . . . 0 C--O 1.247 0.949 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.17 -171.885 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' -4' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 . . . . . 0 N--CA 1.478 0.96 0 CA-C-O 120.957 0.408 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' -3' ' ' GLN . . . . . 0.414 ' HB3' ' HE2' ' A' ' 120' ' ' LYS . 14.0 pt20 -133.56 138.0 45.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.775 -175.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' -2' ' ' THR . . . . . 0.551 ' HA ' ' CD2' ' A' ' 169' ' ' HIS . 0.8 OUTLIER 43.56 -90.82 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 O-C-N 124.293 0.995 . . . . 0.0 113.611 176.339 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' -1' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 75.05 -41.73 0.47 Allowed 'General case' 0 N--CA 1.47 0.567 0 O-C-N 123.987 0.805 . . . . 0.0 109.957 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 0' ' ' PTR . . . . . 0.79 ' HA ' ' O ' ' A' ' 169' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.502 ' HA ' ' OE1' ' A' ' 204' ' ' GLU . . . -50.18 128.23 18.76 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 113.981 -1.463 . . . . 0.0 111.292 -175.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 13.3 m -69.35 -44.02 72.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.171 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.662 HG23 ' HB2' ' A' ' 202' ' ' MET . 15.5 mm 75.27 103.55 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 123.206 0.602 . . . . 0.0 111.398 175.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.568 HG21 ' HB ' ' A' ' 205' ' ' THR . 2.8 m -131.51 86.78 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.508 177.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' PHE . . . . . 0.485 ' CE2' ' HA3' ' A' ' 183' ' ' GLY . 67.5 m-85 -57.2 106.77 0.73 Allowed Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.502 177.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo . . . . . 0 C--O 1.246 0.906 0 C-N-CA 122.76 2.307 . . . . 0.0 112.067 -175.489 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.699 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.83 -166.76 0.36 Allowed 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.864 2.376 . . . . 0.0 112.166 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 97.1 mmm -81.39 78.14 8.19 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.19 0.519 . . . . 0.0 110.479 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -114.62 57.15 0.71 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.285 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.482 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 3.0 m-20 -64.99 127.23 92.59 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.859 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 4.1 Cg_exo -75.63 -5.44 16.5 Favored 'Trans proline' 0 CA--C 1.515 -0.437 0 C-N-CA 123.114 2.542 . . . . 0.0 110.46 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.614 ' HB ' ' CD1' ' A' ' 113' ' ' PHE . 40.6 p -92.49 6.79 45.82 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.079 -1.419 . . . . 0.0 111.121 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.7 t -75.31 52.7 0.62 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.521 0.676 . . . . 0.0 110.588 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.477 ' HG3' ' CZ2' ' A' ' 112' ' ' TRP . 65.3 mm-40 -130.92 169.6 15.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.292 -177.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.423 ' O ' HG23 ' A' ' 218' ' ' THR . 18.7 mmt180 -83.67 -11.61 57.0 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -170.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.518 ' HE3' HG22 ' A' ' 137' ' ' VAL . 1.5 p-90 -92.96 -12.04 31.77 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.054 177.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.614 ' CD1' ' HB ' ' A' ' 108' ' ' THR . 57.5 t80 -84.69 119.5 25.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.385 0.612 . . . . 0.0 110.843 174.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -111.94 117.03 31.61 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -65.11 -66.57 2.39 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.739 -0.664 . . . . 0.0 113.261 -174.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -100.23 104.99 16.52 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.288 0.566 . . . . 0.0 111.34 -175.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 17.4 mt -154.56 130.74 10.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.598 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 68.3 p -84.03 173.06 11.45 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 172.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.73 -49.84 63.82 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.65 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.0 mmtm -61.24 -45.64 93.69 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 123.942 0.436 . . . . 0.0 111.526 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -66.79 -47.22 72.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.677 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.488 ' HB3' ' NH1' ' A' ' 138' ' ' ARG . . . -63.85 -33.87 76.65 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.088 0.47 . . . . 0.0 110.771 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.537 ' HG3' ' HB ' ' A' ' 167' ' ' VAL . 9.1 tt0 -67.26 -46.43 73.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.426 176.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -60.76 -33.25 72.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.757 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.581 HD12 HD13 ' A' ' 216' ' ' LEU . 0.5 OUTLIER -55.69 -52.32 64.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.178 0.514 . . . . 0.0 110.154 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.571 ' CD2' HD12 ' A' ' 216' ' ' LEU . 42.5 mt -75.62 -47.29 27.15 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.5 m -64.18 -33.29 75.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.294 -172.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -96.99 -53.28 3.56 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -91.35 -31.97 15.86 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -171.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -86.95 -163.27 38.61 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.191 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.518 ' C ' ' HD3' ' A' ' 152' ' ' ARG . 0.5 OUTLIER -146.4 174.41 11.4 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 177.813 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -50.86 120.25 4.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.85 0.357 . . . . 0.0 110.937 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.462 ' HA3' ' HD3' ' A' ' 213' ' ' LYS . . . 98.39 -4.51 60.21 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.199 178.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.628 ' HA ' ' O ' ' A' ' 214' ' ' GLN . 66.9 m -72.84 138.51 46.38 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 176.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.448 ' CB ' HG12 ' A' ' 151' ' ' VAL . 49.4 p90 -136.63 149.12 47.82 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.986 0.422 . . . . 0.0 110.62 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.558 ' CD2' ' HB3' ' A' ' 150' ' ' SER . 1.2 pt? -149.99 136.66 19.21 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.655 HG21 HD13 ' A' ' 190' ' ' LEU . 16.2 m -99.5 133.96 40.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.488 ' NH1' ' HB3' ' A' ' 122' ' ' ALA . 10.7 ptt-85 -129.81 172.09 12.02 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -178.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -76.98 127.27 32.4 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.416 ' HB2' HG23 ' A' ' 148' ' ' VAL . 46.2 t -69.55 133.3 47.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.39 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -96.19 -26.03 15.6 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.552 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 41.6 m -81.0 -25.67 37.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.924 0.393 . . . . 0.0 109.94 174.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -126.04 87.23 56.45 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.983 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.0 124.18 15.11 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.342 2.028 . . . . 0.0 111.255 176.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.529 ' O ' ' HB3' ' A' ' 174' ' ' CYS . . . 101.77 -10.44 57.38 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.079 -177.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -114.36 171.9 7.34 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.405 ' CE1' ' HE2' ' A' ' 179' ' ' TYR . 96.6 m-85 -125.8 163.99 21.66 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.832 0.349 . . . . 0.0 110.347 -177.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 4.7 t -125.37 127.27 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.923 -177.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.893 ' HB3' HG22 ' A' ' 170' ' ' VAL . 1.2 tp -91.46 109.36 20.65 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.558 ' HB3' ' CD2' ' A' ' 136' ' ' LEU . 40.3 t -101.89 124.88 48.27 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.541 HG21 ' HB3' ' A' ' 210' ' ' LEU . 34.8 m -128.28 142.95 42.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.829 -173.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.518 ' HD3' ' C ' ' A' ' 131' ' ' LYS . 73.2 ttt180 -90.04 103.14 15.84 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.369 0.604 . . . . 0.0 109.688 176.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.504 HG21 HD12 ' A' ' 210' ' ' LEU . 1.5 p -107.42 148.62 28.89 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.799 -1.092 . . . . 0.0 110.162 -177.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 93.57 143.16 12.8 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 119.67 -1.252 . . . . 0.0 111.21 -175.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -104.78 111.13 23.75 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.586 0.708 . . . . 0.0 110.828 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -68.79 -39.2 80.29 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 122.324 1.059 . . . . 0.0 108.878 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -84.36 93.1 8.18 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.069 176.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 143.1 -5.81 1.96 Allowed Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.496 -171.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.485 ' HA ' ' HB3' ' A' ' 162' ' ' ASP . 46.4 mt-10 72.43 26.61 2.56 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.196 0.599 . . . . 0.0 111.927 173.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 12.5 m -90.59 76.16 6.57 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 8.0 t30 61.8 68.4 0.7 Allowed 'General case' 0 C--O 1.231 0.105 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -170.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.485 ' HB3' ' HA ' ' A' ' 159' ' ' GLU . 4.8 p-10 -86.33 169.7 12.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.278 -174.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 94.32 -50.73 2.13 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -131.04 121.81 25.67 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 172.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 41.6 m -81.66 149.93 28.3 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.858 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -82.41 138.15 34.51 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.262 0.554 . . . . 0.0 111.893 -177.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.537 ' HB ' ' HG3' ' A' ' 123' ' ' GLU . 69.8 t -120.84 113.76 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.768 169.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.771 HG21 HD11 ' A' ' 210' ' ' LEU . 21.6 m -90.2 140.65 29.47 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.462 172.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.8 ' O ' ' HA ' ' B' ' 0' ' ' PTR . 19.4 m-70 -118.47 116.4 26.6 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.893 HG22 ' HB3' ' A' ' 149' ' ' LEU . 0.8 OUTLIER -98.53 138.95 21.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -177.143 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 38.8 tpp -84.91 116.51 23.38 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.995 0.426 . . . . 0.0 110.792 -175.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.567 HD13 HD21 ' A' ' 190' ' ' LEU . 24.5 mt -97.4 108.12 21.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.184 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.682 ' O ' ' HA ' ' A' ' 179' ' ' TYR . 77.3 mtm180 -65.56 123.24 19.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.487 176.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.529 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 48.3 t -116.82 91.6 3.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.459 0.647 . . . . 0.0 109.562 174.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -114.51 114.53 25.91 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.235 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 57.16 45.12 21.19 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.661 0.601 . . . . 0.0 111.116 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 95.7 mt 63.79 22.57 13.11 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.943 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -113.43 132.24 55.71 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 172.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.682 ' HA ' ' O ' ' A' ' 173' ' ' ARG . 71.1 m-85 -110.16 137.57 47.73 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.206 -173.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -152.91 127.35 9.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.121 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.44 HG23 HD11 ' A' ' 193' ' ' LEU . 3.1 t -77.58 -0.64 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-O 121.707 0.765 . . . . 0.0 111.567 -176.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 124.99 -19.44 6.89 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.067 177.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.556 ' HA3' ' CE2' ' B' ' 5' ' ' PHE . . . -137.56 159.6 24.92 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 121.024 -0.607 . . . . 0.0 112.032 177.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 89.32 -135.31 12.9 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.055 175.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -116.06 145.03 43.33 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.56 0.219 . . . . 0.0 110.831 -176.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -75.69 128.79 35.96 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 175.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -105.92 144.04 33.22 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.808 0.337 . . . . 0.0 110.725 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -76.01 -9.81 58.91 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.752 -174.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 35.4 p -140.74 143.9 35.24 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.655 HD13 HG21 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -67.35 -23.08 65.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.914 179.674 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.49 ' HA ' ' CZ2' ' A' ' 112' ' ' TRP . 13.9 m -61.1 -49.01 79.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.355 175.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -65.63 -30.88 71.65 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.833 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.456 ' HB3' HD23 ' A' ' 190' ' ' LEU . 3.3 tm? -64.32 -54.78 27.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.404 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 27.8 m -70.19 -42.21 79.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.558 -174.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -61.42 -39.11 89.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.91 0.386 . . . . 0.0 111.051 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -59.99 -42.27 93.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.823 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.501 ' HB2' HD22 ' A' ' 212' ' ' LEU . 36.6 m-85 -85.24 -13.59 49.37 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.124 0.488 . . . . 0.0 110.951 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -74.2 -27.3 60.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.446 0.641 . . . . 0.0 109.351 176.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -88.79 -36.5 16.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.477 175.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -119.92 105.33 42.98 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.425 -176.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.28 128.96 32.68 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.884 2.389 . . . . 0.0 112.474 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . 0.784 ' SD ' HD23 ' A' ' 210' ' ' LEU . 7.4 ptp -89.6 122.81 33.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.261 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.595 HG22 ' HB ' ' A' ' 209' ' ' VAL . 44.7 t -101.53 139.8 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 120.703 0.287 . . . . 0.0 111.59 -176.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.497 ' O ' HG12 ' A' ' 203' ' ' VAL . 25.6 mt-10 -89.22 162.35 15.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.37 . . . . 0.0 110.245 170.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.429 ' HB ' HG11 ' B' ' 4' ' ' VAL . 14.9 t -74.08 -11.91 60.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.324 0.583 . . . . 0.0 110.024 177.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.434 HD12 ' N ' ' A' ' 206' ' ' LEU . 5.0 mp -83.98 -8.31 59.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.018 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 101.04 -18.89 53.93 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.007 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 58.9 m -65.65 111.76 3.33 Favored 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 175.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.595 ' HB ' HG22 ' A' ' 203' ' ' VAL . 0.9 OUTLIER -112.22 126.99 69.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.6 0.714 . . . . 0.0 110.348 173.68 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.784 HD23 ' SD ' ' A' ' 202' ' ' MET . 0.4 OUTLIER -82.03 110.06 16.93 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.336 -172.188 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -85.17 89.51 7.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.584 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.501 HD22 ' HB2' ' A' ' 197' ' ' TYR . 8.2 mp -77.87 99.19 5.88 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 175.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.462 ' HD3' ' HA3' ' A' ' 133' ' ' GLY . 28.6 mtpp -109.61 -48.84 3.17 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.141 -173.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.628 ' O ' ' HA ' ' A' ' 134' ' ' SER . 0.4 OUTLIER -147.45 147.19 27.33 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 121.081 0.467 . . . . 0.0 111.007 178.006 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.458 ' CB ' ' HB3' ' A' ' 112' ' ' TRP . 93.0 Cg_endo -78.39 147.27 22.69 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.958 2.439 . . . . 0.0 113.222 -175.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.581 HD13 HD12 ' A' ' 125' ' ' LEU . 0.3 OUTLIER -83.86 109.88 17.92 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -56.55 145.98 26.42 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.43 0.456 . . . . 0.0 111.29 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 111' ' ' ARG . 4.8 p -82.13 136.02 35.22 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.58 -177.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.8 t -114.15 118.08 33.01 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.288 173.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 . . . . . 0 C--O 1.246 0.91 0 CA-C-O 118.411 -0.804 . . . . 0.0 110.484 -176.377 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' -4' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 120.949 0.404 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -92.3 158.79 15.92 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' -2' ' ' THR . . . . . 0.688 ' HA ' ' CD2' ' A' ' 169' ' ' HIS . 4.4 m 55.66 -110.68 0.57 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 118.932 -0.556 . . . . 0.0 109.715 -175.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' -1' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 76.84 -38.19 0.3 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.006 0.522 . . . . 0.0 111.225 169.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 0' ' ' PTR . . . . . 0.8 ' HA ' ' O ' ' A' ' 169' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.588 ' HB2' ' CG2' ' A' ' 168' ' ' THR . . . -56.63 141.33 43.86 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 113.929 -1.487 . . . . 0.0 112.384 -171.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 46.2 m -76.02 -49.44 17.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.176 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.576 HD12 ' SD ' ' A' ' 202' ' ' MET . 8.0 mm 73.32 94.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 123.244 0.617 . . . . 0.0 110.732 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.605 ' O ' ' HD3' ' B' ' 6' ' ' PRO . 13.8 m -103.64 113.46 40.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.624 0.726 . . . . 0.0 109.991 176.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' PHE . . . . . 0.556 ' CE2' ' HA3' ' A' ' 183' ' ' GLY . 89.4 m-85 -85.87 100.36 1.3 Allowed Pre-proline 0 C--N 1.308 -1.227 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.8 171.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.605 ' HD3' ' O ' ' B' ' 4' ' ' VAL . 6.9 Cg_endo . . . . . 0 C--O 1.251 1.131 0 C-N-CA 122.929 2.419 . . . . 0.0 111.516 -178.591 . . . . . . . . 1 1 . 1 stop_ save_